
<html lang="en"     class="pb-page"  data-request-id="3404d4a7-4296-4f4c-a955-06966836c93d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-21;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00876"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution" /></meta><meta name="dc.Creator" content="Ross W.  Cheloha" /></meta><meta name="dc.Creator" content="Bingming  Chen" /></meta><meta name="dc.Creator" content="Niyanta N.  Kumar" /></meta><meta name="dc.Creator" content="Tomoyuki  Watanabe" /></meta><meta name="dc.Creator" content="Robert G.  Thorne" /></meta><meta name="dc.Creator" content="Lingjun  Li" /></meta><meta name="dc.Creator" content="Thomas J.  Gardella" /></meta><meta name="dc.Creator" content="Samuel H.  Gellman" /></meta><meta name="dc.Description" content="The parathyroid hormone receptor 1 (PTHR1) is a member of the B-family of GPCRs; these receptors are activated by long polypeptide hormones and constitute targets of drug development efforts. Parat..." /></meta><meta name="Description" content="The parathyroid hormone receptor 1 (PTHR1) is a member of the B-family of GPCRs; these receptors are activated by long polypeptide hormones and constitute targets of drug development efforts. Parat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 24, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00876" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00876" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00876" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00876" /></link>
        
    
    

<title>Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00876" /></meta><meta property="og:title" content="Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0008.jpeg" /></meta><meta property="og:description" content="The parathyroid hormone receptor 1 (PTHR1) is a member of the B-family of GPCRs; these receptors are activated by long polypeptide hormones and constitute targets of drug development efforts. Parathyroid hormone (PTH, 84 residues) and PTH-related protein (PTHrP, 141 residues) are natural agonists of PTHR1, and an N-terminal fragment of PTH, PTH(1–34), is used clinically to treat osteoporosis. Conventional peptides in the 20–40-mer length range are rapidly degraded by proteases, which may limit their biomedical utility. We have used the PTHR1–ligand system to explore the impact of broadly distributed replacement of α-amino acid residues with β-amino acid residues on susceptibility to proteolysis and agonist activity. This effort led us to identify new PTHR1 agonists that contain α → β replacements throughout their sequences, manifest potent agonist activity in cellular assays, and display remarkable resistance to proteolysis, in cases remaining active after extended exposure to simulated gastric fluid. The strategy we have employed suggests a path toward identifying protease-resistant agonists of other B-family GPCRs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00876"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00876">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00876&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00876&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00876&amp;href=/doi/10.1021/acs.jmedchem.7b00876" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8816-8833</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00841" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00924" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ross+W.++Cheloha">Ross W. Cheloha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∇</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-9871-8333" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bingming++Chen">Bingming Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niyanta+N.++Kumar">Niyanta N. Kumar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tomoyuki++Watanabe">Tomoyuki Watanabe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+G.++Thorne">Robert G. Thorne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lingjun++Li">Lingjun Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0056-3869" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+J.++Gardella">Thomas J. Gardella</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samuel+H.++Gellman">Samuel H. Gellman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, University of Wisconsin—Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">School of Pharmacy, University of Wisconsin—Madison, 777 Highland Avenue, Madison, Wisconsin 53705, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Clinical Neuroengineering Training Program, University of Wisconsin—Madison Biomedical Engineering, Engineering Centers Building, Room 2120, 1550 Engineering Drive, Madison Wisconsin 53706, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Neuroscience Training Program & Center for Neuroscience, Wisconsin Institutes for Medical Research II, Rooms 9531 and 9533, 1111 Highland Avenue, Madison, Wisconsin 53705, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Cellular and Molecular Pathology Graduate Training Program, UW Department of Pathology and Laboratory Medicine, University of Wisconsin—Madison, 1685 Highland Avenue, Madison, Wisconsin 53705, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, United States</span></div><div class="corresp-info"><strong>*</strong>T.J.G.: e-mail, <a href="/cdn-cgi/l/email-protection#2641475442434a4a47664e434a4f5e084b414e084e47545047544208434253"><span class="__cf_email__" data-cfemail="1671776472737a7a77567e737a7f6e387b717e387e77646077647238737263">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>S.H.G.: e-mail, <a href="/cdn-cgi/l/email-protection#2c4b494040414d426c4f444941025b455f4f02494859"><span class="__cf_email__" data-cfemail="7017151c1c1d111e301318151d5e071903135e151405">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00876&amp;href=/doi/10.1021%2Facs.jmedchem.7b00876" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8816–8833</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 24, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 June 2017</li><li><span class="item_label"><b>Published</b> online</span>24 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 November 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00876" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00876</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8816%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRoss%2BW.%2BCheloha%252C%2BBingming%2BChen%252C%2BNiyanta%2BN.%2BKumar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D21%26contentID%3Dacs.jmedchem.7b00876%26title%3DDevelopment%2Bof%2BPotent%252C%2BProtease-Resistant%2BAgonists%2Bof%2Bthe%2BParathyroid%2BHormone%2BReceptor%2Bwith%2BBroad%2B%25CE%25B2%2BResidue%2BDistribution%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8833%26publicationDate%3DNovember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00876"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1164</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00876" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ross&quot;,&quot;last_name&quot;:&quot;W. Cheloha&quot;},{&quot;first_name&quot;:&quot;Bingming&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Niyanta&quot;,&quot;last_name&quot;:&quot;N. Kumar&quot;},{&quot;first_name&quot;:&quot;Tomoyuki&quot;,&quot;last_name&quot;:&quot;Watanabe&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;G. Thorne&quot;},{&quot;first_name&quot;:&quot;Lingjun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;J. Gardella&quot;},{&quot;first_name&quot;:&quot;Samuel&quot;,&quot;last_name&quot;:&quot;H. Gellman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8816-8833&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00876&quot;},&quot;abstract&quot;:&quot;The parathyroid hormone receptor 1 (PTHR1) is a member of the B-family of GPCRs; these receptors are activated by long polypeptide hormones and constitute targets of drug development efforts. Parathyroid hormone (PTH, 84 residues) and PTH-related protein (PTHrP, 141 residues) are natural agonists of PTHR1, and an N-terminal fragment of PTH, PTH(1–34), is used clinically to treat osteoporosis. Conventional peptides in the 20–40-mer length range are rapidly degraded by proteases, which may limit their biomedical utility. We have used the PTHR1–ligand system to explore the impact of broadly distributed replacement of α-amino acid residues with β-amino acid residues on susceptibility to proteolysis and agonist activity. This effort led us to identify new PTHR1 agonists that contain α → β replacements throughout their sequences, manifest potent agonist activity in cellular assays, and display remarkable resistance to proteolysis, in cases remaining active after extended exposure to simulated gastric fluid. The str&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00876&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00876" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00876&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00876" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00876&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00876" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00876&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00876&amp;href=/doi/10.1021/acs.jmedchem.7b00876" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00876" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00876" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00876%26sid%3Dliteratum%253Aachs%26pmid%3D29064243%26genre%3Darticle%26aulast%3DCheloha%26date%3D2017%26atitle%3DDevelopment%2Bof%2BPotent%252C%2BProtease-Resistant%2BAgonists%2Bof%2Bthe%2BParathyroid%2BHormone%2BReceptor%2Bwith%2BBroad%2B%25CE%25B2%2BResidue%2BDistribution%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D21%26spage%3D8816%26epage%3D8833%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/jmcmar.2017.60.issue-21/20171109/jmcmar.2017.60.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The parathyroid hormone receptor 1 (PTHR1) is a member of the B-family of GPCRs; these receptors are activated by long polypeptide hormones and constitute targets of drug development efforts. Parathyroid hormone (PTH, 84 residues) and PTH-related protein (PTHrP, 141 residues) are natural agonists of PTHR1, and an N-terminal fragment of PTH, PTH(1–34), is used clinically to treat osteoporosis. Conventional peptides in the 20–40-mer length range are rapidly degraded by proteases, which may limit their biomedical utility. We have used the PTHR1–ligand system to explore the impact of broadly distributed replacement of α-amino acid residues with β-amino acid residues on susceptibility to proteolysis and agonist activity. This effort led us to identify new PTHR1 agonists that contain α → β replacements throughout their sequences, manifest potent agonist activity in cellular assays, and display remarkable resistance to proteolysis, in cases remaining active after extended exposure to simulated gastric fluid. The strategy we have employed suggests a path toward identifying protease-resistant agonists of other B-family GPCRs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73838" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73838" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Individual cells in multicellular organisms must receive and respond to a wide array of molecular messages from other cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Much of this information is conveyed by polypeptides, such as growth factors, cytokines, or peptide hormones. Aberrant polypeptide-mediated signaling is associated with many human diseases, and therapeutic benefits can be achieved through use of synthetic polypeptides to block excessive signaling (e.g., engineered antibodies or receptor fragments) or to augment insufficient signaling (e.g., peptide hormone analogues).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although drug molecules based on the poly-α-amino acid backbone frequently display high potency and selectivity, this molecular class manifests intrinsic limitations. Poly-α-peptides that do not adopt a stable tertiary structure, such as peptide hormones and their analogues, tend to be degraded rapidly by proteases.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">Concerns about poly-α-peptides as drugs have led to exploration of oligomers with unnatural backbones as a source of molecules that can strongly and specifically engage natural target proteins but resist biodegradation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This pursuit offers many opportunities for chemical innovation,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> but progress to date has been limited, particularly in terms of establishing efficacy in vivo<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14">(8-14)</a>and characterizing immune responses.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Our own efforts have focused on peptidic oligomers that contain both α- and β-amino acid residues (α/β-peptides).<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a> We recently demonstrated that α/β analogues of two hormones, glucagon-like peptide-1 (GLP-1) and parathyroid hormone (PTH), can serve as potent agonists of the cognate receptors, the GLP-1R and the PTHR1, respectively, in cell-based assays,<a onclick="showRef(event, 'ref12 ref13 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref22">(12, 13, 22)</a> and these compounds are active in mice.<a onclick="showRef(event, 'ref12 ref13 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref22">(12, 13, 22)</a> The sites of α → β replacement in these bioactive analogues were limited to the C-terminal portions of PTH(1–34) or GLP-1(7–37), regions that are known to be α-helical in the receptor-bound state.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Related studies have been reported with α/β analogues of vasoactive intestinal peptide, a hormone for which no structural information is available.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Although robust strategies have been developed for introducing sets of α → β replacements that maintain the structure and function of α-helical segments,<a onclick="showRef(event, 'ref6 ref21'); return false;" href="javascript:void(0);" class="ref ref6 ref21">(6, 21)</a> there are no guidelines for implementing α → β replacements in nonhelical segments of bioactive polypeptides. This limitation is significant because the receptor-bound conformation is unknown for the N-terminal portion of PTH, and it is possible that this N-terminal segment is partially or entirely nonhelical. Moreover, the N-terminal segment of PTH presumably makes intimate contacts within the core of the transmembrane domain of PTHR1 in order to activate the receptor,<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> and such contacts must be maintained after backbone modification if agonist potency is to be retained. Thus, it is not clear that sufficient β residue density can be achieved in the N-terminal segment of a PTH analogue to provide meaningful protection from proteolysis without loss of agonist activity. Introduction of just one or two α → β replacements in the central portion of a PTHR1 agonist peptide can substantially diminish receptor activation potency,<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> which shows that proper selection of substitution sites in peptide hormone mimics is crucial.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In a study of 19-mer peptides that adopt a specific but irregular conformation and bind to vascular endothelial growth factor (VEGF), we found that it was not possible to introduce α → β replacements without diminution of affinity for VEGF.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Therefore, whether α/β segments can serve as functional mimics of nonhelical or conformationally uncharacterized α-peptide segments remains an open question. Here we address this question in the context of the N-terminal segment of PTH(1–34) and related PTHR1 agonist peptides.</div><div class="NLM_p">This report discloses new α/β-peptide analogues of PTH(1–34), which is the active ingredient in the osteoporosis drug teriparatide.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Our previous examination<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> of analogues containing only C-terminal α → β replacements culminated in evaluation of compounds <b>B5</b> (renamed <b>44</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 17</a> for structure) and <b>D6</b> (renamed <b>21</b> below) in vivo. Both of these α/β-peptides were potent agonists of the PTHR1 as judged by cell-based assays; each matched PTH(1–34)-NH<sub>2</sub> (<b>1</b>) in terms of promoting production of the second messenger cyclic adenosine monophosphate (cAMP).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Upon subcutaneous injection of <b>44</b> or <b>21</b>, mice displayed a “calcemic effect” that is characteristic of <b>1</b> itself; i.e., both α/β-peptides caused a short-term rise in Ca<sup>2+</sup> in the bloodstream.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This outcome provides an easily and rapidly detected indication that the PTHR1 has been engaged in the animal; calcium response assays can thus be helpful in guiding design of subsequent studies aimed at evaluating potential therapeutic utility over longer-term treatment.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> PTHR1 agonists are of interest clinically as they can promote bone growth with continued daily administration.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> Determining whether new analogues of PTHR1 agonist peptides can induce the acute calcemic response in mice serves as a readily accessible initial test of in vivo activity and is well-suited for assessing several candidate compounds in parallel for the prospect of subsequent longer-term evaluation.</div><div class="NLM_p">Our previous studies revealed that α/β-peptide <b>21</b> displayed a calcemic effect of prolonged duration relative to that induced by <b>1</b>, but the calcemic effect induced by <b>44</b> was more transient than that of <b>1</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, both α/β-peptides persisted longer in the mouse bloodstream than did <b>1</b>, with <b>21</b> persisting longer than <b>44</b>. The fact that analogues of <b>1</b> containing five or six α → β replacements retained high agonist activity was significant, given that earlier reports had shown that a single α → β replacement could substantially disrupt PTHR1 agonist activity.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> The lack of correlation between persistence in the bloodstream (<b>21</b> > <b>44</b> > <b>1</b>) and duration of calcemic response (<b>21</b> > <b>1</b> > <b>44</b>) observed for this pair of analogues relative to <b>1</b> shows that measuring the lifetime of the analogue in the bloodstream does not provide a complete assessment of that analogue’s in vivo pharmacokinetics.</div><div class="NLM_p">The studies described here were motivated by three related questions. First, is it possible to place β residues near the N-terminus of an analogue of <b>1</b> while retaining agonist activity? This question is important because long stretches of α residues, such as the 13 N-terminal residues of <b>21</b>, are highly susceptible to proteolysis. Our previous exploration<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> of analogues of <b>1</b> was limited to compounds containing α → β replacements in the portion known to be α-helical in the receptor-bound state, as demonstrated by the cocrystal structure of PTH(15–34) bound to the extracellular domain of the PTHR1.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The design of these initial analogues of <b>1</b> was based on our previous studies of α-helix mimicry with α/β-peptides.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In contrast to the structural information available describing the C-terminal portion of <b>1</b> bound to the PTHR1, the receptor-bound conformation of the N-terminal portion of PTH is unknown.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This segment engages the core of the membrane-embedded heptahelical domain of the PTHR1 to initiate signal transduction.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> No high resolution structural information is available for the transmembrane domain of PTHR1; therefore, we lack atomic-level insights regarding interactions between PTHR1 and the N-terminus of PTH. This lack of structural information prevents rational design of PTHR1 agonist peptides containing α → β replacements near the N-terminus and limits our ability to engage in mechanistic analysis of the results of such replacements. Whether α → β replacements in the N-terminal region of PTHR1 agonists would be tolerated at all was an open question as we began this work, because previous studies showed that incorporation of non-natural α-residues into the N-terminal portion of PTHR1 agonists frequently causes substantial losses in biological activity.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a></div><div class="NLM_p">Our second motivating question: is it possible to generate potent PTHR1 agonists that contain ring-constrained β residues rather than the flexible β<sup>3</sup> residues employed in α/β-peptides such as <b>44</b> and <b>21</b>? This question arises because prior α-helix mimicry efforts have shown that β residues with a five-membered ring constraint, such as ACPC or APC (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), tend to enhance the stability of an α-helix-like secondary structure relative to β<sup>3</sup> residues (i.e., β residues bearing a side chain next to the nitrogen).<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> In addition, these cyclic β residues enhance resistance to proteolysis relative to β<sup>3</sup> residues.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> We expected that cyclic β residues would be tolerated in the C-terminal portion of analogues of <b>1</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> because this region must adopt an α-helix-like conformation,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> but it was necessary to test this prediction. Since the receptor-bound conformation of the N-terminal portion of <b>1</b> is unknown, the effect on agonist activity of placing cyclic β residues in this region could not be predicted.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Sequences of PTH(1–34) analogues in the N-terminal β-scan library and cAMP stimulating potency. Each peptide contains the native sequence comprised of α-residues for positions 10−34 (see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> for full sequence). All peptides are C-terminal amides. In contrast, teriparatide is a C-terminal acid. The single letter code is used to indicate conventional proteinogenic amino acids. Colored dots indicate sites at which α-to-β replacements have been introduced. β<sup>3</sup>-Residues display an identical side chain to that displayed by the corresponding α-residue. cAMP inducing potencies (EC<sub>50</sub>) are shown for analogues with cells expressing hPTHR1. Average EC<sub>50</sub> values are from data obtained in three independent experiments for all <b>2</b>–<b>18</b> or six independent experiments for <b>1</b>. Analogues with “no activity” have activity that is too weak to be characterized using this method. Full dose–response curves are found in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The third motivating question: Is it possible to identify highly active analogues of <b>1</b> that contain β residues throughout the entire sequence? This question is important because of interest in oral delivery of peptide hormone analogues.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44-46)</a> Patients generally prefer orally delivered drug regimens over parenteral administration, and oral delivery may therefore enhance dosing compliance.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> However, poly-α-peptides face two large barriers to oral delivery. First, these molecules must survive the harsh proteolytic environments of the stomach and small intestine, which have been evolutionarily optimized for degradation of poly-α-peptides into amino acids and short peptides that can be absorbed as nutrients.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Second, these molecules must be able to move from the lumen of the intestine into the bloodstream.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Many compounds with MW < 500 and appropriate lipophilicity can move passively from the gut into the blood, but these routes are not generally available to long peptides and proteins.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Previous in vitro studies have shown that α/β-peptides containing at least 25% β residues distributed across the sequence can display substantial resistance to cleavage by aggressive proteases.<a onclick="showRef(event, 'ref17 ref19 ref40'); return false;" href="javascript:void(0);" class="ref ref17 ref19 ref40">(17, 19, 40)</a> We therefore wondered whether it would be possible to achieve the necessary β residue density in a potent PTHR1 agonist to slow degradation under conditions encountered in the digestive tract, since such an α/β-peptide could circumvent the first barrier to oral polypeptide delivery and therefore provide a basis for future efforts to circumvent the second.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> α → β Scan of the N-Terminal Region of <b>1</b></h3><div class="NLM_p">In order to determine whether the N-terminal portion of <b>1</b> can tolerate α → β<sup>3</sup> replacements, we synthesized analogues of this peptide in which each of the first eight residues was individually replaced by the homologous β<sup>3</sup> residue, i.e., by the β<sup>3</sup> residue bearing the same side chain as the original α residue (<b>2</b>–<b>9</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). As with other α/β<sup>3</sup>-peptides described previously, including <b>44</b> and <b>21</b>, α/β<sup>3</sup>-peptides <b>2</b>–<b>9</b> were straightforward to prepare via conventional solid-phase methods; the necessary Fmoc-protected β<sup>3</sup>-amino acid building blocks are commercially available. Peptides <b>1</b>–<b>9</b> were evaluated as agonists of the PTHR1 expressed in HEK293 cells (GP2.3 cell line),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> which have been stably transfected to express this receptor and a modified luciferase that is activated by the second messenger cAMP.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Thus, agonist efficacy can be assessed in terms of the degree to which a peptide induces intracellular production of cAMP via luminescence measurements.</div><div class="NLM_p">The data (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 1</a>) indicate that α → β<sup>3</sup> replacement is well tolerated at position 1 or 2 because analogues <b>2</b> and <b>3</b> display cAMP-inducing potencies comparable to that of <b>1</b>. Substitutions at the remaining six N-terminal positions, however, cause a 10- to 200-fold loss of efficacy (increased EC<sub>50</sub> values). The sensitivity of <b>1</b> to single-site modifications at residues 3–8 is noteworthy because we previously observed that incorporation of five or six α → β<sup>3</sup> modifications in the C-terminal portion (as in <b>44</b> or <b>21</b>) had little or no effect on efficacy as measured by cAMP production.</div><div class="NLM_p">A second set of analogues (<b>10</b>–<b>18</b>) was prepared in which individual N-terminal residues were replaced by a β residue containing a five-membered ring constraint, ACPC or APC (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The nonpolar cyclopentane-based ACPC residue<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> was used at the first eight positions, but APC<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> was used to replace His-9. These choices were dictated by the fact that APC bears a basic side chain nitrogen, which might mirror the basic imidazole ring in the His-9 side chain, while none of the preceding eight residues has a basic side chain. We did not prepare the analogue of <b>1</b> containing a β<sup>3</sup> substitution at position 9 because Fmoc-protected β<sup>3</sup>-hHis is not commercially available, and the reported synthetic route to this molecule is cumbersome.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p">Extensive structural precedent has established that β residues with a five-membered ring constraint and <i>trans</i> disposition of the amino and carboxyl groups support the adoption of an α-helix-like conformation by α/β-peptides.<a onclick="showRef(event, 'ref17 ref21 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref17 ref21 ref40 ref41">(17, 21, 40, 41)</a> ACPC and APC stabilize helical conformations relative to the more flexible β<sup>3</sup> residues. Since the conformation of the N-terminal portion of PTH bound to PTHR1 is unknown, one could not predict whether the cyclic β residues would be tolerated near the N-terminus. It is therefore noteworthy that several of the analogues containing a cyclic β residue matched <b>1</b> in terms of potency and efficacy for promoting cAMP production. Particularly striking were the results of ACPC substitution at position 5, 6, or 7 because in each case the resulting analogue was very similar in agonist activity to <b>1</b>, while the analogous β<sup>3</sup> substitutions caused a 12- to 160-fold decline in efficacy. These trends were mirrored in analogous experiments using a cell line (GD5)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> that stably expresses a truncated version of the PTHR1 that lacks the extracellular domain (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 2</a>). In these experiments, the introduction of ACPC at positions 1, 5, or 7 resulted in relatively minor losses in biological activity, whereas nearly all other β-substitutions caused moderate to complete losses in bioactivity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 2</a>). This finding is consistent with previous observations showing that the biological activities of PTHR1 agonists are more sensitive to N-terminal modifications in assays using cells that express a truncated PTHR1 lacking the extracellular domain in comparison to assays using the full-length PTHR1.<a onclick="showRef(event, 'ref38 ref56'); return false;" href="javascript:void(0);" class="ref ref38 ref56">(38, 56)</a></div><div class="NLM_p">On the basis of the results of single cyclic β substitutions, we examined two analogues of <b>1</b> with multiple cyclic β residues in the N-terminal region (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 3</a>). Placing ACPC residues at positions 1 and 7 generated an α/β-peptide (<b>19</b>) with efficacy indistinguishable from that of the analogues containing only one of the substitutions or from <b>1</b> itself. However, introduction of a third ACPC residue, at position 5 (<b>20</b>), caused a substantial decline in agonist activity.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sequences of a peptides containing α-to-β replacements in the N-terminal segment, C-terminal segment, or both. Differences between the <b>1</b> and M-PTH(1–34) (<b>27</b>) scaffolds are highlighted in bold in the sequence of <b>27</b>. The single letter code is used to indicate conventional proteinogenic amino acids. Colored dots indicate sites at which α-to-β replacements have been introduced. β<sup>3</sup>-Residues display an identical side chain to that displayed by the corresponding α-residue. Note that selected analogues contain an α-amino isobutyric acid residue (Aib) at position 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of the cAMP Inducing Properties of α/β-Peptide Analogues of PTH(1-34)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">hPTHR1 EC<sub>50</sub>, nM (mean ± SEM)</th><th class="colsep0 rowsep0" align="center">(derivative EC<sub>50</sub>)/(<b>1</b> EC<sub>50</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.08 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.14 ± 0.03</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">3.0 ± 0.56</td><td class="colsep0 rowsep0" align="left">36.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">0.17 ± 0.05</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.26 ± 0.05</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">1.84 ± 0.11</td><td class="colsep0 rowsep0" align="left">22.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.71 ± 0.04</td><td class="colsep0 rowsep0" align="left">8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">167 ± 6.3</td><td class="colsep0 rowsep0" align="left">2050</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">19 ± 1.3</td><td class="colsep0 rowsep0" align="left">234</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">0.34 ± 0.04</td><td class="colsep0 rowsep0" align="left">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">0.52 ± 0.19</td><td class="colsep0 rowsep0" align="left">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">0.40 ± 0.11</td><td class="colsep0 rowsep0" align="left">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">0.44 ± 0.10</td><td class="colsep0 rowsep0" align="left">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">0.51 ± 0.15</td><td class="colsep0 rowsep0" align="left">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">0.83 ± 0.07</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">1.8 ± 0.23</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">0.79 ± 0.25</td><td class="colsep0 rowsep0" align="left">9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">0.78 ± 0.12</td><td class="colsep0 rowsep0" align="left">9.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Tabulation of receptor activation for the derivatives in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> with hPTHR1. Mean EC<sub>50</sub> values are averaged from EC<sub>50</sub> values obtained in three independent experiments for <b>19–35</b> or six independent experiments for <b>1</b>. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 3</a> for cAMP dose-response curves and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 9</a> for composite binding curves. See methods section for experimental details.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> α/β-Peptide Analogues of <b>1</b> Containing Multiple Cyclic β Residues and Broad β Distribution</h3><div class="NLM_p">We prepared α/β-peptide <b>22</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) to determine whether replacement of the six β<sup>3</sup> residues in <b>21</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with cyclic β residues would affect agonist activity. At four positions we used the hydrophobic cyclic β residue ACPC, and at the remaining two sites we used the basic cyclic β residue APC. It is straightforward to mimic the natural side chain upon α → β<sup>3</sup> replacement, but side chain mimicry becomes more ambiguous when cyclic β residues are employed, particularly since only a few such residues are currently available. Since β<sup>3</sup>-hTrp, β<sup>3</sup>-hMet, and β<sup>3</sup>-hPhe all bear hydrophobic side chains, it is logical to replace these β<sup>3</sup> residues with ACPC. APC is a logical replacement for β<sup>3</sup>-hLys because both residues have a basic side chain. The remaining two residues bear acidic side chains. We replaced β<sup>3</sup>-hGlu with APC and β<sup>3</sup>-hAsp with ACPC in an effort to balance concern about creating an α/β-peptide that might be excessively hydrophobic with concern about deviating too far from the natural pattern of charged side chains in <b>1</b>. <b>22</b> was indistinguishable from <b>21</b> as a PTHR1 agonist, based on cAMP production, and both were very similar to <b>1</b> itself (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p last">We then prepared two α/β-peptide analogues of <b>1</b> containing α → β replacement at nine sites, <b>25</b> and <b>26</b>, in the hope of identifying a potent PTHR1 agonist with β residues distributed along the entire length (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Analogue <b>25</b>, which combines the three α → cyclic β replacements of <b>20</b> with the six α → β<sup>3</sup> replacements of <b>21</b>, displayed ∼50-fold lower potency relative to the analogue containing only the three N-terminal cyclic β residues (<b>20</b>) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Since <b>1</b> and <b>21</b> are very similar in efficacy, the difference between <b>20</b> and <b>25</b> suggests some sort of anticooperativity, in terms of activating the PTHR1, between the sets of α → β replacements in the N- and C-terminal regions of <b>25</b>. Replacing the six β<sup>3</sup> residues of <b>25</b> with cyclic β residues, to generate <b>26</b>, provided a nearly 10-fold improvement in potency, but <b>26</b> nevertheless displays >200-fold lower potency relative to <b>1</b>, as monitored by stimulation of cAMP production (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> α/β-Peptide Analogues of M-PTH Containing Multiple Cyclic β Residues and Broad β Distribution</h3><div class="NLM_p">A new series of α/β-peptides was prepared based on previously reported potent synthetic analogues of PTH, designated M-PTH, that display a modified signaling profile in vivo relative to PTH.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> M-PTH contains side chain modifications at seven positions relative to PTH (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). These modifications were identified in the course of developing truncated analogues of PTH that retained high PTHR1 affinity and biological activity.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Two versions of M-PTH have been described, one containing the Ser3 → Ala modification and the other with the Ser3 → aminoisobutyric acid (Aib) modification. The Ser3 → Ala substitution was shown to substantially improve the bioactivity of PTH(1–14) analogues in an early structure–activity relationship study,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> while a later study showed that incorporation of Aib at position 3 further enhanced PTHR1 activation potency, at least in PTH(1–14) derivatives.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Our PTHR1 activation assays showed the Ser3 → Ala version of M-PTH(1–34) (<b>27</b>) to have slightly reduced cAMP-inducing potency relative to <b>1</b>, which is consistent with previous reports on the properties of the Ser3 → Aib version of M-PTH(1–34) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 4</a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Analogues of <b>27</b> bearing only C-terminal α → β replacements, <b>30</b> and <b>31</b>, were very similar in efficacy to <b>27</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Thus, the M-PTH scaffold parallels the PTH scaffold in response to C-terminal α → β replacements (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 4</a>).</div><div class="NLM_p">The Ser3 → Aib version of <b>27</b> was used as the basis for analogues containing N-terminal α → β replacements (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In this context, these replacements evoked responses quite different from those caused by analogous replacements in the context of <b>1</b>. Thus, α/β-peptides <b>29</b>, <b>34</b>, and <b>35</b> were all quite similar to the α-peptide prototype, <b>27</b>, in terms of cAMP-inducing potency (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), which contrasts with the substantial declines in potency observed for the corresponding α/β analogues of <b>1</b>. Particularly striking is the observation that the cAMP potencies of <b>35</b> and <b>27</b> differ by <3-fold, while the efficacies of <b>26</b> and <b>1</b> differ by >200-fold (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of the cAMP Inducing Properties of α/β-Peptide Analogues of PTHrP and Abaloparatide<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">derivative</th><th class="colsep0 rowsep0" align="center">hPTHR1 cAMP EC<sub>50</sub>, nM (mean ± SEM)</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">(derivative EC<sub>50</sub>)/(<b>1</b> EC<sub>50</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.07 ± 0.01</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">0.48 ± 0.12</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">0.08 ± 0.02</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">0.32 ± 0.15</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">0.65 ± 0.19</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">0.51 ± 0.16</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">0.02 ± 0.005</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">4.13 ± 0.27</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">60.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">0.18 ± 0.01</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">0.36 ± 0.09</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">5.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Tabulation of receptor activation and binding properties for the derivatives in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> with hPTHR1. Mean EC<sub>50</sub> values are averaged from EC<sub>50</sub> values obtained in the number of independent experiments indicated (<i>n</i>). See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 12</a> for composite binding curves for selected analogues and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 10</a> for composite dose−response cAMP induction curves. See methods section for experimental details. The data found in this figure are derived from experiments distinct from those that provide data for <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></div></div><div class="NLM_p">We examined the conformational propensities of our analogues of <b>1</b> and <b>27</b> by circular dichroism (CD) to determine whether such measurements would provide a mechanistic basis for interpreting the impact of structural modifications on biological activity, as was observed in previous studies.<a onclick="showRef(event, 'ref38 ref59'); return false;" href="javascript:void(0);" class="ref ref38 ref59">(38, 59)</a> All peptides exhibited CD spectra consistent with significant helicity, as indicated by minima near 222 and 208 nm for <b>1</b> and analogues containing only a few β residues and by a single minimum near 208 nm for analogues with higher β residue content (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 5</a>). However, no clear trend was evident between CD intensity, which should correlate with helical propensity, and biological activity. Even the analogue with the weakest bioactivity in this set (<b>25)</b> exhibited a CD signature consistent with substantial helix formation for an α/β-peptide.</div><div class="NLM_p last">The agonist activity of <b>35</b> represents an affirmative answer to all three of the questions that motivated these studies. This α/β-peptide contains multiple α → β replacements near the N-terminus, all of the replacements are derived from cyclic β-amino acids, the sites of α → β replacement are distributed along the entire length, and this analogue approaches <b>1</b> in efficacy and potency as an agonist of the PTHR1. Subsequent studies focused on a more extensive characterization of <b>35</b> in vitro and in vivo.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Susceptibility of <b>35</b> to Proteolysis</h3><div class="NLM_p">the C-terminal acid analogue of <b>1</b> disappears rapidly from the bloodstream following subcutaneous injection.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> This disappearance is due in part to removal via filtration and/or proteolysis by the kidneys.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Proteases in homogenized rat kidney preparations rapidly degrade the C-terminal acid analogue of <b>1</b>, causing cleavage at multiple sites.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> We therefore sought to determine whether the backbone modifications in <b>35</b> would enhance stability relative to <b>1</b> in rat kidney tissue homogenate.</div><div class="NLM_p">HPLC analysis was not feasible for these assays because kidney homogenate contains high levels of diverse biomolecules that complicate chromatographic resolution and interpretation. We therefore developed a mass-spectrometry-based method for quantifying the concentration of intact <b>1</b> or <b>35</b> within samples of kidney homogenate as a function of time. This approach indicated that the half-life of <b>35</b> is about 15 times longer than that of <b>1</b> in rat kidney homogenate (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). Sites of hydrolysis in each peptide were identified using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b,c). Many degradation fragments were observed for <b>1</b> within 5 min of exposure to rat kidney homogenate, and cleavage was so rapid and broadly distributed that few large fragments could be detected after 15 min (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). Intact <b>1</b> could not be detected by MALDI-TOF MS after the first 5 min. In contrast, only a few fragments of <b>35</b> could be detected upon incubation with rat kidney homogenate, and intact α/β-peptide was clearly evident even after 4 h (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>c).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Stability of <b>1</b> or <b>35</b> in rat kidney homogenate. Peptides were incubated in kidney homogenates from a single, female Sprague-Dawley rat for the indicated durations, and intact peptide concentration was evaluated using a liquid chromatography/mass spectrometry (LC/MS) approach or a bioassay readout as described in the methods section. Sites of protease-catalyzed hydrolysis were evaluated using MALDI-TOF mass spectrometry. (a) Concentration of intact peptide from LC/MS analysis as a function of duration of incubation. Data points represent the mean ± standard deviation from two replicates. The curve results from fitting of the data to an exponential decay function, with half-lives listed. (b, c) Identification of peptide fragments derived from <b>1</b> (b) or <b>35</b> (c) by MALDI-TOF mass spectrometry as a function of time for a single experiment. Peptide-derived fragments that may give rise to observed signals are inserted above the peak of interest. Multiple fragments are listed in cases for which the identity of the fragment could not be unambiguously confirmed. (d) Peptide bioactivity following exposure to kidney homogenate was assessed using a biological assay with two replicates. Data points represent the mean ± SEM. Times listed after peptide names represent the duration of time that the peptide was incubated with kidney homogenate before quenching of protease activity. Curves result from fitting of a sigmoidal dose–response model with variable slope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mass spectrometric analysis was complemented by the application of a bioassay method for assessing the persistence of agonist activity (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>d). This method measures the capacity of a preparation of peptide exposed to kidney homogenate, or other degradative conditions, to induce cAMP responses in GP2.3 cells as a function of duration of exposure to the degradative agent. This approach was thus used to monitor the loss of peptide bioactivity in kidney homogenate over time (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>d). After a 30 min exposure to kidney homogenate, the activity of <b>1</b> had declined approximately 1000-fold, as indicated by a rightward shift in the dose–response plot. In contrast, the activity of <b>35</b> in this assay was not significantly altered after 60 min exposure to kidney homogenate. Collectively, these studies revealed that α/β-peptide <b>35</b>, containing nine cyclic β residues distributed throughout the backbone, displays substantial resistance to destruction in the presence of rat kidney homogenate relative to α-peptide <b>1</b>.</div><div class="NLM_p">We turned to simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) for further evaluation of the proteolytic susceptibility of <b>35</b>. The susceptibility of a peptide to degradation by SGF and SIF is not directly relevant for interpretation of the bloodstream persistence of that peptide administered via injection; however, these studies provide insight into the stability of the peptide under conditions that would be encountered following oral administration. Moreover, given the very aggressive proteolytic activity of SGF and SIF, resistance to degradation under these conditions is very likely to correlate with resistance to the milder degradative environment encountered by a peptide in the bloodstream.</div><div class="NLM_p">The stomach environment promotes very rapid breakdown of proteins into short peptides and amino acids.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> SGF, an acidic solution of pepsin, enables one to estimate the lifetime of a peptide or protein in the stomach.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> We used SGF to compare <b>35</b>, <b>1</b>, and <b>21</b> in terms of the likelihood of degradation after oral ingestion. Two assays were employed to assess persistence as a function of time of exposure to SGF. One assay measured the amount of full-length peptide present at various times via HPLC.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The second relied on the bioassay described above for kidney homogenate studies to evaluate the capacity of material generated by SGF treatment to activate the PTHR1 as a function of time of exposure to SGF. These assays provide complementary insights. Results from the latter will reflect net activity based on all species present. Some degradation products, e.g., peptides lacking only a few C-terminal residues, may retain PTHR1 agonist activity, while other degradation products, e.g., those lacking only a few N-terminal residues, may display antagonist activity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">The HPLC assay (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 6</a>) showed that neither <b>1</b> nor the α/β-peptide <b>21</b> could be detected after 5 s in SGF. In striking contrast, <b>35</b> displayed a half-life of 4 h in SGF. These observations show that the profoundly destructive nature of the stomach environment toward conventional peptides such as <b>1</b> is manifested as well toward α/β-peptides that retain long stretches of α-amino acid residues, such as <b>21</b>; however, the degradative actions of the stomach are substantially suppressed toward a peptide with β-residues incorporated along the entire chain, such as <b>35</b>. The relative stability of <b>35</b> in SGF thus supports our hypothesis that distribution of cyclic β residues along the entire length of an α/β-peptide will confer substantial resistance to proteolysis.</div><div class="NLM_p">The PTHR1 activation assay results (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 7</a>) further highlight the remarkable resistance of <b>35</b> to proteolytic degradation. After 5 s exposure to SGF, the sample containing <b>1</b> displayed no detectable agonist activity; only very weak PTHR1 agonist activity was observed for the sample containing <b>21</b> after 5 s in SGF, and the sample containing <b>24</b> exhibited a modest loss in activity over 2 min. In contrast, even after 4 h in SGF the sample containing <b>35</b> displayed very strong agonist activity. Characterization of the peptide fragments produced following incubation in SGF using MALDI-TOF MS (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>e) provides insight into the mechanism by which biological activity is destroyed by SGF. Protease-catalyzed hydrolysis of <b>21</b> following residue 7 produces two fragments that, based on previous structure–activity studies,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> are likely to be devoid of biological activity. The higher stability of <b>25</b> relative to <b>21</b> in SGF probably arises from the presence of the two additional β residues in the N-terminal portion of <b>25</b>; the N-terminal portion of <b>21</b> is completely devoid of β residues. In addition, the higher stability of <b>25</b> is consistent with previous observations that cyclic-β residues can provide superior proteolytic protection relative to β<sup>3</sup>-residues.<a onclick="showRef(event, 'ref17 ref40 ref42'); return false;" href="javascript:void(0);" class="ref ref17 ref40 ref42">(17, 40, 42)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Degradation of PTH(1–34) analogues in SGF and SIF. Peptide bioactivity following exposure to SGF (simulated gastric fluid) was assessed using a biological assay (a–d). Data points represent the mean ± SEM from two technical replicates within a single experiment. Independent experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 7</a>) provide similar results. Curves result from fitting of a sigmoidal dose response model with variable slope to the data. Note that the times listed after peptide names represent the duration of time that the peptide was incubated with in SGF before quenching of protease activity. (e) Sites of proteolysis in <b>1</b> and derivatives in SGF. Sites of protease action were identified by analyzing crude proteolysis mixtures using MALDI-TOF mass spectrometry as described in the methods section from a single experiment. Arrows point to major sites of proteolytic cleavage See <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> for structures. (f, g) Bioassay to assess degradation of <b>1</b> or <b>35</b> in simulated intestinal fluid (SIF). The sigmoidal dose–response model did not provide a well-fitted curve for SIF experiments and was thus omitted in panels f and g. See the methods section for additional details. Data points represent the mean ± SEM from two technical replicates for a single experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">SIF contains a mixture of pancreatic enzymes (pancreatin), including trypsin, in pH-neutral buffer.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Even if a peptide survives passage through the stomach, this molecule must persist in the small intestine in order to have an opportunity to move out of the GI tract.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> Because of the complex composition of SIF, an HPLC-based assay could not be established. Therefore, only the PTHR1 activation bioassay was employed to assess susceptibility to proteolysis in SIF. <b>35</b> and <b>1</b> were compared (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>e,f). After 10 min exposure, very little agonist activity was retained in the sample containing <b>1</b>. In contrast, the sample containing <b>35</b> retained considerable activity at this time point.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Activity of <b>35</b> in Vivo</h3><div class="NLM_p">The potent PTHR1 agonist activity observed for <b>35</b> in cell-based assays (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) and the remarkable resistance to proteolysis demonstrated by studies with kidney homogenates, SGF, and SIF (<a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) prompted us to ask whether this α/β-peptide would activate the PTHR1 in vivo. This question was addressed by monitoring the calcemic effect induced by <b>35</b> in mice after subcutaneous injection (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). This assessment included <b>22</b>, an analogue of <b>1</b> that represents an intermediate stage in the evolution of <b>35</b> from <b>21</b>; α/β-peptide <b>21</b> itself was previously evaluated in vivo.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Properties of PTH(1–34) analogues in mice. Peptides were injected at a dose of 20 nmol/kg by subcutaneous injection in CD1 mice, <i>n</i> = 5, female, 8–12 weeks of age. (∗) <i>p</i> < 0.05 vs vehicle as assessed by one-way ANOVA with Dunnett’s multiple comparison test. Vehicle is 0.05% Tween-80, 10 mM citrate, 150 mM NaCl (pH 5.0). Data points represent the mean ± SEM from the five distinct mice per treatment group. Data points are connected with lines to guide the eye; these lines have no independent meaning. (a) <b>1</b> and derivatives induce a calcemic response following subcutaneous injection into mice. (b) Bloodstream bioavailability time course for <b>1</b> or selected α/β-peptide derivatives. A luminescence response was induced in GP2.3 cells following addition of 2 μL of serum (mixed with CO<sub>2</sub> independent medium) taken from mice at different time points after injection (<i>x</i>-axis). This raw luminescence response was converted to the concentration of peptide in the bloodstream through use of a standard curve relating peptide concentrations to luminescence responses. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 8</a> for the raw luminescence responses induced by serum and standard curves.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">New α/β-peptides <b>35</b> and <b>22</b> are indistinguishable from one another and very similar to <b>1</b> in terms of the temporal profile of changes in bloodstream Ca<sup>2+</sup> concentration they induce (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a). These data indicate that both of the new α/β-peptides are competent to engage the PTHR1 in vivo. It is curious, however, that neither <b>35</b> nor <b>22</b> generates the long-lasting calcemic effect previously observed for <b>21</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and for the α-peptide <b>27</b>.<a onclick="showRef(event, 'ref12 ref57'); return false;" href="javascript:void(0);" class="ref ref12 ref57">(12, 57)</a> As noted above, an excessive calcemic effect is generally regarded as undesirable from a therapeutic perspective in treating osteoporosis.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">An activity-based bioassay was used to monitor the level of <b>35</b> or <b>22</b> in the mouse bloodstream after injection (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b). The conventional method to measure peptide hormone concentration in the bloodstream, involving an enzyme-linked immunosorbant assay, relies on recognition of the peptide by an antibody; however, past work has shown that antibodies that recognize a peptide sequence composed of α-residues are unlikely to cross-react with α/β-peptide analogues with the density of β-residues in the analogues studied here.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The bioassay we employed is based on the ability of serum samples from mice injected with peptide to activate the PTHR1 in our cell-based assay. It is possible that the α/β PTHR1 agonists bind to albumin in the mouse serum samples, but this binding would be unlikely to alter the biological activity observed for these α/β-peptides relative to that measured for the α/β-peptides in a direct cell-based assay for PTHR1 activation, since the cell-based assays are conducted in a medium that contains substantial levels of bovine serum albumin. Thus, the α/β-peptide concentrations deduced in mouse serum samples based on the bioassay are unlikely to be affected by α/β-peptide association with albumin in the serum.</div><div class="NLM_p">Results from the cell-based assay were converted to serum peptide concentrations using a standard curve (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 8</a>). As previously observed,<a onclick="showRef(event, 'ref12 ref57'); return false;" href="javascript:void(0);" class="ref ref12 ref57">(12, 57)</a> after injection of <b>1</b> (positive control) the level of excess PTHR1-stimulating activity in the mouse bloodstream rises almost immediately and then rapidly subsides, nearly returning to the baseline level after 2 h. New α/β-peptides <b>35</b> and <b>22</b> display divergent behavior in terms of bloodstream concentration, in contrast to their similarity in terms of calcemic effect profile (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a). <b>22</b> attains a concentration in the bloodstream that is modestly higher than that of <b>1</b>, and <b>22</b> seems to persist slightly longer than does <b>1</b>. <b>35</b>, on the other hand, is barely detectable in the mouse bloodstream at any point after injection. The contrast between the robust but indistinguishable calcemic responses induced by <b>35</b> and <b>22</b> and the substantial difference between the bloodstream concentration profiles of these two α/β-peptides suggests that bloodstream concentration does not adequately report on the pharmacokinetic behavior of these molecules. This contrast may indicate that <b>35</b> rapidly and tightly binds to cell-surface PTHR1, while the binding of <b>22</b> is slower and/or weaker, causing <b>22</b> to be detectable in the blood for longer periods than is <b>35</b>.</div><div class="NLM_p">We compared affinities of these α/β-peptides and of <b>1</b> for the PTHR1 in the absence of G protein (the R0 state of the receptor) via an established competition assay.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a><b>35</b> binds 2-fold more strongly to the receptor R0 state than does <b>1</b>, while <b>22</b> binds 2-fold <i>less</i> strongly than does <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 9</a>). This trend is consistent with the hypothesis that the low level of <b>35</b> detected in the mouse bloodstream after injection reflects peptide sequestration via receptor binding; however, it is not clear whether the 4-fold affinity difference between <b>35</b> and <b>22</b> is sufficiently large to explain our observations. Another possible source of variation between these two α/β-peptides, which is not captured in the binding assay and was not tested, would involve the rate at which the agonist-PTHR1 complex is removed from the cell surface; the PTH(1–34)-PTHR1 complex is known to be rapidly internalized and to continue signaling from endosomes.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Overall, it appears that strong and rapid binding of <b>35</b> to the PTHR1, possibly augmented by unusually rapid receptor internalization, could explain how this α/β-peptide can exert a strong effect on Ca<sup>2+</sup> levels despite the fact that <b>35</b> is barely detectable in the bloodstream at any point following injection.</div><div class="NLM_p last">There is a parallel between the in vivo behavior documented here for <b>35</b> and that reported previously for <b>27</b>.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Both of these molecules induce a robust calcemic effect upon injection in mice, but neither peptide achieves the bloodstream levels detected for <b>1</b> after injection. This parallel suggests that differences in the M-PTH sequence relative to the PTH sequence impart both strong calcium-mobilization activity and rapid clearance from the bloodstream. Collectively, our observations and previous data for PTHR1 agonist peptides show that there is no correlation between the strength of the calcemic effect induced by a PTHR1 agonist peptide and the duration of that peptide’s persistence in the mouse bloodstream. These findings support the conclusion that monitoring the concentration of a PTHR1 agonist peptide in the mouse bloodstream does not necessarily provide a complete understanding of the peptide’s pharmacokinetic behavior.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Extension of the Optimal α/β Substitution Pattern to Analogues of PTHrP(1–34) (<b>36</b>) and Abaloparatide (<b>40</b>)</h3><div class="NLM_p">There are two known natural agonists of PTHR1, parathyroid hormone and parathyroid hormone-related protein (PTHrP).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> As is the case with PTH, N-terminal segments of PTHrP, such as <b>36</b> or PTHrP(1–36) (<b>45</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 17</a> for structure), retain full agonist activity.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> However, <b>1</b> and <b>45</b> differ considerably in their receptor-activating properties.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a><b>1</b> induces long-lasting receptor activation in which cAMP generation continues after PTHR1 has been internalized; <b>1</b> remains bound to the internalized receptor.<a onclick="showRef(event, 'ref57 ref64'); return false;" href="javascript:void(0);" class="ref ref57 ref64">(57, 64)</a> In contrast, cAMP generation induced by <b>45</b> is short-lived and mostly limited to receptor molecules on the cell surface.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> PTHR1 activated by <b>45</b> is only weakly active after internalization, at which point <b>45</b> has dissociated from the receptor.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Differences in the cAMP signaling profiles for PTH and PTHrP are attributed to a divergence in the capacity of these peptides to bind to the R0 state of PTHR1.<a onclick="showRef(event, 'ref57 ref63 ref64 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref57 ref63 ref64 ref66 ref67">(57, 63, 64, 66, 67)</a><b>1</b> binds more tightly than does <b>45</b> to the R0 state of PTHR1, and <b>27</b> binds even more tightly than does <b>1</b>.<a onclick="showRef(event, 'ref57 ref63 ref67'); return false;" href="javascript:void(0);" class="ref ref57 ref63 ref67">(57, 63, 67)</a> This rank order coincides with the duration of PTHR1-mediated cAMP responses induced by these α-peptides in cell-based assays.<a onclick="showRef(event, 'ref57 ref63 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref57 ref63 ref67 ref68 ref69">(57, 63, 67-69)</a> The mechanistic underpinnings of this correlation are an active area of investigation.<a onclick="showRef(event, 'ref64 ref66 ref70 ref71 ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref64 ref66 ref70 ref71 ref72 ref73 ref74">(64, 66, 70-74)</a></div><div class="NLM_p">The distinctive signaling profile of PTHrP makes analogues of this peptide potentially advantageous as a basis for osteoporosis therapy, relative to analogues of PTH, because some PTHrP analogues can promote bone growth but are less prone to causing an undesirable rise in blood calcium ion levels (decreased calcemic effect).<a onclick="showRef(event, 'ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77">(75-77)</a> The decreased calcium mobilization activity of PTHrP analogues relative to the C-terminal acid analogue of <b>1</b> may be related to the weaker R0 affinity of such peptides.<a onclick="showRef(event, 'ref64 ref78'); return false;" href="javascript:void(0);" class="ref ref64 ref78">(64, 78)</a> The enhanced calcium mobilization activities of <b>27</b> <a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and a newly described PTHR1 agonist, LA-PTH,<a onclick="showRef(event, 'ref69 ref79'); return false;" href="javascript:void(0);" class="ref ref69 ref79">(69, 79)</a> relative to the C-terminal acid analogue of <b>1</b>, along with the higher affinity of these peptides for the PTHR1 R0 state relative to the C-terminal acid analogue of <b>1</b>, support this hypothesis.</div><div class="NLM_p"><b>40</b> is a synthetic peptide based on the sequence of PTHrP(1–34), containing multiple modifications in the segment spanning residues 22–31, that has recently been approved by the US FDA for use as a treatment for osteoporosis.<a onclick="showRef(event, 'ref68 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref68 ref80 ref81">(68, 80, 81)</a><b>40</b> binds even more weakly than does the C-terminal acid analogue of <b>45</b> to the PTHR1 R0 state and also exhibits significantly reduced calcium mobilization activity relative to the C-terminal acid analogue of <b>1</b> in the clinic.<a onclick="showRef(event, 'ref68 ref80'); return false;" href="javascript:void(0);" class="ref ref68 ref80">(68, 80)</a> As is the case with teriparatide, <b>40</b> is delivered via subcutaneous injection.</div><div class="NLM_p">Because the sequences of <b>36</b> and <b>40</b> differ significantly from those of <b>1</b> and <b>27</b>, we used the former two to evaluate the generality of the pattern of nine cyclic β residues in <b>35</b>. This substitution pattern enabled retention of PTHR1 agonist activity in the context of sequence of <b>27</b>, but these nine α → cyclic β substitutions (to generate <b>26</b>) caused a substantial drop in potency in the context of the sequence of <b>1</b>. Therefore, the outcome of these substitutions in the context of <b>36</b> and <b>40</b> could not be predicted (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the structures of highly substituted analogues of PTH(1−34), PTHrP(1−34), and abalopartide. The segment in which <b>40</b> differs from <b>36</b> is highlighted in red lettering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Results of cell-based assays indicate that <b>36</b> is very similar to <b>1</b> in terms of stimulating cAMP production via engagement of the PTHR1 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 10</a>), which is consistent with previous reports.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Imposing the nine α → cyclic β replacements found in <b>35</b> on the sequence of <b>36</b>, to generate <b>39</b>, caused a small decline in agonist potency (∼6-fold), which is very similar to the effect of these replacements in the sequence of <b>27</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Introduction of the nine α → cyclic β replacements in the sequence of <b>40</b> caused a slightly larger decline in agonist potency (∼18-fold), but the resulting α/β-peptide, <b>43</b>, was nevertheless quite potent in terms of stimulating cAMP production (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Incorporating only six α → cyclic β replacements in the C-terminal regions of <b>36</b> and <b>40</b>, at positions analogous to those of the replacements in <b>22</b>, provided analogues <b>38</b> and <b>42</b>, which were similar to one another in exhibiting potent agonist activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 11</a>). In contrast, when β<sup>3</sup> residues were used for the six α → β replacements in the C-terminal region, the derivatives of <b>36</b> and <b>40</b> displayed different behaviors, with <b>37</b> only 4-fold less potent than <b>36</b> whereas <b>41</b> was 200-fold less potent than <b>40</b>.</div><div class="NLM_p">Variation in affinity for different PTHR1 conformational states among <b>1</b>, <b>36</b>, <b>40</b>, and the α/β-peptide analogues offers another potential metric, beyond agonist activity (stimulation of cAMP production), by which peptides containing α → β replacements might be compared to prototype α-peptides and to one another. We observed that <b>36</b> and <b>40</b> bound to the PTHR1 R0 conformational state<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> 3- and 22-fold less tightly than does <b>1</b>, respectively, in accord with past findings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 12</a>).<a onclick="showRef(event, 'ref63 ref68'); return false;" href="javascript:void(0);" class="ref ref63 ref68">(63, 68)</a> The analogues of these peptides with a full set of α → cyclic β replacements, <b>39</b> and <b>43</b>, bound to the PTHR1 R0 state 4- and 3-fold less tightly than does <b>1</b>, respectively. Thus, the incorporation of nine α → cyclic β replacements into the PTHrP scaffold provides an analogue (<b>39</b>) that maintains the diminished PTHR1 R0 affinity characteristic of the prototype α-peptide, <b>36</b>, whereas the introduction of these same replacements in the abaloparatide scaffold, to provide <b>43</b>, modestly increases PTHR1 R0 affinity relative to the prototype (<b>40</b>). The origin of the different responses of the sequences of <b>36</b> and <b>40</b> to the imposition of full sets of α → cyclic β replacements, with respect to R0 affinity, is unknown but could plausibly arise from altered modes of peptide interaction with the conformationally pliable receptor.</div><div class="NLM_p">The PTHR1 bioactivity assay described above was used to evaluate the susceptibilities of <b>36</b>, <b>40</b>, <b>39</b>, and <b>43</b> to degradation in SGF and SIF (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 13</a>). Both of the α-peptides were very rapidly degraded in SGF, as expected, with no agonist activity detected for <b>36</b> after a 3 min exposure and very little activity detected for <b>40</b> at this time point (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). In contrast, no significant decline in agonist activity was detected for either α/β-peptide after a 45 min exposure to SGF.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0007.jpeg" id="GRAPHIC-d127e2591-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Degradation of PTHrP(1−34) and abaloparatide analogues in SGF. Peptide bioactivity following exposure to SGF was assessed using a biological assay. Data points represent the mean ± SEM from two technical replicates in a single experiment. Curves result from fitting of a sigmoidal dose–response model with variable slope to the data. Note that the times listed after peptide names represent the duration of time that the peptide was incubated with in SGF before quenching of protease activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In SIF, <b>36</b> displayed very low agonist activity after a 10 min exposure, and <b>40</b> displayed very low agonist activity after a 20 min exposure (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 13</a>). In each case, however, the analogous α/β-peptide manifested only a small decline in activity at the same time point. Thus, the pattern of α → cyclic β replacements that generated an analogue of <b>27</b> with both potent agonist activity toward PTHR1 and substantial resistance to proteolysis delivers the same favorable combination of properties when extended to the sequences of <b>36</b> and <b>40</b>.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The results described here represent a substantial advance in the development of backbone-modified polypeptide hormone analogues because we have shown that a systematic “β-residue scan” can identify sites in the N-terminal region of <b>1</b> that tolerate α → β replacements. Cyclic β residues prove to be superior to β<sup>3</sup> residues for maintaining potent agonist activity toward the PTHR1. The lack of high resolution structural information for PTHR1 prevents a detailed mechanistic interpretation of these findings, but this lack of structural insight also means that the successful outcome of the β scans could not have been predicted. The new, potent α/β-peptide agonists should be useful for refining models of the PTHR1 in the activated state.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a></div><div class="NLM_p">We find that combining substitutions in the N-terminal region with an α → β substitution pattern previously identified in the C-terminal region of <b>1</b> is most effective if cyclic β residues are employed throughout. Our approach ultimately identified nine sites of α → cyclic β substitution that deliver a modestly potent PTHR1 agonist in the context of <b>1</b> and highly potent agonists in the context of three other sequences known to activate PTHR1, <b>27</b>, <b>36</b>, and <b>40</b>. One of these potent α/β-peptide agonists, <b>35</b>, is active in vivo, inducing a calcemic effect in mice after injection. <b>35</b> is remarkably stable in environments that instantaneously destroy conventional peptides or α/β-peptides that contain long α segments (e.g., <b>21</b>), such as kidney homogenate and simulated gastric fluid. These properties should support future efforts to achieve oral delivery of a bioactive α/β-peptide.</div><div class="NLM_p">The observation that the analogues of <b>27</b>, <b>36</b>, and <b>40</b> containing nine α → β substitutions (<b>35</b>, <b>39</b>, and <b>43</b>) manifest potent agonist activity, whereas the corresponding analogue of <b>1</b> (<b>26</b>) exhibits only moderate potency, suggests that different PTHR1 agonists interact with this receptor in subtly different ways. Since the six C-terminal α → cyclic β substitutions used in this study are uniformly well-tolerated with respect to retention of signaling activity, for all the PTHR1 agonist sequences tested (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 11</a>), it is likely that the divergence in the impact of α → β replacements on biological activity within different sequence contexts stems from modifications in the N-terminal portions of these peptides. The incorporation of an Ile5 → ACPC substitution in the sequence of <b>1</b> or related α/β-peptide analogues causes a substantial loss in agonist potency (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), which is consistent with previous observations that modifications at position 5 of PTH analogues usually reduce agonist activity.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In this context, it is noteworthy that introduction of the Ile5 → ACPC substitution into the sequence of <b>27</b> does not impair agonist activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This finding is consistent with the previously documented capacity of the receptor affinity-enhancing α residue substitutions found in the M-PTH sequence to mask the detrimental effects of unfavorable modifications, such as C-terminal truncation.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Histidine is found instead of isoleucine at position 5 of the sequences of <b>36</b> and <b>40</b>. Past work has shown that His5 → Ile replacement in the PTHrP scaffold enhances PTHR1 affinity.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The hydrophobicity of the ACPC residue found at position 5 of <b>39</b> and <b>43</b> may enable this β residue to mimic the impact of isoleucine at this position of the all-α PTHrP/abaloparatide scaffold. It seems likely that characteristics of the residue at position 5 play a key role in controlling the activities of PTHR1 agonists.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Our results indicate that resistance to proteolysis and lifetime in the bloodstream are not correlated. For example, <b>35</b> is far less susceptible to proteolysis than is <b>1</b> under all conditions evaluated, yet <b>35</b> is only weakly detectable in the mouse bloodstream following injection, whereas <b>1</b> is robustly detected for a short period after injection (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). We speculate that the low levels of <b>35</b> in the bloodstream, even immediately after injection, reflect rapid and essentially irreversible sequestration of this α/β-peptide by the PTHR1 in target tissues. Past work has shown that synthetic α-peptide PTHR1 agonists with high affinity for the R0 state of the PTHR1 are less evident in the bloodstream following injection than is <b>1</b><a onclick="showRef(event, 'ref57 ref79'); return false;" href="javascript:void(0);" class="ref ref57 ref79">(57, 79)</a> Nevertheless, these high-R0-affinity agonists induce more enduring biological responses than does <b>1</b>. This behavior may be related to the capacity of PTHR1 agonists with high R0 affinity to bind pseudoirreversibly to the receptor, which is mostly located on bone and kidney cells, thereby removing peptide from circulation. Pseudoirreversible binding requires the slow dissociation of ligand from receptor. Kinetics experiments have previously shown that <b>45</b> dissociates from PTHR1 more rapidly than does <b>1</b><a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and that PTH(1–28) dissociates more rapidly than does M-PTH(1–28),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> which correlates with the affinity of these ligands for the R0 state of PTHR1. The high R0 affinity of <b>35</b> might therefore underlie the observation that this α/β-peptide is barely detectable in the bloodstream following injection. Differences in the capacity of <b>1</b> and <b>35</b> to induce receptor internalization may also contribute to variation in bloodstream concentrations of these peptides; however, few studies have systematically evaluated structure–activity relationships for PTHR1 internalization. In one such study, significant differences in internalization efficacy were identified among various PTHR1 agonists, but none of the α/β-peptide analogues we developed have been evaluated in this way.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">The relatively modest persistence of <b>22</b> in the mouse bloodstream after injection (only slightly greater than that <b>1</b>) contrasts with the much longer persistence observed previously for <b>21</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The source of this in vivo difference between <b>21</b> and <b>22</b> is not clear, given the similar properties of these α/β-peptides in cell-based assays (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Differences in physicochemical properties might underlie variation in bloodstream persistence. Peptide <b>21</b> shows a larger retention time on C18 reversed-phase HPLC relative to <b>22</b>, which itself shows a larger retention time relative to <b>1</b>; this comparison indicates that the rank order of hydrophobicity is <b>21</b> > <b>22</b> > <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 14</a>). Enhanced peptide hydrophobicity can promote association with serum proteins, which can increase effective molecular weight and thereby slow filtration of the peptide from the bloodstream by kidney.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Since kidney filtration represents a major route of PTH elimination from the bloodstream,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> differences between the bloodstream concentration profiles of <b>21</b> and <b>22</b> may be connected to differences in these molecules’ hydrophobicities.</div><div class="NLM_p">The successful introduction of α → β replacements throughout the sequences of PTHR1 agonists with retention of potent bioactivity raises the possibility that these agonists might ultimately prove to be orally deliverable. The oral route is generally regarded as superior to all others in terms of patient preference, but this delivery strategy is problematic for peptides for at least two reasons. First, peptides are usually degraded rapidly in the stomach or small intestine. Second, peptides are too large to cross the wall of the small intestine passively and enter the bloodstream.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Results reported here show that the peptides <b>35</b>, <b>39</b>, and <b>43</b> overcome the first problem, and they lay the groundwork for future efforts to address the challenge of enabling large peptides to move from the gastrointestinal tract into the bloodstream. Most current attempts to solve this problem rely on formulation of a peptide with small molecules that promote the passive peptide diffusion through epithelial cells that line the intestinal lumen.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Favorable results have been reported for medium-size peptide drugs such as PTH derivatives,<a onclick="showRef(event, 'ref83 ref84 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85 ref86">(83-86)</a> salmon calcitonin, and glucagon-like peptide 1.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> These efforts have relied on empirical screening efforts with large libraries of small molecule permeation enhancers and different dosing conditions using large populations of animals to identify optimal approaches.<a onclick="showRef(event, 'ref85 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref87">(85, 87)</a></div><div class="NLM_p last">The results presented here strengthen the prospect that α/β-peptides will emerge as useful tools for analyzing biological phenomena at the molecular level and perhaps even as therapeutic agents. Large-scale manufacture of α-peptides containing 20–40 residues for clinical use is feasible,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> and the solid-phase synthesis of α/β-peptides is qualitatively similar to α-peptide synthesis. Ultimately, it would be attractive to produce α/β-peptides via the biosynthetic machinery, and recent reports encourage the hope that this goal could be achieved some day. Initial explorations suggested that the ribosomal biosynthesis of polypeptides containing β residues was inefficient or impossible.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89-91)</a> Subsequent findings, however, show that β-amino acids can be incorporated by the ribosome into polypeptides.<a onclick="showRef(event, 'ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94 ref95">(92-95)</a> These findings raise the prospect that evolutionary approaches could be harnessed for discovery of new bioactive α/β-peptides and for the production of optimized compounds.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Peptide Synthesis and Purification</h3><div class="NLM_p">Peptides were synthesized as C-terminal amides on NovaPEG rink amide resin (EMD) using previously reported microwave-assisted solid-phase conditions, based on Fmoc protection of main chain amino groups.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Microwave-assisted reactions were carried out in a MARS multimode microwave reactor (CEM). Rink amide resin was weighed into a fritted polypropylene tube and allowed to swell first in DMF. For coupling of an activated amino acid to an unprotected amine on resin, the desired Fmoc-protected amino acid (125 μmol) and HBTU (47 mg, 125 μmol) were dissolved in 1.25 mL of 0.1 M HOBt in DMF (dimethylformamide). To the solution was added <i>N</i>,<i>N</i>-diethylisopropylamine (35 μL, 200 μmol). This mixture was vortexed briefly and allowed to react for at least 1 min. The activated amino acid solution was then added to the fritted polypropylene tube containing the resin. The resin was heated to 70 °C in the microwave (2 min ramp to 70 °C, 4 min hold at 70 °C) with stirring. After the coupling reaction, the resin was removed from the microwave and washed with DMF (three times). For Fmoc deprotection, 3 mL of 20% piperidine in DMF was added to the resin, and the mixture was heated to 80 °C in the microwave (2 min ramp to 80 °C, 2 min hold at 80 °C) with stirring. After the deprotection reaction, the resin was washed with DMF (three times). The cycles of coupling and deprotection were alternately repeated to give the desired full-length peptide. The resin was washed thoroughly (three times in DMF, three times in CH<sub>2</sub>Cl<sub>2</sub>) and then dried under a stream of air.</div><div class="NLM_p">After synthesis, the peptides were cleaved from the resin, and side chains were deprotected using reagent K (82.5% TFA, 5% phenol, 5% H<sub>2</sub>O, 5% thioanisole, 2.5% ethanedithiol) for 2 h. The TFA solution was dripped into cold diethyl ether to precipitate the deprotected peptide. Peptides were purified on a prep-C18 column using reverse phase-HPLC. Purity was assessed by analytical RP-HPLC (solvent A of 0.1% TFA in water, solvent B of 0.1% TFA in acetonitrile, C18 analytical column (4.6 mm × 250 mm), flow rate 1 mL/min, gradient 10–60% B solvent over 50 min). Masses were measured by MALDI-TOF-MS. All peptides exhibited >95% purity as evaluated using analytical reverse-phase C18 HPLC. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 15</a> for analytical HPLC retention times, purity data, and a list of observed masses from MALDI-TOF-MS (either monoisotopic [M + H]<sup>+</sup>, <i>m</i>/<i>z</i>, or average [M + H]<sup>+</sup>, <i>m</i>/<i>z</i>, listed in the table). See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 16</a> for HPLC traces and MALDI-TOF mass spectra.</div><div class="NLM_p last">Protected β<sup>3</sup>-homoamino acids were purchased from PepTech or ChemImpex. Fmoc-ACPC was purchased from ChemImpex. Fmoc-APC(Boc) was synthesized through a reductive amination functional group exchange protocol performed using a β-ketoester pyrrolidine analogue as previously described.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Binding and cAMP assays</h3><div class="NLM_p">Reported IC<sub>50</sub> and EC<sub>50</sub> values are the average of ≥3 independent measurements, as indicated in figure captions. Data were fitted to a sigmoidal dose–response model with variable slope. Each assay consists of ≥4 data points (different concentrations) per peptide. Binding to the R0 conformation of the human PTHR1 was assessed by competition assays performed in 96-well plates by using membranes from either GP2.3 cells or Cos-7 cells transiently transfected to express human PTHR1. Binding was assessed by using <sup>125</sup>I-PTH(1–34) as tracer radioligand and including GTPγS in the reaction (1 × 10<sup>–5</sup> M).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Cell membranes were incubated with tracer ligand and varied concentrations of the indicated, unlabeled competitor peptide. Following incubation of membranes with peptides for >1 h, free peptide was separated from receptor bound peptide by filtration and the level of tracer peptide binding was evaluated by quantification of γ radiation.</div><div class="NLM_p">cAMP signaling was assessed using HEK-293-derived cell lines that stably express the Glosensor cAMP reporter (Promega Corp.)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> along with wild-type human PTHR1 (GP-2.3 cells) or human PTHR1 lacking the extracellular domain (GD5 cells). For cAMP dose–response assays, monolayers of confluent HEK 293 cells were preincubated with CO<sub>2</sub> independent media (Life Sciences) containing <span class="smallcaps smallerCapital">d</span>-luciferin (0.5 mM) in 96-well plates at room temperature until a stable baseline level of luminescence was established (30 min). Varying concentrations of agonist were then added, and the time course of luminescence response was recorded using a PerkinElmer plate reader following α/β-peptide addition. The maximal luminescence response (observed 12–20 min after ligand addition) was used for generating dose–response curves.</div><div class="NLM_p last">In cases where peptides failed to induce cAMP responses near the maximal response induced by <b>1</b>, a constraint was introduced when fitting of a sigmoidal dose–response curve that specified that the maximal response for each peptide was above a threshold specified in the corresponding figure caption. This constraint enables an estimation of cAMP EC<sub>50</sub> values based on the assumption that these peptides are full agonists. Peptides that possess partial agonism properties are not properly evaluated using this experimental approach.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Simulated Gastric and Intestinal Fluid Stability Studies</h3><div class="NLM_p">Simulated gastric fluid was prepared according to instructions provided for test solutions in the United States Pharmacopeia. NaCl (20 mg) and pepsin from porcine mucosa (32 mg of >2500 U/mg pepsin, Sigma-Aldrich P7012) were dissolved in 9.93 mL of deionized H<sub>2</sub>O. Concentrated HCl (∼37%) (700 μL) was then added to the solution to provide simulated gastric fluid (SGF). The resulting solution had a pH of ∼1.2. SGF was prepared fresh for each assay and was incubated at 37 °C before and during use.</div><div class="NLM_p">All solutions used in the protocol, except peptide stocks, were first submitted to sonication to remove excess gas from the solution. Solutions of peptides (1 mM) dissolved in 10 mM acetic acid were used as stocks for these experiments. Aliquots of peptide stock were added to SGF (20 μL of peptide in 100 μL total solution, for a [peptide] of 200 μM) at <i>t</i> = 0. Proteolysis was quenched at the indicated time by transferring 40 μL of the proteolysis solution into 80 μL of 10× PBS (1.37 M NaCl, 27 mM KCl, 80 mM Na<sub>2</sub>HPO<sub>4</sub>, 20 mM KH<sub>2</sub>PO<sub>4</sub> at pH 7.4), as pepsin is inactive at neutral pH. An additional 80 μL of deionized H<sub>2</sub>O was added to the quenched solution to bring the total volume of the quenched solution to 200 μL ([peptide] in quenched solution was 40 μM). Each proteolysis experiment was run concurrently in duplicate to provide estimated variation (standard deviation) in the analyses described below. Control samples, in which proteolysis is prevented from occurring, were prepared by <i>first</i> mixing 32 μL of SGF with 80 μL of 10× PBS to quench protease activity, followed by addition of 8 μL of peptide stock and 80 μL of deionized H<sub>2</sub>O.</div><div class="NLM_p">From these quenched solutions (either control or proteolysis groups), a portion (180 μL) was transferred to an HPLC vial for injection (injected 150 μL) onto an analytical RP-HPLC (see <a class="ref internalNav" href="#sec4_1" aria-label="Peptide Synthesis and Purification">Peptide Synthesis and Purification</a> section above), and peaks were analyzed. The time course of peptide degradation was experimentally determined by integrating the area of the peak corresponding to the nonhydrolyzed peptide in a series of HPLC traces, with duplicate proteolysis reactions being used to generate error bars corresponding to the standard deviation. A small portion of the reaction solution (1 μL) was used to acquire MALDI-TOF mass spectrometry data for identification of peptide fragments resulting from proteolysis.</div><div class="NLM_p">A portion of these quenched reaction solutions (or control solutions) was diluted 1:40 in CO<sub>2</sub> independent medium to provide 1 μM solutions for peptide bioactivity measurements. These solutions were then serially diluted (1:10) using CO<sub>2</sub> independent medium in a 96-well polypropylene dilution plate (concentration range 1000–1 nM on dilution plate). Aliquots from these serially diluted solutions (10 μL) were then transferred onto a different 96-well plate containing confluent monolayers of GP2.3 cells that had been preincubated with 90 μL of CO<sub>2</sub> independent media with 0.5 mM <span class="smallcaps smallerCapital">d</span>-luciferin. The final peptide concentrations used in this assay ranged from 100 nM to 0.1 nM. Control experiments showed that quenched solutions of SGF without peptide did not induce luminescent responses in GP2.3 cells. Incubation of peptide in solutions of SGF, in which protease activity had been quenched prior to addition of peptide, for up to 4 h did not result in diminished peptide bioactivity relative to freshly prepared peptide stocks in CO<sub>2</sub> independent medium (data not shown). The luminescence responses were used to construct the dose–response curves found in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. Note that concentrations on the <i>x</i>-axis of <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> represent the estimated concentrations of the intact peptide before proteolysis. The concentration of intact peptide after proteolysis is not known for this assay.</div><div class="NLM_p">Simulated intestinal fluid (SIF) was prepared according to instructions provided in the United States Pharmacopeia. KH<sub>2</sub>PO<sub>4</sub> (68 mg) was dissolved in 2.5 mL of H<sub>2</sub>O followed by the addition of 0.77 mL of 0.2 M NaOH. An additional 5 mL of H<sub>2</sub>O was added to this solution followed by addition of 100 mg of porcine pancreatin (US Pharmacopeia grade, MP Bio no. 102557). The pH of the solution was adjusted to pH 6.8 through addition of 0.2 M NaOH. Deionized water was added to a final volume of 10 mL. This solution was prepared immediately before each assay and was incubated at 37 °C before and during use.</div><div class="NLM_p last">Assessment of peptide stability was carried out as described for simulated gastric fluid with the following exceptions. Simulated intestinal fluid was used instead of simulated gastric fluid for all steps. Protease action was quenched through a 1:1 dilution of the proteolysis solution with a 50% solution (volume/volume) of CH<sub>3</sub>CN in H<sub>2</sub>O solution containing 1% (by volume) trifluoroacetic acid (SIF quenching solution). Control solutions, in which the activity of SIF is quenched before addition of peptide, had the following composition: 40 μL of SIF, 50 μL of SIF quenching solution (mixed first), and 10 μL of 1 mM peptide stock (100 μM [peptide] after quenching). HPLC and MALDI-TOF mass spectra analyses were not performed. Quenched solutions were diluted 1:100 into CO<sub>2</sub> independent medium on a polypropylene dilution plate, which was further diluted with three sequential 1:10 dilutions in CO<sub>2</sub> independent medium (concentrations of peptide on the dilution plate range from 1000 nM to 1 nM), as for experiments using SGF. Solutions from the dilution plate were diluted 1:10 onto the plate with GP2.3 cells to provide peptide concentrations ranging from 100 nM to 0.1 nM in the assay. Control experiments showed that quenched diluted solutions of SIF without peptide did not induce luminescence responses from GP2.3 cells and that solutions of SIF that were quenched before addition did not cause erosion of peptide bioactivity (data not shown). Note that concentrations on the <i>x</i>-axis of <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> represent the estimated concentrations of the intact peptide before proteolysis. The concentration of intact peptide after proteolysis is not known for this assay.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Rat Kidney Homogenate Studies</h3><div class="NLM_p">All experimental protocols were approved by the Institutional Animal Care and Use Committee at the University of Wisconsin—Madison and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (8th edition, 2011). Adult female Sprague-Dawley rats (180–200 g; Harlan/Envigo, Indianapolis, IN, USA) were housed individually or in groups of two at room temperature under a 12 h light/dark cycle. Food and water were provided ad libitum. Animals were anesthetized with 1.5 g/kg urethane administered via intraperitoneal injections to effect. Body temperature of anesthetized animals was maintained at 37 °C using a homeothermic blanket (Harvard Apparatus). Anesthetized rats were perfused transcardially with 50 mL of cold 0.01 M PBS (pH 7.4) and then decapitated. Kidney tissues were harvested, washed with ice-cold saline solution, and adhering tissues were trimmed. 4 mL of incubation buffer (50 mM Tris-HCl, pH 7.4) was added per gram of tissue, which was homogenized using a Teflon homogenizer. The homogenates were centrifuged at 2000<i>g</i> for 10 min at 4 °C, and the supernatants were stored at −80 °C for future analysis. The homogenate samples were used for the stability assay within 8 days of tissue collection. Bicinchoninic acid (BCA) assay was used to determine the total protein concentration in the tissue homogenates, which were then diluted to 2.5 mg protein/mL with incubation buffer.</div><div class="NLM_p last">PTH standards (<b>1</b> and <b>35</b>) were spiked in rat kidney homogenates to achieve a final concentration of 50 μg/mL (∼12 μM). Three replicates were prepared for each peptide. The spiked homogenates were incubated at 37 °C water bath, and samples were collected at different time intervals (0, 1, 3, 5, 10, 15, 30, 45, 60, 90, 120 min). Two sets of samples were collected at each time point: a 50 μL sample was collected for liquid chromatography (LC)–mass spectrometry (MS) quantification study, and a 10 μL sample was collected for matrix-assisted laser desorption/ionization (MALDI)-MS analysis. 5 μL of internal standard (IS, 10 μg/mL rat PTH) was spiked in each LC–MS sample as quality control and normalization factor. The collected samples were immediately mixed with equal volumes of 1% trifluoroacetic acid (TFA) to terminate protease activity. The sample mixtures were centrifuged at 10 000<i>g</i> for 10 min at 4 °C. The supernatants were dried in a speed vacuum concentrator and stored in −20 °C until further analysis.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Rat Kidney Homogenate Studies: MALDI-MS Analysis</h3><div class="NLM_p last">A sample from each time point was reconstituted in 10 μL of H<sub>2</sub>O with 0.1% formic acid (FA). 1 μL of reconstituted sample was mixed with 1 μL of 2,5-dihydroxybenzoic acid matrix (DHB, 150 mg/mL dissolved in 49.95% methanol, 49.95% H<sub>2</sub>O, and 0.1% FA) and spotted onto a MALDI target plate. An ultrafleXtreme MALDI-TOF/TOF mass spectrometer (Bruker Daltonics, Bremen, Germany) with reflectron positive mode was used for all MALDI MS analysis. 5000 laser shots were accumulated for each sample at <i>m</i>/<i>z</i> 700–5000. The acquired data were analyzed with flexAnalysis 3.4 (Bruker Daltonics, Bremen, Germany).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Rat Kidney Homogenate Studies: Liquid Chromatography/Mass Spectrometry Analysis</h3><div class="NLM_p">Sample from each time point was reconstituted in 50 μL of H<sub>2</sub>O with 0.1% formic acid (FA). Calibration standards (0, 0.05, 0.1, 0.5, 1, 5, 10, 25, 50, and 75 μg/mL) were prepared by dissolving peptide standards in the same sample matrix (1:1 tissue homogenate/1% TFA in H<sub>2</sub>O with 1 μg/mL rat PTH(1–34) as an internal standard).</div><div class="NLM_p">A Dionex UltiMate 3000 UHPLC system (Thermo Scientific, Bremen, Germany) coupled to a Q Exactive hybrid quadrupole Orbitrap mass spectrometer (Thermo Scientific, Bremen, Germany) was used for all LC/MS analysis. The analyte and IS were separated on a Phenomenex Kinetex C18 column (100 mm × 2.1 mm i.d., 1.7 μm). Mobile phase A was H<sub>2</sub>O with 0.1% FA, and mobile phase B was acetonitrile with 0.1% FA. The following gradient was used to separate the analyte and IS (time/min, % mobile phase B): (0, 15), (3.8, 50), (4, 98), (5.3, 98), (5.4, 15), (6, 15). The flow rate was set at 0.30 mL/min with column temperature at 30 °C and sampler temperature at 10 °C. Three injections were performed for each sample.</div><div class="NLM_p">A multiplexed parallel reaction monitoring (PRM) method was set up on the mass spectrometer. Briefly, two scan events were defined. Scan event 1 was a full MS scan to monitor all ions from <i>m</i>/<i>z</i> 133.4 to 2000 with resolution of 70 000 (<i>m</i>/<i>z</i> 200). Scan event 2 was a targeted MS<sup>2</sup> event that multiplexed twice: +5 charged analyte and IS were fragmented together with normalized collisional energy (NCE) of 26, and +6 charged ions were fragmented together with NCE of 20.</div><div class="NLM_p last">Xcalibur (Thermo Scientific, Bremen, Germany) and Microsoft Excel were used for all data analysis. The y<sub>32</sub> ion peak area ratio of analyte to IS was calculated for each sample. A linear equation between concentrations and peak area ratios was established from calibration standards. The concentrations from unknown samples were calculated based on the peak area ratios and the linear equation.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Rat Kidney Homogenate Studies: Bioassay Analysis</h3><div class="NLM_p last">The stability of peptides in kidney homogenate preparations was performed using a bioassay based readout as described above for simulated gastric fluid and simulated intestinal fluids, with the following exceptions. 1 mM stock solutions of peptide were diluted 1:85 into kidney homogenate at <i>t</i> = 0 (∼12 μM). The concentration of peptide in kidney homogenate following dilution approximates the concentration used in the LC/MS-based approach described above. Protease activity was quenched through a 1:1 dilution of the proteolysis reaction with SIF quenching solution at the indicated times (see above for the composition of this solution for the composition of SIF quenching solution). 10 μL of quenched protease solution was then mixed with 53 μL of CO<sub>2</sub> independent medium on the dilution plate. The concentration of peptide in the solutions provided after dilution into CO<sub>2</sub> independent medium is 1000 nM. This solution was serially diluted (three 1:10 dilutions) on the dilution plate (1000 nM to 1 nM), and 10 μL of solutions from the dilatation plate was transferred to a plate with confluent monolayers of GP2.3 cells that had been preincubated in CO<sub>2</sub> independent medium containing 0.5 mM <span class="smallcaps smallerCapital">d</span>-luciferin for 30 min. Note that concentrations on the <i>x</i>-axis of <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>d represent the estimated concentrations of the intact peptide before proteolysis. The concentration of intact peptide after proteolysis is not known for this assay. Control solutions containing kidney homogenate without added PTHR1 agonist did not induce detectable luminescence in these assays.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo Pharmacology: Calcemic Response and Pharmacokinetics</h3><div class="NLM_p last">Mice (CD1, female, age 9–12 weeks, from Charles River) were treated in accordance with the ethical guidelines adopted by Massachusetts General Hospital as defined by the Institutional Animal Care and Use Committee. Mice were injected subcutaneously with vehicle (10 mM citric acid/150 mM NaCl/0.05% Tween-80, pH 5.0) containing <b>1</b> or α/β-peptide at a dose of 20 nmol/kg body weight using numbers of animals indicated in figure captions. Blood was withdrawn just prior to injection (<i>t</i> = 0) or at times thereafter. Tail vein blood was collected and immediately used for analysis. Blood Ca<sup>2+</sup> concentration was measured with a Siemens RapidLab 348 Ca<sup>2+</sup>/pH analyzer.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> In Vivo Pharmacology: Pharmacokinetics</h3><div class="NLM_p last">Blood content of <b>1</b> or α/β-peptide derivatives was assessed in serum from mice (<i>n</i> = 5) injected with vehicle containing <b>1</b> or an α/β-peptide at a dose of 20 nmol/kg body weight in an experiment performed separately from the calcemic response assays described above. Blood was withdrawn just prior to injection (<i>t</i> = 0) or at times thereafter. Tail vein blood was collected and treated with protease inhibitors (aprotinin, leupeptin, EDTA), centrifuged to remove blood cells, mixed with cAMP response assay buffer, and administered to GP2.3 cells. The raw luminescence readouts recorded in this assay were converted to blood peptide concentrations through use of a standard curve relating luminescence response to known peptide concentrations under identical assay conditions (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 8</a>). Previous work has demonstrated this cAMP response-based method for quantifying the blood concentrations of PTHR1 agonists yields results similar to those from an ELISA-based method. Previous experiments showed GP2.3 cells exposed to plasma from mice injected only with vehicle showed weak luminescence responses, indicating that observed cAMP responses were dependent on exogenous administration of a PTHR1 agonist.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Reversed-Phase Analytical HPLC Retention Time Study</h3><div class="NLM_p last">Peptides were injected onto a reversed phase analytical HPLC column using a 10–60% gradient of solvent B in solvent A, as described in the peptide synthesis section above. The retention time indicated corresponds to the time at which the maximal signal corresponding to the peptide of interest was observed. All peptides were injected consecutively on the same day using identical conditions. <b>1</b> was injected at the beginning and end of the studies to provide an estimation for variation in retention time resulting from alterations in instrument function. This variation is estimated to be less than 2 min.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Circular Dichroism Spectroscopy</h3><div class="NLM_p last">Data collection was performed using an Aviv 420 circular dichroism spectrophotometer. Wavelength scans were acquired at 20 °C using a 1 nm step size and an averaging time of 3.0 s from 260 to 195 nm. A 0.1 cm cell was used for all spectra. All samples were prepared at a peptide concentration of 50 μM in 10 mM sodium phosphate buffer, pH 7.0. Peptide concentrations were calculated by measuring absorption at 280 nm after dissolving lyophilized peptide samples in sodium phosphate buffer (assuming ε(Trp) = 5690 M<sup>–1</sup> cm<sup>–1</sup> at 280 nm).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Data Calculations</h3><div class="NLM_p last">Data were processed by using the Microsoft Excel and GraphPad Prism 4.0 software packages. Data from binding and cAMP dose–response assays were analyzed using a sigmoidal dose–response model with variable slope. Selected data sets were statistically compared by using one-way ANOVA with Dunnett’s multiple comparison post hoc test. Significance was assumed for <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00876">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00876" class="ext-link">10.1021/acs.jmedchem.7b00876</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Supplementary methods and supplementary Figures 1–17 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_001.csv">jm7b00876_si_001.csv (30.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf">jm7b00876_si_002.pdf (6.81 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00876" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas J. Gardella</span> - <span class="hlFld-Affiliation affiliation">Endocrine
Unit, Massachusetts General Hospital and
Harvard Medical School, Boston, Massachusetts 02114, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#86e1e7f4e2e3eaeae7c6eee3eaeffea8ebe1eea8eee7f4f0e7f4e2a8e3e2f3"><span class="__cf_email__" data-cfemail="3a5d5b485e5f56565b7a525f56534214575d5214525b484c5b485e145f5e4f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samuel H. Gellman</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Wisconsin—Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddbab8b1b1b0bcb39dbeb5b8b0f3aab4aebef3b8b9a8"><span class="__cf_email__" data-cfemail="aacdcfc6c6c7cbc4eac9c2cfc784ddc3d9c984cfcedf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ross W. Cheloha</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Wisconsin—Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9871-8333" title="Orcid link">http://orcid.org/0000-0001-9871-8333</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bingming Chen</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Wisconsin—Madison, 777 Highland Avenue, Madison, Wisconsin 53705, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niyanta N. Kumar</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Wisconsin—Madison, 777 Highland Avenue, Madison, Wisconsin 53705, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomoyuki Watanabe</span> - <span class="hlFld-Affiliation affiliation">Endocrine
Unit, Massachusetts General Hospital and
Harvard Medical School, Boston, Massachusetts 02114, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert G. Thorne</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Wisconsin—Madison, 777 Highland Avenue, Madison, Wisconsin 53705, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Clinical
Neuroengineering Training Program, University
of Wisconsin—Madison Biomedical Engineering, Engineering Centers Building, Room 2120, 1550 Engineering
Drive, Madison Wisconsin 53706, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Neuroscience
Training Program & Center for Neuroscience, Wisconsin Institutes for Medical Research II, Rooms 9531 and 9533, 1111 Highland Avenue, Madison, Wisconsin 53705, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Cellular
and Molecular Pathology Graduate Training Program, UW Department of
Pathology and Laboratory Medicine, University
of Wisconsin—Madison, 1685 Highland Avenue, Madison, Wisconsin 53705, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lingjun Li</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Wisconsin—Madison, 777 Highland Avenue, Madison, Wisconsin 53705, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Wisconsin—Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0056-3869" title="Orcid link">http://orcid.org/0000-0003-0056-3869</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): S.H.G. is a co-founder of Longevity Biotech, Inc., which is pursuing biomedical applications of α/β-peptides. S.H.G., R.W.C., and T.J.G. are co-inventors on a patent application covering the PTH analogues described here. T.W. is an employee of Chugai Pharmaceutical Co. Ltd. and contributed to this work as an appointee at Massachusetts General Hospital.<br /></br></div></li></ul></div><div class="ack" id="ACK-d127e3257-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Institutes of Health Grants GM-056414 (R01, S.H.G.), DK11794 (PO1, T.J.G.), and AR066261 (P30, T.J.G.). R.W.C. was supported in part by Biotechnology Training Grant T32 GM008349 from NIGMS. Additional support was provided by the Wisconsin Alumni Research Foundation Discovery Challenge (R.W.C., B.C., N.N.K.), the University of Wisconsin—Madison Institute for Clinical and Translational Research and the Clinical and Translational Science Award program administered through the NIH National Center for Advancing Translational Sciences (NIH Grants UL1TR000427 and KL2TR00428 to R.G.T), and the University of Wisconsin–Madison School of Pharmacy (N.N.K, R.G.T). The LC/MS instrument was purchased through funding support from NIH Grant S10 RR029531. L.L. acknowledges a Vilas Distinguished Achievement Professorship with funding provided by the WARF and University of Wisconsin—Madison School of Pharmacy. We thank the Analytical Instrumentation Center (School of Pharmacy, University of Wisconsin—Madison) for instrumentation support. We thank Thomas Dean (Massachusetts General Hospital) for excellent technical assistance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">PTHR1</td><td class="NLM_def"><p class="first last">type 1 parathyroid hormone receptor</p></td></tr><tr><td class="NLM_term">ACPC</td><td class="NLM_def"><p class="first last">(1<i>S</i>,2<i>S</i>)-2-aminocyclopentanecarboxylic acid</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">(3<i>R</i>,4<i>S</i>)-<i>trans</i>-4-aminopyrrolidine-3-carboxylic acid</p></td></tr><tr><td class="NLM_term">SGF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term">SIF</td><td class="NLM_def"><p class="first last">simulated intestinal fluid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 95 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Signaling - 2000 and beyond</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)81688-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2FS0092-8674%2800%2981688-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=113-127&issue=1&author=T.+Hunter&title=Signaling+-+2000+and+beyond&doi=10.1016%2FS0092-8674%2800%2981688-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981688-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981688-8%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DSignaling%2520-%25202000%2520and%2520beyond%26jtitle%3DCell%26date%3D2000%26volume%3D100%26issue%3D1%26spage%3D113%26epage%3D127%26doi%3D10.1016%2FS0092-8674%2800%2981688-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Leader, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golan, D. E.</span><span> </span><span class="NLM_article-title">Protein therapeutics: A summary and pharmacological classification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/nrd2399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnrd2399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=18097458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=21-39&issue=1&author=B.+Leaderauthor=Q.+J.+Bacaauthor=D.+E.+Golan&title=Protein+therapeutics%3A+A+summary+and+pharmacological+classification&doi=10.1038%2Fnrd2399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein therapeutics: a summary and pharmacological classification</span></div><div class="casAuthors">Leader, Benjamin; Baca, Quentin J.; Golan, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-39</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in no. and frequency of use since the introduction of the first recombinant protein therapeutic - human insulin - 25 years ago.  Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy.  This article overviews some of the key characteristics of protein therapeutics, summarizes the more than 130 protein therapeutics used currently and suggests a new classification of these proteins according to their pharmacol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDJwirgv5WN7Vg90H21EOLACvtfcHk0lj4bgGh9LFEyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ygtQ%253D%253D&md5=761a9860e38c98295385641dda94b31f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2399%26sid%3Dliteratum%253Aachs%26aulast%3DLeader%26aufirst%3DB.%26aulast%3DBaca%26aufirst%3DQ.%2BJ.%26aulast%3DGolan%26aufirst%3DD.%2BE.%26atitle%3DProtein%2520therapeutics%253A%2520A%2520summary%2520and%2520pharmacological%2520classification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D1%26spage%3D21%26epage%3D39%26doi%3D10.1038%2Fnrd2399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Diao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meibohm, B.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1007/s40262-013-0079-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1007%2Fs40262-013-0079-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23719681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSmt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=855-868&issue=10&author=L.+Diaoauthor=B.+Meibohm&title=Pharmacokinetics+and+pharmacokinetic-pharmacodynamic+correlations+of+therapeutic+peptides&doi=10.1007%2Fs40262-013-0079-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Correlations of Therapeutic Peptides</span></div><div class="casAuthors">Diao, Lei; Meibohm, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">855-868</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Peptides, defined as polymers of less than 50 amino acids with a mol. wt. of less than 10 kDa, represent a fast-growing class of new therapeutics which has unique pharmacokinetic characteristics compared to large proteins or small mol. drugs.  Unmodified peptides usually undergo extensive proteolytic cleavage, resulting in short plasma half-lives.  As a result of their low permeability and susceptibility to catabolic degrdn., therapeutic peptides usually have very limited oral bioavailability and are administered either by the i.v., s.c., or i.m. route, although other routes such as nasal delivery are utilized as well.  Distribution processes are mainly driven by a combination of diffusion and to a lesser degree convective extravasation dependent on the size of the peptide, with vols. of distribution frequently not larger than the vol. of the extracellular body fluid.  Owing to the ubiquitous availability of proteases and peptidases throughout the body, proteolytic degrdn. is not limited to classic elimination organs.  Since peptides are generally freely filtered by the kidneys, glomerular filtration and subsequent renal metab. by proteolysis contribute to the elimination of many therapeutic peptides.  Although small peptides have usually limited immunogenicity, formation of anti-drug antibodies with subsequent hypersensitivity reactions has been described for some peptide therapeutics.  Numerous strategies have been applied to improve the pharmacokinetic properties of therapeutic peptides, esp. to overcome their metabolic instability, low permeability, and limited tissue residence time.  Applied techniques include amino acid substitutions, modification of the peptide terminus, inclusion of disulfide bonds, and conjugation with polymers or macromols. such as antibody fragments or albumin.  Application of model-based pharmacokinetic-pharmacodynamic correlations has been widely used for therapeutic peptides in support of drug development and dosage regimen design, esp. because their targets are often well-described endogenous regulatory pathways and processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmlFFOIFoZBrVg90H21EOLACvtfcHk0lj4bgGh9LFEyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSmt77I&md5=975af68c1bbc3dda4b3dbe42b3e40181</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs40262-013-0079-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-013-0079-0%26sid%3Dliteratum%253Aachs%26aulast%3DDiao%26aufirst%3DL.%26aulast%3DMeibohm%26aufirst%3DB.%26atitle%3DPharmacokinetics%2520and%2520pharmacokinetic-pharmacodynamic%2520correlations%2520of%2520therapeutic%2520peptides%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26issue%3D10%26spage%3D855%26epage%3D868%26doi%3D10.1007%2Fs40262-013-0079-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Vlieghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khrestchatisky, M.</span><span> </span><span class="NLM_article-title">Synthetic therapeutic peptides: science and market</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.drudis.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.drudis.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19879957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsV2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=40-56&issue=1%E2%80%932&author=P.+Vliegheauthor=V.+Lisowskiauthor=J.+Martinezauthor=M.+Khrestchatisky&title=Synthetic+therapeutic+peptides%3A+science+and+market&doi=10.1016%2Fj.drudis.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic therapeutic peptides: science and market</span></div><div class="casAuthors">Vlieghe, Patrick; Lisowski, Vincent; Martinez, Jean; Khrestchatisky, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">40-56</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The decreasing no. of approved drugs produced by the pharmaceutical industry, which has been accompanied by increasing expenses for R&D, demands alternative approaches to increase pharmaceutical R&D productivity.  This situation has contributed to a revival of interest in peptides as potential drug candidates.  New synthetic strategies for limiting metab. and alternative routes of administration have emerged in recent years and resulted in a large no. of peptide-based drugs that are now being marketed.  This review reports on the unexpected and considerable no. of peptides that are currently available as drugs and the chem. strategies that were used to bring them into the market.  As demonstrated here, peptide-based drug discovery could be a serious option for addressing new therapeutic challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsoAe6RtqbV7Vg90H21EOLACvtfcHk0lj7B1IFSXpu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsV2iug%253D%253D&md5=9d72257b9e9e8530a19ed959b88507f3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DVlieghe%26aufirst%3DP.%26aulast%3DLisowski%26aufirst%3DV.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26atitle%3DSynthetic%2520therapeutic%2520peptides%253A%2520science%2520and%2520market%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26issue%3D1%25E2%2580%25932%26spage%3D40%26epage%3D56%26doi%3D10.1016%2Fj.drudis.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fosgerau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span> </span><span class="NLM_article-title">Peptide therapeutics: current status and future directions</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.drudis.2014.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25450771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2ksLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=122-128&issue=1&author=K.+Fosgerauauthor=T.+Hoffmann&title=Peptide+therapeutics%3A+current+status+and+future+directions&doi=10.1016%2Fj.drudis.2014.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide therapeutics: current status and future directions</span></div><div class="casAuthors">Fosgerau, Keld; Hoffmann, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-128</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated.  Consequently, there is an increased interest in peptides in pharmaceutical research and development (R&D), and approx. 140 peptide therapeutics are currently being evaluated in clin. trials.  Given that the low-hanging fruits in the form of obvious peptide targets have already been picked, it has now become necessary to explore new routes beyond traditional peptide design.  Examples of such approaches are multifunctional and cell penetrating peptides, as well as peptide drug conjugates.  Here, we discuss the current status, strengths, and weaknesses of peptides as medicines and the emerging new opportunities in peptide drug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmhpp8GnJ6JLVg90H21EOLACvtfcHk0lj7B1IFSXpu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2ksLnM&md5=f6b74aaa4e3fdb317b091b0450f3618a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DFosgerau%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DT.%26atitle%3DPeptide%2520therapeutics%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26issue%3D1%26spage%3D122%26epage%3D128%26doi%3D10.1016%2Fj.drudis.2014.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Targeting recognition surfaces on natural proteins with peptidic foldamers</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.sbi.2016.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.sbi.2016.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=27390896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGitr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=96-105&author=J.+W.+Checcoauthor=S.+H.+Gellman&title=Targeting+recognition+surfaces+on+natural+proteins+with+peptidic+foldamers&doi=10.1016%2Fj.sbi.2016.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting recognition surfaces on natural proteins with peptidic foldamers</span></div><div class="casAuthors">Checco, James W.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-105</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Mols. intended to antagonize protein-protein interactions or augment polypeptide-based signaling must bind tightly to large and sp. surfaces on target proteins.  Some types of unnatural oligomers with discrete folding propensities ('foldamers') have recently been shown to display this capability.  This review covers important recent advances among several classes of foldamers, including α-peptides with secondary structures stabilized by covalent bonds, D-α-peptides, α/β-peptides and oligo-oxopiperazines.  Recent advances in this area have involved enhancing membrane permeability to provide access to intracellular protein targets, improving pharmacokinetics and duration of action in vivo, and developing strategies appropriate for targeting large and irregularly-shaped protein surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpip8E4TMLoWLVg90H21EOLACvtfcHk0lj7B1IFSXpu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGitr%252FE&md5=59db458d1a2f21a7c60ecf3ff6cdc862</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2016.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2016.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DTargeting%2520recognition%2520surfaces%2520on%2520natural%2520proteins%2520with%2520peptidic%2520foldamers%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2016%26volume%3D39%26spage%3D96%26epage%3D105%26doi%3D10.1016%2Fj.sbi.2016.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pelay-Gimeno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, T. N.</span><span> </span><span class="NLM_article-title">Structure-based design of inhibitors of protein-protein interactions: mimicking peptide binding epitopes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">8896</span><span class="NLM_x">–</span> <span class="NLM_lpage">8927</span><span class="refDoi"> DOI: 10.1002/anie.201412070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fanie.201412070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOmu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=8896-8927&issue=31&author=M.+Pelay-Gimenoauthor=A.+Glasauthor=O.+Kochauthor=T.+N.+Grossmann&title=Structure-based+design+of+inhibitors+of+protein-protein+interactions%3A+mimicking+peptide+binding+epitopes&doi=10.1002%2Fanie.201412070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes</span></div><div class="casAuthors">Pelay-Gimeno, Marta; Glas, Adrian; Koch, Oliver; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">8896-8927</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions (PPIs) are involved at all levels of cellular organization, thus making the development of PPI inhibitors extremely valuable.  The identification of selective inhibitors is challenging because of the shallow and extended nature of PPI interfaces.  Inhibitors can be obtained by mimicking peptide binding epitopes in their bioactive conformation.  For this purpose, several strategies have been evolved to enable a projection of side chain functionalities in analogy to peptide secondary structures, thereby yielding mols. that are generally referred to as peptidomimetics.  Herein, we introduce a new classification of peptidomimetics (classes A-D) that enables a clear assignment of available approaches.  Based on this classification, the Review summarizes strategies that have been applied for the structure-based design of PPI inhibitors through stabilizing or mimicking turns, β-sheets, and helixes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPTEmZpatXbrVg90H21EOLACvtfcHk0ljnzWc6QgqrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOmu7rM&md5=447c84aab6275b1057fda9a610918f2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fanie.201412070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201412070%26sid%3Dliteratum%253Aachs%26aulast%3DPelay-Gimeno%26aufirst%3DM.%26aulast%3DGlas%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DO.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DStructure-based%2520design%2520of%2520inhibitors%2520of%2520protein-protein%2520interactions%253A%2520mimicking%2520peptide%2520binding%2520epitopes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26issue%3D31%26spage%3D8896%26epage%3D8927%26doi%3D10.1002%2Fanie.201412070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kushal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henchey, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesallati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traaseth, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olenyuk, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, P. S.</span><span> </span><span class="NLM_article-title">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">39</span><span class="NLM_x">) </span> <span class="NLM_fpage">15602</span><span class="NLM_x">–</span> <span class="NLM_lpage">15607</span><span class="refDoi"> DOI: 10.1073/pnas.1312473110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1312473110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24019500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15602-15607&issue=39&author=S.+Kushalauthor=B.+B.+Laoauthor=L.+K.+Hencheyauthor=R.+Dubeyauthor=H.+Mesallatiauthor=N.+J.+Traasethauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=Protein+domain+mimetics+as+in+vivo+modulators+of+hypoxia-inducible+factor+signaling&doi=10.1073%2Fpnas.1312473110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span></div><div class="casAuthors">Kushal, Swati; Lao, Brooke Bullock; Henchey, Laura K.; Dubey, Ramin; Mesallati, Hanah; Traaseth, Nathaniel J.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15602-15607,S15602/1-S15602/29</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Selective blockade of gene expression by designed small mols. is a fundamental challenge at the interface of chem., biol., and medicine.  Transcription factors have been among the most elusive targets in genetics and drug discovery, but the fields of chem. biol. and genetics have evolved to a point where this task can be addressed.  Herein we report the design, synthesis, and in vivo efficacy evaluation of a protein domain mimetic targeting the interaction of the p300/CBP coactivator with the transcription factor hypoxia-inducible factor-1α.  Our results indicate that disrupting this interaction results in a rapid down-regulation of hypoxia-inducible genes crit. for cancer progression.  The obsd. effects were compd.-specific and dose-dependent.  Gene expression profiling with oligonucleotide microarrays revealed effective inhibition of hypoxia-inducible genes with relatively minimal perturbation of nontargeted signaling pathways.  We obsd. remarkable efficacy of the compd. HBS 1 in suppressing tumor growth in the fully established murine xenograft models of renal cell carcinoma of the clear cell type.  Our results suggest that rationally designed synthetic mimics of protein subdomains that target the transcription factor-coactivator interfaces represent a unique approach for in vivo modulation of oncogenic signaling and arresting tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM3XHm6lQqWrVg90H21EOLACvtfcHk0ljnzWc6QgqrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK&md5=230a70f6e32b3abc3c10abd7fb8df533</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312473110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312473110%26sid%3Dliteratum%253Aachs%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DTraaseth%26aufirst%3DN.%2BJ.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DProtein%2520domain%2520mimetics%2520as%2520in%2520vivo%2520modulators%2520of%2520hypoxia-inducible%2520factor%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D39%26spage%3D15602%26epage%3D15607%26doi%3D10.1073%2Fpnas.1312473110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Takada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhdeo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivdasani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, D. R.</span><span> </span><span class="NLM_article-title">Targeted disruption of the BCL9/beta-catenin complex inhibits oncogenic Wnt signaling</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">148</span><span class="NLM_x">) </span> <span class="NLM_fpage">148ra117</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1126%2Fscitranslmed.3003808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=22914623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=148ra117&issue=148&author=K.+Takadaauthor=D.+Zhuauthor=G.+H.+Birdauthor=K.+Sukhdeoauthor=J.+J.+Zhaoauthor=M.+Maniauthor=M.+Lemieuxauthor=D.+E.+Carrascoauthor=J.+Ryanauthor=D.+Horstauthor=M.+Fulcinitiauthor=N.+C.+Munshiauthor=W.+Q.+Xuauthor=A.+L.+Kungauthor=R.+A.+Shivdasaniauthor=L.+D.+Walenskyauthor=D.+R.+Carrasco&title=Targeted+disruption+of+the+BCL9%2Fbeta-catenin+complex+inhibits+oncogenic+Wnt+signaling&doi=10.1126%2Fscitranslmed.3003808"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003808%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DSukhdeo%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DMani%26aufirst%3DM.%26aulast%3DLemieux%26aufirst%3DM.%26aulast%3DCarrasco%26aufirst%3DD.%2BE.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DHorst%26aufirst%3DD.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DXu%26aufirst%3DW.%2BQ.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DCarrasco%26aufirst%3DD.%2BR.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520BCL9%252Fbeta-catenin%2520complex%2520inhibits%2520oncogenic%2520Wnt%2520signaling%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26issue%3D148%26spage%3D148ra117%26doi%3D10.1126%2Fscitranslmed.3003808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishagin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesallati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olenyuk, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, P. S.</span><span> </span><span class="NLM_article-title">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">7531</span><span class="NLM_x">–</span> <span class="NLM_lpage">7536</span><span class="refDoi"> DOI: 10.1073/pnas.1402393111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1402393111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24821806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=7531-7536&issue=21&author=B.+B.+Laoauthor=I.+Grishaginauthor=H.+Mesallatiauthor=T.+F.+Brewerauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=In+vivo+modulation+of+hypoxia-inducible+signaling+by+topographical+helix+mimetics&doi=10.1073%2Fpnas.1402393111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span></div><div class="casAuthors">Lao, Brooke Bullock; Grishagin, Ivan; Mesallati, Hanah; Brewer, Thomas F.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Development of small-mol. inhibitors of protein-protein interactions is a fundamental challenge at the interface of chem. and cancer biol.  Successful methods for design of protein-protein interaction inhibitors include computational and exptl. high-throughput and fragment-based screening strategies to locate small-mol. fragments that bind protein surfaces.  An alternative rational design approach seeks to mimic the orientation and disposition of crit. binding residues at protein interfaces.  The authors describe the design, synthesis, biochem., and in vivo evaluation of a small-mol. scaffold that captures the topog. of α-helixes.  The authors designed mimics of a key α-helical domain at the interface of hypoxia-inducible factor 1α and p300 to develop inhibitors of hypoxia-inducible signaling.  The hypoxia-inducible factor/p300 interaction regulates the transcription of key genes, whose expression contributes to angiogenesis, metastasis, and altered energy metab. in cancer.  The designed compds. target the desired protein with high affinity and in a predetd. manner, with the optimal ligand providing effective redn. of tumor burden in exptl. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7DvqFbX-7prVg90H21EOLACvtfcHk0ljCmNTyuNZ0tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D&md5=34b4289424a570528a22e6eca0fb502e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1402393111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1402393111%26sid%3Dliteratum%253Aachs%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DGrishagin%26aufirst%3DI.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DBrewer%26aufirst%3DT.%2BF.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DIn%2520vivo%2520modulation%2520of%2520hypoxia-inducible%2520signaling%2520by%2520topographical%2520helix%2520mimetics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D21%26spage%3D7531%26epage%3D7536%26doi%3D10.1073%2Fpnas.1402393111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Backbone modification of a parathyroid hormone receptor-1 antagonist/inverse agonist</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2752</span><span class="NLM_x">–</span> <span class="NLM_lpage">2762</span><span class="refDoi"> DOI: 10.1021/acschembio.6b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2752-2762&issue=10&author=R.+W.+Chelohaauthor=T.+Watanabeauthor=T.+Deanauthor=S.+H.+Gellmanauthor=T.+J.+Gardella&title=Backbone+modification+of+a+parathyroid+hormone+receptor-1+antagonist%2Finverse+agonist&doi=10.1021%2Facschembio.6b00404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00404%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DBackbone%2520modification%2520of%2520a%2520parathyroid%2520hormone%2520receptor-1%2520antagonist%252Finverse%2520agonist%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D10%26spage%3D2752%26epage%3D2762%26doi%3D10.1021%2Facschembio.6b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Backbone modification of a polypeptide drug alters duration of action in vivo</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1038/nbt.2920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnbt.2920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24929976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslGis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=653-655&issue=7&author=R.+W.+Chelohaauthor=A.+Maedaauthor=T.+Deanauthor=T.+J.+Gardellaauthor=S.+H.+Gellman&title=Backbone+modification+of+a+polypeptide+drug+alters+duration+of+action+in+vivo&doi=10.1038%2Fnbt.2920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Backbone modification of a polypeptide drug alters duration of action in vivo</span></div><div class="casAuthors">Cheloha, Ross W.; Maeda, Akira; Dean, Thomas; Gardella, Thomas J.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">653-655</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Systematic modification of the backbone of bioactive polypeptides through β-amino acid residue incorporation could provide a strategy for generating mols. with improved drug properties, but such alterations can result in lower receptor affinity and potency.  Using an agonist of parathyroid hormone receptor-1 (PTHR1), a G protein-coupled receptor in the B-family, we present an approach for α→β residue replacement that enables both high activity and improved pharmacokinetic properties in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8cWxIA-3shbVg90H21EOLACvtfcHk0ljCmNTyuNZ0tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslGis7k%253D&md5=100382f0d7e67fe9c11fd39886e7acac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2920%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DMaeda%26aufirst%3DA.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DBackbone%2520modification%2520of%2520a%2520polypeptide%2520drug%2520alters%2520duration%2520of%2520action%2520in%2520vivo%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26issue%3D7%26spage%3D653%26epage%3D655%26doi%3D10.1038%2Fnbt.2920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFedries, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabaglia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attie, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghatelian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">A Potent alpha/beta-peptide analogue of GLP-1 with prolonged action in vivo</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x"> (</span><span class="NLM_issue">37</span><span class="NLM_x">) </span> <span class="NLM_fpage">12848</span><span class="NLM_x">–</span> <span class="NLM_lpage">12851</span><span class="refDoi"> DOI: 10.1021/ja507168t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja507168t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=12848-12851&issue=37&author=L.+M.+Johnsonauthor=S.+Barrickauthor=M.+V.+Hagerauthor=A.+McFedriesauthor=E.+A.+Homanauthor=M.+E.+Rabagliaauthor=M.+P.+Kellerauthor=A.+D.+Attieauthor=A.+Saghatelianauthor=A.+Biselloauthor=S.+H.+Gellman&title=A+Potent+alpha%2Fbeta-peptide+analogue+of+GLP-1+with+prolonged+action+in+vivo&doi=10.1021%2Fja507168t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja507168t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja507168t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DBarrick%26aufirst%3DS.%26aulast%3DHager%26aufirst%3DM.%2BV.%26aulast%3DMcFedries%26aufirst%3DA.%26aulast%3DHoman%26aufirst%3DE.%2BA.%26aulast%3DRabaglia%26aufirst%3DM.%2BE.%26aulast%3DKeller%26aufirst%3DM.%2BP.%26aulast%3DAttie%26aufirst%3DA.%2BD.%26aulast%3DSaghatelian%26aufirst%3DA.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DA%2520Potent%2520alpha%252Fbeta-peptide%2520analogue%2520of%2520GLP-1%2520with%2520prolonged%2520action%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D37%26spage%3D12848%26epage%3D12851%26doi%3D10.1021%2Fja507168t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Olson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosloski-Bilek, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggs, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gledhill, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandler, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">16463</span><span class="NLM_x">–</span> <span class="NLM_lpage">16478</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2131-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1523%2FJNEUROSCI.2131-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26674871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKksrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=16463-16478&issue=50&author=K.+E.+Olsonauthor=L.+M.+Kosloski-Bilekauthor=K.+M.+Andersonauthor=B.+J.+Diggsauthor=B.+E.+Clarkauthor=J.+M.+Gledhillauthor=S.+J.+Shandlerauthor=R.+L.+Mosleyauthor=H.+E.+Gendelman&title=Selective+VIP+receptor+agonists+facilitate+immune+transformation+for+dopaminergic+neuroprotection+in+MPTP-intoxicated+mice&doi=10.1523%2FJNEUROSCI.2131-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice</span></div><div class="casAuthors">Olson, Katherine E.; Kosloski-Bilek, Lisa M.; Anderson, Kristi M.; Diggs, Breha J.; Clark, Barbara E.; Gledhill, John M., Jr.; Shandler, Scott J.; Mosley, R. Lee; Gendelman, Howard E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">16463-16478</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Vasoactive intestinal peptide (VIP) mediates a broad range of biol. responses by activating two related receptors, VIP receptor 1 and 2 (VIPR1 and VIPR2).  Although the use of native VIP facilitates neuroprotection, clin. application of the hormone is limited due to VIP's rapid metab. and inability to distinguish between VIPR1 and VIPR2 receptors.  In addn., activation of both receptors by therapeutics may increase adverse secondary toxicities.  Therefore, we developed metabolically stable and receptor-selective agonists for VIPR1 and VIPR2 to improve pharmacokinetic and pharmacodynamic therapeutic end points.  Selective agonists were investigated for their abilities to protect mice against MPTP-induced neurodegeneration used to model Parkinson's disease (PD).  Survival of tyrosine hydroxylase neurons in the substantia nigra was detd. by stereol. tests after MPTP intoxication in mice pretreated with either VIPR1 or VIPR2 agonist or after adoptive transfer of splenic cell populations from agonist-treated mice administered to MPTP-intoxicated animals.  Treatment with VIPR2 agonist or splenocytes from agonist-treated mice resulted in increased neuronal sparing.  Immunohistochem. tests showed that agonist-treated mice displayed redns. in microglial responses, with the most pronounced effects in VIPR2 agonist-treated, MPTP-intoxicated mice.  In parallel studies, we obsd. redns. in proinflammatory cytokine release that included IL-17A, IL-6, and IFN-γ and increases in GM-CSF transcripts in CD4+ T cells recovered from VIPR2 agonist-treated animals.  Moreover, a phenotypic shift of effector to regulatory T cells was obsd.  These results support the use of VIPR2-selective agonists as neuroprotective agents for PD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRx4gmaC1rqbVg90H21EOLACvtfcHk0ljSt8v-_QGw4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKksrzL&md5=1d2a7514f18eb697d8e7a411d6f7349d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2131-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2131-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DK.%2BE.%26aulast%3DKosloski-Bilek%26aufirst%3DL.%2BM.%26aulast%3DAnderson%26aufirst%3DK.%2BM.%26aulast%3DDiggs%26aufirst%3DB.%2BJ.%26aulast%3DClark%26aufirst%3DB.%2BE.%26aulast%3DGledhill%26aufirst%3DJ.%2BM.%26aulast%3DShandler%26aufirst%3DS.%2BJ.%26aulast%3DMosley%26aufirst%3DR.%2BL.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DSelective%2520VIP%2520receptor%2520agonists%2520facilitate%2520immune%2520transformation%2520for%2520dopaminergic%2520neuroprotection%2520in%2520MPTP-intoxicated%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D50%26spage%3D16463%26epage%3D16478%26doi%3D10.1523%2FJNEUROSCI.2131-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sand, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suresh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Consequences of periodic alpha-to-beta(3) residue replacement for immunological recognition of peptide epitopes</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1021/cb500888q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500888q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=844-854&issue=3&author=R.+W.+Chelohaauthor=J.+A.+Sullivanauthor=T.+Wangauthor=J.+M.+Sandauthor=J.+Sidneyauthor=A.+Setteauthor=M.+E.+Cookauthor=M.+Sureshauthor=S.+H.+Gellman&title=Consequences+of+periodic+alpha-to-beta%283%29+residue+replacement+for+immunological+recognition+of+peptide+epitopes&doi=10.1021%2Fcb500888q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb500888q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500888q%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DSullivan%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DSand%26aufirst%3DJ.%2BM.%26aulast%3DSidney%26aufirst%3DJ.%26aulast%3DSette%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DM.%2BE.%26aulast%3DSuresh%26aufirst%3DM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DConsequences%2520of%2520periodic%2520alpha-to-beta%25283%2529%2520residue%2520replacement%2520for%2520immunological%2520recognition%2520of%2520peptide%2520epitopes%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D3%26spage%3D844%26epage%3D854%26doi%3D10.1021%2Fcb500888q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Uppalapati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault-Riche, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, S. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, S. S.</span><span> </span><span class="NLM_article-title">A potent D-protein antagonist of VEGF-A is nonimmunogenic, metabolically stable, and longer-circulating in vivo</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span><span class="refDoi"> DOI: 10.1021/acschembio.5b01006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b01006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1058-1065&issue=4&author=M.+Uppalapatiauthor=D.+J.+Leeauthor=K.+Mandalauthor=H.+Y.+Liauthor=L.+P.+Mirandaauthor=J.+Lowitzauthor=J.+Kenneyauthor=J.+J.+Adamsauthor=D.+Ault-Richeauthor=S.+B.+H.+Kentauthor=S.+S.+Sidhu&title=A+potent+D-protein+antagonist+of+VEGF-A+is+nonimmunogenic%2C+metabolically+stable%2C+and+longer-circulating+in+vivo&doi=10.1021%2Facschembio.5b01006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b01006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b01006%26sid%3Dliteratum%253Aachs%26aulast%3DUppalapati%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DD.%2BJ.%26aulast%3DMandal%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.%2BY.%26aulast%3DMiranda%26aufirst%3DL.%2BP.%26aulast%3DLowitz%26aufirst%3DJ.%26aulast%3DKenney%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DJ.%2BJ.%26aulast%3DAult-Riche%26aufirst%3DD.%26aulast%3DKent%26aufirst%3DS.%2BB.%2BH.%26aulast%3DSidhu%26aufirst%3DS.%2BS.%26atitle%3DA%2520potent%2520D-protein%2520antagonist%2520of%2520VEGF-A%2520is%2520nonimmunogenic%252C%2520metabolically%2520stable%252C%2520and%2520longer-circulating%2520in%2520vivo%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D4%26spage%3D1058%26epage%3D1065%26doi%3D10.1021%2Facschembio.5b01006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klasse, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">14751</span><span class="NLM_x">–</span> <span class="NLM_lpage">14756</span><span class="refDoi"> DOI: 10.1073/pnas.0902663106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0902663106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19706443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGrtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=14751-14756&issue=35&author=W.+S.+Horneauthor=L.+M.+Johnsonauthor=T.+J.+Ketasauthor=P.+J.+Klasseauthor=M.+Luauthor=J.+P.+Mooreauthor=S.+H.+Gellman&title=Structural+and+biological+mimicry+of+protein+surface+recognition+by+alpha%2Fbeta-peptide+foldamers&doi=10.1073%2Fpnas.0902663106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers</span></div><div class="casAuthors">Horne, W. Seth; Johnson, Lisa M.; Ketas, Thomas J.; Klasse, Per Johan; Lu, Min; Moore, John P.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">14751-14756, S14751/1-S14751/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Unnatural oligomers that can mimic protein surfaces offer a potentially useful strategy for blocking biomedically important protein-protein interactions.  Here we evaluate an approach based on combining α- and β-amino acid residues in the context of a polypeptide sequence from the HIV protein gp41, which represents an excellent testbed because of the wealth of available structural and biol. information.  We show that α/β-peptides can mimic structural and functional properties of a crit. gp41 subunit.  Phys. studies in soln., crystallog. data, and results from cell-fusion and virus-infectivity assays collectively indicate that the gp41-mimetic α/β-peptides effectively block HIV-cell fusion via a mechanism comparable to that of gp41-derived α-peptides.  An optimized α/β-peptide is far less susceptible to proteolytic degrdn. than is an analogous α-peptide.  Our findings show how a two-stage design approach, in which sequence-based α → β replacements are followed by site-specific backbone rigidification, can lead to phys. and biol. mimicry of a natural biorecognition process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAN0drYgQtaLVg90H21EOLACvtfcHk0ljrIR6qYc2E5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGrtrfP&md5=e56297c79b7388ae517515c271c0fef3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0902663106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0902663106%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DStructural%2520and%2520biological%2520mimicry%2520of%2520protein%2520surface%2520recognition%2520by%2520alpha%252Fbeta-peptide%2520foldamers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D35%26spage%3D14751%26epage%3D14756%26doi%3D10.1073%2Fpnas.0902663106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">2853</span><span class="NLM_x">–</span> <span class="NLM_lpage">2856</span><span class="refDoi"> DOI: 10.1002/anie.200705315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fanie.200705315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=2853-2856&issue=15&author=W.+S.+Horneauthor=M.+D.+Boersmaauthor=M.+A.+Windsorauthor=S.+H.+Gellman&title=Sequence-based+design+of+alpha%2Fbeta-peptide+foldamers+that+mimic+BH3+domains&doi=10.1002%2Fanie.200705315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.200705315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200705315%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DBoersma%26aufirst%3DM.%2BD.%26aulast%3DWindsor%26aufirst%3DM.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DSequence-based%2520design%2520of%2520alpha%252Fbeta-peptide%2520foldamers%2520that%2520mimic%2520BH3%2520domains%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26issue%3D15%26spage%3D2853%26epage%3D2856%26doi%3D10.1002%2Fanie.200705315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreitler, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettko, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forest, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Targeting diverse protein-protein interaction interfaces with alpha/beta-peptides derived from the Z-domain scaffold</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4552</span><span class="NLM_x">–</span> <span class="NLM_lpage">4557</span><span class="refDoi"> DOI: 10.1073/pnas.1420380112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1420380112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=4552-4557&issue=15&author=J.+W.+Checcoauthor=D.+F.+Kreitlerauthor=N.+C.+Thomasauthor=D.+G.+Belairauthor=N.+J.+Rettkoauthor=W.+L.+Murphyauthor=K.+T.+Forestauthor=S.+H.+Gellman&title=Targeting+diverse+protein-protein+interaction+interfaces+with+alpha%2Fbeta-peptides+derived+from+the+Z-domain+scaffold&doi=10.1073%2Fpnas.1420380112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420380112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420380112%26sid%3Dliteratum%253Aachs%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DKreitler%26aufirst%3DD.%2BF.%26aulast%3DThomas%26aufirst%3DN.%2BC.%26aulast%3DBelair%26aufirst%3DD.%2BG.%26aulast%3DRettko%26aufirst%3DN.%2BJ.%26aulast%3DMurphy%26aufirst%3DW.%2BL.%26aulast%3DForest%26aufirst%3DK.%2BT.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DTargeting%2520diverse%2520protein-protein%2520interaction%2520interfaces%2520with%2520alpha%252Fbeta-peptides%2520derived%2520from%2520the%2520Z-domain%2520scaffold%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D15%26spage%3D4552%26epage%3D4557%26doi%3D10.1073%2Fpnas.1420380112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleebs, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettikiriarachchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershaw, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddinger, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eller, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raines, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W.</span><span> </span><span class="NLM_article-title">D. alpha/beta-Peptide foldamers targeting intracellular protein-protein interactions with activity in living cells</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">11365</span><span class="NLM_x">–</span> <span class="NLM_lpage">11375</span><span class="refDoi"> DOI: 10.1021/jacs.5b05896</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b05896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=11365-11375&issue=35&author=J.+W.+Checcoauthor=E.+F.+Leeauthor=M.+Evangelistaauthor=N.+J.+Sleebsauthor=K.+Rogersauthor=A.+Pettikiriarachchiauthor=N.+J.+Kershawauthor=G.+A.+Eddingerauthor=D.+G.+Belairauthor=J.+L.+Wilsonauthor=C.+H.+Ellerauthor=R.+T.+Rainesauthor=W.+L.+Murphyauthor=B.+J.+Smithauthor=S.+H.+Gellmanauthor=W.+Fairlie&title=D.+alpha%2Fbeta-Peptide+foldamers+targeting+intracellular+protein-protein+interactions+with+activity+in+living+cells&doi=10.1021%2Fjacs.5b05896"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b05896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b05896%26sid%3Dliteratum%253Aachs%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DEvangelista%26aufirst%3DM.%26aulast%3DSleebs%26aufirst%3DN.%2BJ.%26aulast%3DRogers%26aufirst%3DK.%26aulast%3DPettikiriarachchi%26aufirst%3DA.%26aulast%3DKershaw%26aufirst%3DN.%2BJ.%26aulast%3DEddinger%26aufirst%3DG.%2BA.%26aulast%3DBelair%26aufirst%3DD.%2BG.%26aulast%3DWilson%26aufirst%3DJ.%2BL.%26aulast%3DEller%26aufirst%3DC.%2BH.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26aulast%3DMurphy%26aufirst%3DW.%2BL.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DFairlie%26aufirst%3DW.%26atitle%3DD.%2520alpha%252Fbeta-Peptide%2520foldamers%2520targeting%2520intracellular%2520protein-protein%2520interactions%2520with%2520activity%2520in%2520living%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26issue%3D35%26spage%3D11365%26epage%3D11375%26doi%3D10.1021%2Fjacs.5b05896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">alpha-Helix mimicry with alpha/beta-peptides</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">523</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1016/B978-0-12-394292-0.00019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2FB978-0-12-394292-0.00019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23422441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2013&pages=407-429&author=L.+M.+Johnsonauthor=S.+H.+Gellman&title=alpha-Helix+mimicry+with+alpha%2Fbeta-peptides&doi=10.1016%2FB978-0-12-394292-0.00019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">α-helix mimicry with α/β-peptides</span></div><div class="casAuthors">Johnson, Lisa M.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">Methods in Protein Design</span>),
    <span class="NLM_cas:pages">407-429</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  We describe a general strategy for creating peptidic oligomers that have unnatural backbones but nevertheless adopt a conformation very similar to the α-helix.  These oligomers contain both α- and β-amino acid residues (α/β-peptides).  If the β content reaches 25-30% of the residue total, and the β residues are evenly distributed along the backbone, then substantial resistance to proteolytic degrdn. is often obsd.  These α/β-peptides can mimic the informational properties of α-helixes involved in protein-protein recognition events, as documented in numerous crystal structures.  Thus, these unnatural oligomers can be a source of antagonists of undesirable protein-protein interactions that are mediated by natural α-helixes, or agonists of receptors for which the natural polypeptide ligands are α-helical.  Successes include mimicry of BH3 domains found in proapoptotic proteins, which leads to ligands for anti-apoptotic Bcl-2 family proteins, and mimicry of the gp41 CHR domain, which leads to inhibition of HIV infection in cell-based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4sEtSi8lWmrVg90H21EOLACvtfcHk0liTf-rrplsNVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSiu78%253D&md5=679f0dd73406c6c9c6f7cf8f751b558a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-394292-0.00019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-394292-0.00019-9%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3Dalpha-Helix%2520mimicry%2520with%2520alpha%252Fbeta-peptides%26jtitle%3DMethods%2520Enzymol.%26date%3D2013%26volume%3D523%26spage%3D407%26epage%3D429%26doi%3D10.1016%2FB978-0-12-394292-0.00019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hager, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">β-Arrestin-biased agonists of the GLP-1 receptor from β-amino acid residue incorporation into GLP-1 analogues</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">14970</span><span class="NLM_x">–</span> <span class="NLM_lpage">14979</span><span class="refDoi"> DOI: 10.1021/jacs.6b08323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b08323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqtbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=14970-14979&issue=45&author=M.+V.+Hagerauthor=L.+M.+Johnsonauthor=D.+Woottenauthor=P.+M.+Sextonauthor=S.+H.+Gellman&title=%CE%B2-Arrestin-biased+agonists+of+the+GLP-1+receptor+from+%CE%B2-amino+acid+residue+incorporation+into+GLP-1+analogues&doi=10.1021%2Fjacs.6b08323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues</span></div><div class="casAuthors">Hager, Marlies V.; Johnson, Lisa M.; Wootten, Denise; Sexton, Patrick M.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14970-14979</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of a G protein-coupled receptor (GPCR) causes recruitment of multiple intracellular proteins, each of which can activate distinct signaling pathways.  This complexity has engendered interest in agonists that preferentially stimulate subsets among the natural signaling pathways ("biased agonists").  We have examd. analogs of glucagon-like peptide-1 (GLP-1) contg. β-amino acid residues in place of native α residues at selected sites and found that some analogs differ from GLP-1 in terms of their relative abilities to promote G protein activation (as monitored via cAMP prodn.) vs. β-arrestin recruitment (as monitored via BRET assays).  The α → β replacements generally cause modest declines in stimulation of cAMP prodn. and β-arrestin recruitment, but for some replacement sets cAMP prodn. is more strongly affected than is β-arrestin recruitment.  The central portion of GLP-1 appears to be crit. for achieving bias toward β-arrestin recruitment.  These results suggest that backbone modification via α → β residue replacement may be a versatile source of agonists with biased GLP-1R activation profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7U5uooT8IC7Vg90H21EOLACvtfcHk0liTf-rrplsNVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqtbbM&md5=32deb7351b8727459a900b7da9010984</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b08323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b08323%26sid%3Dliteratum%253Aachs%26aulast%3DHager%26aufirst%3DM.%2BV.%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3D%25CE%25B2-Arrestin-biased%2520agonists%2520of%2520the%2520GLP-1%2520receptor%2520from%2520%25CE%25B2-amino%2520acid%2520residue%2520incorporation%2520into%2520GLP-1%2520analogues%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D45%26spage%3D14970%26epage%3D14979%26doi%3D10.1021%2Fjacs.6b08323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Pioszak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Molecular recognition of parathyroid hormone by its G protein-coupled receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">5034</span><span class="NLM_x">–</span> <span class="NLM_lpage">5039</span><span class="refDoi"> DOI: 10.1073/pnas.0801027105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0801027105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=18375760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVOmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5034-5039&issue=13&author=A.+A.+Pioszakauthor=H.+E.+Xu&title=Molecular+recognition+of+parathyroid+hormone+by+its+G+protein-coupled+receptor&doi=10.1073%2Fpnas.0801027105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of parathyroid hormone by its G protein-coupled receptor</span></div><div class="casAuthors">Pioszak, Augen A.; Xu, H. Eric</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5034-5039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parathyroid hormone (PTH) is central to calcium homeostasis and bone maintenance in vertebrates, and as such it has been used for treating osteoporosis.  It acts primarily by binding to its receptor, PTH1R, a member of the class B G protein-coupled receptor (GPCR) family that also includes receptors for glucagon, calcitonin, and other therapeutically important peptide hormones.  Despite considerable interest and much research, detg. the structure of the receptor-hormone complex has been hindered by difficulties in purifying the receptor and obtaining diffraction-quality crystals.  Here, we present a method for expression and purifn. of the extracellular domain (ECD) of human PTH1R engineered as a maltose-binding protein (MBP) fusion that readily crystallizes.  The 1.95-Å structure of PTH bound to the MBP-PTH1R-ECD fusion reveals that PTH docks as an amphipathic helix into a central hydrophobic groove formed by a three-layer α-β-βα fold of the PTH1R ECD, resembling a hot dog in a bun.  Conservation in the ECD scaffold and the helical structure of peptide hormones emphasizes this hot dog model as a general mechanism of hormone recognition common to class B GPCRs.  Our findings reveal crit. insights into PTH actions and provide a rational template for drug design that targets this hormone signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoijvIBSYYwLVg90H21EOLACvtfcHk0ljSbPSHvyviQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVOmurY%253D&md5=fef532f9c738b477bf5d914037bc3997</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0801027105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0801027105%26sid%3Dliteratum%253Aachs%26aulast%3DPioszak%26aufirst%3DA.%2BA.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DMolecular%2520recognition%2520of%2520parathyroid%2520hormone%2520by%2520its%2520G%2520protein-coupled%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D13%26spage%3D5034%26epage%3D5039%26doi%3D10.1073%2Fpnas.0801027105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Underwood, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garibay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastrup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedtz-Runge, S.</span><span> </span><span class="NLM_article-title">Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1074/jbc.M109.033829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M109.033829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19861722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SqtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=723-730&issue=1&author=C.+R.+Underwoodauthor=P.+Garibayauthor=L.+B.+Knudsenauthor=S.+Hastrupauthor=G.+H.+Petersauthor=R.+Rudolphauthor=S.+Reedtz-Runge&title=Crystal+structure+of+glucagon-like+peptide-1+in+complex+with+the+extracellular+domain+of+the+glucagon-like+peptide-1+receptor&doi=10.1074%2Fjbc.M109.033829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor</span></div><div class="casAuthors">Underwood, Christina Rye; Garibay, Patrick; Knudsen, Lotte Bjerre; Hastrup, Sven; Peters, Guenther H.; Rudolph, Rainer; Reedtz-Runge, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GLP-1 (glucagon-like peptide-1) is an incretin released from intestinal L-cells in response to food intake.  Activation of the GLP-1 receptor potentiates the synthesis and release of insulin from pancreatic β-cells in a glucose-dependent manner.  The GLP-1 receptor belongs to class B of the G-protein-coupled receptors, a subfamily characterized by a large N-terminal extracellular ligand binding domain.  Exendin-4 and GLP-1 are 50% identical, and exendin-4 is a full agonist with similar affinity and potency for the GLP-1 receptor.  We recently solved the crystal structure of the GLP-1 receptor extracellular domain in complex with the competitive antagonist exendin-4(9-39).  Interestingly, the isolated extracellular domain binds exendin-4 with much higher affinity than the endogenous agonist GLP-1.  Here, we have solved the crystal structure of the extracellular domain in complex with GLP-1 to 2.1 Åresoln.  The structure shows that important hydrophobic ligand-receptor interactions are conserved in agonist- and antagonist-bound forms of the extracellular domain, but certain residues in the ligand-binding site adopt a GLP-1-specific conformation.  GLP-1 is a kinked but continuous α-helix from Thr13 to Val33 when bound to the extracellular domain.  We supplemented the crystal structure with site-directed mutagenesis to link the structural information of the isolated extracellular domain with the binding properties of the full-length receptor.  The data support the existence of differences in the binding modes of GLP-1 and exendin-4 on the full-length GLP-1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpex-ZPbuqSCrVg90H21EOLACvtfcHk0ljSbPSHvyviQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SqtrrM&md5=59f7b2cee843c4299acab5900036172c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033829%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DC.%2BR.%26aulast%3DGaribay%26aufirst%3DP.%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DHastrup%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DG.%2BH.%26aulast%3DRudolph%26aufirst%3DR.%26aulast%3DReedtz-Runge%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520glucagon-like%2520peptide-1%2520in%2520complex%2520with%2520the%2520extracellular%2520domain%2520of%2520the%2520glucagon-like%2520peptide-1%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D1%26spage%3D723%26epage%3D730%26doi%3D10.1074%2Fjbc.M109.033829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liang, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoshouei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radjainia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glukhova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrasch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furness, S. G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudrat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiniotis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span> </span><span class="NLM_article-title">Phase-plate cryo-EM structure of a class B GPCR–G-protein complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">7656</span><span class="NLM_x">) </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1038/nature22327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnature22327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=28437792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslehs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=118-123&issue=7656&author=Y.-L.+Liangauthor=M.+Khoshoueiauthor=M.+Radjainiaauthor=Y.+Zhangauthor=A.+Glukhovaauthor=J.+Tarraschauthor=D.+M.+Thalauthor=S.+G.+B.+Furnessauthor=G.+Christopoulosauthor=T.+Coudratauthor=R.+Danevauthor=W.+Baumeisterauthor=L.+J.+Millerauthor=A.+Christopoulosauthor=B.+K.+Kobilkaauthor=D.+Woottenauthor=G.+Skiniotisauthor=P.+M.+Sexton&title=Phase-plate+cryo-EM+structure+of+a+class+B+GPCR%E2%80%93G-protein+complex&doi=10.1038%2Fnature22327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phase-plate cryo-EM structure of a class B GPCR-G-protein complex</span></div><div class="casAuthors">Liang, Yi-Lynn; Khoshouei, Maryam; Radjainia, Mazdak; Zhang, Yan; Glukhova, Alisa; Tarrasch, Jeffrey; Thal, David M.; Furness, Sebastian G. B.; Christopoulos, George; Coudrat, Thomas; Danev, Radostin; Baumeister, Wolfgang; Miller, Laurence J.; Christopoulos, Arthur; Kobilka, Brian K.; Wootten, Denise; Skiniotis, Georgios; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7656</span>),
    <span class="NLM_cas:pages">118-123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Class B G-protein-coupled receptors (GPCRs) are major targets for the treatment of chronic diseases, such as osteoporosis, diabetes, and obesity.  Here, we report the structure of a full-length class B GPCR receptor, the calcitonin receptor, in complex with the peptide ligand, calcitonin, and a heterotrimeric Gαsβγ protein detd. by Volta phase-plate single-particle cryo-electron microscopy.  The peptide agonist, calcitonin, engaged the receptor by binding to an extended hydrophobic pocket facilitated by the large outward movement of the extracellular ends of transmembrane helixes 6 and 7.  This conformation was accompanied by a 60° kink in helix 6 and a large outward movement of the intracellular end of this helix, opening the bundle to accommodate interactions with the α5-helix of Gαs.  Also obsd. was an extended intracellular helix 8 that contributed to both receptor stability and functional G-protein coupling via an interaction with the Gβ subunit.  Thus, this structure provides a new framework for understanding GPCR receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoag8XLOHZArLVg90H21EOLACvtfcHk0liRLjxk2Hp4vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslehs7w%253D&md5=cf34886db58191741437168ac3256c03</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature22327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22327%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.-L.%26aulast%3DKhoshouei%26aufirst%3DM.%26aulast%3DRadjainia%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGlukhova%26aufirst%3DA.%26aulast%3DTarrasch%26aufirst%3DJ.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DFurness%26aufirst%3DS.%2BG.%2BB.%26aulast%3DChristopoulos%26aufirst%3DG.%26aulast%3DCoudrat%26aufirst%3DT.%26aulast%3DDanev%26aufirst%3DR.%26aulast%3DBaumeister%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DPhase-plate%2520cryo-EM%2520structure%2520of%2520a%2520class%2520B%2520GPCR%25E2%2580%2593G-protein%2520complex%26jtitle%3DNature%26date%3D2017%26volume%3D546%26issue%3D7656%26spage%3D118%26epage%3D123%26doi%3D10.1038%2Fnature22327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jazayeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kean, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiez-Vandal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baig, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teobald, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doré, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Crystal structure of the GLP-1 receptor bound to a peptide agonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">7657</span><span class="NLM_x">) </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1038/nature22800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnature22800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=28562585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=254-258&issue=7657&author=A.+Jazayeriauthor=M.+Rappasauthor=A.+J.+H.+Brownauthor=J.+Keanauthor=J.+C.+Erreyauthor=N.+J.+Robertsonauthor=C.+Fiez-Vandalauthor=S.+P.+Andrewsauthor=M.+Congreveauthor=A.+Bortolatoauthor=J.+S.+Masonauthor=A.+H.+Baigauthor=I.+Teobaldauthor=A.+S.+Dor%C3%A9author=M.+Weirauthor=R.+M.+Cookeauthor=F.+H.+Marshall&title=Crystal+structure+of+the+GLP-1+receptor+bound+to+a+peptide+agonist&doi=10.1038%2Fnature22800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the GLP-1 receptor bound to a peptide agonist</span></div><div class="casAuthors">Jazayeri, Ali; Rappas, Mathieu; Brown, Alastair J. H.; Kean, James; Errey, James C.; Robertson, Nathan J.; Fiez-Vandal, Cedric; Andrews, Stephen P.; Congreve, Miles; Bortolato, Andrea; Mason, Jonathan S.; Baig, Asma H.; Teobald, Iryna; Dore, Andrew S.; Weir, Malcolm; Cooke, Robert M.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">254-258</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) regulates glucose homeostasis through the control of insulin release from the pancreas.  GLP-1 peptide agonists are efficacious drugs for the treatment of diabetes.  To gain insight into the mol. mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist.  The peptide agonist retains an α-helical conformation as it sits deep within the receptor-binding pocket.  The arrangement of the transmembrane helixes reveals hallmarks of an active conformation similar to that obsd. in class A receptors.  Guided by this structural information, we design peptide agonists with potent in vivo activity in a mouse model of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX6Ibc110QxrVg90H21EOLACvtfcHk0liRLjxk2Hp4vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D&md5=0a5c99161af8bae506a184e0ab6306c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature22800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22800%26sid%3Dliteratum%253Aachs%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DRappas%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DKean%26aufirst%3DJ.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DN.%2BJ.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DBaig%26aufirst%3DA.%2BH.%26aulast%3DTeobald%26aufirst%3DI.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520the%2520GLP-1%2520receptor%2520bound%2520to%2520a%2520peptide%2520agonist%26jtitle%3DNature%26date%3D2017%26volume%3D546%26issue%3D7657%26spage%3D254%26epage%3D258%26doi%3D10.1038%2Fnature22800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrasch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun Kobilka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiniotis, G.</span><span> </span><span class="NLM_article-title">Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">7657</span><span class="NLM_x">) </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1038/nature22394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnature22394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=28538729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=248-253&issue=7657&author=Y.+Zhangauthor=B.+Sunauthor=D.+Fengauthor=H.+Huauthor=M.+Chuauthor=Q.+Quauthor=J.+T.+Tarraschauthor=S.+Liauthor=T.+Sun+Kobilkaauthor=B.+K.+Kobilkaauthor=G.+Skiniotis&title=Cryo-EM+structure+of+the+activated+GLP-1+receptor+in+complex+with+a+G+protein&doi=10.1038%2Fnature22394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein</span></div><div class="casAuthors">Zhang, Yan; Sun, Bingfa; Feng, Dan; Hu, Hongli; Chu, Matthew; Qu, Qianhui; Tarrasch, Jeffrey T.; Li, Shane; Sun Kobilka, Tong; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) is a hormone with essential roles in regulating insulin secretion, carbohydrate metab. and appetite.  GLP-1 effects are mediated through binding to the GLP-1 receptor (GLP-1R), a class B G-protein-coupled receptor (GPCR) that signals primarily through the stimulatory G protein Gs.  Class B GPCRs are important therapeutic targets; however, our understanding of their mechanism of action is limited by the lack of structural information on activated and full-length receptors.  Here we report the cryo-electron microscopy structure of the peptide-activated GLP-1R-Gs complex at near at. resoln.  The peptide is clasped between the N-terminal domain and the transmembrane core of the receptor, and further stabilized by extracellular loops.  Conformational changes in the transmembrane domain result in a sharp kink in the middle of transmembrane helix 6, which pivots its intracellular half outward to accommodate the α5-helix of the Ras-like domain of Gs.  These results provide a structural framework for understanding class B GPCR activation through hormone binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDRFGRwMs1bVg90H21EOLACvtfcHk0lgadugetu9Myw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D&md5=5e7ebd94012ba47ecc299ad0502975de</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature22394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22394%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DTarrasch%26aufirst%3DJ.%2BT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSun%2BKobilka%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DCryo-EM%2520structure%2520of%2520the%2520activated%2520GLP-1%2520receptor%2520in%2520complex%2520with%2520a%2520G%2520protein%26jtitle%3DNature%26date%3D2017%26volume%3D546%26issue%3D7657%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature22394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Peggion, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schievano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiebler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblatt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span> </span><span class="NLM_article-title">Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">8162</span><span class="NLM_x">–</span> <span class="NLM_lpage">8175</span><span class="refDoi"> DOI: 10.1021/bi0200155</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0200155" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=8162-8175&issue=25&author=E.+Peggionauthor=S.+Mammiauthor=E.+Schievanoauthor=L.+Silvestriauthor=L.+Schieblerauthor=A.+Biselloauthor=M.+Rosenblattauthor=M.+Chorev&title=Structure-function+studies+of+analogues+of+parathyroid+hormone+%28PTH%29-1-34+containing+beta-amino+acid+residues+in+positions+11-13&doi=10.1021%2Fbi0200155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbi0200155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0200155%26sid%3Dliteratum%253Aachs%26aulast%3DPeggion%26aufirst%3DE.%26aulast%3DMammi%26aufirst%3DS.%26aulast%3DSchievano%26aufirst%3DE.%26aulast%3DSilvestri%26aufirst%3DL.%26aulast%3DSchiebler%26aufirst%3DL.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DRosenblatt%26aufirst%3DM.%26aulast%3DChorev%26aufirst%3DM.%26atitle%3DStructure-function%2520studies%2520of%2520analogues%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529-1-34%2520containing%2520beta-amino%2520acid%2520residues%2520in%2520positions%252011-13%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26issue%3D25%26spage%3D8162%26epage%3D8175%26doi%3D10.1021%2Fbi0200155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Schievano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblatt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, E.</span><span> </span><span class="NLM_article-title">Conformational and biological characterization of human parathyroid hormone hPTH(1-34) analogues containing beta-amino acid residues in positions 17-19</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1002/bip.10508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fbip.10508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2003&pages=534-547&issue=4&author=E.+Schievanoauthor=S.+Mammiauthor=E.+Carrettaauthor=N.+Fioriauthor=M.+Corichauthor=A.+Biselloauthor=M.+Rosenblattauthor=M.+Chorevauthor=E.+Peggion&title=Conformational+and+biological+characterization+of+human+parathyroid+hormone+hPTH%281-34%29+analogues+containing+beta-amino+acid+residues+in+positions+17-19&doi=10.1002%2Fbip.10508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbip.10508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.10508%26sid%3Dliteratum%253Aachs%26aulast%3DSchievano%26aufirst%3DE.%26aulast%3DMammi%26aufirst%3DS.%26aulast%3DCarretta%26aufirst%3DE.%26aulast%3DFiori%26aufirst%3DN.%26aulast%3DCorich%26aufirst%3DM.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DRosenblatt%26aufirst%3DM.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DPeggion%26aufirst%3DE.%26atitle%3DConformational%2520and%2520biological%2520characterization%2520of%2520human%2520parathyroid%2520hormone%2520hPTH%25281-34%2529%2520analogues%2520containing%2520beta-amino%2520acid%2520residues%2520in%2520positions%252017-19%26jtitle%3DBiopolymers%26date%3D2003%26volume%3D70%26issue%3D4%26spage%3D534%26epage%3D547%26doi%3D10.1002%2Fbip.10508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Denton, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepartz, A.</span><span> </span><span class="NLM_article-title">A beta-peptide agonist of the GLP-1 receptor, a Class B GPCR</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5318</span><span class="NLM_x">–</span> <span class="NLM_lpage">5321</span><span class="refDoi"> DOI: 10.1021/ol402568j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol402568j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=5318-5321&issue=20&author=E.+V.+Dentonauthor=C.+J.+Craigauthor=R.+L.+Pongratzauthor=J.+S.+Appelbaumauthor=A.+E.+Doernerauthor=A.+Narayananauthor=G.+I.+Shulmanauthor=G.+W.+Clineauthor=A.+Schepartz&title=A+beta-peptide+agonist+of+the+GLP-1+receptor%2C+a+Class+B+GPCR&doi=10.1021%2Fol402568j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol402568j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol402568j%26sid%3Dliteratum%253Aachs%26aulast%3DDenton%26aufirst%3DE.%2BV.%26aulast%3DCraig%26aufirst%3DC.%2BJ.%26aulast%3DPongratz%26aufirst%3DR.%2BL.%26aulast%3DAppelbaum%26aufirst%3DJ.%2BS.%26aulast%3DDoerner%26aufirst%3DA.%2BE.%26aulast%3DNarayanan%26aufirst%3DA.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DSchepartz%26aufirst%3DA.%26atitle%3DA%2520beta-peptide%2520agonist%2520of%2520the%2520GLP-1%2520receptor%252C%2520a%2520Class%2520B%2520GPCR%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26issue%3D20%26spage%3D5318%26epage%3D5321%26doi%3D10.1021%2Fol402568j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Haase, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson-Kaufman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levengood, S. K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Extending foldamer design beyond alpha-helix mimicry: alpha/beta-peptide inhibitors of vascular endothelial growth factor signaling</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7652</span><span class="NLM_x">–</span> <span class="NLM_lpage">7655</span><span class="refDoi"> DOI: 10.1021/ja302469a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302469a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=7652-7655&issue=18&author=H.+S.+Haaseauthor=K.+J.+Peterson-Kaufmanauthor=S.+K.+L.+Levengoodauthor=J.+W.+Checcoauthor=W.+L.+Murphyauthor=S.+H.+Gellman&title=Extending+foldamer+design+beyond+alpha-helix+mimicry%3A+alpha%2Fbeta-peptide+inhibitors+of+vascular+endothelial+growth+factor+signaling&doi=10.1021%2Fja302469a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja302469a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302469a%26sid%3Dliteratum%253Aachs%26aulast%3DHaase%26aufirst%3DH.%2BS.%26aulast%3DPeterson-Kaufman%26aufirst%3DK.%2BJ.%26aulast%3DLevengood%26aufirst%3DS.%2BK.%2BL.%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DMurphy%26aufirst%3DW.%2BL.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DExtending%2520foldamer%2520design%2520beyond%2520alpha-helix%2520mimicry%253A%2520alpha%252Fbeta-peptide%2520inhibitors%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D18%26spage%3D7652%26epage%3D7655%26doi%3D10.1021%2Fja302469a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Neer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaud, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchetta, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaich, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reginster, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodsman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ish-Shalom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genant, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitlak, B. H.</span><span> </span><span class="NLM_article-title">Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">1434</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span><span class="refDoi"> DOI: 10.1056/NEJM200105103441904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1056%2FNEJM200105103441904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=11346808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1434-1441&issue=19&author=R.+M.+Neerauthor=C.+D.+Arnaudauthor=J.+R.+Zanchettaauthor=R.+Princeauthor=G.+A.+Gaichauthor=J.+Y.+Reginsterauthor=A.+B.+Hodsmanauthor=E.+F.+Eriksenauthor=S.+Ish-Shalomauthor=H.+K.+Genantauthor=O.+H.+Wangauthor=B.+H.+Mitlak&title=Effect+of+parathyroid+hormone+%281%E2%80%9334%29+on+fractures+and+bone+mineral+density+in+postmenopausal+women+with+osteoporosis&doi=10.1056%2FNEJM200105103441904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis</span></div><div class="casAuthors">Neer, Robert M.; Arnaud, Claude D.; Zanchetta, Jose R.; Prince, Richard; Gaich, Gregory A.; Reginster, Jean-Yves; Hodsman, Anthony B.; Eriksen, Erik F.; Ish-Shalom, Sophia; Genant, Harry K.; Wang, Ouhong; Mitlak, Bruce H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1434-1441</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Once-daily injections of parathyroid hormone or its N-terminal fragments increase bone formation and bone mass without causing hypercalcemia, but their effects on fractures are unknown.  Methods: The authors randomly assigned 1637 postmenopausal women with prior vertebral fractures to receive 20 or 40 μg of parathyroid hormone (1-34) or placebo, administered s.c. by the women daily.  The authors obtained vertebral radiographs at base line and at the end of the study (median duration of observation, 21 mo) and performed serial measurements of bone mass by dual-energy x-ray absorptiometry.  Results: New vertebral fractures occurred in 14 % of the women in the placebo group and in 5 % and 4 %, resp., of the women in the 20-μg and 40-μg parathyroid hormone groups; the resp. relative risks of fracture in the 20-μg and 40-μg groups, as compared with the placebo group, were 0.35 and 0.31 (95 % confidence intervals, 0.22 to 0.55 and 0.19 to 0.50).  New nonvertebral fragility fractures occurred in 6 % of the women in the placebo group and in 3 % of those in each parathyroid hormone group (relative risk, 0.47 and 0.46, resp. [95 % confidence intervals, 0.25 to 0.88 and 0.25 to 0.86]).  As compared with placebo, the 20-μg and 40-μg doses of parathyroid hormone increased bone mineral d. by 9 and 13 more percentage points in the lumbar spine and by 3 and 6 more percentage points in the femoral neck; the 40-μg dose decreased bone mineral d. at the shaft of the radius by 2 more percentage points.  Both doses increased total-body bone mineral by 2 to 4 more percentage points than did placebo.  Parathyroid hormone had only minor side effects (occasional nausea and headache).  Conclusions: Treatment of postmenopausal osteoporosis with parathyroid hormone (1-34) decreases the risk of vertebral and nonvertebral fractures; increases vertebral, femoral, and total-body bone mineral d.; and is well tolerated.  The 40-μg dose increased bone mineral d. more than the 20-μg dose but had similar effects on the risk of fracture and was more likely to have side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKXlDv2ykMk7Vg90H21EOLACvtfcHk0ljoA6Gmrxm8pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSgsbw%253D&md5=214d564b481429eb4fd0a8bc6213f288</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJM200105103441904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200105103441904%26sid%3Dliteratum%253Aachs%26aulast%3DNeer%26aufirst%3DR.%2BM.%26aulast%3DArnaud%26aufirst%3DC.%2BD.%26aulast%3DZanchetta%26aufirst%3DJ.%2BR.%26aulast%3DPrince%26aufirst%3DR.%26aulast%3DGaich%26aufirst%3DG.%2BA.%26aulast%3DReginster%26aufirst%3DJ.%2BY.%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DIsh-Shalom%26aufirst%3DS.%26aulast%3DGenant%26aufirst%3DH.%2BK.%26aulast%3DWang%26aufirst%3DO.%2BH.%26aulast%3DMitlak%26aufirst%3DB.%2BH.%26atitle%3DEffect%2520of%2520parathyroid%2520hormone%2520%25281%25E2%2580%259334%2529%2520on%2520fractures%2520and%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26issue%3D19%26spage%3D1434%26epage%3D1441%26doi%3D10.1056%2FNEJM200105103441904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggatt, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, N. C.</span><span> </span><span class="NLM_article-title">Parathyroid hormone: a double-edged sword for bone metabolism</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.tem.2004.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.tem.2004.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=15036251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsV2rs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=60-65&issue=2&author=L.+Qinauthor=L.+J.+Raggattauthor=N.+C.+Partridge&title=Parathyroid+hormone%3A+a+double-edged+sword+for+bone+metabolism&doi=10.1016%2Fj.tem.2004.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone: a double-edged sword for bone metabolism</span></div><div class="casAuthors">Qin, Ling; Raggatt, Liza J.; Partridge, Nicola C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">60-65</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone (PTH) is the major hormone regulating calcium metab.  It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily.  However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects.  Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing no. of mol. and cellular mechanisms underlying these effects have emerged.  Here, the authors outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtx-54dxdIbVg90H21EOLACvtfcHk0ljoA6Gmrxm8pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsV2rs7w%253D&md5=c431d0dd0bdf62e9bf2dd846db1e4b64</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2004.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2004.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DRaggatt%26aufirst%3DL.%2BJ.%26aulast%3DPartridge%26aufirst%3DN.%2BC.%26atitle%3DParathyroid%2520hormone%253A%2520a%2520double-edged%2520sword%2520for%2520bone%2520metabolism%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2004%26volume%3D15%26issue%3D2%26spage%3D60%26epage%3D65%26doi%3D10.1016%2Fj.tem.2004.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">PTH receptor-1 signalling--mechanistic insights and therapeutic prospects</span> <span class="citation_source-journal">Nat. Rev. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span><span class="refDoi"> DOI: 10.1038/nrendo.2015.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnrendo.2015.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26303600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVartb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=712-724&author=R.+W.+Chelohaauthor=S.+H.+Gellmanauthor=J.-P.+Vilardagaauthor=T.+J.+Gardella&title=PTH+receptor-1+signalling%2D%2Dmechanistic+insights+and+therapeutic+prospects&doi=10.1038%2Fnrendo.2015.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">PTH receptor-1 signalling-mechanistic insights and therapeutic prospects</span></div><div class="casAuthors">Cheloha, Ross W.; Gellman, Samuel H.; Vilardaga, Jean-Pierre; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">712-724</span>CODEN:
                <span class="NLM_cas:coden">NREABD</span>;
        ISSN:<span class="NLM_cas:issn">1759-5029</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Parathyroid hormone/parathyroid hormone-related protein receptor (PTH/PTHrP type 1 receptor; commonly known as PTHR1) is a family B G-protein-coupled receptor (GPCR) that regulates skeletal development, bone turnover and mineral ion homeostasis.  PTHR1 transduces stimuli from PTH and PTHrP into the interior of target cells to promote diverse biochem. responses.  Evaluation of the signalling properties of structurally modified PTHR1 ligands has helped to elucidate determinants of receptor function and mechanisms of downstream cellular and physiol. responses.  Anal. of PTHR1 responses induced by structurally modified ligands suggests that PTHR1 can continue to signal through a G-protein-mediated pathway within endosomes.  Such findings challenge the longstanding paradigm in GPCR biol. that the receptor is transiently activated at the cell membrane, followed by rapid deactivation and receptor internalization.  Evaluation of structurally modified PTHR1 ligands has further led to the identification of ligand analogs that differ from PTH or PTHrP in the type, strength and duration of responses induced at the receptor, cellular and organism levels.  These modified ligands, and the biochem. principles revealed through their use, might facilitate an improved understanding of PTHR1 function in vivo and enable the treatment of disorders resulting from defects in PTHR1 signalling.  This Review discusses current understanding of PTHR1 modes of action and how these findings might be applied in future therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6fH4WKMgL0bVg90H21EOLACvtfcHk0ljywY_5AJk7_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVartb%252FN&md5=963fc35b7ad4c26e6ed46740e3ea3fd5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrendo.2015.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrendo.2015.139%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DVilardaga%26aufirst%3DJ.-P.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DPTH%2520receptor-1%2520signalling--mechanistic%2520insights%2520and%2520therapeutic%2520prospects%26jtitle%3DNat.%2520Rev.%2520Endocrinol.%26date%3D2015%26volume%3D11%26spage%3D712%26epage%3D724%26doi%3D10.1038%2Fnrendo.2015.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J.-P.</span><span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors-family B G protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1124/pr.114.009464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1124%2Fpr.114.009464" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=310-337&issue=2&author=T.+J.+Gardellaauthor=J.-P.+Vilardaga&title=International+Union+of+Basic+and+Clinical+Pharmacology.+XCIII.+The+parathyroid+hormone+receptors-family+B+G+protein-coupled+receptors&doi=10.1124%2Fpr.114.009464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009464%26sid%3Dliteratum%253Aachs%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.-P.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520XCIII.%2520The%2520parathyroid%2520hormone%2520receptors-family%2520B%2520G%2520protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26issue%3D2%26spage%3D310%26epage%3D337%26doi%3D10.1124%2Fpr.114.009464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Insights into the structure of class B GPCRs</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.tips.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24359917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyksLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=12-22&issue=1&author=K.+Hollensteinauthor=C.+de+Graafauthor=A.+Bortolatoauthor=M.+W.+Wangauthor=F.+H.+Marshallauthor=R.+C.+Stevens&title=Insights+into+the+structure+of+class+B+GPCRs&doi=10.1016%2Fj.tips.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the structure of class B GPCRs</span></div><div class="casAuthors">Hollenstein, Kaspar; de Graaf, Chris; Bortolato, Andrea; Wang, Ming-Wei; Marshall, Fiona H.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-22</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The secretin-like (class B) family of G protein-coupled receptors (GPCRs) are key players in hormonal homeostasis and are interesting drug targets for the treatment of several metabolic disorders (such as type 2 diabetes, osteoporosis, and obesity) and nervous system diseases (such as migraine, anxiety, and depression).  The recently solved crystal structures of the transmembrane domains of the human glucagon receptor and human corticotropin-releasing factor receptor 1 have opened up new opportunities to study the structure and function of class B GPCRs.  The current review shows how these structures offer more detailed explanations to previous biochem. and pharmacol. studies of class B GPCRs, and provides new insights into their interactions with ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIUYDGGnHDArVg90H21EOLACvtfcHk0ljywY_5AJk7_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyksLjK&md5=c35d188eafbd5e26dddf7f4a12505de3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DM.%2BW.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DInsights%2520into%2520the%2520structure%2520of%2520class%2520B%2520GPCRs%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26issue%3D1%26spage%3D12%26epage%3D22%26doi%3D10.1016%2Fj.tips.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Structure of Class B GPCRs: new horizons for drug discovery</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3145</span><span class="refDoi"> DOI: 10.1111/bph.12689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1111%2Fbph.12689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24628305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3132-3145&issue=13&author=A.+Bortolatoauthor=A.+S.+Doreauthor=K.+Hollensteinauthor=B.+G.+Tehanauthor=J.+S.+Masonauthor=F.+H.+Marshall&title=Structure+of+Class+B+GPCRs%3A+new+horizons+for+drug+discovery&doi=10.1111%2Fbph.12689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Class B GPCRs: new horizons for drug discovery</span></div><div class="casAuthors">Bortolato, Andrea; Dore, Andrew S.; Hollenstein, Kaspar; Tehan, Benjamin G.; Mason, Jonathan S.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3132-3145</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Class B GPCRs of the secretin family are important drug targets in many human diseases including diabetes, neurodegeneration, cardiovascular disease and psychiatric disorders.  X-ray crystal structures for the glucagon receptor and corticotropin-releasing factor receptor 1 have now been published.  In this review, we analyze the new structures and how they compare with each other and with Class A and F receptors.  We also consider the differences in druggability and possible similarity in the activation mechanisms.  Finally, we discuss the potential for the design of small-mol. modulators for these important targets in drug discovery.  This new structural insight allows, for the first time, structure-based drug design methods to be applied to Class B GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprqe_GGLyHcbVg90H21EOLACvtfcHk0ljywY_5AJk7_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKrtr0%253D&md5=3e08525e9309b28bc3a7a268fd83067e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fbph.12689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12689%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DTehan%26aufirst%3DB.%2BG.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DStructure%2520of%2520Class%2520B%2520GPCRs%253A%2520new%2520horizons%2520for%2520drug%2520discovery%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D13%26spage%3D3132%26epage%3D3145%26doi%3D10.1111%2Fbph.12689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">52</span><span class="NLM_x">) </span> <span class="NLM_fpage">49003</span><span class="NLM_x">–</span> <span class="NLM_lpage">49012</span><span class="refDoi"> DOI: 10.1074/jbc.M106827200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M106827200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=49003-49012&issue=52&author=N.+Shimizuauthor=J.+Guoauthor=T.+J.+Gardella&title=Parathyroid+hormone+%28PTH%29-%281-14%29+and+-%281-11%29+analogs+conformationally+constrained+by+alpha-aminoisobutyric+acid+mediate+full+agonist+responses+via+the+juxtamembrane+region+of+the+PTH-1+receptor&doi=10.1074%2Fjbc.M106827200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106827200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106827200%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DParathyroid%2520hormone%2520%2528PTH%2529-%25281-14%2529%2520and%2520-%25281-11%2529%2520analogs%2520conformationally%2520constrained%2520by%2520alpha-aminoisobutyric%2520acid%2520mediate%2520full%2520agonist%2520responses%2520via%2520the%2520juxtamembrane%2520region%2520of%2520the%2520PTH-1%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D52%26spage%3D49003%26epage%3D49012%26doi%3D10.1074%2Fjbc.M106827200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Caporale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schievano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittelsberger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, E.</span><span> </span><span class="NLM_article-title">Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">611</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.ejphar.2009.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19303868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Oluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=611&publication_year=2009&pages=1-7&issue=1%E2%80%933&author=A.+Caporaleauthor=B.+Biondiauthor=E.+Schievanoauthor=A.+Wittelsbergerauthor=S.+Mammiauthor=E.+Peggion&title=Structure-function+relationship+studies+of+PTH%281-11%29+analogues+containing+D-amino+acids&doi=10.1016%2Fj.ejphar.2009.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids</span></div><div class="casAuthors">Caporale, Andrea; Biondi, Barbara; Schievano, Elisabetta; Wittelsberger, Angela; Mammi, Stefano; Peggion, Evaristo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">611</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parathyroid hormone (PTH) is an 84-amino acid peptide hormone.  Produced in the parathyroid glands, it acts primarily on bone and kidney to maintain extracellular calcium levels within normal limits.  It has been shown that the 1-34 amino acid fragment of PTH is sufficient to bind and activate the PTH type-I receptor.  Recent investigations focusing on the interaction of N-terminal fragments of PTH with PTH type-I receptor showed that certain modifications can increase signaling potency in peptides as short as 11 amino acids.  To understand the role of the side chains of all the amino acid residues in PTH(1-11), we synthesized all- PTH, three retro-inverso analogs of the most active modified PTH(1-11), H-Aib-Val-Aib-Glu-Ile-Gln-Leu-Nle-His-Gln-Har-NH2, and we substituted every -AA of the latter with the corresponding -AA, obtaining a library of PTH(1-11) analogs that were tested as agonists.  The library was synthesized by SPPS, employing the Fmoc protocol.  The biol. tests showed that the activity of the -Har11 analog is of the same order of magnitude of that of the most active modified PTH(1-11).  This behavior is paralleled by an increase of the helical content on going from the -Val2 to the -Har11 analog.  This is in agreement with previous work where a correlation between activity and helical content has been demonstrated.  The importance of a pos. charged group in the C-terminal position is shown to be independent of the configuration of the Cα-carbon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqOjkNCNQVjbVg90H21EOLACvtfcHk0lh_aprxgLZibA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Oluro%253D&md5=378ff5e06f4cd39881452093311b9ead</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DCaporale%26aufirst%3DA.%26aulast%3DBiondi%26aufirst%3DB.%26aulast%3DSchievano%26aufirst%3DE.%26aulast%3DWittelsberger%26aufirst%3DA.%26aulast%3DMammi%26aufirst%3DS.%26aulast%3DPeggion%26aufirst%3DE.%26atitle%3DStructure-function%2520relationship%2520studies%2520of%2520PTH%25281-11%2529%2520analogues%2520containing%2520D-amino%2520acids%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D611%26issue%3D1%25E2%2580%25933%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.ejphar.2009.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Peterson-Kaufman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haase, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Residue-based preorganization of BH3-derived alpha/beta-peptides: modulating affinity, selectivity and proteolytic susceptibility in alpha-helix mimics</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1675</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00109</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00109" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1667-1675&issue=7&author=K.+J.+Peterson-Kaufmanauthor=H.+S.+Haaseauthor=M.+D.+Boersmaauthor=E.+F.+Leeauthor=W.+D.+Fairlieauthor=S.+H.+Gellman&title=Residue-based+preorganization+of+BH3-derived+alpha%2Fbeta-peptides%3A+modulating+affinity%2C+selectivity+and+proteolytic+susceptibility+in+alpha-helix+mimics&doi=10.1021%2Facschembio.5b00109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00109%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson-Kaufman%26aufirst%3DK.%2BJ.%26aulast%3DHaase%26aufirst%3DH.%2BS.%26aulast%3DBoersma%26aufirst%3DM.%2BD.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DResidue-based%2520preorganization%2520of%2520BH3-derived%2520alpha%252Fbeta-peptides%253A%2520modulating%2520affinity%252C%2520selectivity%2520and%2520proteolytic%2520susceptibility%2520in%2520alpha-helix%2520mimics%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D7%26spage%3D1667%26epage%3D1675%26doi%3D10.1021%2Facschembio.5b00109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Interplay among side chain sequence, backbone composition, and residue rigidification in polypeptide folding and assembly</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">27</span><span class="NLM_x">) </span> <span class="NLM_fpage">9151</span><span class="NLM_x">–</span> <span class="NLM_lpage">9156</span><span class="refDoi"> DOI: 10.1073/pnas.0801135105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0801135105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9151-9156&issue=27&author=W.+S.+Horneauthor=J.+L.+Priceauthor=S.+H.+Gellman&title=Interplay+among+side+chain+sequence%2C+backbone+composition%2C+and+residue+rigidification+in+polypeptide+folding+and+assembly&doi=10.1073%2Fpnas.0801135105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0801135105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0801135105%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DInterplay%2520among%2520side%2520chain%2520sequence%252C%2520backbone%2520composition%252C%2520and%2520residue%2520rigidification%2520in%2520polypeptide%2520folding%2520and%2520assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D27%26spage%3D9151%26epage%3D9156%26doi%3D10.1073%2Fpnas.0801135105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortenson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Enhancement of alpha-helix mimicry by an alpha/beta-peptide foldamer via incorporation of a dense ionic side-chain array</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">7317</span><span class="NLM_x">–</span> <span class="NLM_lpage">7320</span><span class="refDoi"> DOI: 10.1021/ja302428d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302428d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=7317-7320&issue=17&author=L.+M.+Johnsonauthor=D.+E.+Mortensonauthor=H.+G.+Yunauthor=W.+S.+Horneauthor=T.+J.+Ketasauthor=M.+Luauthor=J.+P.+Mooreauthor=S.+H.+Gellman&title=Enhancement+of+alpha-helix+mimicry+by+an+alpha%2Fbeta-peptide+foldamer+via+incorporation+of+a+dense+ionic+side-chain+array&doi=10.1021%2Fja302428d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja302428d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302428d%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DMortenson%26aufirst%3DD.%2BE.%26aulast%3DYun%26aufirst%3DH.%2BG.%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DEnhancement%2520of%2520alpha-helix%2520mimicry%2520by%2520an%2520alpha%252Fbeta-peptide%2520foldamer%2520via%2520incorporation%2520of%2520a%2520dense%2520ionic%2520side-chain%2520array%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D17%26spage%3D7317%26epage%3D7320%26doi%3D10.1021%2Fja302428d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Werner, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalteja, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, W. S.</span><span> </span><span class="NLM_article-title">Peptide backbone composition and protease susceptibility: impact of modification type, position, and tandem substitution</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1002/cbic.201500312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fcbic.201500312" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=712-718&issue=8&author=H.+M.+Wernerauthor=C.+C.+Cabaltejaauthor=W.+S.+Horne&title=Peptide+backbone+composition+and+protease+susceptibility%3A+impact+of+modification+type%2C+position%2C+and+tandem+substitution&doi=10.1002%2Fcbic.201500312"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201500312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201500312%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DH.%2BM.%26aulast%3DCabalteja%26aufirst%3DC.%2BC.%26aulast%3DHorne%26aufirst%3DW.%2BS.%26atitle%3DPeptide%2520backbone%2520composition%2520and%2520protease%2520susceptibility%253A%2520impact%2520of%2520modification%2520type%252C%2520position%252C%2520and%2520tandem%2520substitution%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26issue%3D8%26spage%3D712%26epage%3D718%26doi%3D10.1002%2Fcbic.201500312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Karsdal, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riis, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, K.</span><span> </span><span class="NLM_article-title">Lessons learned from the clinical development of oral peptides</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span><span class="refDoi"> DOI: 10.1111/bcp.12557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1111%2Fbcp.12557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25408230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2015&pages=720-732&issue=5&author=M.+A.+Karsdalauthor=B.+J.+Riisauthor=N.+Mehtaauthor=W.+Sternauthor=E.+Arbitauthor=C.+Christiansenauthor=K.+Henriksen&title=Lessons+learned+from+the+clinical+development+of+oral+peptides&doi=10.1111%2Fbcp.12557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the clinical development of oral peptides</span></div><div class="casAuthors">Karsdal, Morten Asser; Riis, Bente Juul; Mehta, Nozer; Stern, William; Arbit, Ehud; Christiansen, Claus; Henriksen, Kim</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">720-732</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The oral delivery of peptides and proteins has been hampered by an array of obstacles.  However, several promising novel oral delivery systems have been developed.  This paper reviews the most advanced oral formulation technologies, and highlights key lessons and implications from studies undertaken to date with these oral formulations.  Special interest is given to oral salmon calcitonin (CT), glucagon-like peptide-1 (GLP-1), insulin, PYY-(3-36), recombinant human parathyroid hormone (rhPTH(1-31)-NH2) and PTH(1-34), by different technologies.  The issues addressed include (i) interaction with water, (ii) interaction with food, (iii) diurnal variation, (iv) inter- and intra-subject variability, (v) correlation between efficacy and exposure and (vi) key deliverables of different technologies.  These key lessons may aid research in the development of other oral formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBun32dB2rgrVg90H21EOLACvtfcHk0lgE2X8ryrqlHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOnu7Y%253D&md5=0f636db3549478f73bbc4ecb958e385d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12557%26sid%3Dliteratum%253Aachs%26aulast%3DKarsdal%26aufirst%3DM.%2BA.%26aulast%3DRiis%26aufirst%3DB.%2BJ.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DStern%26aufirst%3DW.%26aulast%3DArbit%26aufirst%3DE.%26aulast%3DChristiansen%26aufirst%3DC.%26aulast%3DHenriksen%26aufirst%3DK.%26atitle%3DLessons%2520learned%2520from%2520the%2520clinical%2520development%2520of%2520oral%2520peptides%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D79%26issue%3D5%26spage%3D720%26epage%3D732%26doi%3D10.1111%2Fbcp.12557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Smart, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basit, A. W.</span><span> </span><span class="NLM_article-title">Oral peptide and protein delivery: intestinal obstacles and commercial prospects</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1323</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span><span class="refDoi"> DOI: 10.1517/17425247.2014.917077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1517%2F17425247.2014.917077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=1323-1335&issue=8&author=A.+L.+Smartauthor=S.+Gaisfordauthor=A.+W.+Basit&title=Oral+peptide+and+protein+delivery%3A+intestinal+obstacles+and+commercial+prospects&doi=10.1517%2F17425247.2014.917077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1517%2F17425247.2014.917077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2014.917077%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DA.%2BL.%26aulast%3DGaisford%26aufirst%3DS.%26aulast%3DBasit%26aufirst%3DA.%2BW.%26atitle%3DOral%2520peptide%2520and%2520protein%2520delivery%253A%2520intestinal%2520obstacles%2520and%2520commercial%2520prospects%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2014%26volume%3D11%26issue%3D8%26spage%3D1323%26epage%3D1335%26doi%3D10.1517%2F17425247.2014.917077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Henriksen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riis, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkol, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandersen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrjalsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedergaard, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglbjaerg, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsdal, M. A.</span><span> </span><span class="NLM_article-title">Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone rhPTH(1-31)NH2 in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1016/j.bone.2012.11.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.bone.2012.11.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=160-166&issue=1&author=K.+Henriksenauthor=J.+R.+Andersenauthor=B.+J.+Riisauthor=N.+Mehtaauthor=R.+Tavakkolauthor=P.+Alexandersenauthor=I.+Byrjalsenauthor=I.+Valterauthor=B.+S.+Nedergaardauthor=C.+S.+Teglbjaergauthor=W.+Sternauthor=A.+Sturmerauthor=S.+Mittaauthor=A.+J.+Ninoauthor=L.+A.+Fitzpatrickauthor=C.+Christiansenauthor=M.+A.+Karsdal&title=Evaluation+of+the+efficacy%2C+safety+and+pharmacokinetic+profile+of+oral+recombinant+human+parathyroid+hormone+rhPTH%281-31%29NH2+in+postmenopausal+women+with+osteoporosis&doi=10.1016%2Fj.bone.2012.11.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2012.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2012.11.045%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DK.%26aulast%3DAndersen%26aufirst%3DJ.%2BR.%26aulast%3DRiis%26aufirst%3DB.%2BJ.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DTavakkol%26aufirst%3DR.%26aulast%3DAlexandersen%26aufirst%3DP.%26aulast%3DByrjalsen%26aufirst%3DI.%26aulast%3DValter%26aufirst%3DI.%26aulast%3DNedergaard%26aufirst%3DB.%2BS.%26aulast%3DTeglbjaerg%26aufirst%3DC.%2BS.%26aulast%3DStern%26aufirst%3DW.%26aulast%3DSturmer%26aufirst%3DA.%26aulast%3DMitta%26aufirst%3DS.%26aulast%3DNino%26aufirst%3DA.%2BJ.%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26aulast%3DChristiansen%26aufirst%3DC.%26aulast%3DKarsdal%26aufirst%3DM.%2BA.%26atitle%3DEvaluation%2520of%2520the%2520efficacy%252C%2520safety%2520and%2520pharmacokinetic%2520profile%2520of%2520oral%2520recombinant%2520human%2520parathyroid%2520hormone%2520rhPTH%25281-31%2529NH2%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DBone%26date%3D2013%26volume%3D53%26issue%3D1%26spage%3D160%26epage%3D166%26doi%3D10.1016%2Fj.bone.2012.11.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">DiBonaventura, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodovicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentakota, S.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radican, L.</span><span> </span><span class="NLM_article-title">Multinational internet-based survey of patient preference for newer oral or injectable type 2 diabetes medication</span> <span class="citation_source-journal">Patient Prefer. Adherence</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.2147/PPA.S14477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.2147%2FPPA.S14477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=21206515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FovFyqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=397-406&author=M.+D.+DiBonaventuraauthor=J.+S.+Wagnerauthor=C.+J.+Girmanauthor=K.+Brodoviczauthor=Q.+Y.+Zhangauthor=Y.+Qiuauthor=S.-R.+Pentakotaauthor=L.+Radican&title=Multinational+internet-based+survey+of+patient+preference+for+newer+oral+or+injectable+type+2+diabetes+medication&doi=10.2147%2FPPA.S14477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication</span></div><div class="casAuthors">Dibonaventura Marco Dacosta; Wagner Jan-Samuel; Girman Cynthia J; Brodovicz Kimberly; Zhang Qiaoyi; Qiu Ying; Pentakota Sri-Ram; Radican Larry</div><div class="citationInfo"><span class="NLM_cas:title">Patient preference and adherence</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">397-406</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The prevalence of Type 2 diabetes mellitus continues to rise.  Although glucagon-like peptide-1 (GLP-1) analog and dipeptidyl peptidase-4 (DPP-4) inhibitor medications are effective, there are differences between these products, including method of administration (injectable versus oral).  The objective of this study was to examine patient preferences (and predictors of preferences) for two different medication profiles, one similar to a GLP-1 analog (liraglutide) and another similar to a DPP-4 inhibitor (sitagliptin).  METHODS:  Internet survey data were collected in two waves (wave 1, n = 2402; wave 2, n = 1340) using patients from the US and Europe.  Patients were presented with two hypothetical medication profiles ("drug A" and "drug B", resembling sitagliptin and liraglutide, respectively) and asked to report their preferences.  RESULTS:  Most patients in wave 1 and wave 2 reported that overall they would prefer a drug with the sitagliptin-like profile (81.9% and 84.4%, respectively) over a drug with the liraglutide-like profile (18.1% and 15.6%, respectively), and >80% of patients reported that they would be able to take a drug with the sitagliptin-like profile as directed by their physician for a longer period.  The likelihood of preferring the sitagliptin-like profile significantly increased as age (odds ratio [OR] = 1.02) and importance placed on method of administration (OR = 1.32) increased (P < 0.05).  Although the sitagliptin-like profile was preferred by the majority of patients in all subgroups, a lower proportion of patients with obesity, with weight gain, with A1C values above target, and who exercised preferred the sitagliptin-like profile compared with those without obesity (77.0% versus 87.9%), without weight gain (77.8% versus 86.7%), with A1C values at or below target (79.0% versus 86.5%), and who did not exercise (81.6% versus 86.4%), respectively (P < 0.05).  CONCLUSIONS:  This research suggests that patients (across geographies) prefer an oral medication with a profile resembling sitagliptin to an injectable medication with a profile resembling liraglutide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWeeUnfSbuqpPq5LRczm8ffW6udTcc2ebtrj6A1nYpsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FovFyqsw%253D%253D&md5=7a066686bbe18e69b3facadbb2d65759</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2147%2FPPA.S14477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FPPA.S14477%26sid%3Dliteratum%253Aachs%26aulast%3DDiBonaventura%26aufirst%3DM.%2BD.%26aulast%3DWagner%26aufirst%3DJ.%2BS.%26aulast%3DGirman%26aufirst%3DC.%2BJ.%26aulast%3DBrodovicz%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DPentakota%26aufirst%3DS.-R.%26aulast%3DRadican%26aufirst%3DL.%26atitle%3DMultinational%2520internet-based%2520survey%2520of%2520patient%2520preference%2520for%2520newer%2520oral%2520or%2520injectable%2520type%25202%2520diabetes%2520medication%26jtitle%3DPatient%2520Prefer.%2520Adherence%26date%3D2010%26volume%3D4%26spage%3D397%26epage%3D406%26doi%3D10.2147%2FPPA.S14477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fallowfield, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langridge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, M.</span><span> </span><span class="NLM_article-title">Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1093/annonc/mdj044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1093%2Fannonc%2Fmdj044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=16239231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FjvVGmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=205-210&issue=2&author=L.+Fallowfieldauthor=L.+Atkinsauthor=S.+Cattauthor=A.+Coxauthor=C.+Coxonauthor=C.+Langridgeauthor=R.+Morrisauthor=M.+Price&title=Patients%E2%80%99+preference+for+administration+of+endocrine+treatments+by+injection+or+tablets%3A+results+from+a+study+of+women+with+breast+cancer&doi=10.1093%2Fannonc%2Fmdj044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer</span></div><div class="casAuthors">Fallowfield L; Atkins L; Catt S; Cox A; Coxon C; Langridge C; Morris R; Price M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-10</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">BACKGROUND:  Endocrine therapies for advanced breast cancer include tablets and intramuscular injections.  When treatments have similar efficacy and tolerability profiles, addressing preferences about routes of administration is important.  PATIENTS AND METHODS:  Two hundred and eight women>2 years post-breast cancer diagnosis were interviewed about their preferences for daily tablets or monthly intramuscular injections.  Health-care professionals treating the women estimated patients' preferences.  RESULTS:  Sixty-three per cent of patients preferred tablets, 24.5% preferred the injection and 12.5% had no preference.  The most cited reasons for tablet preference were convenience and dislike of needles; for injection preference, adherence and convenience.  Variables associated with preferences were body mass index, educational level, attitudes towards injections and efficacy perceptions.  Estimates about patients' preferences by health-care professionals varied widely.  When asked to imagine scenarios where injections produced fewer hot flushes, or where two injections monthly improved efficacy, injection preference increased to 60.6% and 74.5%, respectively.  Disturbingly, approximately 50% of patients admitted they sometimes forgot or chose not to take their current oral medication.  CONCLUSIONS:  The majority of breast cancer patients preferred hormone therapy via daily tablets rather than monthly injections.  Information about side-effects or improved efficacy altered these preferences.  Adherence to treatment cannot be assumed; patients' preferences about drug administration may influence this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThMrYbu676lRwLZxei1HN8fW6udTcc2ebjvK1syF3zz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FjvVGmtw%253D%253D&md5=f9364cd9c72101236a6c32f0612b2132</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdj044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdj044%26sid%3Dliteratum%253Aachs%26aulast%3DFallowfield%26aufirst%3DL.%26aulast%3DAtkins%26aufirst%3DL.%26aulast%3DCatt%26aufirst%3DS.%26aulast%3DCox%26aufirst%3DA.%26aulast%3DCoxon%26aufirst%3DC.%26aulast%3DLangridge%26aufirst%3DC.%26aulast%3DMorris%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DM.%26atitle%3DPatients%25E2%2580%2599%2520preference%2520for%2520administration%2520of%2520endocrine%2520treatments%2520by%2520injection%2520or%2520tablets%253A%2520results%2520from%2520a%2520study%2520of%2520women%2520with%2520breast%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2006%26volume%3D17%26issue%3D2%26spage%3D205%26epage%3D210%26doi%3D10.1093%2Fannonc%2Fmdj044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajiri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basit, A. W.</span><span> </span><span class="NLM_article-title">Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span><span class="refDoi"> DOI: 10.1021/mp500809f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500809f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=966-973&issue=3&author=J.+Wangauthor=V.+Yadavauthor=A.+L.+Smartauthor=S.+Tajiriauthor=A.+W.+Basit&title=Toward+oral+delivery+of+biopharmaceuticals%3A+an+assessment+of+the+gastrointestinal+stability+of+17+peptide+drugs&doi=10.1021%2Fmp500809f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Toward Oral Delivery of Biopharmaceuticals: An Assessment of the Gastrointestinal Stability of 17 Peptide Drugs</span></div><div class="casAuthors">Wang, Jie; Yadav, Vipul; Smart, Alice L.; Tajiri, Shinichiro; Basit, Abdul W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">966-973</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major barrier to successful oral delivery of peptide and protein mols. is their inherent instability in the lumen of the gastrointestinal tract.  The aim of this study was to det. the stability of 17 disparate peptide drugs (insulin, calcitonin, glucagon, secretin, somatostatin, desmopressin, oxytocin, [Arg8]-vasopressin, octreotide, ciclosporin, leuprolide, nafarelin, buserelin, histrelin, [D-Ser]4-gonadorelin, deslorelin, and goserelin) in gastric and small intestinal fluids from both humans and pigs, and in simulated gastric and intestinal fluids.  In human gastric fluid, the larger peptides including somatostatin, calcitonin, secretin, glucagon, and insulin were metabolized rapidly, while the smaller peptides showed good stability.  In human small intestinal fluid, however, both small and large peptides degraded rapidly with the exception of the cyclic peptide ciclosporin and the disulfide-bridge contg. peptides octreotide and desmopressin, which showed good stability.  The stability of peptides in both simulated gastric fluid and pig gastric fluid correlated well with stability in human gastric fluid.  However, it was not possible to establish such a correlation with the small intestinal fluids because of the rapid rate of peptide degrdn.  This work has identified the mol. features in the structure of a wide range of peptides that influence their stability in the environment of the gastrointestinal tract, which in turn will allow for better selection of peptide candidates for oral delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraciXJLe-z4rVg90H21EOLACvtfcHk0ljSarhNqJRnLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyqsb8%253D&md5=a29abd913a44604892e879e735818ff9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fmp500809f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500809f%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYadav%26aufirst%3DV.%26aulast%3DSmart%26aufirst%3DA.%2BL.%26aulast%3DTajiri%26aufirst%3DS.%26aulast%3DBasit%26aufirst%3DA.%2BW.%26atitle%3DToward%2520oral%2520delivery%2520of%2520biopharmaceuticals%253A%2520an%2520assessment%2520of%2520the%2520gastrointestinal%2520stability%2520of%252017%2520peptide%2520drugs%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26issue%3D3%26spage%3D966%26epage%3D973%26doi%3D10.1021%2Fmp500809f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Pawar, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meher, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaurasia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chourasia, M. K.</span><span> </span><span class="NLM_article-title">Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: Strategies and industrial perspectives</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2014.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.jconrel.2014.09.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2014&pages=168-183&author=V.+K.+Pawarauthor=J.+G.+Meherauthor=Y.+Singhauthor=M.+Chaurasiaauthor=B.+S.+Reddyauthor=M.+K.+Chourasia&title=Targeting+of+gastrointestinal+tract+for+amended+delivery+of+protein%2Fpeptide+therapeutics%3A+Strategies+and+industrial+perspectives&doi=10.1016%2Fj.jconrel.2014.09.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DPawar%26aufirst%3DV.%2BK.%26aulast%3DMeher%26aufirst%3DJ.%2BG.%26aulast%3DSingh%26aufirst%3DY.%26aulast%3DChaurasia%26aufirst%3DM.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DChourasia%26aufirst%3DM.%2BK.%26atitle%3DTargeting%2520of%2520gastrointestinal%2520tract%2520for%2520amended%2520delivery%2520of%2520protein%252Fpeptide%2520therapeutics%253A%2520Strategies%2520and%2520industrial%2520perspectives%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2014%26volume%3D196%26spage%3D168%26epage%3D183%26doi%3D10.1016%2Fj.jconrel.2014.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Binkowski, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stecha, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggers, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidugiris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. V.</span><span> </span><span class="NLM_article-title">A luminescent biosensor with increased dynamic range for intracellular cAMP</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span><span class="refDoi"> DOI: 10.1021/cb200248h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200248h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1193-1197&issue=11&author=B.+F.+Binkowskiauthor=B.+L.+Butlerauthor=P.+F.+Stechaauthor=C.+T.+Eggersauthor=P.+Ottoauthor=K.+Zimmermanauthor=G.+Vidugirisauthor=M.+G.+Woodauthor=L.+P.+Encellauthor=F.+Fanauthor=K.+V.+Wood&title=A+luminescent+biosensor+with+increased+dynamic+range+for+intracellular+cAMP&doi=10.1021%2Fcb200248h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fcb200248h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200248h%26sid%3Dliteratum%253Aachs%26aulast%3DBinkowski%26aufirst%3DB.%2BF.%26aulast%3DButler%26aufirst%3DB.%2BL.%26aulast%3DStecha%26aufirst%3DP.%2BF.%26aulast%3DEggers%26aufirst%3DC.%2BT.%26aulast%3DOtto%26aufirst%3DP.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DVidugiris%26aufirst%3DG.%26aulast%3DWood%26aufirst%3DM.%2BG.%26aulast%3DEncell%26aufirst%3DL.%2BP.%26aulast%3DFan%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DA%2520luminescent%2520biosensor%2520with%2520increased%2520dynamic%2520range%2520for%2520intracellular%2520cAMP%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26issue%3D11%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fcb200248h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">LePlae, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">An efficient route to either enantiomer of trans-2-aminocyclopentanecarboxylic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5632</span><span class="refDoi"> DOI: 10.1021/jo010279h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010279h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=5629-5632&issue=16&author=P.+R.+LePlaeauthor=N.+Umezawaauthor=H.+S.+Leeauthor=S.+H.+Gellman&title=An+efficient+route+to+either+enantiomer+of+trans-2-aminocyclopentanecarboxylic+acid&doi=10.1021%2Fjo010279h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo010279h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010279h%26sid%3Dliteratum%253Aachs%26aulast%3DLePlae%26aufirst%3DP.%2BR.%26aulast%3DUmezawa%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAn%2520efficient%2520route%2520to%2520either%2520enantiomer%2520of%2520trans-2-aminocyclopentanecarboxylic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26issue%3D16%26spage%3D5629%26epage%3D5632%26doi%3D10.1021%2Fjo010279h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LePlae, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">An efficient route to either enantiomer of orthogonally protected trans-3-aminopyrrolidine-4-carboxylic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3597</span><span class="NLM_x">–</span> <span class="NLM_lpage">3599</span><span class="refDoi"> DOI: 10.1021/jo001534l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo001534l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=3597-3599&issue=10&author=H.+S.+Leeauthor=P.+R.+LePlaeauthor=E.+A.+Porterauthor=S.+H.+Gellman&title=An+efficient+route+to+either+enantiomer+of+orthogonally+protected+trans-3-aminopyrrolidine-4-carboxylic+acid&doi=10.1021%2Fjo001534l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjo001534l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001534l%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DLePlae%26aufirst%3DP.%2BR.%26aulast%3DPorter%26aufirst%3DE.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAn%2520efficient%2520route%2520to%2520either%2520enantiomer%2520of%2520orthogonally%2520protected%2520trans-3-aminopyrrolidine-4-carboxylic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26issue%3D10%26spage%3D3597%26epage%3D3599%26doi%3D10.1021%2Fjo001534l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Lelais, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micuch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien-Lefebvre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seebach, D.</span><span> </span><span class="NLM_article-title">Preparation of protected beta(2)- and beta(3)-homocysteine, beta(2)- and beta(3)-homohistidine, and beta(2)-homoserine for solid-phase syntheses</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3131</span><span class="NLM_x">–</span> <span class="NLM_lpage">3159</span><span class="refDoi"> DOI: 10.1002/hlca.200490280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fhlca.200490280" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2004&pages=3131-3159&issue=12&author=G.+Lelaisauthor=P.+Micuchauthor=D.+Josien-Lefebvreauthor=F.+Rossiauthor=D.+Seebach&title=Preparation+of+protected+beta%282%29-+and+beta%283%29-homocysteine%2C+beta%282%29-+and+beta%283%29-homohistidine%2C+and+beta%282%29-homoserine+for+solid-phase+syntheses&doi=10.1002%2Fhlca.200490280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200490280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200490280%26sid%3Dliteratum%253Aachs%26aulast%3DLelais%26aufirst%3DG.%26aulast%3DMicuch%26aufirst%3DP.%26aulast%3DJosien-Lefebvre%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DSeebach%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520protected%2520beta%25282%2529-%2520and%2520beta%25283%2529-homocysteine%252C%2520beta%25282%2529-%2520and%2520beta%25283%2529-homohistidine%252C%2520and%2520beta%25282%2529-homoserine%2520for%2520solid-phase%2520syntheses%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2004%26volume%3D87%26issue%3D12%26spage%3D3131%26epage%3D3159%26doi%3D10.1002%2Fhlca.200490280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Carter, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhayana, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1210/me.2014-1129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fme.2014-1129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25584411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=307-321&issue=2&author=P.+H.+Carterauthor=T.+Deanauthor=B.+Bhayanaauthor=A.+Khatriauthor=R.+Rajurauthor=T.+J.+Gardella&title=Actions+of+the+small+molecule+ligands+SW106+and+AH-3960+on+the+type-1+parathyroid+hormone+receptor&doi=10.1210%2Fme.2014-1129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor</span></div><div class="casAuthors">Carter, Percy H.; Dean, Thomas; Bhayana, Brijesh; Khatri, Ashok; Rajur, Raj; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-321/1-307-321/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The parathyroid hormone receptor-1 (PTHR1) plays crit. roles in regulating blood calcium levels and bone metab. and is thus of interest for small-mol. ligand development.  Of the few small-mol. ligands reported for the PTHR1, most are of low affinity, and none has a well-defined mechanism of action.  Here, we show that SW106 and AH-3960, compds. previously identified to act as an antagonist and agonist, resp., on the PTHR1, each bind to PTHR1-delNT, a PTHR1 construct that lacks the large amino-terminal extracellular domain used for binding endogenous PTH peptide ligands, with the same micromolar affinity with which it binds to the intact PTHR1.  SW106 antagonized PTHR1-mediated cAMP signaling induced by the peptide analog, M-PTH(1-11), as well as by the native PTH(1-9) sequence, as tethered to the extracellular end of transmembrane domain (TMD) helix-1 of the receptor.  SW106, however, did not function as an inverse agonist on either PTHR1-H223R or PTHR1-T410P, which have activating mutations at the cytoplasmic ends of TMD helixes 2 and 6, resp.  The overall data indicate that SW106 and AH-3960 each bind to the PTHR1 TMD region and likely to within an extracellularly exposed area that is occupied by the N-terminal residues of PTH peptides.  Addnl., they suggest that the inhibitory effects of SW106 are limited to the extracellular portions of the TMD region that mediate interactions with agonist ligands but do not extend to receptor-activation determinants situated more deeply in the helical bundle.  The study helps to elucidate potential mechanisms of small-mol. binding at the PTHR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC428wNJkPF7Vg90H21EOLACvtfcHk0liukpQSNufTXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFGqt7Y%253D&md5=68b9c3fed11e185abeb3f2ce78d17464</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1210%2Fme.2014-1129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2014-1129%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DBhayana%26aufirst%3DB.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DRajur%26aufirst%3DR.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DActions%2520of%2520the%2520small%2520molecule%2520ligands%2520SW106%2520and%2520AH-3960%2520on%2520the%2520type-1%2520parathyroid%2520hormone%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2015%26volume%3D29%26issue%3D2%26spage%3D307%26epage%3D321%26doi%3D10.1210%2Fme.2014-1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hoare, S. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usdin, T. B.</span><span> </span><span class="NLM_article-title">Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor - Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">7741</span><span class="NLM_x">–</span> <span class="NLM_lpage">7753</span><span class="refDoi"> DOI: 10.1074/jbc.M009395200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M009395200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=7741-7753&issue=11&author=S.+R.+J.+Hoareauthor=T.+J.+Gardellaauthor=T.+B.+Usdin&title=Evaluating+the+signal+transduction+mechanism+of+the+parathyroid+hormone+1+receptor+-+Effect+of+receptor-G-protein+interaction+on+the+ligand+binding+mechanism+and+receptor+conformation&doi=10.1074%2Fjbc.M009395200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M009395200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M009395200%26sid%3Dliteratum%253Aachs%26aulast%3DHoare%26aufirst%3DS.%2BR.%2BJ.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DUsdin%26aufirst%3DT.%2BB.%26atitle%3DEvaluating%2520the%2520signal%2520transduction%2520mechanism%2520of%2520the%2520parathyroid%2520hormone%25201%2520receptor%2520-%2520Effect%2520of%2520receptor-G-protein%2520interaction%2520on%2520the%2520ligand%2520binding%2520mechanism%2520and%2520receptor%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D11%26spage%3D7741%26epage%3D7753%26doi%3D10.1074%2Fjbc.M009395200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Okazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouxsein, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">16525</span><span class="NLM_x">–</span> <span class="NLM_lpage">16530</span><span class="refDoi"> DOI: 10.1073/pnas.0808750105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0808750105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=16525-16530&issue=43&author=M.+Okazakiauthor=S.+Ferrandonauthor=J.+P.+Vilardagaauthor=M.+L.+Bouxseinauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Prolonged+signaling+at+the+parathyroid+hormone+receptor+by+peptide+ligands+targeted+to+a+specific+receptor+conformation&doi=10.1073%2Fpnas.0808750105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0808750105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0808750105%26sid%3Dliteratum%253Aachs%26aulast%3DOkazaki%26aufirst%3DM.%26aulast%3DFerrandon%26aufirst%3DS.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26aulast%3DBouxsein%26aufirst%3DM.%2BL.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DProlonged%2520signaling%2520at%2520the%2520parathyroid%2520hormone%2520receptor%2520by%2520peptide%2520ligands%2520targeted%2520to%2520a%2520specific%2520receptor%2520conformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D43%26spage%3D16525%26epage%3D16530%26doi%3D10.1073%2Fpnas.0808750105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Shimizu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Minimization of parathyroid hormone - Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">21836</span><span class="NLM_x">–</span> <span class="NLM_lpage">21843</span><span class="refDoi"> DOI: 10.1074/jbc.M909861199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M909861199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21836-21843&issue=29&author=M.+Shimizuauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Minimization+of+parathyroid+hormone+-+Novel+amino-terminal+parathyroid+hormone+fragments+with+enhanced+potency+in+activating+the+type-1+parathyroid+hormone+receptor&doi=10.1074%2Fjbc.M909861199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M909861199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M909861199%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DMinimization%2520of%2520parathyroid%2520hormone%2520-%2520Novel%2520amino-terminal%2520parathyroid%2520hormone%2520fragments%2520with%2520enhanced%2520potency%2520in%2520activating%2520the%2520type-1%2520parathyroid%2520hormone%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D29%26spage%3D21836%26epage%3D21843%26doi%3D10.1074%2Fjbc.M909861199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Tsomaia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierke, D. F.</span><span> </span><span class="NLM_article-title">Toward parathyroid hormone minimization: Conformational studies of cyclic PTH(1-14) analogues</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1021/bi035703i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi035703i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=690-699&issue=3&author=N.+Tsomaiaauthor=M.+Pellegriniauthor=K.+Hydeauthor=T.+J.+Gardellaauthor=D.+F.+Mierke&title=Toward+parathyroid+hormone+minimization%3A+Conformational+studies+of+cyclic+PTH%281-14%29+analogues&doi=10.1021%2Fbi035703i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fbi035703i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi035703i%26sid%3Dliteratum%253Aachs%26aulast%3DTsomaia%26aufirst%3DN.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DK.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DMierke%26aufirst%3DD.%2BF.%26atitle%3DToward%2520parathyroid%2520hormone%2520minimization%253A%2520Conformational%2520studies%2520of%2520cyclic%2520PTH%25281-14%2529%2520analogues%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26issue%3D3%26spage%3D690%26epage%3D699%26doi%3D10.1021%2Fbi035703i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Kent, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveridge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, J. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of synthetic human parathyroid-hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1042/cs0680171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1042%2Fcs0680171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=3967464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADyaL2MXhtVKrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1985&pages=171-177&issue=2&author=G.+N.+Kentauthor=N.+Loveridgeauthor=J.+Reeveauthor=J.+M.+Zanelli&title=Pharmacokinetics+of+synthetic+human+parathyroid-hormone+1-34+in+man+measured+by+cytochemical+bioassay+and+radioimmunoassay&doi=10.1042%2Fcs0680171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay</span></div><div class="casAuthors">Kent, G. N.; Loveridge, N.; Reeve, J.; Zanelli, Joan M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-7</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    </div><div class="casAbstract">Synthetic human parathyroid hormone (1-34) [(hPTH) 1-34]  [52232-67-4] was given by i.v. injection to healthy men.  The time course of its appearance in and disappearance from the plasma was monitored both by cytochem. bioassay and by a specific RIA system.  Immunoreactive N-region parathyroid hormone (iPTH) reached peak concns. in plasma at 2 min after injection, whereas peak concns. of biol. active parathyroid hormone (bioPTH) were delayed until 4-6 min.  Bioassayable PTH-like activity then disappeared from the plasma (mean transit times 5.8 and 8.6 min), approx. twice as fast as immunoreactivity.  After sep. s.c. administrations, a calcd. 22-37% of administered hPTH 1-34 was subsequently detected in the plasma, by both assay systems.  It was not possible to explain fully the nonparallel appearances of bio- and immuno-reactivities in the plasma after i.v. injection nor the non-parallel disappearances after both i.v. and s.c. injections on the basis of the present data.  In the process of biol. degrdn. the immunoreactive locus is apparently inactivated by a different reaction from that which destroys bioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonzJBnG_hx47Vg90H21EOLACvtfcHk0ljmqGRGzla57g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtVKrtLY%253D&md5=a9941ea2009ad69c76ebd899a4ac2809</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1042%2Fcs0680171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fcs0680171%26sid%3Dliteratum%253Aachs%26aulast%3DKent%26aufirst%3DG.%2BN.%26aulast%3DLoveridge%26aufirst%3DN.%26aulast%3DReeve%26aufirst%3DJ.%26aulast%3DZanelli%26aufirst%3DJ.%2BM.%26atitle%3DPharmacokinetics%2520of%2520synthetic%2520human%2520parathyroid-hormone%25201-34%2520in%2520man%2520measured%2520by%2520cytochemical%2520bioassay%2520and%2520radioimmunoassay%26jtitle%3DClin.%2520Sci.%26date%3D1985%26volume%3D68%26issue%3D2%26spage%3D171%26epage%3D177%26doi%3D10.1042%2Fcs0680171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Serada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai-Tanikawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibusawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohira, T.</span><span> </span><span class="NLM_article-title">The role of the liver and kidneys in the pharmacokinetics of subcutaneously administered teriparatide acetate in rats</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.3109/00498254.2011.622811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.3109%2F00498254.2011.622811" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=398-407&issue=4&author=M.+Seradaauthor=A.+Sakurai-Tanikawaauthor=M.+Igarashiauthor=K.+Mitsugiauthor=T.+Takanoauthor=K.+Shibusawaauthor=T.+Kohira&title=The+role+of+the+liver+and+kidneys+in+the+pharmacokinetics+of+subcutaneously+administered+teriparatide+acetate+in+rats&doi=10.3109%2F00498254.2011.622811"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3109%2F00498254.2011.622811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2011.622811%26sid%3Dliteratum%253Aachs%26aulast%3DSerada%26aufirst%3DM.%26aulast%3DSakurai-Tanikawa%26aufirst%3DA.%26aulast%3DIgarashi%26aufirst%3DM.%26aulast%3DMitsugi%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DT.%26aulast%3DShibusawa%26aufirst%3DK.%26aulast%3DKohira%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520the%2520liver%2520and%2520kidneys%2520in%2520the%2520pharmacokinetics%2520of%2520subcutaneously%2520administered%2520teriparatide%2520acetate%2520in%2520rats%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26issue%3D4%26spage%3D398%26epage%3D407%26doi%3D10.3109%2F00498254.2011.622811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qie, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, J. X.</span><span> </span><span class="NLM_article-title">Metabolic stability of human parathyroid hormone peptide hPTH (1-34) in rat tissue homogenates: kinetics and products of proteolytic degradation</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1605</span><span class="refDoi"> DOI: 10.1007/s00726-009-0376-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1007%2Fs00726-009-0376-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1595-1605&issue=5&author=S.+Liaoauthor=J.+K.+Qieauthor=M.+Xueauthor=Z.+Q.+Zhangauthor=K.+L.+Liuauthor=J.+X.+Ruan&title=Metabolic+stability+of+human+parathyroid+hormone+peptide+hPTH+%281-34%29+in+rat+tissue+homogenates%3A+kinetics+and+products+of+proteolytic+degradation&doi=10.1007%2Fs00726-009-0376-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs00726-009-0376-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-009-0376-y%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DQie%26aufirst%3DJ.%2BK.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%2BQ.%26aulast%3DLiu%26aufirst%3DK.%2BL.%26aulast%3DRuan%26aufirst%3DJ.%2BX.%26atitle%3DMetabolic%2520stability%2520of%2520human%2520parathyroid%2520hormone%2520peptide%2520hPTH%2520%25281-34%2529%2520in%2520rat%2520tissue%2520homogenates%253A%2520kinetics%2520and%2520products%2520of%2520proteolytic%2520degradation%26jtitle%3DAmino%2520Acids%26date%3D2010%26volume%3D38%26issue%3D5%26spage%3D1595%26epage%3D1605%26doi%3D10.1007%2Fs00726-009-0376-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1210/me.2007-0274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fme.2007-0274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=17872377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1SitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=156-166&issue=1&author=T.+Deanauthor=J.+P.+Vilardagaauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Altered+selectivity+of+parathyroid+hormone+%28PTH%29+and+PTH-related+protein+%28PTHrP%29+for+distinct+conformations+of+the+PTH%2FPTHrP+receptor&doi=10.1210%2Fme.2007-0274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor</span></div><div class="casAuthors">Dean, Thomas; Vilardaga, Jean-Pierre; Potts, John T., Jr.; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">PTH and PTHrP use the same G protein-coupled receptor, the PTH/PTHrP receptor (PTHR), to mediate their distinct biol. actions.  The extent to which the mechanisms by which the two ligands bind to the PTHR differ is unclear.  The authors examd. this question using several pharmacol. and biophys. approaches.  Kinetic dissocn. and equil. binding assays revealed that the binding of [125I]PTHrP(1-36) to the PTHR was more sensitive to GTPγS (added to functionally uncouple PTHR-G protein complexes) than was the binding of [125I]PTH(1-34) (∼75% maximal inhibition vs. ∼20%).  Fluorescence resonance energy transfer-based kinetic analyses revealed that PTHrP(1-36) bound to the PTHR more slowly and dissocd. from it more rapidly than did PTH(1-34).  The cAMP signaling response capacity of PTHrP(1-36) in cells decayed more rapidly than did that of PTH(1-34) (t1/2 = ∼1 vs. ∼2 h).  Divergent residue 5 in the ligand, Ile in PTH and His in PTHrP, was identified as a key determinant of the altered receptor-interaction responses exhibited by the two peptides.  The authors conclude that, whereas PTH and PTHrP bind similarly to the G protein-coupled PTHR conformation (RG), PTH has a greater capacity to bind to the G protein-uncoupled conformation (Ro) and, hence, can produce cumulatively greater signaling responses (via Ro→RG isomerization) than can PTHrP.  Such conformational selectivity may relate to the distinct modes by which PTH and PTHrP act biol., endocrine vs. paracrine, and may help explain reported differences in the effects that the ligands have on calcium and bone metab. when administered to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgXJg6PTzY47Vg90H21EOLACvtfcHk0ljmqGRGzla57g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1SitA%253D%253D&md5=da008d93f1a5261060589ad1a2246b56</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1210%2Fme.2007-0274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2007-0274%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DT.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DAltered%2520selectivity%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520and%2520PTH-related%2520protein%2520%2528PTHrP%2529%2520for%2520distinct%2520conformations%2520of%2520the%2520PTH%252FPTHrP%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2008%26volume%3D22%26issue%3D1%26spage%3D156%26epage%3D166%26doi%3D10.1210%2Fme.2007-0274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Ferrandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J.-P.</span><span> </span><span class="NLM_article-title">Sustained cyclic AMP production by parathyroid hormone receptor endocytosis</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span><span class="refDoi"> DOI: 10.1038/nchembio.206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19701185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=734-742&issue=10&author=S.+Ferrandonauthor=T.+N.+Feinsteinauthor=M.+Castroauthor=B.+Wangauthor=R.+Bouleyauthor=J.+T.+Pottsauthor=T.+J.+Gardellaauthor=J.-P.+Vilardaga&title=Sustained+cyclic+AMP+production+by+parathyroid+hormone+receptor+endocytosis&doi=10.1038%2Fnchembio.206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained cyclic AMP production by parathyroid hormone receptor endocytosis</span></div><div class="casAuthors">Ferrandon, Sebastien; Feinstein, Timothy N.; Castro, Marian; Wang, Bin; Bouley, Richard; Potts, John T.; Gardella, Thomas J.; Vilardaga, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">734-742</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cell signaling mediated by the G protein-coupled parathyroid hormone receptor type 1 (PTHR) is fundamental to bone and kidney physiol.  It has been unclear how the two ligand systems-PTH, endocrine and homeostatic, and PTH-related peptide (PTHrP), paracrine-can effectively operate with only one receptor and trigger different durations of the cAMP responses.  Here we analyze the ligand response by measuring the kinetics of activation and deactivation for each individual reaction step along the PTHR signaling cascade.  We found that during the time frame of G protein coupling and cAMP prodn., PTHrP1-36 action was restricted to the cell surface, whereas PTH1-34 had moved to internalized compartments where it remained assocd. with the PTHR and Gαs, potentially as a persistent and active ternary complex.  Such marked differences suggest a mechanism by which PTH and PTHrP induce differential responses, and these results indicate that the central tenet that cAMP prodn. originates exclusively at the cell membrane must be revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLUPOKhhnJrVg90H21EOLACvtfcHk0lg_oLh6ipxE7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrO&md5=9df689536dcc90bc69ca6c558545d229</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.206%26sid%3Dliteratum%253Aachs%26aulast%3DFerrandon%26aufirst%3DS.%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DCastro%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBouley%26aufirst%3DR.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.-P.%26atitle%3DSustained%2520cyclic%2520AMP%2520production%2520by%2520parathyroid%2520hormone%2520receptor%2520endocytosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26issue%3D10%26spage%3D734%26epage%3D742%26doi%3D10.1038%2Fnchembio.206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Cupp, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayak, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adem, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W. J.</span><span> </span><span class="NLM_article-title">Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1124/jpet.112.199752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1124%2Fjpet.112.199752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23516330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=404-418&issue=3&author=M.+E.+Cuppauthor=S.+K.+Nayakauthor=A.+S.+Ademauthor=W.+J.+Thomsen&title=Parathyroid+hormone+%28PTH%29+and+PTH-related+peptide+domains+contributing+to+activation+of+different+PTH+receptor-mediated+signaling+pathways&doi=10.1124%2Fjpet.112.199752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways</span></div><div class="casAuthors">Cupp, Meghan E.; Nayak, Surendra K.; Adem, Amina S.; Thomsen, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">404-418</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP), acting through the osteoblast PTH1 receptor (PTH1R), play important roles in bone remodeling.  Intermittent administration of PTH(1-34) (teriparatide) leads to bone formation, whereas continuous administration paradoxically leads to bone resorption.  Activation of PTH1R promotes regulation of multiple signaling pathways, including Gs/cAMP/protein kinase A, Gq/calcium/protein kinase C, β-arrestin recruitment, and extracellular signal-related kinase (ERK)1/2 phosphorylation, as well as receptor internalization, but their role in promoting anabolic and catabolic actions of PTH(1-34) are unclear.  In the present investigation, a collection of PTH(1-34) and PTHrP(1-34) peptide analogs were evaluated in orthogonal human PTH1R (hPTH1R) functional assays capturing Gs- and Gq-signaling, β-arrestin recruitment, ERK1/2 phosphorylation, and receptor internalization to further define the patterns of PTH1R signaling that they stimulate and further establish peptide domains contributing to agonist activity.  Results indicate that both N- and C-terminal domains of PTH and PTHrP are crit. for activation of signaling pathways.  However, modifications of both regions lead to more substantial decreases in agonist potency and efficacy to stimulate Gq-signaling, β-arrestin recruitment, ERK1/2 phosphorylation, and receptor internalization than to stimulate Gs-signaling.  The substantial contribution of the peptide C-terminal domain in activation of hPTH1R signaling suggests a role in positioning of the peptide N-terminal region into the receptor J-domain.  Several PTH and PTHrP peptides evaluated in this study promote different patterns of biased agonist signaling and may serve as useful tools to further elucidate therapeutically relevant PTH1R signaling in osteoblasts.  With a better understanding of therapeutically relevant signaling, novel biased peptides with desired signaling could be designed for safer and more effective treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYnRF2BDhnkrVg90H21EOLACvtfcHk0lg_oLh6ipxE7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgs7o%253D&md5=470334b657042c5ecbfb92a86aa28d7f</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.199752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.199752%26sid%3Dliteratum%253Aachs%26aulast%3DCupp%26aufirst%3DM.%2BE.%26aulast%3DNayak%26aufirst%3DS.%2BK.%26aulast%3DAdem%26aufirst%3DA.%2BS.%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26atitle%3DParathyroid%2520hormone%2520%2528PTH%2529%2520and%2520PTH-related%2520peptide%2520domains%2520contributing%2520to%2520activation%2520of%2520different%2520PTH%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D345%26issue%3D3%26spage%3D404%26epage%3D418%26doi%3D10.1124%2Fjpet.112.199752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Alphonse, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Endosomal generation of cAMP in GPCR signaling</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1038/nchembio.1611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.1611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25271346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOlur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=700-706&issue=9&author=J.+P.+Vilardagaauthor=F.+G.+Jean-Alphonseauthor=T.+J.+Gardella&title=Endosomal+generation+of+cAMP+in+GPCR+signaling&doi=10.1038%2Fnchembio.1611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal generation of cAMP in GPCR signaling</span></div><div class="casAuthors">Vilardaga, Jean-Pierre; Jean-Alphonse, Frederic G.; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">700-706</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has been widely assumed that the prodn. of the ubiquitous second messenger cAMP, which is mediated by cell surface G protein-coupled receptors (GPCRs), and its termination take place exclusively at the plasma membrane.  Recent studies reveal that diverse GPCRs do not always follow this conventional paradigm.  In the new model, GPCRs mediate G-protein signaling not only from the plasma membrane but also from endosomal membranes.  This model proposes that following ligand binding and activation, cell surface GPCRs internalize and redistribute into early endosomes, where trimeric G protein signaling can be maintained for an extended period of time.  This Perspective discusses the mol. and cellular mechanistic subtleties as well as the physiol. consequences of this unexpected process, which is considerably changing how we think about GPCR signaling and regulation and how we study drugs that target this receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoryRANziMK-LVg90H21EOLACvtfcHk0lg_oLh6ipxE7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOlur%252FE&md5=437e81bee0c5fc175c4b57b75fe82a99</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1611%26sid%3Dliteratum%253Aachs%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26aulast%3DJean-Alphonse%26aufirst%3DF.%2BG.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DEndosomal%2520generation%2520of%2520cAMP%2520in%2520GPCR%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D9%26spage%3D700%26epage%3D706%26doi%3D10.1038%2Fnchembio.1611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linglart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastepe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juppner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for G alpha(S)-coupled receptor conformations</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span><span class="refDoi"> DOI: 10.1210/me.2005-0349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fme.2005-0349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=16339275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1yjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=931-943&issue=4&author=T.+Deanauthor=A.+Linglartauthor=M.+J.+Mahonauthor=M.+Bastepeauthor=H.+Juppnerauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Mechanisms+of+ligand+binding+to+the+parathyroid+hormone+%28PTH%29%2FPTH-related+protein+receptor%3A+selectivity+of+a+modified+PTH%281-15%29+radioligand+for+G+alpha%28S%29-coupled+receptor+conformations&doi=10.1210%2Fme.2005-0349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for Gαs-coupled receptor conformations</span></div><div class="casAuthors">Dean, Thomas; Linglart, Agnes; Mahon, Matthew J.; Bastepe, Murat; Juppner, Harald; Potts, John T., Jr.; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">931-943</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Mechanisms of ligand binding to the PTH/PTHrP receptor (PTHR) were explored using PTH fragment analogs as radioligands in binding assays.  In particular, the modified amino-terminal fragment analog, 125I-[Aib1,3,Nle8,Gln10,homoarginine11,Ala12,Trp14,Tyr15]rPTH(1-15)NH2, 125I-[Aib1,3,M]PTH(1-15), was used as a radioligand that we hypothesized to bind solely to the juxtamembrane (J) portion of the PTHR contg. the extracellular loops and transmembrane helixes.  We also employed 125I-PTH(1-34) as a radioligand that binds to both the amino-terminal extracellular (N) and J domains of the PTHR.  Binding was examd. in membranes derived from cells expressing either wild-type or mutant PTHRs.  We found that the binding of 125I-[Aib1,3,M]PTH(1-15) to the wild-type PTHR was strongly (∼90%) inhibited by guanosine 5'-O-(3-thio)triphosphate (GTPγS), whereas the binding of 125I-PTH(1-34) was only mildly (∼25%) inhibited by GTPγS.  Of these two radioligands, only 125I-[Aib1,3,M]PTH(1-15) bound to PTHR-delNt, which lacks most of the receptor's N domain, and again this binding was strongly inhibited by GTPγS.  Binding of 125I-[Aib1,3,M]PTH(1-15) to the constitutively active receptor, PTHR-H223R, was only mildly (∼20%) inhibited by GTPγS, as was the binding of 125I-PTH(1-34).  In membranes prepd. from cells lacking Gαs via knockout mutation of Gnas, no binding of 125I-[Aib1,3,M]PTH(1-15) was obsd., but binding of 125I-[Aib1,3,M]PTH(1-15) was recovered by virally transducing the cells to heterologously express Gαs.  125I-PTH(1-34) bound to the membranes with or without Gαs.  The overall findings confirm the hypothesis that 125I-[Aib1,3,M]PTH(1-15) binds solely to the J domain of the PTHR.  They further show that this binding is strongly dependent on coupling of the receptor to Gαs-contg. heterotrimeric G proteins, whereas the binding of 125I-PTH(1-34) can occur in the absence of such coupling.  Thus, 125I-[Aib1,3,M]PTH(1-15) appears to function as a selective probe of Gαs-coupled, active-state PTHR conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrftLjkby1a_LVg90H21EOLACvtfcHk0lj29KEB7LxOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1yjsrc%253D&md5=1a799a3c936112a4a773ea45d710789c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0349%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DT.%26aulast%3DLinglart%26aufirst%3DA.%26aulast%3DMahon%26aufirst%3DM.%2BJ.%26aulast%3DBastepe%26aufirst%3DM.%26aulast%3DJuppner%26aufirst%3DH.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DMechanisms%2520of%2520ligand%2520binding%2520to%2520the%2520parathyroid%2520hormone%2520%2528PTH%2529%252FPTH-related%2520protein%2520receptor%253A%2520selectivity%2520of%2520a%2520modified%2520PTH%25281-15%2529%2520radioligand%2520for%2520G%2520alpha%2528S%2529-coupled%2520receptor%2520conformations%26jtitle%3DMol.%2520Endocrinol.%26date%3D2006%26volume%3D20%26issue%3D4%26spage%3D931%26epage%3D943%26doi%3D10.1210%2Fme.2005-0349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Hattersley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.1210/en.2015-1726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fen.2015-1726" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=141-149&issue=1&author=G.+Hattersleyauthor=T.+Deanauthor=B.+A.+Corbinauthor=H.+Baharauthor=T.+J.+Gardella&title=Binding+selectivity+of+abaloparatide+for+PTH-type-1-receptor+conformations+and+effects+on+downstream+signaling&doi=10.1210%2Fen.2015-1726"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1210%2Fen.2015-1726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2015-1726%26sid%3Dliteratum%253Aachs%26aulast%3DHattersley%26aufirst%3DG.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DCorbin%26aufirst%3DB.%2BA.%26aulast%3DBahar%26aufirst%3DH.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DBinding%2520selectivity%2520of%2520abaloparatide%2520for%2520PTH-type-1-receptor%2520conformations%2520and%2520effects%2520on%2520downstream%2520signaling%26jtitle%3DEndocrinology%26date%3D2016%26volume%3D157%26issue%3D1%26spage%3D141%26epage%3D149%26doi%3D10.1210%2Fen.2015-1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Maeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Samra, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jueppner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloch, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5864</span><span class="NLM_x">–</span> <span class="NLM_lpage">5869</span><span class="refDoi"> DOI: 10.1073/pnas.1301674110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1301674110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5864-5869&issue=15&author=A.+Maedaauthor=M.+Okazakiauthor=D.+M.+Baronauthor=T.+Deanauthor=A.+Khatriauthor=M.+Mahonauthor=H.+Segawaauthor=A.+B.+Abou-Samraauthor=H.+Jueppnerauthor=K.+D.+Blochauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Critical+role+of+parathyroid+hormone+%28PTH%29+receptor-1+phosphorylation+in+regulating+acute+responses+to+PTH&doi=10.1073%2Fpnas.1301674110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301674110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301674110%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DA.%26aulast%3DOkazaki%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DD.%2BM.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DMahon%26aufirst%3DM.%26aulast%3DSegawa%26aufirst%3DH.%26aulast%3DAbou-Samra%26aufirst%3DA.%2BB.%26aulast%3DJueppner%26aufirst%3DH.%26aulast%3DBloch%26aufirst%3DK.%2BD.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DCritical%2520role%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520receptor-1%2520phosphorylation%2520in%2520regulating%2520acute%2520responses%2520to%2520PTH%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D15%26spage%3D5864%26epage%3D5869%26doi%3D10.1073%2Fpnas.1301674110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Castro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaev, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">44</span><span class="NLM_x">) </span> <span class="NLM_fpage">16084</span><span class="NLM_x">–</span> <span class="NLM_lpage">16089</span><span class="refDoi"> DOI: 10.1073/pnas.0503942102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0503942102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16084-16089&issue=44&author=M.+Castroauthor=V.+O.+Nikolaevauthor=D.+Palmauthor=M.+J.+Lohseauthor=J.+P.+Vilardaga&title=Turn-on+switch+in+parathyroid+hormone+receptor+by+a+two-step+parathyroid+hormone+binding+mechanism&doi=10.1073%2Fpnas.0503942102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0503942102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0503942102%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DM.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DPalm%26aufirst%3DD.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DTurn-on%2520switch%2520in%2520parathyroid%2520hormone%2520receptor%2520by%2520a%2520two-step%2520parathyroid%2520hormone%2520binding%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D44%26spage%3D16084%26epage%3D16089%26doi%3D10.1073%2Fpnas.0503942102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehbi, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardura, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Retromer terminates the generation of cAMP by internalized PTH receptors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1038/nchembio.545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=21445058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=278-284&issue=5&author=T.+N.+Feinsteinauthor=V.+L.+Wehbiauthor=J.+A.+Arduraauthor=D.+S.+Wheelerauthor=S.+Ferrandonauthor=T.+J.+Gardellaauthor=J.+P.+Vilardaga&title=Retromer+terminates+the+generation+of+cAMP+by+internalized+PTH+receptors&doi=10.1038%2Fnchembio.545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Retromer terminates the generation of cAMP by internalized PTH receptors</span></div><div class="casAuthors">Feinstein, Timothy N.; Wehbi, Vanessa L.; Ardura, Juan A.; Wheeler, David S.; Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">278-284</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The generation of cAMP by G protein-coupled receptors (GPCRs) and its termination are currently thought to occur exclusively at the plasma membrane of cells.  Under existing models of receptor regulation, this signal is primarily restricted by desensitization of the receptors through their binding to β-arrestins.  However, this paradigm is not consistent with recent observations that the parathyroid hormone receptor type 1 (PTHR) continues to stimulate cAMP prodn. even after receptor internalization, as β-arrestins are known to rapidly bind and internalize activated PTHR.  Here we show that binding to β-arrestin1 prolongs rather than terminates the generation of cAMP by PTHR, and that cAMP generation correlates with the persistence of arrestin-receptor complexes on endosomes.  PTHR signaling is instead turned off by the retromer complex, which regulates the movement of internalized receptor from endosomes to the Golgi app.  Thus, binding by the retromer complex regulates the sustained generation of cAMP triggered by an internalized GPCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVgwwu0vNEhbVg90H21EOLACvtfcHk0lj29KEB7LxOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOhsb8%253D&md5=3096a0b6cb76ce68b3dcf9ee1acdf0e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.545%26sid%3Dliteratum%253Aachs%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DWehbi%26aufirst%3DV.%2BL.%26aulast%3DArdura%26aufirst%3DJ.%2BA.%26aulast%3DWheeler%26aufirst%3DD.%2BS.%26aulast%3DFerrandon%26aufirst%3DS.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DRetromer%2520terminates%2520the%2520generation%2520of%2520cAMP%2520by%2520internalized%2520PTH%2520receptors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26issue%3D5%26spage%3D278%26epage%3D284%26doi%3D10.1038%2Fnchembio.545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehbi, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallows, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">39</span><span class="NLM_x">) </span> <span class="NLM_fpage">27849</span><span class="NLM_x">–</span> <span class="NLM_lpage">27860</span><span class="refDoi"> DOI: 10.1074/jbc.M112.445098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M112.445098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=27849-27860&issue=39&author=T.+N.+Feinsteinauthor=N.+Yuiauthor=M.+J.+Webberauthor=V.+L.+Wehbiauthor=H.+P.+Stevensonauthor=J.+D.+Kingauthor=K.+R.+Hallowsauthor=D.+Brownauthor=R.+Bouleyauthor=J.+P.+Vilardaga&title=Noncanonical+control+of+vasopressin+receptor+type+2+signaling+by+retromer+and+arrestin&doi=10.1074%2Fjbc.M112.445098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.445098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.445098%26sid%3Dliteratum%253Aachs%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DYui%26aufirst%3DN.%26aulast%3DWebber%26aufirst%3DM.%2BJ.%26aulast%3DWehbi%26aufirst%3DV.%2BL.%26aulast%3DStevenson%26aufirst%3DH.%2BP.%26aulast%3DKing%26aufirst%3DJ.%2BD.%26aulast%3DHallows%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBouley%26aufirst%3DR.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DNoncanonical%2520control%2520of%2520vasopressin%2520receptor%2520type%25202%2520signaling%2520by%2520retromer%2520and%2520arrestin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D39%26spage%3D27849%26epage%3D27860%26doi%3D10.1074%2Fjbc.M112.445098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Gidon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Bataineh, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Alphonse, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor-Soler, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1038/nchembio.1589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.1589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25064832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ait7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=707-709&issue=9&author=A.+Gidonauthor=M.+M.+Al-Batainehauthor=F.+G.+Jean-Alphonseauthor=H.+P.+Stevensonauthor=T.+Watanabeauthor=C.+Louetauthor=A.+Khatriauthor=G.+Caleroauthor=N.+M.+Pastor-Solerauthor=T.+J.+Gardellaauthor=J.+P.+Vilardaga&title=Endosomal+GPCR+signaling+turned+off+by+negative+feedback+actions+of+PKA+and+v-ATPase&doi=10.1038%2Fnchembio.1589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase</span></div><div class="casAuthors">Gidon, Alexandre; Al-Bataineh, Mohammad M.; Jean-Alphonse, Frederic G.; Stevenson, Hilary P.; Watanabe, Tomoyuki; Louet, Claire; Khatri, Ashok; Calero, Guillermo; Pastor-Soler, Nuria M.; Gardella, Thomas J.; Vilardaga, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">707-709</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The PTH receptor is to our knowledge one of the first G protein-coupled receptor (GPCR) found to sustain cAMP signaling after internalization of the ligand-receptor complex in endosomes.  This unexpected model is adding a new dimension on how we think about GPCR signaling, but its mechanism is incompletely understood.  We report here that endosomal acidification mediated by the PKA action on the v-ATPase provides a neg. feedback mechanism by which endosomal receptor signaling is turned off.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDTn8ZWbawmrVg90H21EOLACvtfcHk0ljmI7e9xxwl5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ait7bP&md5=9fe3414e50fb69648783ed217ef5d14d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1589%26sid%3Dliteratum%253Aachs%26aulast%3DGidon%26aufirst%3DA.%26aulast%3DAl-Bataineh%26aufirst%3DM.%2BM.%26aulast%3DJean-Alphonse%26aufirst%3DF.%2BG.%26aulast%3DStevenson%26aufirst%3DH.%2BP.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DLouet%26aufirst%3DC.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DCalero%26aufirst%3DG.%26aulast%3DPastor-Soler%26aufirst%3DN.%2BM.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DEndosomal%2520GPCR%2520signaling%2520turned%2520off%2520by%2520negative%2520feedback%2520actions%2520of%2520PKA%2520and%2520v-ATPase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D9%26spage%3D707%26epage%3D709%26doi%3D10.1038%2Fnchembio.1589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Gidon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Studying the regulation of endosomal cAMP production in GPCR signaling</span> <span class="citation_source-journal">Methods Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/bs.mcb.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fbs.mcb.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26928541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A280%3ADC%252BC28jlvValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2016&pages=109-126&author=A.+Gidonauthor=T.+N.+Feinsteinauthor=K.+H.+Xiaoauthor=J.+P.+Vilardaga&title=Studying+the+regulation+of+endosomal+cAMP+production+in+GPCR+signaling&doi=10.1016%2Fbs.mcb.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Studying the regulation of endosomal cAMP production in GPCR signaling</span></div><div class="casAuthors">Gidon Alexandre; Feinstein Timothy N; Xiao Kunhong; Vilardaga Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Methods in cell biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109-26</span>
        ISSN:<span class="NLM_cas:issn">0091-679X</span>.
    </div><div class="casAbstract">We describe methods based on live cell fluorescent microscopy and mass spectrometry to characterize the mechanism of endosomal cAMP production and its regulation using the parathyroid hormone (PTH) type 1 receptor as a prime example.  These methods permit to measure rapid changes of cAMP levels in response to PTH, kinetics of endosomal ligand-receptor interaction, pH changes associated with receptor trafficking, and to identify the endosomal receptor interactome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHWwt7jjsE3rHHuJhbyicZfW6udTcc2eak_chr6n_QbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jlvValsg%253D%253D&md5=8fb9b3d76c3d35cf506d6f9249b3db5d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fbs.mcb.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.mcb.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DGidon%26aufirst%3DA.%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DXiao%26aufirst%3DK.%2BH.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DStudying%2520the%2520regulation%2520of%2520endosomal%2520cAMP%2520production%2520in%2520GPCR%2520signaling%26jtitle%3DMethods%2520Cell%2520Biol.%26date%3D2016%26volume%3D132%26spage%3D109%26epage%3D126%26doi%3D10.1016%2Fbs.mcb.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Horwitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. F.</span><span> </span><span class="NLM_article-title">Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1210/jc.2002-021122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fjc.2002-021122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=12574182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtlChsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=569-575&issue=2&author=M.+J.+Horwitzauthor=M.+B.+Tedescoauthor=C.+Gundbergauthor=A.+Garcia-Ocanaauthor=A.+F.+Stewart&title=Short-term%2C+high-dose+parathyroid+hormone-related+protein+as+a+skeletal+anabolic+agent+for+the+treatment+of+postmenopausal+osteoporosis&doi=10.1210%2Fjc.2002-021122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis</span></div><div class="casAuthors">Horwitz, Mara J.; Tedesco, Mary Beth; Gundberg, Caren; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">569-575</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">PTH-related protein (PTHrP) is homologous with PTH.  PTH, an effective anabolic agent for treating osteoporosis, has been shown to stimulate both bone resorption by osteoclasts and bone formation by osteoblasts.  We examd. whether PTHrP might share anabolic properties in osteoporosis.  A 3-mo double-blind, prospective, placebo-controlled, randomized clin. trial was performed in 16 healthy postmenopausal women with osteoporosis.  All received calcium and vitamin D, and all continued their prior hormone replacement therapy.  One group also received daily s.c. PTHrP (6.56 μg/kg/d, or approx. 400 μg/d), and the other group received placebo injections.  The PTHrP group displayed a 4.7% increase in lumbar spine bone mineral d. (BMD) and also demonstrated an increase in osteoblastic bone formation, as assessed using serum osteocalcin measurements.  In contrast, there was no increase in bone-specific alk. phosphatase and collagen-1 propeptide or either of two markers of osteoclastic bone resorption, N-telopeptide, or deoxypyridinoline.  One subject in the placebo group withdrew from the study, but there were no significant adverse events in the PTHrP group.  PTHrP administered s.c. in high doses for only 3 mo appears to be a potent anabolic agent, producing a 4.7% increase in lumbar spine BMD.  This compares very favorably to available antiresorptive drugs for osteoporosis and is similar to the increases in BMD at this early time point reported for PTH.  Despite the high doses, PTHrP was well tolerated.  Larger clin. trials are required to confirm these results and fully assess the anabolic potential of PTHrP in osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_WiufiKZDibVg90H21EOLACvtfcHk0ljmI7e9xxwl5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtlChsb8%253D&md5=dcdb06885b37163d11f57ddcc22a3f63</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fjc.2002-021122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2002-021122%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DM.%2BJ.%26aulast%3DTedesco%26aufirst%3DM.%2BB.%26aulast%3DGundberg%26aufirst%3DC.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DShort-term%252C%2520high-dose%2520parathyroid%2520hormone-related%2520protein%2520as%2520a%2520skeletal%2520anabolic%2520agent%2520for%2520the%2520treatment%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26issue%3D2%26spage%3D569%26epage%3D575%26doi%3D10.1210%2Fjc.2002-021122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Horwitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sereika, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prebehala, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundberg, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. F.</span><span> </span><span class="NLM_article-title">Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span><span class="refDoi"> DOI: 10.1210/jc.2009-0233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fjc.2009-0233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=20061412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Kqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1279-1287&issue=3&author=M.+J.+Horwitzauthor=M.+B.+Tedescoauthor=A.+Garcia-Ocanaauthor=S.+M.+Sereikaauthor=L.+Prebehalaauthor=A.+Biselloauthor=B.+W.+Hollisauthor=C.+M.+Gundbergauthor=A.+F.+Stewart&title=Parathyroid+hormone-related+protein+for+the+treatment+of+postmenopausal+osteoporosis%3A+defining+the+maximal+tolerable+dose&doi=10.1210%2Fjc.2009-0233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose</span></div><div class="casAuthors">Horwitz, Mara J.; Tedesco, Mary Beth; Garcia-Ocana, Adolfo; Sereika, Susan M.; Prebehala, Linda; Bisello, Alessandro; Hollis, Bruce W.; Gundberg, Caren M.; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1279-1287</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: PTH is the only approved skeletal anabolic agent for the treatment of human osteoporosis.  Unlike PTH, which is a mixed anabolic and catabolic agent, PTHrP displays features suggesting that it may be a pure anabolic agent when intermittently administered.  The full dose range of PTHrP is unknown.  Objectives: The primary objective of the study was to define the complete therapeutic window and dose-limiting toxicities of PTHrP.  The secondary objective was to det. whether PTHrP retains a pure anabolic profile at the highest usable doses.  Design: This was a single-blinded, two-part, dose-escalating clin. trial.  Setting: The study was conducted in a university academic setting.  Patients or Other Participants: Participants included 41 healthy postmenopausal women between the ages of 45 and 75 yr.  Intervention: Interventions included PTHrP(1-36) or placebo in a dose-escalating design for 3 wk.  Main Outcome Measures: Safety measures (hypercalcemia, nausea, vomiting, hemodynamics, flushing, misc.) and bone turnover markers were measured.  Results: Intermittent PTHrP was administered safely and without serious adverse events in subjects receiving 500 and 625 μg/d for 3 wk.  Subjects receiving 750 μg/d developed mild hypercalcemia.  Bone turnover markers suggested that even at the highest doses, daily s.c. PTHrP may not activate bone resorption, i.e. may be purely anabolic.  Interestingly, when hypercalcemia occurred, it may have resulted not from bone resorption but from activation of intestinal calcium absorption by 1,25 dihydroxyvitamin D.  Conclusions: In doses as high as 750 μg/d, in contrast to PTH, intermittently administered PTHrP appears to act as a pure skeletal anabolic agent.  Surprisingly, PTHrP in the High doses studied activates 1,25 dihydroxyvitamin D prodn.  Dosing information obtained herein can be used to design a longer term head-to-head comparative efficacy trial of PTHrP vs. PTH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOWyayTrRyk7Vg90H21EOLACvtfcHk0ljMswVTxxsGKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Kqt7Y%253D&md5=1da45c88d671a208e41530b2498fa96d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1210%2Fjc.2009-0233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2009-0233%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DM.%2BJ.%26aulast%3DTedesco%26aufirst%3DM.%2BB.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DSereika%26aufirst%3DS.%2BM.%26aulast%3DPrebehala%26aufirst%3DL.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DHollis%26aufirst%3DB.%2BW.%26aulast%3DGundberg%26aufirst%3DC.%2BM.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DParathyroid%2520hormone-related%2520protein%2520for%2520the%2520treatment%2520of%2520postmenopausal%2520osteoporosis%253A%2520defining%2520the%2520maximal%2520tolerable%2520dose%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26issue%3D3%26spage%3D1279%26epage%3D1287%26doi%3D10.1210%2Fjc.2009-0233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Horwitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laslavic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sereika, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundberg, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. F.</span><span> </span><span class="NLM_article-title">A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2266</span><span class="NLM_x">–</span> <span class="NLM_lpage">2276</span><span class="refDoi"> DOI: 10.1002/jbmr.1978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjbmr.1978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23661240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=2266-2276&issue=11&author=M.+J.+Horwitzauthor=M.+Augustineauthor=L.+Kahnauthor=E.+Martinauthor=C.+C.+Oakleyauthor=R.+M.+Carneiroauthor=M.+B.+Tedescoauthor=A.+Laslavicauthor=S.+M.+Sereikaauthor=A.+Biselloauthor=A.+Garcia-Ocanaauthor=C.+M.+Gundbergauthor=J.+A.+Cauleyauthor=A.+F.+Stewart&title=A+comparison+of+parathyroid+hormone-related+protein+%281-36%29+and+parathyroid+hormone+%281-34%29+on+markers+of+bone+turnover+and+bone+density+in+postmenopausal+women%3A+the+PrOP+study&doi=10.1002%2Fjbmr.1978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: The PrOP study</span></div><div class="casAuthors">Horwitz, Mara J.; Augustine, Marilyn; Kahn, Leila; Martin, Emily; Oakley, Christine C.; Carneiro, Raquel M.; Tedesco, Mary Beth; Laslavic, Angela; Sereika, Susan M.; Bisello, Alessandro; Garcia-Ocana, Adolfo; Gundberg, Caren M.; Cauley, Jane A.; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2266-2276</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Parathyroid hormone-related protein (PTHrP)(1-36) increases lumbar spine (LS) bone mineral d. (BMD), acting as an anabolic agent when injected intermittently, but it has not been directly compared with parathyroid hormone (PTH)(1-34).  We performed a 3-mo randomized, prospective study in 105 postmenopausal women with low bone d. or osteoporosis, comparing daily s.c. injections of PTHrP(1-36) to PTH(1-34).  Thirty-five women were randomized to each of three groups: PTHrP(1-36) 400 μg/day; PTHrP(1-36) 600 μg/day; and PTH(1-34) 20 μg/day.  The primary outcome measures were changes in amino-terminal telopeptides of procollagen 1 (PINP) and carboxy-terminal telopeptides of collagen 1 (CTX).  Secondary measures included safety parameters, 1,25(OH)2 vitamin D, and BMD.  The increase in bone resorption (CTX) by PTH(1-34) (92%) (p < 0.005) was greater than for PTHrP(1-36) (30%) (p < 0.05).  PTH(1-34) also increased bone formation (PINP) (171%) (p < 0.0005) more than either dose of PTHrP(1-36) (46% and 87%).  The increase in PINP was earlier (day 15) and greater than the increase in CTX for all three groups.  LS BMD increased equivalently in each group (p < 0.05 for all).  Total hip (TH) and femoral neck (FN) BMD increased equivalently in each group but were only significant for the two doses of PTHrP(1-36) (p < 0.05) at the TH and for PTHrP(1-36) 400 (p < 0.05) at the FN.  PTHrP(1-36) 400 induced mild, transient (day 15) hypercalcemia.  PTHrP(1-36) 600 required a dose redn. for hypercalcemia in three subjects.  PTH(1-34) was not assocd. with hypercalcemia.  Each peptide induced a marked biphasic increase in 1,25(OH)2D.  Adverse events (AE) were similar among the three groups.  This study demonstrates that PTHrP(1-36) and PTH(1-34) cause similar increases in LS BMD.  PTHrP(1-36) also increased hip BMD.  PTH(1-34) induced greater changes in bone turnover than PTHrP(1-36).  PTHrP(1-36) was assocd. with mild transient hypercalcemia.  Longer-term studies using lower doses of PTHrP(1-36) are needed to define both the optimal dose and full clin. benefits of PTHrP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq840iCWuvr1bVg90H21EOLACvtfcHk0ljMswVTxxsGKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr3E&md5=e4f7b775087b7345cb48e09239bbe128</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.1978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.1978%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DM.%2BJ.%26aulast%3DAugustine%26aufirst%3DM.%26aulast%3DKahn%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DOakley%26aufirst%3DC.%2BC.%26aulast%3DCarneiro%26aufirst%3DR.%2BM.%26aulast%3DTedesco%26aufirst%3DM.%2BB.%26aulast%3DLaslavic%26aufirst%3DA.%26aulast%3DSereika%26aufirst%3DS.%2BM.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DGundberg%26aufirst%3DC.%2BM.%26aulast%3DCauley%26aufirst%3DJ.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520comparison%2520of%2520parathyroid%2520hormone-related%2520protein%2520%25281-36%2529%2520and%2520parathyroid%2520hormone%2520%25281-34%2529%2520on%2520markers%2520of%2520bone%2520turnover%2520and%2520bone%2520density%2520in%2520postmenopausal%2520women%253A%2520the%2520PrOP%2520study%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2013%26volume%3D28%26issue%3D11%26spage%3D2266%26epage%3D2276%26doi%3D10.1002%2Fjbmr.1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Pioszak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x"> (</span><span class="NLM_issue">41</span><span class="NLM_x">) </span> <span class="NLM_fpage">28382</span><span class="NLM_x">–</span> <span class="NLM_lpage">28391</span><span class="refDoi"> DOI: 10.1074/jbc.M109.022905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M109.022905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=28382-28391&issue=41&author=A.+A.+Pioszakauthor=N.+R.+Parkerauthor=T.+J.+Gardellaauthor=H.+E.+Xu&title=Structural+basis+for+parathyroid+hormone-related+protein+binding+to+the+parathyroid+hormone+receptor+and+design+of+conformation-selective+peptides&doi=10.1074%2Fjbc.M109.022905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.022905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.022905%26sid%3Dliteratum%253Aachs%26aulast%3DPioszak%26aufirst%3DA.%2BA.%26aulast%3DParker%26aufirst%3DN.%2BR.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520parathyroid%2520hormone-related%2520protein%2520binding%2520to%2520the%2520parathyroid%2520hormone%2520receptor%2520and%2520design%2520of%2520conformation-selective%2520peptides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D41%26spage%3D28382%26epage%3D28391%26doi%3D10.1074%2Fjbc.M109.022905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Shimizu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyashiki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayasu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, Y.</span><span> </span><span class="NLM_article-title">Pharmacodynamic actions of a long-acting PTH analog (LA-PTH) in thyroparathyroidectomized (TPTX) rats and normal monkeys</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.1002/jbmr.2811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjbmr.2811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26865415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSisr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=1405-1412&issue=7&author=M.+Shimizuauthor=E.+Joyashikiauthor=H.+Nodaauthor=T.+Watanabeauthor=M.+Okazakiauthor=M.+Nagayasuauthor=K.+Adachiauthor=T.+Tamuraauthor=J.+T.+Pottsauthor=T.+J.+Gardellaauthor=Y.+Kawabe&title=Pharmacodynamic+actions+of+a+long-acting+PTH+analog+%28LA-PTH%29+in+thyroparathyroidectomized+%28TPTX%29+rats+and+normal+monkeys&doi=10.1002%2Fjbmr.2811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys</span></div><div class="casAuthors">Shimizu, Masaru; Joyashiki, Eri; Noda, Hiroshi; Watanabe, Tomoyuki; Okazaki, Makoto; Nagayasu, Miho; Adachi, Kenji; Tamura, Tatsuya; Potts, John T., Jr.; Gardella, Thomas J.; Kawabe, Yoshiki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1405-1412</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hypoparathyroidism is a disease of chronic hypocalcemia and hyperphosphatemia due to a deficiency of parathyroid hormone (PTH).  PTH and analogs of the hormone are of interest as potential therapies.  Accordingly, we examd. the pharmacol. properties of a long-acting PTH analog, [Ala1,3,12,18,22, Gln10,Arg11,Trp14,Lys26]-PTH(1-14)/PTHrP(15-36) (LA-PTH) in thyroparathyroidectomized (TPTX) rats, a model of HP, as well as in normal monkeys.  In TPTX rats, a single i.v. administration of LA-PTH at a dose of 0.9 nmol/kg increased serum calcium (sCa) and decreased serum phosphate (sPi) to near-normal levels for longer than 48 h, whereas PTH(1-34) and PTH(1-84), each injected at a dose 80-fold higher than that used for LA-PTH, increased sCa and decreased sPi only modestly and transiently (<6 h).  LA-PTH also exhibited enhanced and prolonged efficacy vs. PTH(1-34) and PTH(1-84) for elevating sCa when administered s.c. (s.c.) into monkeys.  Daily s.c. administration of LA-PTH (1.8 nmol/kg) into TPTX rats for 28 days elevated sCa to near normal levels without causing hypercalciuria or increasing bone resorption markers, a desirable goal in the treatment of hypoparathyroidism.  The results are supportive of further study of long-acting PTH analogs as potential therapies for patients with hypoparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRFGGixnuSILVg90H21EOLACvtfcHk0lgQqU3t8I0Grw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSisr3N&md5=9e32912223b6ab446f7e15a7f0a1d65a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.2811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.2811%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DJoyashiki%26aufirst%3DE.%26aulast%3DNoda%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DM.%26aulast%3DNagayasu%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DKawabe%26aufirst%3DY.%26atitle%3DPharmacodynamic%2520actions%2520of%2520a%2520long-acting%2520PTH%2520analog%2520%2528LA-PTH%2529%2520in%2520thyroparathyroidectomized%2520%2528TPTX%2529%2520rats%2520and%2520normal%2520monkeys%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2016%26volume%3D31%26issue%3D7%26spage%3D1405%26epage%3D1412%26doi%3D10.1002%2Fjbmr.2811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Varela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouinard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesage, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattersley, G.</span><span> </span><span class="NLM_article-title">One year of abaloparatide, a selective activator of the PTH1 receptor, increased bone formation and bone mass in osteopenic ovariectomized rats without increasing bone resorption</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1002/jbmr.3003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjbmr.3003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=27748532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Cjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=24-33&issue=1&author=A.+Varelaauthor=L.+Chouinardauthor=E.+Lesageauthor=S.+Y.+Smithauthor=G.+Hattersley&title=One+year+of+abaloparatide%2C+a+selective+activator+of+the+PTH1+receptor%2C+increased+bone+formation+and+bone+mass+in+osteopenic+ovariectomized+rats+without+increasing+bone+resorption&doi=10.1002%2Fjbmr.3003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption</span></div><div class="casAuthors">Varela, Aurore; Chouinard, Luc; Lesage, Elisabeth; Smith, Susan Y.; Hattersley, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-33</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Abaloparatide is a novel 34-amino acid peptide selected to be a potent and selective activator of the parathyroid hormone receptor (PTH1R) signaling pathway with 41% homol. to PTH(1-34) and 76% homol. to PTHrP(1-34).  A 12-mo treatment study was conducted in osteopenic ovariectomized (OVX) rats to characterize the mechanisms by which abaloparatide increases bone mass.  Sprague-Dawley (SD) rats were subjected to OVX or sham surgery at age 6 mo and left untreated for 3 mo to allow OVX-induced bone loss.  Ten OVX rats were euthanized after this bone depletion period, and the remaining OVX rats received daily s.c. injections of vehicle (n = 18) or abaloparatide at 1, 5, or 25 μg/kg/d (n = 18/dose level) for 12 mo.  Sham controls (n = 18) received vehicle daily.  Bone densitometry and biochem. markers of bone formation and resorption were assessed longitudinally, and L3 vertebra and tibia were collected at necropsy for histomorphometry.  Abaloparatide increased biochem. bone formation markers without increasing bone resorption markers or causing hypercalcemia.  Abaloparatide increased histomorphometric indexes of bone formation on trabecular, endocortical, and periosteal surfaces without increasing osteoclasts or eroded surfaces.  Abaloparatide induced substantial increases in trabecular bone vol. and d. and improvements in trabecular microarchitecture.  Abaloparatide stimulated periosteal expansion and endocortical bone apposition at the tibial diaphysis, leading to marked increases in cortical bone vol. and d.  Whole-body bone mineral d. (BMD) remained stable in OVX-Vehicle controls while increasing 25% after 12 mo of abaloparatide (25 μg/kg).  Histomorphometry and biomarker data suggest that gains in cortical and trabecular bone mass were attributable to selective anabolic effects of abaloparatide, without evidence for stimulated bone resorption. © 2016 American Society for Bone and Mineral Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZHU1bwilJ37Vg90H21EOLACvtfcHk0lgQqU3t8I0Grw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Cjuw%253D%253D&md5=e3f5736a0ccdef9f1debaec8351532bb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.3003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.3003%26sid%3Dliteratum%253Aachs%26aulast%3DVarela%26aufirst%3DA.%26aulast%3DChouinard%26aufirst%3DL.%26aulast%3DLesage%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DS.%2BY.%26aulast%3DHattersley%26aufirst%3DG.%26atitle%3DOne%2520year%2520of%2520abaloparatide%252C%2520a%2520selective%2520activator%2520of%2520the%2520PTH1%2520receptor%252C%2520increased%2520bone%2520formation%2520and%2520bone%2520mass%2520in%2520osteopenic%2520ovariectomized%2520rats%2520without%2520increasing%2520bone%2520resorption%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D24%26epage%3D33%26doi%3D10.1002%2Fjbmr.3003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Leder, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dea, L. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchetta, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyttle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattersley, G.</span><span> </span><span class="NLM_article-title">Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1210/jc.2014-3718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fjc.2014-3718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25393645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=697-706&issue=2&author=B.+Z.+Lederauthor=L.+S.+L.+O%E2%80%99Deaauthor=J.+R.+Zanchettaauthor=P.+Kumarauthor=K.+Banksauthor=K.+McKayauthor=C.+R.+Lyttleauthor=G.+Hattersley&title=Effects+of+abaloparatide%2C+a+human+parathyroid+hormone-related+peptide+analog%2C+on+bone+mineral+density+in+postmenopausal+women+with+osteoporosis&doi=10.1210%2Fjc.2014-3718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis</span></div><div class="casAuthors">Leder, Benjamin Z.; O'Dea, Louis St. L.; Zanchetta, Jose R.; Kumar, Prasana; Banks, Kathleen; McKay, Kathleen; Lyttle, C. Richard; Hattersley, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">697-706</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Abaloparatide is a novel synthetic peptide analog of parathyroid hormone-related protein (PTHrP) that is currently being developed as a potential anabolic agent in the treatment of postmenopausal osteoporosis.  Objective: This study sought to assess the effects of abaloparatide on bone mineral d. (BMD) at the lumbar spine, total hip, and femoral neck in postmenopausal women with osteoporosis.  Design: Multi-center, multi-national, double-blind placebo controlled trial in which postmenopausal women were randomly assigned to receive 24 wk of treatment with daily s.c. injections of placebo, abaloparatide, 20, 40, or 80 μg, or teriparatide, 20 μg.  A 24-wk extension was also performed in a subset of subjects.  Participants: Postmenopausal women with osteoporosis (n = 222).  Main Outcome Measures: BMD by dual-x-ray absorptiometry and biochem. markers of bone turnover.  Results: At 24 wk, lumbar spine BMD increased by 2.9, 5.2, and 6.7% in the abaloparatide, 20-, 40-, and 80-μg groups, resp., and 5.5% in the teriparatide group.  The increases in the 40- and 80-μg abaloparatide groups and the teriparatide group were significantly greater than placebo (1.6%).  Femoral neck BMD increased by 2.7, 2.2, and 3.1% in abaloparatide, 20-, 40-, and 80-μg groups, resp., and 1.1% in the teriparatide group.  The increase in femoral neck BMD with abaloparatide, 80 μg was significantly greater than placebo (0.8%).  Total hip BMD increased by 1.4, 2.0, and 2.6% in the abaloparatide, 20-, 40-, and 80-μg groups, resp.  The total hip increases in the 40- and 80-μg abaloparatide groups were greater than both placebo (0.4%) and teriparatide (0.5%).  Conclusions: Compared with placebo, 24 wk of daily s.c. abaloparatide increases BMD of the lumbar spine, femoral neck, and total hip in a dose-dependent fashion.  Moreover, the abaloparatide-induced BMD increases at the total hip are greater than with the marketed dose of teriparatide.  These results support the further investigation of abaloparatide as an anabolic therapy in postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMfmPAtEaEK7Vg90H21EOLACvtfcHk0lgQqU3t8I0Grw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVWqtLw%253D&md5=a9f9c6fca641f9dc8fd589e69af02f91</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1210%2Fjc.2014-3718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2014-3718%26sid%3Dliteratum%253Aachs%26aulast%3DLeder%26aufirst%3DB.%2BZ.%26aulast%3DO%25E2%2580%2599Dea%26aufirst%3DL.%2BS.%2BL.%26aulast%3DZanchetta%26aufirst%3DJ.%2BR.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DBanks%26aufirst%3DK.%26aulast%3DMcKay%26aufirst%3DK.%26aulast%3DLyttle%26aufirst%3DC.%2BR.%26aulast%3DHattersley%26aufirst%3DG.%26atitle%3DEffects%2520of%2520abaloparatide%252C%2520a%2520human%2520parathyroid%2520hormone-related%2520peptide%2520analog%252C%2520on%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26issue%3D2%26spage%3D697%26epage%3D706%26doi%3D10.1210%2Fjc.2014-3718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Plum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, J. B.</span><span> </span><span class="NLM_article-title">In vitro protein binding of liraglutide in human plasma determined by reiterated stepwise equilibrium dialysis</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2882</span><span class="NLM_x">–</span> <span class="NLM_lpage">2888</span><span class="refDoi"> DOI: 10.1002/jps.23648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjps.23648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23853127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=2882-2888&issue=8&author=A.+Plumauthor=L.+B.+Jensenauthor=J.+B.+Kristensen&title=In+vitro+protein+binding+of+liraglutide+in+human+plasma+determined+by+reiterated+stepwise+equilibrium+dialysis&doi=10.1002%2Fjps.23648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro protein binding of liraglutide in human plasma determined by reiterated stepwise equilibrium dialysis</span></div><div class="casAuthors">Plum, Anne; Jensen, Lisbeth Bjerring; Kristensen, Jesper Boggild</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2882-2888</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Liraglutide is a human glucagon-like peptide-1 (GLP-1) analog approved for the treatment of type 2 diabetes.  It is based on human GLP-1 with the addn. of a 16-carbon fatty acid, which facilitates binding to plasma proteins, thus prolonging the elimination half-life and allowing once-daily administration.  It has not been possible to quantify liraglutide protein binding by ultrafiltration (the usual method of choice), as the lipophilic mol. becomes trapped in the filter membrane.  Therefore, the aim of this study was to develop a methodol. that could det. the extent of liraglutide binding to plasma proteins in vitro.  We report here the details of a novel reiterated stepwise equil. dialysis assay that has successfully been used to quantify liraglutide plasma protein binding.  The assay allowed quantification of liraglutide binding to proteins in purified plasma protein solns. and human plasma samples and was effective at plasma dilns. as low as 5%.  At a clin. relevant liraglutide concn. (104 pM), greater than 98.9% of liraglutide was bound to protein.  Specific binding to human serum albumin and α1-acid glycoprotein was 99.4% and 99.3%, resp.  The novel methodol. described herein could have an application in the quantification of plasma protein binding of other highly lipophilic drug mols. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYNomc4wEpbbVg90H21EOLACvtfcHk0ljfQaFBcBkynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsbrL&md5=6e2ea60f185c85351f3d46a5f17421ed</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fjps.23648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23648%26sid%3Dliteratum%253Aachs%26aulast%3DPlum%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DL.%2BB.%26aulast%3DKristensen%26aufirst%3DJ.%2BB.%26atitle%3DIn%2520vitro%2520protein%2520binding%2520of%2520liraglutide%2520in%2520human%2520plasma%2520determined%2520by%2520reiterated%2520stepwise%2520equilibrium%2520dialysis%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26issue%3D8%26spage%3D2882%26epage%3D2888%26doi%3D10.1002%2Fjps.23648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Sturmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagatay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkol, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, W.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of oral recombinant human parathyroid hormone rhPTH(1-31)NH2 in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1007/s40262-013-0083-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1007%2Fs40262-013-0083-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23719683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=995-1004&issue=11&author=A.+Sturmerauthor=N.+Mehtaauthor=J.+Giacchiauthor=T.+Cagatayauthor=R.+Tavakkolauthor=S.+Mittaauthor=L.+Fitzpatrickauthor=J.+Waldauthor=J.+Trangauthor=W.+Stern&title=Pharmacokinetics+of+oral+recombinant+human+parathyroid+hormone+rhPTH%281-31%29NH2+in+postmenopausal+women+with+osteoporosis&doi=10.1007%2Fs40262-013-0083-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1-31)NH2] in Postmenopausal Women with Osteoporosis</span></div><div class="casAuthors">Sturmer, Amy; Mehta, Nozer; Giacchi, Jenna; Cagatay, Tulin; Tavakkol, Roxanne; Mitta, Sheela; Fitzpatrick, Lorraine; Wald, Jeff; Trang, John; Stern, William</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">995-1004</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives Teriparatide [rhPTH(1-34)OH] is a s.c. administered bone anabolic drug that increases bone mineral d. (BMD) and reduces the risk of osteoporotic fracture.  Because rhPTH(1-34)OH is administered by injection, oral delivery is a desirable alternative.  However, the peroral delivery of peptides is challenging due to their susceptibility to protease digestion and low permeability through the intestinal layers.  The objective of this study was to assess the pharmacokinetics of a PTH analog (rhPTH(1-31)NH2) in a novel oral tablet formulation and to compare them to s.c. administered teriparatide in postmenopausal osteoporotic women in a phase 2 proof-of-concept clin. study.  Methods This was a 24-wk repeat-dose, randomized, double blind, parallel group phase 2 study with three once-daily treatment arms: oral rhPTH(1-31)NH2 tablets (5 mg), matching placebo tablets, and open-label teriparatide (20 μg daily s.c. injection).  The primary endpoint of this study was to assess the change in lumbar spine BMD of orally administered rhPTH(1-31)NH2 tablets compared to baseline.  This study was conducted at three sites in Denmark and at one site in Estonia.  The patients included were women diagnosed with postmenopausal osteoporosis as detected by lumbar spine dual-energy X-ray absorptiometry, with exclusion of those with prior treatment with bone-active agents.  The study treatment consisted of orally formulated recombinant human PTH(1-31)NH2, placebo, or s.c. teriparatide as an active comparator.  Results The pharmacokinetic profile at first and last dose was evaluated and correlated with the primary endpoint, which was to characterize the percent change from baseline in BMD of the lumbar spine after 24 wk of once daily treatment with rhPTH(1-31)NH2.  The pharmacokinetic profile for the tablets showed a pulsatile peak with durations of at least 1 h but less than 5 h, which is consistent with the requirement for bone anabolic activity.  The mean max. (peak) plasma drug concn. (Cmax) values for patients receiving tablets at week 0 (n = 32) and week 24 (n = 28) were 295 and 207 pg/mL, resp.  The mean time to reach max. (peak) plasma concn. following drug administration (tmax) for both week 0 and week 24 was 3.25 h.  The mean area under the concn.-time curve (AUC) for week 0 and week 24 was 178 and 141 pg·h/mL, resp.  No significant differences were obsd. between weeks 0 and 24 in any pharmacokinetic parameters tested, demonstrating good reproducibility, no time-dependent changes, and little or no accumulation of the study drug.  The systemic exposure as measured by Cmax values was higher for the oral tablets formulation than for s.c. teriparatide.  Conclusions The obsd. data demonstrate that the enteric-coated tablet formulation technol. was able to generate consistently robust and pulsatile levels of exposure of rhPTH(1-31)NH2.  There was no apparent correlation between higher exposures and adverse events, even though the pharmacokinetic variability was somewhat higher with the tablets.  These pos. results recommend this orally delivered drug candidate for further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof4v0PbF9YmrVg90H21EOLACvtfcHk0lhZghXGguM1Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtr3J&md5=ae35a7d88b5c1e74571218518a5cff30</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs40262-013-0083-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-013-0083-4%26sid%3Dliteratum%253Aachs%26aulast%3DSturmer%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DGiacchi%26aufirst%3DJ.%26aulast%3DCagatay%26aufirst%3DT.%26aulast%3DTavakkol%26aufirst%3DR.%26aulast%3DMitta%26aufirst%3DS.%26aulast%3DFitzpatrick%26aufirst%3DL.%26aulast%3DWald%26aufirst%3DJ.%26aulast%3DTrang%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DW.%26atitle%3DPharmacokinetics%2520of%2520oral%2520recombinant%2520human%2520parathyroid%2520hormone%2520rhPTH%25281-31%2529NH2%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26issue%3D11%26spage%3D995%26epage%3D1004%26doi%3D10.1007%2Fs40262-013-0083-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Guo, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M. X.</span><span> </span><span class="NLM_article-title">Preliminary evaluation of a novel oral delivery system for rhPTH1-34: In vitro and in vivo</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2011.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.ijpharm.2011.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=21888960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWmt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2011&pages=172-179&issue=1&author=L.+T.+Guoauthor=E.+L.+Maauthor=H.+W.+Zhaoauthor=Y.+F.+Longauthor=C.+X.+Zhengauthor=M.+X.+Duan&title=Preliminary+evaluation+of+a+novel+oral+delivery+system+for+rhPTH1-34%3A+In+vitro+and+in+vivo&doi=10.1016%2Fj.ijpharm.2011.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary evaluation of a novel oral delivery system for rhPTH1-34: In vitro and in vivo</span></div><div class="casAuthors">Guo, Liting; Ma, Erli; Zhao, Haiwei; Long, Yingfang; Zheng, Changxue; Duan, Mingxing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-179</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RhPTH1-34 is clin. used for osteoporosis treatment.  However, this peptide drug has no oral bioavailability because of proteolysis and low membrane permeability in gastrointestinal gut.  This study explored the possibility of absorption enhancement for rhPTH1-34 through the oral delivery of the microemulsion.  The microemulsion (85:15, oil/water) consisting of Labrasol, Crodamol GTCC, Solutol HS 15, D-α-tocopheryl acetate (6:2:1:1, wt./wt.) and saline water was developed and characterized, including particle size, morphol., drug loading efficiency and permeability, stability, and pharmacokinetics.  The microemulsion showed high drug loading efficiency (83%) and permeability, and significantly higher resistance to proteolysis in vitro study.  The relative oral bioavailability was 5.4% and 12.0% when delivered to gastric and ileum.  Besides, osteoporosis rats were induced and treated with oral rhPTH1-34 microemulsion (0.05 mg/kg), injection (0.01 mg/kg) and vehicle, resp., for 8 wk.  The proximal tibia bone mineral content and d. in oral rats (0.188 ± 0.008 g, 0.283 ± 0.014 g/cm2) was significantly increased compared to the control rats (0.169 ± 0.006 g, 0.266 ± 0.011 g/cm2), reaching to the sham rats.  And the proximal tibia microstructure of oral rats was improved greatly, approaching sham level too.  These findings revealed that oral microemulsion may represent an effective oral delivery system for rhPTH1-34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQly38MUAdrVg90H21EOLACvtfcHk0lhZghXGguM1Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWmt77L&md5=5a3453aa28d635d8fba9d67b8da5f52e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2011.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2011.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DL.%2BT.%26aulast%3DMa%26aufirst%3DE.%2BL.%26aulast%3DZhao%26aufirst%3DH.%2BW.%26aulast%3DLong%26aufirst%3DY.%2BF.%26aulast%3DZheng%26aufirst%3DC.%2BX.%26aulast%3DDuan%26aufirst%3DM.%2BX.%26atitle%3DPreliminary%2520evaluation%2520of%2520a%2520novel%2520oral%2520delivery%2520system%2520for%2520rhPTH1-34%253A%2520In%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D420%26issue%3D1%26spage%3D172%26epage%3D179%26doi%3D10.1016%2Fj.ijpharm.2011.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Leone-Bay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarubbi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughman, R. A.</span><span> </span><span class="NLM_article-title">Oral delivery of biologically active parathyroid hormone</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">964</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1023/A:1010936227570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1023%2FA%3A1010936227570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=964-970&issue=7&author=A.+Leone-Bayauthor=M.+Satoauthor=D.+Patonauthor=A.+H.+Huntauthor=D.+Sarubbiauthor=M.+Carozzaauthor=J.+Chouauthor=J.+McDonoughauthor=R.+A.+Baughman&title=Oral+delivery+of+biologically+active+parathyroid+hormone&doi=10.1023%2FA%3A1010936227570"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010936227570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010936227570%26sid%3Dliteratum%253Aachs%26aulast%3DLeone-Bay%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DPaton%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DA.%2BH.%26aulast%3DSarubbi%26aufirst%3DD.%26aulast%3DCarozza%26aufirst%3DM.%26aulast%3DChou%26aufirst%3DJ.%26aulast%3DMcDonough%26aufirst%3DJ.%26aulast%3DBaughman%26aufirst%3DR.%2BA.%26atitle%3DOral%2520delivery%2520of%2520biologically%2520active%2520parathyroid%2520hormone%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26issue%3D7%26spage%3D964%26epage%3D970%26doi%3D10.1023%2FA%3A1010936227570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Hammerle, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mindeholm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harfst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, M. R.</span><span> </span><span class="NLM_article-title">The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span><span class="refDoi"> DOI: 10.1016/j.bone.2012.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.bone.2012.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=965-973&issue=4&author=S.+P.+Hammerleauthor=L.+Mindeholmauthor=A.+Launonenauthor=B.+Kieseauthor=R.+Loefflerauthor=E.+Harfstauthor=M.+Azriaauthor=M.+Arnoldauthor=M.+R.+John&title=The+single+dose+pharmacokinetic+profile+of+a+novel+oral+human+parathyroid+hormone+formulation+in+healthy+postmenopausal+women&doi=10.1016%2Fj.bone.2012.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2012.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2012.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DHammerle%26aufirst%3DS.%2BP.%26aulast%3DMindeholm%26aufirst%3DL.%26aulast%3DLaunonen%26aufirst%3DA.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DLoeffler%26aufirst%3DR.%26aulast%3DHarfst%26aufirst%3DE.%26aulast%3DAzria%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DM.%26aulast%3DJohn%26aufirst%3DM.%2BR.%26atitle%3DThe%2520single%2520dose%2520pharmacokinetic%2520profile%2520of%2520a%2520novel%2520oral%2520human%2520parathyroid%2520hormone%2520formulation%2520in%2520healthy%2520postmenopausal%2520women%26jtitle%3DBone%26date%3D2012%26volume%3D50%26issue%3D4%26spage%3D965%26epage%3D973%26doi%3D10.1016%2Fj.bone.2012.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Leone-Bay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lercara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Toole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gschneidner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVincent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercogliano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipold, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughman, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span><span class="refDoi"> DOI: 10.1021/jm970811m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970811m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1163-1171&issue=7&author=A.+Leone-Bayauthor=D.+R.+Patonauthor=J.+Freemanauthor=C.+Lercaraauthor=D.+O%E2%80%99Tooleauthor=D.+Gschneidnerauthor=E.+Wangauthor=E.+Harrisauthor=C.+Rosadoauthor=T.+Riveraauthor=A.+DeVincentauthor=M.+Taiauthor=F.+Mercoglianoauthor=R.+Agarwalauthor=H.+Leipoldauthor=R.+A.+Baughman&title=Synthesis+and+evaluation+of+compounds+that+facilitate+the+gastrointestinal+absorption+of+heparin&doi=10.1021%2Fjm970811m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm970811m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970811m%26sid%3Dliteratum%253Aachs%26aulast%3DLeone-Bay%26aufirst%3DA.%26aulast%3DPaton%26aufirst%3DD.%2BR.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DLercara%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DD.%26aulast%3DGschneidner%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DE.%26aulast%3DRosado%26aufirst%3DC.%26aulast%3DRivera%26aufirst%3DT.%26aulast%3DDeVincent%26aufirst%3DA.%26aulast%3DTai%26aufirst%3DM.%26aulast%3DMercogliano%26aufirst%3DF.%26aulast%3DAgarwal%26aufirst%3DR.%26aulast%3DLeipold%26aufirst%3DH.%26aulast%3DBaughman%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520compounds%2520that%2520facilitate%2520the%2520gastrointestinal%2520absorption%2520of%2520heparin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D7%26spage%3D1163%26epage%3D1171%26doi%3D10.1021%2Fjm970811m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Bray, B. L.</span><span> </span><span class="NLM_article-title">Large-scale manufacture of peptide therapeutics by chemical synthesis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span><span class="refDoi"> DOI: 10.1038/nrd1133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnrd1133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=12815383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=587-593&issue=7&author=B.+L.+Bray&title=Large-scale+manufacture+of+peptide+therapeutics+by+chemical+synthesis&doi=10.1038%2Fnrd1133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Innovation: Large-scale manufacture of peptide therapeutics by chemical synthesis</span></div><div class="casAuthors">Bray, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">587-593</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The large-scale com. prodn. of a 36-amino-acid peptide by chem. synthesis has been demonstrated in the development of enfuvirtide (T-20 or Fuzeon), a first-in-class membrane fusion inhibitor for the treatment of HIV.  The rationale behind route selection and the scale-up of the process used to manuf. enfuvirtide are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq23FtVAsqBerVg90H21EOLACvtfcHk0lgTnccLcYNuHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr4%253D&md5=cd8a087455cf8058855d84076bc75927</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnrd1133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1133%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DB.%2BL.%26atitle%3DLarge-scale%2520manufacture%2520of%2520peptide%2520therapeutics%2520by%2520chemical%2520synthesis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D7%26spage%3D587%26epage%3D593%26doi%3D10.1038%2Fnrd1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Hartman, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josephson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szostak, J. W.</span><span> </span><span class="NLM_article-title">Enzymatic aminoacylation of tRNA with unnatural amino acids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4361</span><span class="refDoi"> DOI: 10.1073/pnas.0509219103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0509219103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=16537388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjt1Kjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=4356-4361&issue=12&author=M.+C.+T.+Hartmanauthor=K.+Josephsonauthor=J.+W.+Szostak&title=Enzymatic+aminoacylation+of+tRNA+with+unnatural+amino+acids&doi=10.1073%2Fpnas.0509219103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic aminoacylation of tRNA with unnatural amino acids</span></div><div class="casAuthors">Hartman, Matthew C. T.; Josephson, Kristopher; Szostak, Jack W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4356-4361</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The biochem. flexibility of the cellular translation app. offers, in principle, a simple route to the synthesis of drug-like modified peptides and novel biopolymers.  However, only ≈ 75 unnatural building blocks are known to be fully compatible with enzymic tRNA acylation and subsequent ribosomal synthesis of modified peptides.  Although the translation system can reject substrate analogs at several steps along the pathway to peptide synthesis, much of the specificity resides at the level of the aminoacyl-tRNA synthetase (AARS) enzymes that are responsible for charging tRNAs with amino acids.  The authors have developed an AARS assay based on mass spectrometry that can be used to rapidly identify unnatural monomers that can be enzymically charged onto tRNA.  By using this assay, the authors have found 59 previously unknown AARS substrates.  These include numerous side-chain analogs with useful functional properties.  Remarkably, many β-amino acids, N-Me amino acids, and α,α-disubstituted amino acids are also AARS substrates.  These previously unidentified AARS substrates will be useful in studies of the specificity of subsequent steps in translation and may significantly expand the no. of analogs that can be used for the ribosomal synthesis of modified peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnEHUjtOS17Vg90H21EOLACvtfcHk0lgTnccLcYNuHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjt1Kjsbg%253D&md5=52776e7a3eb8e6c37e1d49de7bdc404c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0509219103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0509219103%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DM.%2BC.%2BT.%26aulast%3DJosephson%26aufirst%3DK.%26aulast%3DSzostak%26aufirst%3DJ.%2BW.%26atitle%3DEnzymatic%2520aminoacylation%2520of%2520tRNA%2520with%2520unnatural%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D12%26spage%3D4356%26epage%3D4361%26doi%3D10.1073%2Fpnas.0509219103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Site-specific incorporation of novel backbone structures into proteins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x"> (</span><span class="NLM_issue">5041</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1126/science.1553546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1126%2Fscience.1553546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1553546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADyaK38Xht1ensbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1992&pages=197-200&issue=5041&author=J.+A.+Ellmanauthor=D.+Mendelauthor=P.+G.+Schultz&title=Site-specific+incorporation+of+novel+backbone+structures+into+proteins&doi=10.1126%2Fscience.1553546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific incorporation of novel backbone structures into proteins</span></div><div class="casAuthors">Ellman, Jonathan A.; Mendel, David; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">5041</span>),
    <span class="NLM_cas:pages">197-200</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A no. of unnatural amino acids and amino acid analogs with modified backbone structures were substituted for alanine-82 in T4 lysozyme.  Replacements included α,α-disubstituted amino acids, N-alkyl amino acids, and lactic acid, an isoelectronic analog of alanine.  The effects of these electronic and structural perturbations on the stability of T4 lysozyme were detd.  The relatively broad substrate specificity of the Escherichia coli protein biosynthetic machinery suggests that a wide range of backbone and side-chain substitutions can be introduced, allowing a more precise definition of the factors affecting protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1fsNHwxpw0LVg90H21EOLACvtfcHk0lgTnccLcYNuHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1ensbs%253D&md5=2892e6efc4a73b93eaf5569ef663dc38</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1126%2Fscience.1553546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1553546%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DMendel%26aufirst%3DD.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSite-specific%2520incorporation%2520of%2520novel%2520backbone%2520structures%2520into%2520proteins%26jtitle%3DScience%26date%3D1992%26volume%3D255%26issue%3D5041%26spage%3D197%26epage%3D200%26doi%3D10.1126%2Fscience.1553546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Tan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklow, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornish, V. W.</span><span> </span><span class="NLM_article-title">Amino acid backbone specificity of the Escherichia coli translation machinery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">40</span><span class="NLM_x">) </span> <span class="NLM_fpage">12752</span><span class="NLM_x">–</span> <span class="NLM_lpage">12753</span><span class="refDoi"> DOI: 10.1021/ja0472174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0472174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=12752-12753&issue=40&author=Z.+P.+Tanauthor=A.+C.+Forsterauthor=S.+C.+Blacklowauthor=V.+W.+Cornish&title=Amino+acid+backbone+specificity+of+the+Escherichia+coli+translation+machinery&doi=10.1021%2Fja0472174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fja0472174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0472174%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DZ.%2BP.%26aulast%3DForster%26aufirst%3DA.%2BC.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DCornish%26aufirst%3DV.%2BW.%26atitle%3DAmino%2520acid%2520backbone%2520specificity%2520of%2520the%2520Escherichia%2520coli%2520translation%2520machinery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D40%26spage%3D12752%26epage%3D12753%26doi%3D10.1021%2Fja0472174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Dedkova, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahmi, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span> </span><span class="NLM_article-title">beta-Puromycin selection of modified ribosomes for in vitro incorporation of beta-amino acids</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1021/bi2016124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2016124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=401-415&issue=1&author=L.+M.+Dedkovaauthor=N.+E.+Fahmiauthor=R.+Paulauthor=M.+del+Rosarioauthor=L.+Zhangauthor=S.+Chenauthor=G.+Federauthor=S.+M.+Hecht&title=beta-Puromycin+selection+of+modified+ribosomes+for+in+vitro+incorporation+of+beta-amino+acids&doi=10.1021%2Fbi2016124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fbi2016124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2016124%26sid%3Dliteratum%253Aachs%26aulast%3DDedkova%26aufirst%3DL.%2BM.%26aulast%3DFahmi%26aufirst%3DN.%2BE.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3Ddel%2BRosario%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeder%26aufirst%3DG.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3Dbeta-Puromycin%2520selection%2520of%2520modified%2520ribosomes%2520for%2520in%2520vitro%2520incorporation%2520of%2520beta-amino%2520acids%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26issue%3D1%26spage%3D401%26epage%3D415%26doi%3D10.1021%2Fbi2016124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Maini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedkova, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcala-Torano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span> </span><span class="NLM_article-title">Incorporation of beta-amino acids into dihydrofolate reductase by ribosomes having modifications in the peptidyltransferase center</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.bmc.2013.01.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1088-1096&issue=5&author=R.+Mainiauthor=D.+T.+Nguyenauthor=S.+X.+Chenauthor=L.+M.+Dedkovaauthor=S.+R.+Chowdhuryauthor=R.+Alcala-Toranoauthor=S.+M.+Hecht&title=Incorporation+of+beta-amino+acids+into+dihydrofolate+reductase+by+ribosomes+having+modifications+in+the+peptidyltransferase+center&doi=10.1016%2Fj.bmc.2013.01.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DD.%2BT.%26aulast%3DChen%26aufirst%3DS.%2BX.%26aulast%3DDedkova%26aufirst%3DL.%2BM.%26aulast%3DChowdhury%26aufirst%3DS.%2BR.%26aulast%3DAlcala-Torano%26aufirst%3DR.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DIncorporation%2520of%2520beta-amino%2520acids%2520into%2520dihydrofolate%2520reductase%2520by%2520ribosomes%2520having%2520modifications%2520in%2520the%2520peptidyltransferase%2520center%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D5%26spage%3D1088%26epage%3D1096%26doi%3D10.1016%2Fj.bmc.2013.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Fujino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span> </span><span class="NLM_article-title">Ribosomal synthesis of peptides with multiple beta-Amino Acids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1962</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span><span class="refDoi"> DOI: 10.1021/jacs.5b12482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b12482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=1962-1969&issue=6&author=T.+Fujinoauthor=Y.+Gotoauthor=H.+Sugaauthor=H.+Murakami&title=Ribosomal+synthesis+of+peptides+with+multiple+beta-Amino+Acids&doi=10.1021%2Fjacs.5b12482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b12482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b12482%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DSuga%26aufirst%3DH.%26aulast%3DMurakami%26aufirst%3DH.%26atitle%3DRibosomal%2520synthesis%2520of%2520peptides%2520with%2520multiple%2520beta-Amino%2520Acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D6%26spage%3D1962%26epage%3D1969%26doi%3D10.1021%2Fjacs.5b12482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Czekster, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepartz, A.</span><span> </span><span class="NLM_article-title">In vivo biosynthesis of a beta-amino acid-containing protein</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5194</span><span class="NLM_x">–</span> <span class="NLM_lpage">5197</span><span class="refDoi"> DOI: 10.1021/jacs.6b01023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b01023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=5194-5197&issue=16&author=C.+M.+Czeksterauthor=W.+E.+Robertsonauthor=A.+S.+Walkerauthor=D.+Sollauthor=A.+Schepartz&title=In+vivo+biosynthesis+of+a+beta-amino+acid-containing+protein&doi=10.1021%2Fjacs.6b01023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b01023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b01023%26sid%3Dliteratum%253Aachs%26aulast%3DCzekster%26aufirst%3DC.%2BM.%26aulast%3DRobertson%26aufirst%3DW.%2BE.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26aulast%3DSoll%26aufirst%3DD.%26aulast%3DSchepartz%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520biosynthesis%2520of%2520a%2520beta-amino%2520acid-containing%2520protein%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D16%26spage%3D5194%26epage%3D5197%26doi%3D10.1021%2Fjacs.6b01023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shi Liu, Frederic G. Jean-Alphonse, Alex D. White, Denise Wootten, Patrick M. Sexton, Thomas J. Gardella, Jean-Pierre Vilardaga, <span class="NLM_string-name hlFld-ContribAuthor">Samuel H. Gellman</span>. </span><span class="cited-content_cbyCitation_article-title">Use of Backbone Modification To Enlarge the Spatiotemporal Diversity of Parathyroid Hormone Receptor-1 Signaling via Biased Agonism. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (37)
                                     , 14486-14490. <a href="https://doi.org/10.1021/jacs.9b04179" title="DOI URL">https://doi.org/10.1021/jacs.9b04179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b04179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b04179%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DUse%252Bof%252BBackbone%252BModification%252BTo%252BEnlarge%252Bthe%252BSpatiotemporal%252BDiversity%252Bof%252BParathyroid%252BHormone%252BReceptor-1%252BSignaling%252Bvia%252BBiased%252BAgonism%26aulast%3DLiu%26aufirst%3DShi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17042019%26date%3D09092019%26volume%3D141%26issue%3D37%26spage%3D14486%26epage%3D14490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuteng  Wu</span>, <span class="hlFld-ContribAuthor ">Jack  Williams</span>, <span class="hlFld-ContribAuthor ">Ewen D. D.  Calder</span>, <span class="hlFld-ContribAuthor ">Louise J.  Walport</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to expand peptide functionality through hybridisation with a small molecule component. </span><span class="cited-content_cbyCitation_journal-name">RSC Chemical Biology</span><span> <strong>2021,</strong> <em>2 </em>
                                    (1)
                                     , 151-165. <a href="https://doi.org/10.1039/D0CB00167H" title="DOI URL">https://doi.org/10.1039/D0CB00167H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CB00167H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CB00167H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Chemical%2520Biology%26atitle%3DStrategies%252Bto%252Bexpand%252Bpeptide%252Bfunctionality%252Bthrough%252Bhybridisation%252Bwith%252Ba%252Bsmall%252Bmolecule%252Bcomponent%26aulast%3DWu%26aufirst%3DYuteng%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D1%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulina  Fortuna</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Twarda-Clapa</span>, <span class="hlFld-ContribAuthor ">Lukasz  Skalniak</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Ożga</span>, <span class="hlFld-ContribAuthor ">Tad A.  Holak</span>, <span class="hlFld-ContribAuthor ">Łukasz  Berlicki</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic ‘foldamerization’ of peptide inhibiting p53-MDM2/X interactions by the incorporation of trans- or cis-2-aminocyclopentanecarboxylic acid residues. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112814. <a href="https://doi.org/10.1016/j.ejmech.2020.112814" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112814%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystematic%252B%2525E2%252580%252598foldamerization%2525E2%252580%252599%252Bof%252Bpeptide%252Binhibiting%252Bp53-MDM2%25252FX%252Binteractions%252Bby%252Bthe%252Bincorporation%252Bof%252Btrans-%252Bor%252Bcis-2-aminocyclopentanecarboxylic%252Bacid%252Bresidues%26aulast%3DFortuna%26aufirst%3DPaulina%26date%3D2020%26volume%3D208%26spage%3D112814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ross W.  Cheloha</span>, <span class="hlFld-ContribAuthor ">Fabian A.  Fischer</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Woodham</span>, <span class="hlFld-ContribAuthor ">Eileen  Daley</span>, <span class="hlFld-ContribAuthor ">Naomi  Suminski</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Gardella</span>, <span class="hlFld-ContribAuthor ">Hidde L.  Ploegh</span>. </span><span class="cited-content_cbyCitation_article-title">Improved GPCR ligands from nanobody tethering. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-15884-8" title="DOI URL">https://doi.org/10.1038/s41467-020-15884-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-15884-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-15884-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DImproved%252BGPCR%252Bligands%252Bfrom%252Bnanobody%252Btethering%26aulast%3DCheloha%26aufirst%3DRoss%2BW.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Attila  Tököli</span>, <span class="hlFld-ContribAuthor ">Beáta  Mag</span>, <span class="hlFld-ContribAuthor ">Éva  Bartus</span>, <span class="hlFld-ContribAuthor ">Edit  Wéber</span>, <span class="hlFld-ContribAuthor ">Gerda  Szakonyi</span>, <span class="hlFld-ContribAuthor ">Márton A.  Simon</span>, <span class="hlFld-ContribAuthor ">Ágnes  Czibula</span>, <span class="hlFld-ContribAuthor ">Éva  Monostori</span>, <span class="hlFld-ContribAuthor ">László  Nyitray</span>, <span class="hlFld-ContribAuthor ">Tamás A.  Martinek</span>. </span><span class="cited-content_cbyCitation_article-title">Proteomimetic surface fragments distinguish targets by function. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (38)
                                     , 10390-10398. <a href="https://doi.org/10.1039/D0SC03525D" title="DOI URL">https://doi.org/10.1039/D0SC03525D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC03525D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC03525D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DProteomimetic%252Bsurface%252Bfragments%252Bdistinguish%252Btargets%252Bby%252Bfunction%26aulast%3DT%25C3%25B6k%25C3%25B6li%26aufirst%3DAttila%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D38%26spage%3D10390%26epage%3D10398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingming  Chen</span>, <span class="hlFld-ContribAuthor ">Marissa  Vavrek</span>, <span class="hlFld-ContribAuthor ">Richard  Gundersdorf</span>, <span class="hlFld-ContribAuthor ">Wendy  Zhong</span>, <span class="hlFld-ContribAuthor ">Mark T.  Cancilla</span>. </span><span class="cited-content_cbyCitation_article-title">Combining MALDI mass spectrometry imaging and droplet-base surface sampling analysis for tissue distribution, metabolite profiling, and relative quantification of cyclic peptide melanotan II. </span><span class="cited-content_cbyCitation_journal-name">Analytica Chimica Acta</span><span> <strong>2020,</strong> <em>1125 </em>, 279-287. <a href="https://doi.org/10.1016/j.aca.2020.05.050" title="DOI URL">https://doi.org/10.1016/j.aca.2020.05.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aca.2020.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aca.2020.05.050%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytica%2520Chimica%2520Acta%26atitle%3DCombining%252BMALDI%252Bmass%252Bspectrometry%252Bimaging%252Band%252Bdroplet-base%252Bsurface%252Bsampling%252Banalysis%252Bfor%252Btissue%252Bdistribution%25252C%252Bmetabolite%252Bprofiling%25252C%252Band%252Brelative%252Bquantification%252Bof%252Bcyclic%252Bpeptide%252Bmelanotan%252BII%26aulast%3DChen%26aufirst%3DBingming%26date%3D2020%26volume%3D1125%26spage%3D279%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian P.  Cary</span>, <span class="hlFld-ContribAuthor ">Marlies V.  Hager</span>, <span class="hlFld-ContribAuthor ">Samuel H.  Gellman</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Substitution Registry on the Receptor‐Activation Profiles of Backbone‐Modified Glucagon‐like Peptide‐1 Analogues. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2019,</strong> <em>20 </em>
                                    (22)
                                     , 2834-2840. <a href="https://doi.org/10.1002/cbic.201900300" title="DOI URL">https://doi.org/10.1002/cbic.201900300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201900300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201900300%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DImpact%252Bof%252BSubstitution%252BRegistry%252Bon%252Bthe%252BReceptor%2525E2%252580%252590Activation%252BProfiles%252Bof%252BBackbone%2525E2%252580%252590Modified%252BGlucagon%2525E2%252580%252590like%252BPeptide%2525E2%252580%2525901%252BAnalogues%26aulast%3DCary%26aufirst%3DBrian%2BP.%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D22%26spage%3D2834%26epage%3D2840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ieva  Sutkeviciute</span>, <span class="hlFld-ContribAuthor ">Lisa J.  Clark</span>, <span class="hlFld-ContribAuthor ">Alex D.  White</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Gardella</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Vilardaga</span>. </span><span class="cited-content_cbyCitation_article-title">PTH/PTHrP Receptor Signaling, Allostery, and Structures. </span><span class="cited-content_cbyCitation_journal-name">Trends in Endocrinology & Metabolism</span><span> <strong>2019,</strong> <em>30 </em>
                                    (11)
                                     , 860-874. <a href="https://doi.org/10.1016/j.tem.2019.07.011" title="DOI URL">https://doi.org/10.1016/j.tem.2019.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tem.2019.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tem.2019.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Endocrinology%2520%2526%2520Metabolism%26atitle%3DPTH%25252FPTHrP%252BReceptor%252BSignaling%25252C%252BAllostery%25252C%252Band%252BStructures%26aulast%3DSutkeviciute%26aufirst%3DIeva%26date%3D2019%26volume%3D30%26issue%3D11%26spage%3D860%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliette  Fremaux</span>, <span class="hlFld-ContribAuthor ">Claire  Venin</span>, <span class="hlFld-ContribAuthor ">Laura  Mauran</span>, <span class="hlFld-ContribAuthor ">Robert  Zimmer</span>, <span class="hlFld-ContribAuthor ">Florian  Koensgen</span>, <span class="hlFld-ContribAuthor ">Didier  Rognan</span>, <span class="hlFld-ContribAuthor ">Stavroula  Bitsi</span>, <span class="hlFld-ContribAuthor ">Maria A.  Lucey</span>, <span class="hlFld-ContribAuthor ">Ben  Jones</span>, <span class="hlFld-ContribAuthor ">Alejandra  Tomas</span>, <span class="hlFld-ContribAuthor ">Gilles  Guichard</span>, <span class="hlFld-ContribAuthor ">Sébastien R.  Goudreau</span>. </span><span class="cited-content_cbyCitation_article-title">Ureidopeptide GLP-1 analogues with prolonged activity
              in vivo via
              signal bias and altered receptor trafficking. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2019,</strong> <em>10 </em>
                                    (42)
                                     , 9872-9879. <a href="https://doi.org/10.1039/C9SC02079A" title="DOI URL">https://doi.org/10.1039/C9SC02079A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC02079A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC02079A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DUreidopeptide%252BGLP-1%252Banalogues%252Bwith%252Bprolonged%252Bactivity%252Bin%252Bvivo%252Bvia%252Bsignal%252Bbias%252Band%252Baltered%252Breceptor%252Btrafficking%26aulast%3DFremaux%26aufirst%3DJuliette%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D42%26spage%3D9872%26epage%3D9879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi  Liu</span>, <span class="hlFld-ContribAuthor ">Ross W.  Cheloha</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Gardella</span>, <span class="hlFld-ContribAuthor ">Samuel H.  Gellman</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor selectivity from minimal backbone modification of a polypeptide agonist. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (49)
                                     , 12383-12388. <a href="https://doi.org/10.1073/pnas.1815294115" title="DOI URL">https://doi.org/10.1073/pnas.1815294115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1815294115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1815294115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DReceptor%252Bselectivity%252Bfrom%252Bminimal%252Bbackbone%252Bmodification%252Bof%252Ba%252Bpolypeptide%252Bagonist%26aulast%3DLiu%26aufirst%3DShi%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D49%26spage%3D12383%26epage%3D12388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Sequences of PTH(1–34) analogues in the N-terminal β-scan library and cAMP stimulating potency. Each peptide contains the native sequence comprised of α-residues for positions 10−34 (see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> for full sequence). All peptides are C-terminal amides. In contrast, teriparatide is a C-terminal acid. The single letter code is used to indicate conventional proteinogenic amino acids. Colored dots indicate sites at which α-to-β replacements have been introduced. β<sup>3</sup>-Residues display an identical side chain to that displayed by the corresponding α-residue. cAMP inducing potencies (EC<sub>50</sub>) are shown for analogues with cells expressing hPTHR1. Average EC<sub>50</sub> values are from data obtained in three independent experiments for all <b>2</b>–<b>18</b> or six independent experiments for <b>1</b>. Analogues with “no activity” have activity that is too weak to be characterized using this method. Full dose–response curves are found in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sequences of a peptides containing α-to-β replacements in the N-terminal segment, C-terminal segment, or both. Differences between the <b>1</b> and M-PTH(1–34) (<b>27</b>) scaffolds are highlighted in bold in the sequence of <b>27</b>. The single letter code is used to indicate conventional proteinogenic amino acids. Colored dots indicate sites at which α-to-β replacements have been introduced. β<sup>3</sup>-Residues display an identical side chain to that displayed by the corresponding α-residue. Note that selected analogues contain an α-amino isobutyric acid residue (Aib) at position 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Stability of <b>1</b> or <b>35</b> in rat kidney homogenate. Peptides were incubated in kidney homogenates from a single, female Sprague-Dawley rat for the indicated durations, and intact peptide concentration was evaluated using a liquid chromatography/mass spectrometry (LC/MS) approach or a bioassay readout as described in the methods section. Sites of protease-catalyzed hydrolysis were evaluated using MALDI-TOF mass spectrometry. (a) Concentration of intact peptide from LC/MS analysis as a function of duration of incubation. Data points represent the mean ± standard deviation from two replicates. The curve results from fitting of the data to an exponential decay function, with half-lives listed. (b, c) Identification of peptide fragments derived from <b>1</b> (b) or <b>35</b> (c) by MALDI-TOF mass spectrometry as a function of time for a single experiment. Peptide-derived fragments that may give rise to observed signals are inserted above the peak of interest. Multiple fragments are listed in cases for which the identity of the fragment could not be unambiguously confirmed. (d) Peptide bioactivity following exposure to kidney homogenate was assessed using a biological assay with two replicates. Data points represent the mean ± SEM. Times listed after peptide names represent the duration of time that the peptide was incubated with kidney homogenate before quenching of protease activity. Curves result from fitting of a sigmoidal dose–response model with variable slope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Degradation of PTH(1–34) analogues in SGF and SIF. Peptide bioactivity following exposure to SGF (simulated gastric fluid) was assessed using a biological assay (a–d). Data points represent the mean ± SEM from two technical replicates within a single experiment. Independent experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 7</a>) provide similar results. Curves result from fitting of a sigmoidal dose response model with variable slope to the data. Note that the times listed after peptide names represent the duration of time that the peptide was incubated with in SGF before quenching of protease activity. (e) Sites of proteolysis in <b>1</b> and derivatives in SGF. Sites of protease action were identified by analyzing crude proteolysis mixtures using MALDI-TOF mass spectrometry as described in the methods section from a single experiment. Arrows point to major sites of proteolytic cleavage See <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> for structures. (f, g) Bioassay to assess degradation of <b>1</b> or <b>35</b> in simulated intestinal fluid (SIF). The sigmoidal dose–response model did not provide a well-fitted curve for SIF experiments and was thus omitted in panels f and g. See the methods section for additional details. Data points represent the mean ± SEM from two technical replicates for a single experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Properties of PTH(1–34) analogues in mice. Peptides were injected at a dose of 20 nmol/kg by subcutaneous injection in CD1 mice, <i>n</i> = 5, female, 8–12 weeks of age. (∗) <i>p</i> < 0.05 vs vehicle as assessed by one-way ANOVA with Dunnett’s multiple comparison test. Vehicle is 0.05% Tween-80, 10 mM citrate, 150 mM NaCl (pH 5.0). Data points represent the mean ± SEM from the five distinct mice per treatment group. Data points are connected with lines to guide the eye; these lines have no independent meaning. (a) <b>1</b> and derivatives induce a calcemic response following subcutaneous injection into mice. (b) Bloodstream bioavailability time course for <b>1</b> or selected α/β-peptide derivatives. A luminescence response was induced in GP2.3 cells following addition of 2 μL of serum (mixed with CO<sub>2</sub> independent medium) taken from mice at different time points after injection (<i>x</i>-axis). This raw luminescence response was converted to the concentration of peptide in the bloodstream through use of a standard curve relating peptide concentrations to luminescence responses. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf" class="ext-link">Supporting Information Figure 8</a> for the raw luminescence responses induced by serum and standard curves.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the structures of highly substituted analogues of PTH(1−34), PTHrP(1−34), and abalopartide. The segment in which <b>40</b> differs from <b>36</b> is highlighted in red lettering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/medium/jm-2017-00876h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0007.jpeg" id="rightTab-GRAPHIC-d127e2591-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Degradation of PTHrP(1−34) and abaloparatide analogues in SGF. Peptide bioactivity following exposure to SGF was assessed using a biological assay. Data points represent the mean ± SEM from two technical replicates in a single experiment. Curves result from fitting of a sigmoidal dose–response model with variable slope to the data. Note that the times listed after peptide names represent the duration of time that the peptide was incubated with in SGF before quenching of protease activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00876/20171103/images/large/jm-2017-00876h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00876&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 95 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Signaling - 2000 and beyond</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)81688-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2FS0092-8674%2800%2981688-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=113-127&issue=1&author=T.+Hunter&title=Signaling+-+2000+and+beyond&doi=10.1016%2FS0092-8674%2800%2981688-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981688-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981688-8%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DSignaling%2520-%25202000%2520and%2520beyond%26jtitle%3DCell%26date%3D2000%26volume%3D100%26issue%3D1%26spage%3D113%26epage%3D127%26doi%3D10.1016%2FS0092-8674%2800%2981688-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Leader, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golan, D. E.</span><span> </span><span class="NLM_article-title">Protein therapeutics: A summary and pharmacological classification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/nrd2399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnrd2399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=18097458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=21-39&issue=1&author=B.+Leaderauthor=Q.+J.+Bacaauthor=D.+E.+Golan&title=Protein+therapeutics%3A+A+summary+and+pharmacological+classification&doi=10.1038%2Fnrd2399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein therapeutics: a summary and pharmacological classification</span></div><div class="casAuthors">Leader, Benjamin; Baca, Quentin J.; Golan, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-39</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in no. and frequency of use since the introduction of the first recombinant protein therapeutic - human insulin - 25 years ago.  Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy.  This article overviews some of the key characteristics of protein therapeutics, summarizes the more than 130 protein therapeutics used currently and suggests a new classification of these proteins according to their pharmacol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDJwirgv5WN7Vg90H21EOLACvtfcHk0liG3jRALu8h2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ygtQ%253D%253D&md5=761a9860e38c98295385641dda94b31f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2399%26sid%3Dliteratum%253Aachs%26aulast%3DLeader%26aufirst%3DB.%26aulast%3DBaca%26aufirst%3DQ.%2BJ.%26aulast%3DGolan%26aufirst%3DD.%2BE.%26atitle%3DProtein%2520therapeutics%253A%2520A%2520summary%2520and%2520pharmacological%2520classification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D1%26spage%3D21%26epage%3D39%26doi%3D10.1038%2Fnrd2399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Diao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meibohm, B.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1007/s40262-013-0079-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1007%2Fs40262-013-0079-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23719681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSmt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=855-868&issue=10&author=L.+Diaoauthor=B.+Meibohm&title=Pharmacokinetics+and+pharmacokinetic-pharmacodynamic+correlations+of+therapeutic+peptides&doi=10.1007%2Fs40262-013-0079-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Correlations of Therapeutic Peptides</span></div><div class="casAuthors">Diao, Lei; Meibohm, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">855-868</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Peptides, defined as polymers of less than 50 amino acids with a mol. wt. of less than 10 kDa, represent a fast-growing class of new therapeutics which has unique pharmacokinetic characteristics compared to large proteins or small mol. drugs.  Unmodified peptides usually undergo extensive proteolytic cleavage, resulting in short plasma half-lives.  As a result of their low permeability and susceptibility to catabolic degrdn., therapeutic peptides usually have very limited oral bioavailability and are administered either by the i.v., s.c., or i.m. route, although other routes such as nasal delivery are utilized as well.  Distribution processes are mainly driven by a combination of diffusion and to a lesser degree convective extravasation dependent on the size of the peptide, with vols. of distribution frequently not larger than the vol. of the extracellular body fluid.  Owing to the ubiquitous availability of proteases and peptidases throughout the body, proteolytic degrdn. is not limited to classic elimination organs.  Since peptides are generally freely filtered by the kidneys, glomerular filtration and subsequent renal metab. by proteolysis contribute to the elimination of many therapeutic peptides.  Although small peptides have usually limited immunogenicity, formation of anti-drug antibodies with subsequent hypersensitivity reactions has been described for some peptide therapeutics.  Numerous strategies have been applied to improve the pharmacokinetic properties of therapeutic peptides, esp. to overcome their metabolic instability, low permeability, and limited tissue residence time.  Applied techniques include amino acid substitutions, modification of the peptide terminus, inclusion of disulfide bonds, and conjugation with polymers or macromols. such as antibody fragments or albumin.  Application of model-based pharmacokinetic-pharmacodynamic correlations has been widely used for therapeutic peptides in support of drug development and dosage regimen design, esp. because their targets are often well-described endogenous regulatory pathways and processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmlFFOIFoZBrVg90H21EOLACvtfcHk0liG3jRALu8h2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSmt77I&md5=975af68c1bbc3dda4b3dbe42b3e40181</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs40262-013-0079-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-013-0079-0%26sid%3Dliteratum%253Aachs%26aulast%3DDiao%26aufirst%3DL.%26aulast%3DMeibohm%26aufirst%3DB.%26atitle%3DPharmacokinetics%2520and%2520pharmacokinetic-pharmacodynamic%2520correlations%2520of%2520therapeutic%2520peptides%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26issue%3D10%26spage%3D855%26epage%3D868%26doi%3D10.1007%2Fs40262-013-0079-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Vlieghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khrestchatisky, M.</span><span> </span><span class="NLM_article-title">Synthetic therapeutic peptides: science and market</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.drudis.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.drudis.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19879957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsV2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=40-56&issue=1%E2%80%932&author=P.+Vliegheauthor=V.+Lisowskiauthor=J.+Martinezauthor=M.+Khrestchatisky&title=Synthetic+therapeutic+peptides%3A+science+and+market&doi=10.1016%2Fj.drudis.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic therapeutic peptides: science and market</span></div><div class="casAuthors">Vlieghe, Patrick; Lisowski, Vincent; Martinez, Jean; Khrestchatisky, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">40-56</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The decreasing no. of approved drugs produced by the pharmaceutical industry, which has been accompanied by increasing expenses for R&D, demands alternative approaches to increase pharmaceutical R&D productivity.  This situation has contributed to a revival of interest in peptides as potential drug candidates.  New synthetic strategies for limiting metab. and alternative routes of administration have emerged in recent years and resulted in a large no. of peptide-based drugs that are now being marketed.  This review reports on the unexpected and considerable no. of peptides that are currently available as drugs and the chem. strategies that were used to bring them into the market.  As demonstrated here, peptide-based drug discovery could be a serious option for addressing new therapeutic challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsoAe6RtqbV7Vg90H21EOLACvtfcHk0ljVMoc0OnIG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsV2iug%253D%253D&md5=9d72257b9e9e8530a19ed959b88507f3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DVlieghe%26aufirst%3DP.%26aulast%3DLisowski%26aufirst%3DV.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26atitle%3DSynthetic%2520therapeutic%2520peptides%253A%2520science%2520and%2520market%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26issue%3D1%25E2%2580%25932%26spage%3D40%26epage%3D56%26doi%3D10.1016%2Fj.drudis.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fosgerau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span> </span><span class="NLM_article-title">Peptide therapeutics: current status and future directions</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.drudis.2014.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25450771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2ksLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=122-128&issue=1&author=K.+Fosgerauauthor=T.+Hoffmann&title=Peptide+therapeutics%3A+current+status+and+future+directions&doi=10.1016%2Fj.drudis.2014.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide therapeutics: current status and future directions</span></div><div class="casAuthors">Fosgerau, Keld; Hoffmann, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-128</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated.  Consequently, there is an increased interest in peptides in pharmaceutical research and development (R&D), and approx. 140 peptide therapeutics are currently being evaluated in clin. trials.  Given that the low-hanging fruits in the form of obvious peptide targets have already been picked, it has now become necessary to explore new routes beyond traditional peptide design.  Examples of such approaches are multifunctional and cell penetrating peptides, as well as peptide drug conjugates.  Here, we discuss the current status, strengths, and weaknesses of peptides as medicines and the emerging new opportunities in peptide drug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmhpp8GnJ6JLVg90H21EOLACvtfcHk0ljVMoc0OnIG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2ksLnM&md5=f6b74aaa4e3fdb317b091b0450f3618a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DFosgerau%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DT.%26atitle%3DPeptide%2520therapeutics%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26issue%3D1%26spage%3D122%26epage%3D128%26doi%3D10.1016%2Fj.drudis.2014.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Targeting recognition surfaces on natural proteins with peptidic foldamers</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.sbi.2016.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.sbi.2016.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=27390896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGitr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=96-105&author=J.+W.+Checcoauthor=S.+H.+Gellman&title=Targeting+recognition+surfaces+on+natural+proteins+with+peptidic+foldamers&doi=10.1016%2Fj.sbi.2016.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting recognition surfaces on natural proteins with peptidic foldamers</span></div><div class="casAuthors">Checco, James W.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-105</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Mols. intended to antagonize protein-protein interactions or augment polypeptide-based signaling must bind tightly to large and sp. surfaces on target proteins.  Some types of unnatural oligomers with discrete folding propensities ('foldamers') have recently been shown to display this capability.  This review covers important recent advances among several classes of foldamers, including α-peptides with secondary structures stabilized by covalent bonds, D-α-peptides, α/β-peptides and oligo-oxopiperazines.  Recent advances in this area have involved enhancing membrane permeability to provide access to intracellular protein targets, improving pharmacokinetics and duration of action in vivo, and developing strategies appropriate for targeting large and irregularly-shaped protein surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpip8E4TMLoWLVg90H21EOLACvtfcHk0lhzYvZIotu-TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGitr%252FE&md5=59db458d1a2f21a7c60ecf3ff6cdc862</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2016.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2016.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DTargeting%2520recognition%2520surfaces%2520on%2520natural%2520proteins%2520with%2520peptidic%2520foldamers%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2016%26volume%3D39%26spage%3D96%26epage%3D105%26doi%3D10.1016%2Fj.sbi.2016.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pelay-Gimeno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, T. N.</span><span> </span><span class="NLM_article-title">Structure-based design of inhibitors of protein-protein interactions: mimicking peptide binding epitopes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">8896</span><span class="NLM_x">–</span> <span class="NLM_lpage">8927</span><span class="refDoi"> DOI: 10.1002/anie.201412070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fanie.201412070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOmu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=8896-8927&issue=31&author=M.+Pelay-Gimenoauthor=A.+Glasauthor=O.+Kochauthor=T.+N.+Grossmann&title=Structure-based+design+of+inhibitors+of+protein-protein+interactions%3A+mimicking+peptide+binding+epitopes&doi=10.1002%2Fanie.201412070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes</span></div><div class="casAuthors">Pelay-Gimeno, Marta; Glas, Adrian; Koch, Oliver; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">8896-8927</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions (PPIs) are involved at all levels of cellular organization, thus making the development of PPI inhibitors extremely valuable.  The identification of selective inhibitors is challenging because of the shallow and extended nature of PPI interfaces.  Inhibitors can be obtained by mimicking peptide binding epitopes in their bioactive conformation.  For this purpose, several strategies have been evolved to enable a projection of side chain functionalities in analogy to peptide secondary structures, thereby yielding mols. that are generally referred to as peptidomimetics.  Herein, we introduce a new classification of peptidomimetics (classes A-D) that enables a clear assignment of available approaches.  Based on this classification, the Review summarizes strategies that have been applied for the structure-based design of PPI inhibitors through stabilizing or mimicking turns, β-sheets, and helixes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPTEmZpatXbrVg90H21EOLACvtfcHk0lhzYvZIotu-TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOmu7rM&md5=447c84aab6275b1057fda9a610918f2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fanie.201412070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201412070%26sid%3Dliteratum%253Aachs%26aulast%3DPelay-Gimeno%26aufirst%3DM.%26aulast%3DGlas%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DO.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DStructure-based%2520design%2520of%2520inhibitors%2520of%2520protein-protein%2520interactions%253A%2520mimicking%2520peptide%2520binding%2520epitopes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26issue%3D31%26spage%3D8896%26epage%3D8927%26doi%3D10.1002%2Fanie.201412070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kushal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henchey, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesallati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traaseth, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olenyuk, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, P. S.</span><span> </span><span class="NLM_article-title">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">39</span><span class="NLM_x">) </span> <span class="NLM_fpage">15602</span><span class="NLM_x">–</span> <span class="NLM_lpage">15607</span><span class="refDoi"> DOI: 10.1073/pnas.1312473110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1312473110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24019500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15602-15607&issue=39&author=S.+Kushalauthor=B.+B.+Laoauthor=L.+K.+Hencheyauthor=R.+Dubeyauthor=H.+Mesallatiauthor=N.+J.+Traasethauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=Protein+domain+mimetics+as+in+vivo+modulators+of+hypoxia-inducible+factor+signaling&doi=10.1073%2Fpnas.1312473110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span></div><div class="casAuthors">Kushal, Swati; Lao, Brooke Bullock; Henchey, Laura K.; Dubey, Ramin; Mesallati, Hanah; Traaseth, Nathaniel J.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15602-15607,S15602/1-S15602/29</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Selective blockade of gene expression by designed small mols. is a fundamental challenge at the interface of chem., biol., and medicine.  Transcription factors have been among the most elusive targets in genetics and drug discovery, but the fields of chem. biol. and genetics have evolved to a point where this task can be addressed.  Herein we report the design, synthesis, and in vivo efficacy evaluation of a protein domain mimetic targeting the interaction of the p300/CBP coactivator with the transcription factor hypoxia-inducible factor-1α.  Our results indicate that disrupting this interaction results in a rapid down-regulation of hypoxia-inducible genes crit. for cancer progression.  The obsd. effects were compd.-specific and dose-dependent.  Gene expression profiling with oligonucleotide microarrays revealed effective inhibition of hypoxia-inducible genes with relatively minimal perturbation of nontargeted signaling pathways.  We obsd. remarkable efficacy of the compd. HBS 1 in suppressing tumor growth in the fully established murine xenograft models of renal cell carcinoma of the clear cell type.  Our results suggest that rationally designed synthetic mimics of protein subdomains that target the transcription factor-coactivator interfaces represent a unique approach for in vivo modulation of oncogenic signaling and arresting tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM3XHm6lQqWrVg90H21EOLACvtfcHk0liYf_XdgdRUjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK&md5=230a70f6e32b3abc3c10abd7fb8df533</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312473110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312473110%26sid%3Dliteratum%253Aachs%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DTraaseth%26aufirst%3DN.%2BJ.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DProtein%2520domain%2520mimetics%2520as%2520in%2520vivo%2520modulators%2520of%2520hypoxia-inducible%2520factor%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D39%26spage%3D15602%26epage%3D15607%26doi%3D10.1073%2Fpnas.1312473110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Takada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhdeo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivdasani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, D. R.</span><span> </span><span class="NLM_article-title">Targeted disruption of the BCL9/beta-catenin complex inhibits oncogenic Wnt signaling</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">148</span><span class="NLM_x">) </span> <span class="NLM_fpage">148ra117</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1126%2Fscitranslmed.3003808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=22914623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=148ra117&issue=148&author=K.+Takadaauthor=D.+Zhuauthor=G.+H.+Birdauthor=K.+Sukhdeoauthor=J.+J.+Zhaoauthor=M.+Maniauthor=M.+Lemieuxauthor=D.+E.+Carrascoauthor=J.+Ryanauthor=D.+Horstauthor=M.+Fulcinitiauthor=N.+C.+Munshiauthor=W.+Q.+Xuauthor=A.+L.+Kungauthor=R.+A.+Shivdasaniauthor=L.+D.+Walenskyauthor=D.+R.+Carrasco&title=Targeted+disruption+of+the+BCL9%2Fbeta-catenin+complex+inhibits+oncogenic+Wnt+signaling&doi=10.1126%2Fscitranslmed.3003808"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003808%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DSukhdeo%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DMani%26aufirst%3DM.%26aulast%3DLemieux%26aufirst%3DM.%26aulast%3DCarrasco%26aufirst%3DD.%2BE.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DHorst%26aufirst%3DD.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DXu%26aufirst%3DW.%2BQ.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DCarrasco%26aufirst%3DD.%2BR.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520BCL9%252Fbeta-catenin%2520complex%2520inhibits%2520oncogenic%2520Wnt%2520signaling%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26issue%3D148%26spage%3D148ra117%26doi%3D10.1126%2Fscitranslmed.3003808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishagin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesallati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olenyuk, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, P. S.</span><span> </span><span class="NLM_article-title">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">7531</span><span class="NLM_x">–</span> <span class="NLM_lpage">7536</span><span class="refDoi"> DOI: 10.1073/pnas.1402393111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1402393111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24821806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=7531-7536&issue=21&author=B.+B.+Laoauthor=I.+Grishaginauthor=H.+Mesallatiauthor=T.+F.+Brewerauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=In+vivo+modulation+of+hypoxia-inducible+signaling+by+topographical+helix+mimetics&doi=10.1073%2Fpnas.1402393111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span></div><div class="casAuthors">Lao, Brooke Bullock; Grishagin, Ivan; Mesallati, Hanah; Brewer, Thomas F.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Development of small-mol. inhibitors of protein-protein interactions is a fundamental challenge at the interface of chem. and cancer biol.  Successful methods for design of protein-protein interaction inhibitors include computational and exptl. high-throughput and fragment-based screening strategies to locate small-mol. fragments that bind protein surfaces.  An alternative rational design approach seeks to mimic the orientation and disposition of crit. binding residues at protein interfaces.  The authors describe the design, synthesis, biochem., and in vivo evaluation of a small-mol. scaffold that captures the topog. of α-helixes.  The authors designed mimics of a key α-helical domain at the interface of hypoxia-inducible factor 1α and p300 to develop inhibitors of hypoxia-inducible signaling.  The hypoxia-inducible factor/p300 interaction regulates the transcription of key genes, whose expression contributes to angiogenesis, metastasis, and altered energy metab. in cancer.  The designed compds. target the desired protein with high affinity and in a predetd. manner, with the optimal ligand providing effective redn. of tumor burden in exptl. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7DvqFbX-7prVg90H21EOLACvtfcHk0ljMgTTEMoQ_CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D&md5=34b4289424a570528a22e6eca0fb502e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1402393111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1402393111%26sid%3Dliteratum%253Aachs%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DGrishagin%26aufirst%3DI.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DBrewer%26aufirst%3DT.%2BF.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DIn%2520vivo%2520modulation%2520of%2520hypoxia-inducible%2520signaling%2520by%2520topographical%2520helix%2520mimetics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D21%26spage%3D7531%26epage%3D7536%26doi%3D10.1073%2Fpnas.1402393111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Backbone modification of a parathyroid hormone receptor-1 antagonist/inverse agonist</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2752</span><span class="NLM_x">–</span> <span class="NLM_lpage">2762</span><span class="refDoi"> DOI: 10.1021/acschembio.6b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2752-2762&issue=10&author=R.+W.+Chelohaauthor=T.+Watanabeauthor=T.+Deanauthor=S.+H.+Gellmanauthor=T.+J.+Gardella&title=Backbone+modification+of+a+parathyroid+hormone+receptor-1+antagonist%2Finverse+agonist&doi=10.1021%2Facschembio.6b00404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00404%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DBackbone%2520modification%2520of%2520a%2520parathyroid%2520hormone%2520receptor-1%2520antagonist%252Finverse%2520agonist%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D10%26spage%3D2752%26epage%3D2762%26doi%3D10.1021%2Facschembio.6b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Backbone modification of a polypeptide drug alters duration of action in vivo</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1038/nbt.2920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnbt.2920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24929976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslGis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=653-655&issue=7&author=R.+W.+Chelohaauthor=A.+Maedaauthor=T.+Deanauthor=T.+J.+Gardellaauthor=S.+H.+Gellman&title=Backbone+modification+of+a+polypeptide+drug+alters+duration+of+action+in+vivo&doi=10.1038%2Fnbt.2920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Backbone modification of a polypeptide drug alters duration of action in vivo</span></div><div class="casAuthors">Cheloha, Ross W.; Maeda, Akira; Dean, Thomas; Gardella, Thomas J.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">653-655</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Systematic modification of the backbone of bioactive polypeptides through β-amino acid residue incorporation could provide a strategy for generating mols. with improved drug properties, but such alterations can result in lower receptor affinity and potency.  Using an agonist of parathyroid hormone receptor-1 (PTHR1), a G protein-coupled receptor in the B-family, we present an approach for α→β residue replacement that enables both high activity and improved pharmacokinetic properties in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8cWxIA-3shbVg90H21EOLACvtfcHk0lhwVjTKuGeioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslGis7k%253D&md5=100382f0d7e67fe9c11fd39886e7acac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2920%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DMaeda%26aufirst%3DA.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DBackbone%2520modification%2520of%2520a%2520polypeptide%2520drug%2520alters%2520duration%2520of%2520action%2520in%2520vivo%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26issue%3D7%26spage%3D653%26epage%3D655%26doi%3D10.1038%2Fnbt.2920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFedries, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabaglia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attie, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghatelian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">A Potent alpha/beta-peptide analogue of GLP-1 with prolonged action in vivo</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x"> (</span><span class="NLM_issue">37</span><span class="NLM_x">) </span> <span class="NLM_fpage">12848</span><span class="NLM_x">–</span> <span class="NLM_lpage">12851</span><span class="refDoi"> DOI: 10.1021/ja507168t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja507168t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=12848-12851&issue=37&author=L.+M.+Johnsonauthor=S.+Barrickauthor=M.+V.+Hagerauthor=A.+McFedriesauthor=E.+A.+Homanauthor=M.+E.+Rabagliaauthor=M.+P.+Kellerauthor=A.+D.+Attieauthor=A.+Saghatelianauthor=A.+Biselloauthor=S.+H.+Gellman&title=A+Potent+alpha%2Fbeta-peptide+analogue+of+GLP-1+with+prolonged+action+in+vivo&doi=10.1021%2Fja507168t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja507168t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja507168t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DBarrick%26aufirst%3DS.%26aulast%3DHager%26aufirst%3DM.%2BV.%26aulast%3DMcFedries%26aufirst%3DA.%26aulast%3DHoman%26aufirst%3DE.%2BA.%26aulast%3DRabaglia%26aufirst%3DM.%2BE.%26aulast%3DKeller%26aufirst%3DM.%2BP.%26aulast%3DAttie%26aufirst%3DA.%2BD.%26aulast%3DSaghatelian%26aufirst%3DA.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DA%2520Potent%2520alpha%252Fbeta-peptide%2520analogue%2520of%2520GLP-1%2520with%2520prolonged%2520action%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D37%26spage%3D12848%26epage%3D12851%26doi%3D10.1021%2Fja507168t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Olson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosloski-Bilek, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggs, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gledhill, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandler, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">16463</span><span class="NLM_x">–</span> <span class="NLM_lpage">16478</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2131-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1523%2FJNEUROSCI.2131-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26674871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKksrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=16463-16478&issue=50&author=K.+E.+Olsonauthor=L.+M.+Kosloski-Bilekauthor=K.+M.+Andersonauthor=B.+J.+Diggsauthor=B.+E.+Clarkauthor=J.+M.+Gledhillauthor=S.+J.+Shandlerauthor=R.+L.+Mosleyauthor=H.+E.+Gendelman&title=Selective+VIP+receptor+agonists+facilitate+immune+transformation+for+dopaminergic+neuroprotection+in+MPTP-intoxicated+mice&doi=10.1523%2FJNEUROSCI.2131-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice</span></div><div class="casAuthors">Olson, Katherine E.; Kosloski-Bilek, Lisa M.; Anderson, Kristi M.; Diggs, Breha J.; Clark, Barbara E.; Gledhill, John M., Jr.; Shandler, Scott J.; Mosley, R. Lee; Gendelman, Howard E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">16463-16478</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Vasoactive intestinal peptide (VIP) mediates a broad range of biol. responses by activating two related receptors, VIP receptor 1 and 2 (VIPR1 and VIPR2).  Although the use of native VIP facilitates neuroprotection, clin. application of the hormone is limited due to VIP's rapid metab. and inability to distinguish between VIPR1 and VIPR2 receptors.  In addn., activation of both receptors by therapeutics may increase adverse secondary toxicities.  Therefore, we developed metabolically stable and receptor-selective agonists for VIPR1 and VIPR2 to improve pharmacokinetic and pharmacodynamic therapeutic end points.  Selective agonists were investigated for their abilities to protect mice against MPTP-induced neurodegeneration used to model Parkinson's disease (PD).  Survival of tyrosine hydroxylase neurons in the substantia nigra was detd. by stereol. tests after MPTP intoxication in mice pretreated with either VIPR1 or VIPR2 agonist or after adoptive transfer of splenic cell populations from agonist-treated mice administered to MPTP-intoxicated animals.  Treatment with VIPR2 agonist or splenocytes from agonist-treated mice resulted in increased neuronal sparing.  Immunohistochem. tests showed that agonist-treated mice displayed redns. in microglial responses, with the most pronounced effects in VIPR2 agonist-treated, MPTP-intoxicated mice.  In parallel studies, we obsd. redns. in proinflammatory cytokine release that included IL-17A, IL-6, and IFN-γ and increases in GM-CSF transcripts in CD4+ T cells recovered from VIPR2 agonist-treated animals.  Moreover, a phenotypic shift of effector to regulatory T cells was obsd.  These results support the use of VIPR2-selective agonists as neuroprotective agents for PD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRx4gmaC1rqbVg90H21EOLACvtfcHk0lhwVjTKuGeioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKksrzL&md5=1d2a7514f18eb697d8e7a411d6f7349d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2131-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2131-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DK.%2BE.%26aulast%3DKosloski-Bilek%26aufirst%3DL.%2BM.%26aulast%3DAnderson%26aufirst%3DK.%2BM.%26aulast%3DDiggs%26aufirst%3DB.%2BJ.%26aulast%3DClark%26aufirst%3DB.%2BE.%26aulast%3DGledhill%26aufirst%3DJ.%2BM.%26aulast%3DShandler%26aufirst%3DS.%2BJ.%26aulast%3DMosley%26aufirst%3DR.%2BL.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DSelective%2520VIP%2520receptor%2520agonists%2520facilitate%2520immune%2520transformation%2520for%2520dopaminergic%2520neuroprotection%2520in%2520MPTP-intoxicated%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D50%26spage%3D16463%26epage%3D16478%26doi%3D10.1523%2FJNEUROSCI.2131-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sand, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suresh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Consequences of periodic alpha-to-beta(3) residue replacement for immunological recognition of peptide epitopes</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1021/cb500888q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500888q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=844-854&issue=3&author=R.+W.+Chelohaauthor=J.+A.+Sullivanauthor=T.+Wangauthor=J.+M.+Sandauthor=J.+Sidneyauthor=A.+Setteauthor=M.+E.+Cookauthor=M.+Sureshauthor=S.+H.+Gellman&title=Consequences+of+periodic+alpha-to-beta%283%29+residue+replacement+for+immunological+recognition+of+peptide+epitopes&doi=10.1021%2Fcb500888q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb500888q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500888q%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DSullivan%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DSand%26aufirst%3DJ.%2BM.%26aulast%3DSidney%26aufirst%3DJ.%26aulast%3DSette%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DM.%2BE.%26aulast%3DSuresh%26aufirst%3DM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DConsequences%2520of%2520periodic%2520alpha-to-beta%25283%2529%2520residue%2520replacement%2520for%2520immunological%2520recognition%2520of%2520peptide%2520epitopes%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D3%26spage%3D844%26epage%3D854%26doi%3D10.1021%2Fcb500888q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Uppalapati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault-Riche, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, S. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, S. S.</span><span> </span><span class="NLM_article-title">A potent D-protein antagonist of VEGF-A is nonimmunogenic, metabolically stable, and longer-circulating in vivo</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span><span class="refDoi"> DOI: 10.1021/acschembio.5b01006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b01006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1058-1065&issue=4&author=M.+Uppalapatiauthor=D.+J.+Leeauthor=K.+Mandalauthor=H.+Y.+Liauthor=L.+P.+Mirandaauthor=J.+Lowitzauthor=J.+Kenneyauthor=J.+J.+Adamsauthor=D.+Ault-Richeauthor=S.+B.+H.+Kentauthor=S.+S.+Sidhu&title=A+potent+D-protein+antagonist+of+VEGF-A+is+nonimmunogenic%2C+metabolically+stable%2C+and+longer-circulating+in+vivo&doi=10.1021%2Facschembio.5b01006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b01006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b01006%26sid%3Dliteratum%253Aachs%26aulast%3DUppalapati%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DD.%2BJ.%26aulast%3DMandal%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.%2BY.%26aulast%3DMiranda%26aufirst%3DL.%2BP.%26aulast%3DLowitz%26aufirst%3DJ.%26aulast%3DKenney%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DJ.%2BJ.%26aulast%3DAult-Riche%26aufirst%3DD.%26aulast%3DKent%26aufirst%3DS.%2BB.%2BH.%26aulast%3DSidhu%26aufirst%3DS.%2BS.%26atitle%3DA%2520potent%2520D-protein%2520antagonist%2520of%2520VEGF-A%2520is%2520nonimmunogenic%252C%2520metabolically%2520stable%252C%2520and%2520longer-circulating%2520in%2520vivo%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D4%26spage%3D1058%26epage%3D1065%26doi%3D10.1021%2Facschembio.5b01006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klasse, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">14751</span><span class="NLM_x">–</span> <span class="NLM_lpage">14756</span><span class="refDoi"> DOI: 10.1073/pnas.0902663106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0902663106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19706443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGrtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=14751-14756&issue=35&author=W.+S.+Horneauthor=L.+M.+Johnsonauthor=T.+J.+Ketasauthor=P.+J.+Klasseauthor=M.+Luauthor=J.+P.+Mooreauthor=S.+H.+Gellman&title=Structural+and+biological+mimicry+of+protein+surface+recognition+by+alpha%2Fbeta-peptide+foldamers&doi=10.1073%2Fpnas.0902663106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers</span></div><div class="casAuthors">Horne, W. Seth; Johnson, Lisa M.; Ketas, Thomas J.; Klasse, Per Johan; Lu, Min; Moore, John P.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">14751-14756, S14751/1-S14751/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Unnatural oligomers that can mimic protein surfaces offer a potentially useful strategy for blocking biomedically important protein-protein interactions.  Here we evaluate an approach based on combining α- and β-amino acid residues in the context of a polypeptide sequence from the HIV protein gp41, which represents an excellent testbed because of the wealth of available structural and biol. information.  We show that α/β-peptides can mimic structural and functional properties of a crit. gp41 subunit.  Phys. studies in soln., crystallog. data, and results from cell-fusion and virus-infectivity assays collectively indicate that the gp41-mimetic α/β-peptides effectively block HIV-cell fusion via a mechanism comparable to that of gp41-derived α-peptides.  An optimized α/β-peptide is far less susceptible to proteolytic degrdn. than is an analogous α-peptide.  Our findings show how a two-stage design approach, in which sequence-based α → β replacements are followed by site-specific backbone rigidification, can lead to phys. and biol. mimicry of a natural biorecognition process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAN0drYgQtaLVg90H21EOLACvtfcHk0li0mOv3sthBWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGrtrfP&md5=e56297c79b7388ae517515c271c0fef3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0902663106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0902663106%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DStructural%2520and%2520biological%2520mimicry%2520of%2520protein%2520surface%2520recognition%2520by%2520alpha%252Fbeta-peptide%2520foldamers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D35%26spage%3D14751%26epage%3D14756%26doi%3D10.1073%2Fpnas.0902663106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">2853</span><span class="NLM_x">–</span> <span class="NLM_lpage">2856</span><span class="refDoi"> DOI: 10.1002/anie.200705315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fanie.200705315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=2853-2856&issue=15&author=W.+S.+Horneauthor=M.+D.+Boersmaauthor=M.+A.+Windsorauthor=S.+H.+Gellman&title=Sequence-based+design+of+alpha%2Fbeta-peptide+foldamers+that+mimic+BH3+domains&doi=10.1002%2Fanie.200705315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.200705315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200705315%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DBoersma%26aufirst%3DM.%2BD.%26aulast%3DWindsor%26aufirst%3DM.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DSequence-based%2520design%2520of%2520alpha%252Fbeta-peptide%2520foldamers%2520that%2520mimic%2520BH3%2520domains%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26issue%3D15%26spage%3D2853%26epage%3D2856%26doi%3D10.1002%2Fanie.200705315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreitler, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettko, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forest, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Targeting diverse protein-protein interaction interfaces with alpha/beta-peptides derived from the Z-domain scaffold</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4552</span><span class="NLM_x">–</span> <span class="NLM_lpage">4557</span><span class="refDoi"> DOI: 10.1073/pnas.1420380112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1420380112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=4552-4557&issue=15&author=J.+W.+Checcoauthor=D.+F.+Kreitlerauthor=N.+C.+Thomasauthor=D.+G.+Belairauthor=N.+J.+Rettkoauthor=W.+L.+Murphyauthor=K.+T.+Forestauthor=S.+H.+Gellman&title=Targeting+diverse+protein-protein+interaction+interfaces+with+alpha%2Fbeta-peptides+derived+from+the+Z-domain+scaffold&doi=10.1073%2Fpnas.1420380112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420380112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420380112%26sid%3Dliteratum%253Aachs%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DKreitler%26aufirst%3DD.%2BF.%26aulast%3DThomas%26aufirst%3DN.%2BC.%26aulast%3DBelair%26aufirst%3DD.%2BG.%26aulast%3DRettko%26aufirst%3DN.%2BJ.%26aulast%3DMurphy%26aufirst%3DW.%2BL.%26aulast%3DForest%26aufirst%3DK.%2BT.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DTargeting%2520diverse%2520protein-protein%2520interaction%2520interfaces%2520with%2520alpha%252Fbeta-peptides%2520derived%2520from%2520the%2520Z-domain%2520scaffold%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D15%26spage%3D4552%26epage%3D4557%26doi%3D10.1073%2Fpnas.1420380112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleebs, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettikiriarachchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershaw, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddinger, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eller, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raines, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W.</span><span> </span><span class="NLM_article-title">D. alpha/beta-Peptide foldamers targeting intracellular protein-protein interactions with activity in living cells</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">11365</span><span class="NLM_x">–</span> <span class="NLM_lpage">11375</span><span class="refDoi"> DOI: 10.1021/jacs.5b05896</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b05896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=11365-11375&issue=35&author=J.+W.+Checcoauthor=E.+F.+Leeauthor=M.+Evangelistaauthor=N.+J.+Sleebsauthor=K.+Rogersauthor=A.+Pettikiriarachchiauthor=N.+J.+Kershawauthor=G.+A.+Eddingerauthor=D.+G.+Belairauthor=J.+L.+Wilsonauthor=C.+H.+Ellerauthor=R.+T.+Rainesauthor=W.+L.+Murphyauthor=B.+J.+Smithauthor=S.+H.+Gellmanauthor=W.+Fairlie&title=D.+alpha%2Fbeta-Peptide+foldamers+targeting+intracellular+protein-protein+interactions+with+activity+in+living+cells&doi=10.1021%2Fjacs.5b05896"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b05896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b05896%26sid%3Dliteratum%253Aachs%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DEvangelista%26aufirst%3DM.%26aulast%3DSleebs%26aufirst%3DN.%2BJ.%26aulast%3DRogers%26aufirst%3DK.%26aulast%3DPettikiriarachchi%26aufirst%3DA.%26aulast%3DKershaw%26aufirst%3DN.%2BJ.%26aulast%3DEddinger%26aufirst%3DG.%2BA.%26aulast%3DBelair%26aufirst%3DD.%2BG.%26aulast%3DWilson%26aufirst%3DJ.%2BL.%26aulast%3DEller%26aufirst%3DC.%2BH.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26aulast%3DMurphy%26aufirst%3DW.%2BL.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DFairlie%26aufirst%3DW.%26atitle%3DD.%2520alpha%252Fbeta-Peptide%2520foldamers%2520targeting%2520intracellular%2520protein-protein%2520interactions%2520with%2520activity%2520in%2520living%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26issue%3D35%26spage%3D11365%26epage%3D11375%26doi%3D10.1021%2Fjacs.5b05896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">alpha-Helix mimicry with alpha/beta-peptides</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">523</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1016/B978-0-12-394292-0.00019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2FB978-0-12-394292-0.00019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23422441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2013&pages=407-429&author=L.+M.+Johnsonauthor=S.+H.+Gellman&title=alpha-Helix+mimicry+with+alpha%2Fbeta-peptides&doi=10.1016%2FB978-0-12-394292-0.00019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">α-helix mimicry with α/β-peptides</span></div><div class="casAuthors">Johnson, Lisa M.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">Methods in Protein Design</span>),
    <span class="NLM_cas:pages">407-429</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  We describe a general strategy for creating peptidic oligomers that have unnatural backbones but nevertheless adopt a conformation very similar to the α-helix.  These oligomers contain both α- and β-amino acid residues (α/β-peptides).  If the β content reaches 25-30% of the residue total, and the β residues are evenly distributed along the backbone, then substantial resistance to proteolytic degrdn. is often obsd.  These α/β-peptides can mimic the informational properties of α-helixes involved in protein-protein recognition events, as documented in numerous crystal structures.  Thus, these unnatural oligomers can be a source of antagonists of undesirable protein-protein interactions that are mediated by natural α-helixes, or agonists of receptors for which the natural polypeptide ligands are α-helical.  Successes include mimicry of BH3 domains found in proapoptotic proteins, which leads to ligands for anti-apoptotic Bcl-2 family proteins, and mimicry of the gp41 CHR domain, which leads to inhibition of HIV infection in cell-based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4sEtSi8lWmrVg90H21EOLACvtfcHk0li6VD4N6ZexZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSiu78%253D&md5=679f0dd73406c6c9c6f7cf8f751b558a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-394292-0.00019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-394292-0.00019-9%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3Dalpha-Helix%2520mimicry%2520with%2520alpha%252Fbeta-peptides%26jtitle%3DMethods%2520Enzymol.%26date%3D2013%26volume%3D523%26spage%3D407%26epage%3D429%26doi%3D10.1016%2FB978-0-12-394292-0.00019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hager, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">β-Arrestin-biased agonists of the GLP-1 receptor from β-amino acid residue incorporation into GLP-1 analogues</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">14970</span><span class="NLM_x">–</span> <span class="NLM_lpage">14979</span><span class="refDoi"> DOI: 10.1021/jacs.6b08323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b08323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqtbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=14970-14979&issue=45&author=M.+V.+Hagerauthor=L.+M.+Johnsonauthor=D.+Woottenauthor=P.+M.+Sextonauthor=S.+H.+Gellman&title=%CE%B2-Arrestin-biased+agonists+of+the+GLP-1+receptor+from+%CE%B2-amino+acid+residue+incorporation+into+GLP-1+analogues&doi=10.1021%2Fjacs.6b08323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues</span></div><div class="casAuthors">Hager, Marlies V.; Johnson, Lisa M.; Wootten, Denise; Sexton, Patrick M.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14970-14979</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of a G protein-coupled receptor (GPCR) causes recruitment of multiple intracellular proteins, each of which can activate distinct signaling pathways.  This complexity has engendered interest in agonists that preferentially stimulate subsets among the natural signaling pathways ("biased agonists").  We have examd. analogs of glucagon-like peptide-1 (GLP-1) contg. β-amino acid residues in place of native α residues at selected sites and found that some analogs differ from GLP-1 in terms of their relative abilities to promote G protein activation (as monitored via cAMP prodn.) vs. β-arrestin recruitment (as monitored via BRET assays).  The α → β replacements generally cause modest declines in stimulation of cAMP prodn. and β-arrestin recruitment, but for some replacement sets cAMP prodn. is more strongly affected than is β-arrestin recruitment.  The central portion of GLP-1 appears to be crit. for achieving bias toward β-arrestin recruitment.  These results suggest that backbone modification via α → β residue replacement may be a versatile source of agonists with biased GLP-1R activation profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7U5uooT8IC7Vg90H21EOLACvtfcHk0li6VD4N6ZexZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqtbbM&md5=32deb7351b8727459a900b7da9010984</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b08323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b08323%26sid%3Dliteratum%253Aachs%26aulast%3DHager%26aufirst%3DM.%2BV.%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3D%25CE%25B2-Arrestin-biased%2520agonists%2520of%2520the%2520GLP-1%2520receptor%2520from%2520%25CE%25B2-amino%2520acid%2520residue%2520incorporation%2520into%2520GLP-1%2520analogues%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D45%26spage%3D14970%26epage%3D14979%26doi%3D10.1021%2Fjacs.6b08323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Pioszak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Molecular recognition of parathyroid hormone by its G protein-coupled receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">5034</span><span class="NLM_x">–</span> <span class="NLM_lpage">5039</span><span class="refDoi"> DOI: 10.1073/pnas.0801027105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0801027105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=18375760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVOmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5034-5039&issue=13&author=A.+A.+Pioszakauthor=H.+E.+Xu&title=Molecular+recognition+of+parathyroid+hormone+by+its+G+protein-coupled+receptor&doi=10.1073%2Fpnas.0801027105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of parathyroid hormone by its G protein-coupled receptor</span></div><div class="casAuthors">Pioszak, Augen A.; Xu, H. Eric</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5034-5039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parathyroid hormone (PTH) is central to calcium homeostasis and bone maintenance in vertebrates, and as such it has been used for treating osteoporosis.  It acts primarily by binding to its receptor, PTH1R, a member of the class B G protein-coupled receptor (GPCR) family that also includes receptors for glucagon, calcitonin, and other therapeutically important peptide hormones.  Despite considerable interest and much research, detg. the structure of the receptor-hormone complex has been hindered by difficulties in purifying the receptor and obtaining diffraction-quality crystals.  Here, we present a method for expression and purifn. of the extracellular domain (ECD) of human PTH1R engineered as a maltose-binding protein (MBP) fusion that readily crystallizes.  The 1.95-Å structure of PTH bound to the MBP-PTH1R-ECD fusion reveals that PTH docks as an amphipathic helix into a central hydrophobic groove formed by a three-layer α-β-βα fold of the PTH1R ECD, resembling a hot dog in a bun.  Conservation in the ECD scaffold and the helical structure of peptide hormones emphasizes this hot dog model as a general mechanism of hormone recognition common to class B GPCRs.  Our findings reveal crit. insights into PTH actions and provide a rational template for drug design that targets this hormone signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoijvIBSYYwLVg90H21EOLACvtfcHk0lhhBnkaB2MNdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVOmurY%253D&md5=fef532f9c738b477bf5d914037bc3997</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0801027105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0801027105%26sid%3Dliteratum%253Aachs%26aulast%3DPioszak%26aufirst%3DA.%2BA.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DMolecular%2520recognition%2520of%2520parathyroid%2520hormone%2520by%2520its%2520G%2520protein-coupled%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D13%26spage%3D5034%26epage%3D5039%26doi%3D10.1073%2Fpnas.0801027105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Underwood, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garibay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastrup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedtz-Runge, S.</span><span> </span><span class="NLM_article-title">Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1074/jbc.M109.033829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M109.033829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19861722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SqtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=723-730&issue=1&author=C.+R.+Underwoodauthor=P.+Garibayauthor=L.+B.+Knudsenauthor=S.+Hastrupauthor=G.+H.+Petersauthor=R.+Rudolphauthor=S.+Reedtz-Runge&title=Crystal+structure+of+glucagon-like+peptide-1+in+complex+with+the+extracellular+domain+of+the+glucagon-like+peptide-1+receptor&doi=10.1074%2Fjbc.M109.033829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor</span></div><div class="casAuthors">Underwood, Christina Rye; Garibay, Patrick; Knudsen, Lotte Bjerre; Hastrup, Sven; Peters, Guenther H.; Rudolph, Rainer; Reedtz-Runge, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GLP-1 (glucagon-like peptide-1) is an incretin released from intestinal L-cells in response to food intake.  Activation of the GLP-1 receptor potentiates the synthesis and release of insulin from pancreatic β-cells in a glucose-dependent manner.  The GLP-1 receptor belongs to class B of the G-protein-coupled receptors, a subfamily characterized by a large N-terminal extracellular ligand binding domain.  Exendin-4 and GLP-1 are 50% identical, and exendin-4 is a full agonist with similar affinity and potency for the GLP-1 receptor.  We recently solved the crystal structure of the GLP-1 receptor extracellular domain in complex with the competitive antagonist exendin-4(9-39).  Interestingly, the isolated extracellular domain binds exendin-4 with much higher affinity than the endogenous agonist GLP-1.  Here, we have solved the crystal structure of the extracellular domain in complex with GLP-1 to 2.1 Åresoln.  The structure shows that important hydrophobic ligand-receptor interactions are conserved in agonist- and antagonist-bound forms of the extracellular domain, but certain residues in the ligand-binding site adopt a GLP-1-specific conformation.  GLP-1 is a kinked but continuous α-helix from Thr13 to Val33 when bound to the extracellular domain.  We supplemented the crystal structure with site-directed mutagenesis to link the structural information of the isolated extracellular domain with the binding properties of the full-length receptor.  The data support the existence of differences in the binding modes of GLP-1 and exendin-4 on the full-length GLP-1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpex-ZPbuqSCrVg90H21EOLACvtfcHk0lhhBnkaB2MNdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SqtrrM&md5=59f7b2cee843c4299acab5900036172c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033829%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DC.%2BR.%26aulast%3DGaribay%26aufirst%3DP.%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DHastrup%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DG.%2BH.%26aulast%3DRudolph%26aufirst%3DR.%26aulast%3DReedtz-Runge%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520glucagon-like%2520peptide-1%2520in%2520complex%2520with%2520the%2520extracellular%2520domain%2520of%2520the%2520glucagon-like%2520peptide-1%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D1%26spage%3D723%26epage%3D730%26doi%3D10.1074%2Fjbc.M109.033829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liang, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoshouei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radjainia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glukhova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrasch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furness, S. G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudrat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiniotis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span> </span><span class="NLM_article-title">Phase-plate cryo-EM structure of a class B GPCR–G-protein complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">7656</span><span class="NLM_x">) </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1038/nature22327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnature22327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=28437792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslehs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=118-123&issue=7656&author=Y.-L.+Liangauthor=M.+Khoshoueiauthor=M.+Radjainiaauthor=Y.+Zhangauthor=A.+Glukhovaauthor=J.+Tarraschauthor=D.+M.+Thalauthor=S.+G.+B.+Furnessauthor=G.+Christopoulosauthor=T.+Coudratauthor=R.+Danevauthor=W.+Baumeisterauthor=L.+J.+Millerauthor=A.+Christopoulosauthor=B.+K.+Kobilkaauthor=D.+Woottenauthor=G.+Skiniotisauthor=P.+M.+Sexton&title=Phase-plate+cryo-EM+structure+of+a+class+B+GPCR%E2%80%93G-protein+complex&doi=10.1038%2Fnature22327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phase-plate cryo-EM structure of a class B GPCR-G-protein complex</span></div><div class="casAuthors">Liang, Yi-Lynn; Khoshouei, Maryam; Radjainia, Mazdak; Zhang, Yan; Glukhova, Alisa; Tarrasch, Jeffrey; Thal, David M.; Furness, Sebastian G. B.; Christopoulos, George; Coudrat, Thomas; Danev, Radostin; Baumeister, Wolfgang; Miller, Laurence J.; Christopoulos, Arthur; Kobilka, Brian K.; Wootten, Denise; Skiniotis, Georgios; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7656</span>),
    <span class="NLM_cas:pages">118-123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Class B G-protein-coupled receptors (GPCRs) are major targets for the treatment of chronic diseases, such as osteoporosis, diabetes, and obesity.  Here, we report the structure of a full-length class B GPCR receptor, the calcitonin receptor, in complex with the peptide ligand, calcitonin, and a heterotrimeric Gαsβγ protein detd. by Volta phase-plate single-particle cryo-electron microscopy.  The peptide agonist, calcitonin, engaged the receptor by binding to an extended hydrophobic pocket facilitated by the large outward movement of the extracellular ends of transmembrane helixes 6 and 7.  This conformation was accompanied by a 60° kink in helix 6 and a large outward movement of the intracellular end of this helix, opening the bundle to accommodate interactions with the α5-helix of Gαs.  Also obsd. was an extended intracellular helix 8 that contributed to both receptor stability and functional G-protein coupling via an interaction with the Gβ subunit.  Thus, this structure provides a new framework for understanding GPCR receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoag8XLOHZArLVg90H21EOLACvtfcHk0lhiU7sCUEth6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslehs7w%253D&md5=cf34886db58191741437168ac3256c03</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature22327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22327%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.-L.%26aulast%3DKhoshouei%26aufirst%3DM.%26aulast%3DRadjainia%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGlukhova%26aufirst%3DA.%26aulast%3DTarrasch%26aufirst%3DJ.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DFurness%26aufirst%3DS.%2BG.%2BB.%26aulast%3DChristopoulos%26aufirst%3DG.%26aulast%3DCoudrat%26aufirst%3DT.%26aulast%3DDanev%26aufirst%3DR.%26aulast%3DBaumeister%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DPhase-plate%2520cryo-EM%2520structure%2520of%2520a%2520class%2520B%2520GPCR%25E2%2580%2593G-protein%2520complex%26jtitle%3DNature%26date%3D2017%26volume%3D546%26issue%3D7656%26spage%3D118%26epage%3D123%26doi%3D10.1038%2Fnature22327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jazayeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kean, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiez-Vandal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baig, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teobald, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doré, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Crystal structure of the GLP-1 receptor bound to a peptide agonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">7657</span><span class="NLM_x">) </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1038/nature22800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnature22800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=28562585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=254-258&issue=7657&author=A.+Jazayeriauthor=M.+Rappasauthor=A.+J.+H.+Brownauthor=J.+Keanauthor=J.+C.+Erreyauthor=N.+J.+Robertsonauthor=C.+Fiez-Vandalauthor=S.+P.+Andrewsauthor=M.+Congreveauthor=A.+Bortolatoauthor=J.+S.+Masonauthor=A.+H.+Baigauthor=I.+Teobaldauthor=A.+S.+Dor%C3%A9author=M.+Weirauthor=R.+M.+Cookeauthor=F.+H.+Marshall&title=Crystal+structure+of+the+GLP-1+receptor+bound+to+a+peptide+agonist&doi=10.1038%2Fnature22800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the GLP-1 receptor bound to a peptide agonist</span></div><div class="casAuthors">Jazayeri, Ali; Rappas, Mathieu; Brown, Alastair J. H.; Kean, James; Errey, James C.; Robertson, Nathan J.; Fiez-Vandal, Cedric; Andrews, Stephen P.; Congreve, Miles; Bortolato, Andrea; Mason, Jonathan S.; Baig, Asma H.; Teobald, Iryna; Dore, Andrew S.; Weir, Malcolm; Cooke, Robert M.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">254-258</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) regulates glucose homeostasis through the control of insulin release from the pancreas.  GLP-1 peptide agonists are efficacious drugs for the treatment of diabetes.  To gain insight into the mol. mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist.  The peptide agonist retains an α-helical conformation as it sits deep within the receptor-binding pocket.  The arrangement of the transmembrane helixes reveals hallmarks of an active conformation similar to that obsd. in class A receptors.  Guided by this structural information, we design peptide agonists with potent in vivo activity in a mouse model of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX6Ibc110QxrVg90H21EOLACvtfcHk0lhiU7sCUEth6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D&md5=0a5c99161af8bae506a184e0ab6306c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature22800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22800%26sid%3Dliteratum%253Aachs%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DRappas%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DKean%26aufirst%3DJ.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DN.%2BJ.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DBaig%26aufirst%3DA.%2BH.%26aulast%3DTeobald%26aufirst%3DI.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520the%2520GLP-1%2520receptor%2520bound%2520to%2520a%2520peptide%2520agonist%26jtitle%3DNature%26date%3D2017%26volume%3D546%26issue%3D7657%26spage%3D254%26epage%3D258%26doi%3D10.1038%2Fnature22800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrasch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun Kobilka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiniotis, G.</span><span> </span><span class="NLM_article-title">Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">7657</span><span class="NLM_x">) </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1038/nature22394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnature22394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=28538729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=248-253&issue=7657&author=Y.+Zhangauthor=B.+Sunauthor=D.+Fengauthor=H.+Huauthor=M.+Chuauthor=Q.+Quauthor=J.+T.+Tarraschauthor=S.+Liauthor=T.+Sun+Kobilkaauthor=B.+K.+Kobilkaauthor=G.+Skiniotis&title=Cryo-EM+structure+of+the+activated+GLP-1+receptor+in+complex+with+a+G+protein&doi=10.1038%2Fnature22394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein</span></div><div class="casAuthors">Zhang, Yan; Sun, Bingfa; Feng, Dan; Hu, Hongli; Chu, Matthew; Qu, Qianhui; Tarrasch, Jeffrey T.; Li, Shane; Sun Kobilka, Tong; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) is a hormone with essential roles in regulating insulin secretion, carbohydrate metab. and appetite.  GLP-1 effects are mediated through binding to the GLP-1 receptor (GLP-1R), a class B G-protein-coupled receptor (GPCR) that signals primarily through the stimulatory G protein Gs.  Class B GPCRs are important therapeutic targets; however, our understanding of their mechanism of action is limited by the lack of structural information on activated and full-length receptors.  Here we report the cryo-electron microscopy structure of the peptide-activated GLP-1R-Gs complex at near at. resoln.  The peptide is clasped between the N-terminal domain and the transmembrane core of the receptor, and further stabilized by extracellular loops.  Conformational changes in the transmembrane domain result in a sharp kink in the middle of transmembrane helix 6, which pivots its intracellular half outward to accommodate the α5-helix of the Ras-like domain of Gs.  These results provide a structural framework for understanding class B GPCR activation through hormone binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDRFGRwMs1bVg90H21EOLACvtfcHk0li0rWSWpHeCtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D&md5=5e7ebd94012ba47ecc299ad0502975de</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature22394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22394%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DTarrasch%26aufirst%3DJ.%2BT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSun%2BKobilka%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DCryo-EM%2520structure%2520of%2520the%2520activated%2520GLP-1%2520receptor%2520in%2520complex%2520with%2520a%2520G%2520protein%26jtitle%3DNature%26date%3D2017%26volume%3D546%26issue%3D7657%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature22394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Peggion, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schievano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiebler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblatt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span> </span><span class="NLM_article-title">Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">8162</span><span class="NLM_x">–</span> <span class="NLM_lpage">8175</span><span class="refDoi"> DOI: 10.1021/bi0200155</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0200155" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=8162-8175&issue=25&author=E.+Peggionauthor=S.+Mammiauthor=E.+Schievanoauthor=L.+Silvestriauthor=L.+Schieblerauthor=A.+Biselloauthor=M.+Rosenblattauthor=M.+Chorev&title=Structure-function+studies+of+analogues+of+parathyroid+hormone+%28PTH%29-1-34+containing+beta-amino+acid+residues+in+positions+11-13&doi=10.1021%2Fbi0200155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbi0200155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0200155%26sid%3Dliteratum%253Aachs%26aulast%3DPeggion%26aufirst%3DE.%26aulast%3DMammi%26aufirst%3DS.%26aulast%3DSchievano%26aufirst%3DE.%26aulast%3DSilvestri%26aufirst%3DL.%26aulast%3DSchiebler%26aufirst%3DL.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DRosenblatt%26aufirst%3DM.%26aulast%3DChorev%26aufirst%3DM.%26atitle%3DStructure-function%2520studies%2520of%2520analogues%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529-1-34%2520containing%2520beta-amino%2520acid%2520residues%2520in%2520positions%252011-13%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26issue%3D25%26spage%3D8162%26epage%3D8175%26doi%3D10.1021%2Fbi0200155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Schievano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblatt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, E.</span><span> </span><span class="NLM_article-title">Conformational and biological characterization of human parathyroid hormone hPTH(1-34) analogues containing beta-amino acid residues in positions 17-19</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1002/bip.10508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fbip.10508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2003&pages=534-547&issue=4&author=E.+Schievanoauthor=S.+Mammiauthor=E.+Carrettaauthor=N.+Fioriauthor=M.+Corichauthor=A.+Biselloauthor=M.+Rosenblattauthor=M.+Chorevauthor=E.+Peggion&title=Conformational+and+biological+characterization+of+human+parathyroid+hormone+hPTH%281-34%29+analogues+containing+beta-amino+acid+residues+in+positions+17-19&doi=10.1002%2Fbip.10508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbip.10508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.10508%26sid%3Dliteratum%253Aachs%26aulast%3DSchievano%26aufirst%3DE.%26aulast%3DMammi%26aufirst%3DS.%26aulast%3DCarretta%26aufirst%3DE.%26aulast%3DFiori%26aufirst%3DN.%26aulast%3DCorich%26aufirst%3DM.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DRosenblatt%26aufirst%3DM.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DPeggion%26aufirst%3DE.%26atitle%3DConformational%2520and%2520biological%2520characterization%2520of%2520human%2520parathyroid%2520hormone%2520hPTH%25281-34%2529%2520analogues%2520containing%2520beta-amino%2520acid%2520residues%2520in%2520positions%252017-19%26jtitle%3DBiopolymers%26date%3D2003%26volume%3D70%26issue%3D4%26spage%3D534%26epage%3D547%26doi%3D10.1002%2Fbip.10508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Denton, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepartz, A.</span><span> </span><span class="NLM_article-title">A beta-peptide agonist of the GLP-1 receptor, a Class B GPCR</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5318</span><span class="NLM_x">–</span> <span class="NLM_lpage">5321</span><span class="refDoi"> DOI: 10.1021/ol402568j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol402568j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=5318-5321&issue=20&author=E.+V.+Dentonauthor=C.+J.+Craigauthor=R.+L.+Pongratzauthor=J.+S.+Appelbaumauthor=A.+E.+Doernerauthor=A.+Narayananauthor=G.+I.+Shulmanauthor=G.+W.+Clineauthor=A.+Schepartz&title=A+beta-peptide+agonist+of+the+GLP-1+receptor%2C+a+Class+B+GPCR&doi=10.1021%2Fol402568j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol402568j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol402568j%26sid%3Dliteratum%253Aachs%26aulast%3DDenton%26aufirst%3DE.%2BV.%26aulast%3DCraig%26aufirst%3DC.%2BJ.%26aulast%3DPongratz%26aufirst%3DR.%2BL.%26aulast%3DAppelbaum%26aufirst%3DJ.%2BS.%26aulast%3DDoerner%26aufirst%3DA.%2BE.%26aulast%3DNarayanan%26aufirst%3DA.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DSchepartz%26aufirst%3DA.%26atitle%3DA%2520beta-peptide%2520agonist%2520of%2520the%2520GLP-1%2520receptor%252C%2520a%2520Class%2520B%2520GPCR%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26issue%3D20%26spage%3D5318%26epage%3D5321%26doi%3D10.1021%2Fol402568j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Haase, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson-Kaufman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levengood, S. K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checco, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Extending foldamer design beyond alpha-helix mimicry: alpha/beta-peptide inhibitors of vascular endothelial growth factor signaling</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7652</span><span class="NLM_x">–</span> <span class="NLM_lpage">7655</span><span class="refDoi"> DOI: 10.1021/ja302469a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302469a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=7652-7655&issue=18&author=H.+S.+Haaseauthor=K.+J.+Peterson-Kaufmanauthor=S.+K.+L.+Levengoodauthor=J.+W.+Checcoauthor=W.+L.+Murphyauthor=S.+H.+Gellman&title=Extending+foldamer+design+beyond+alpha-helix+mimicry%3A+alpha%2Fbeta-peptide+inhibitors+of+vascular+endothelial+growth+factor+signaling&doi=10.1021%2Fja302469a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja302469a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302469a%26sid%3Dliteratum%253Aachs%26aulast%3DHaase%26aufirst%3DH.%2BS.%26aulast%3DPeterson-Kaufman%26aufirst%3DK.%2BJ.%26aulast%3DLevengood%26aufirst%3DS.%2BK.%2BL.%26aulast%3DChecco%26aufirst%3DJ.%2BW.%26aulast%3DMurphy%26aufirst%3DW.%2BL.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DExtending%2520foldamer%2520design%2520beyond%2520alpha-helix%2520mimicry%253A%2520alpha%252Fbeta-peptide%2520inhibitors%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D18%26spage%3D7652%26epage%3D7655%26doi%3D10.1021%2Fja302469a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Neer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaud, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchetta, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaich, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reginster, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodsman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ish-Shalom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genant, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitlak, B. H.</span><span> </span><span class="NLM_article-title">Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">1434</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span><span class="refDoi"> DOI: 10.1056/NEJM200105103441904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1056%2FNEJM200105103441904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=11346808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1434-1441&issue=19&author=R.+M.+Neerauthor=C.+D.+Arnaudauthor=J.+R.+Zanchettaauthor=R.+Princeauthor=G.+A.+Gaichauthor=J.+Y.+Reginsterauthor=A.+B.+Hodsmanauthor=E.+F.+Eriksenauthor=S.+Ish-Shalomauthor=H.+K.+Genantauthor=O.+H.+Wangauthor=B.+H.+Mitlak&title=Effect+of+parathyroid+hormone+%281%E2%80%9334%29+on+fractures+and+bone+mineral+density+in+postmenopausal+women+with+osteoporosis&doi=10.1056%2FNEJM200105103441904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis</span></div><div class="casAuthors">Neer, Robert M.; Arnaud, Claude D.; Zanchetta, Jose R.; Prince, Richard; Gaich, Gregory A.; Reginster, Jean-Yves; Hodsman, Anthony B.; Eriksen, Erik F.; Ish-Shalom, Sophia; Genant, Harry K.; Wang, Ouhong; Mitlak, Bruce H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1434-1441</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Once-daily injections of parathyroid hormone or its N-terminal fragments increase bone formation and bone mass without causing hypercalcemia, but their effects on fractures are unknown.  Methods: The authors randomly assigned 1637 postmenopausal women with prior vertebral fractures to receive 20 or 40 μg of parathyroid hormone (1-34) or placebo, administered s.c. by the women daily.  The authors obtained vertebral radiographs at base line and at the end of the study (median duration of observation, 21 mo) and performed serial measurements of bone mass by dual-energy x-ray absorptiometry.  Results: New vertebral fractures occurred in 14 % of the women in the placebo group and in 5 % and 4 %, resp., of the women in the 20-μg and 40-μg parathyroid hormone groups; the resp. relative risks of fracture in the 20-μg and 40-μg groups, as compared with the placebo group, were 0.35 and 0.31 (95 % confidence intervals, 0.22 to 0.55 and 0.19 to 0.50).  New nonvertebral fragility fractures occurred in 6 % of the women in the placebo group and in 3 % of those in each parathyroid hormone group (relative risk, 0.47 and 0.46, resp. [95 % confidence intervals, 0.25 to 0.88 and 0.25 to 0.86]).  As compared with placebo, the 20-μg and 40-μg doses of parathyroid hormone increased bone mineral d. by 9 and 13 more percentage points in the lumbar spine and by 3 and 6 more percentage points in the femoral neck; the 40-μg dose decreased bone mineral d. at the shaft of the radius by 2 more percentage points.  Both doses increased total-body bone mineral by 2 to 4 more percentage points than did placebo.  Parathyroid hormone had only minor side effects (occasional nausea and headache).  Conclusions: Treatment of postmenopausal osteoporosis with parathyroid hormone (1-34) decreases the risk of vertebral and nonvertebral fractures; increases vertebral, femoral, and total-body bone mineral d.; and is well tolerated.  The 40-μg dose increased bone mineral d. more than the 20-μg dose but had similar effects on the risk of fracture and was more likely to have side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKXlDv2ykMk7Vg90H21EOLACvtfcHk0lhA84nZSOb8tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSgsbw%253D&md5=214d564b481429eb4fd0a8bc6213f288</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJM200105103441904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200105103441904%26sid%3Dliteratum%253Aachs%26aulast%3DNeer%26aufirst%3DR.%2BM.%26aulast%3DArnaud%26aufirst%3DC.%2BD.%26aulast%3DZanchetta%26aufirst%3DJ.%2BR.%26aulast%3DPrince%26aufirst%3DR.%26aulast%3DGaich%26aufirst%3DG.%2BA.%26aulast%3DReginster%26aufirst%3DJ.%2BY.%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DIsh-Shalom%26aufirst%3DS.%26aulast%3DGenant%26aufirst%3DH.%2BK.%26aulast%3DWang%26aufirst%3DO.%2BH.%26aulast%3DMitlak%26aufirst%3DB.%2BH.%26atitle%3DEffect%2520of%2520parathyroid%2520hormone%2520%25281%25E2%2580%259334%2529%2520on%2520fractures%2520and%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26issue%3D19%26spage%3D1434%26epage%3D1441%26doi%3D10.1056%2FNEJM200105103441904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggatt, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, N. C.</span><span> </span><span class="NLM_article-title">Parathyroid hormone: a double-edged sword for bone metabolism</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.tem.2004.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.tem.2004.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=15036251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsV2rs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=60-65&issue=2&author=L.+Qinauthor=L.+J.+Raggattauthor=N.+C.+Partridge&title=Parathyroid+hormone%3A+a+double-edged+sword+for+bone+metabolism&doi=10.1016%2Fj.tem.2004.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone: a double-edged sword for bone metabolism</span></div><div class="casAuthors">Qin, Ling; Raggatt, Liza J.; Partridge, Nicola C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">60-65</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone (PTH) is the major hormone regulating calcium metab.  It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily.  However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects.  Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing no. of mol. and cellular mechanisms underlying these effects have emerged.  Here, the authors outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtx-54dxdIbVg90H21EOLACvtfcHk0lgFUYK9RQ7U3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsV2rs7w%253D&md5=c431d0dd0bdf62e9bf2dd846db1e4b64</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2004.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2004.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DRaggatt%26aufirst%3DL.%2BJ.%26aulast%3DPartridge%26aufirst%3DN.%2BC.%26atitle%3DParathyroid%2520hormone%253A%2520a%2520double-edged%2520sword%2520for%2520bone%2520metabolism%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2004%26volume%3D15%26issue%3D2%26spage%3D60%26epage%3D65%26doi%3D10.1016%2Fj.tem.2004.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Cheloha, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">PTH receptor-1 signalling--mechanistic insights and therapeutic prospects</span> <span class="citation_source-journal">Nat. Rev. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span><span class="refDoi"> DOI: 10.1038/nrendo.2015.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnrendo.2015.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26303600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVartb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=712-724&author=R.+W.+Chelohaauthor=S.+H.+Gellmanauthor=J.-P.+Vilardagaauthor=T.+J.+Gardella&title=PTH+receptor-1+signalling%2D%2Dmechanistic+insights+and+therapeutic+prospects&doi=10.1038%2Fnrendo.2015.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">PTH receptor-1 signalling-mechanistic insights and therapeutic prospects</span></div><div class="casAuthors">Cheloha, Ross W.; Gellman, Samuel H.; Vilardaga, Jean-Pierre; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">712-724</span>CODEN:
                <span class="NLM_cas:coden">NREABD</span>;
        ISSN:<span class="NLM_cas:issn">1759-5029</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Parathyroid hormone/parathyroid hormone-related protein receptor (PTH/PTHrP type 1 receptor; commonly known as PTHR1) is a family B G-protein-coupled receptor (GPCR) that regulates skeletal development, bone turnover and mineral ion homeostasis.  PTHR1 transduces stimuli from PTH and PTHrP into the interior of target cells to promote diverse biochem. responses.  Evaluation of the signalling properties of structurally modified PTHR1 ligands has helped to elucidate determinants of receptor function and mechanisms of downstream cellular and physiol. responses.  Anal. of PTHR1 responses induced by structurally modified ligands suggests that PTHR1 can continue to signal through a G-protein-mediated pathway within endosomes.  Such findings challenge the longstanding paradigm in GPCR biol. that the receptor is transiently activated at the cell membrane, followed by rapid deactivation and receptor internalization.  Evaluation of structurally modified PTHR1 ligands has further led to the identification of ligand analogs that differ from PTH or PTHrP in the type, strength and duration of responses induced at the receptor, cellular and organism levels.  These modified ligands, and the biochem. principles revealed through their use, might facilitate an improved understanding of PTHR1 function in vivo and enable the treatment of disorders resulting from defects in PTHR1 signalling.  This Review discusses current understanding of PTHR1 modes of action and how these findings might be applied in future therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6fH4WKMgL0bVg90H21EOLACvtfcHk0lgFUYK9RQ7U3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVartb%252FN&md5=963fc35b7ad4c26e6ed46740e3ea3fd5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrendo.2015.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrendo.2015.139%26sid%3Dliteratum%253Aachs%26aulast%3DCheloha%26aufirst%3DR.%2BW.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DVilardaga%26aufirst%3DJ.-P.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DPTH%2520receptor-1%2520signalling--mechanistic%2520insights%2520and%2520therapeutic%2520prospects%26jtitle%3DNat.%2520Rev.%2520Endocrinol.%26date%3D2015%26volume%3D11%26spage%3D712%26epage%3D724%26doi%3D10.1038%2Fnrendo.2015.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J.-P.</span><span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors-family B G protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1124/pr.114.009464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1124%2Fpr.114.009464" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=310-337&issue=2&author=T.+J.+Gardellaauthor=J.-P.+Vilardaga&title=International+Union+of+Basic+and+Clinical+Pharmacology.+XCIII.+The+parathyroid+hormone+receptors-family+B+G+protein-coupled+receptors&doi=10.1124%2Fpr.114.009464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009464%26sid%3Dliteratum%253Aachs%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.-P.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520XCIII.%2520The%2520parathyroid%2520hormone%2520receptors-family%2520B%2520G%2520protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26issue%3D2%26spage%3D310%26epage%3D337%26doi%3D10.1124%2Fpr.114.009464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Insights into the structure of class B GPCRs</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.tips.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24359917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyksLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=12-22&issue=1&author=K.+Hollensteinauthor=C.+de+Graafauthor=A.+Bortolatoauthor=M.+W.+Wangauthor=F.+H.+Marshallauthor=R.+C.+Stevens&title=Insights+into+the+structure+of+class+B+GPCRs&doi=10.1016%2Fj.tips.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the structure of class B GPCRs</span></div><div class="casAuthors">Hollenstein, Kaspar; de Graaf, Chris; Bortolato, Andrea; Wang, Ming-Wei; Marshall, Fiona H.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-22</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The secretin-like (class B) family of G protein-coupled receptors (GPCRs) are key players in hormonal homeostasis and are interesting drug targets for the treatment of several metabolic disorders (such as type 2 diabetes, osteoporosis, and obesity) and nervous system diseases (such as migraine, anxiety, and depression).  The recently solved crystal structures of the transmembrane domains of the human glucagon receptor and human corticotropin-releasing factor receptor 1 have opened up new opportunities to study the structure and function of class B GPCRs.  The current review shows how these structures offer more detailed explanations to previous biochem. and pharmacol. studies of class B GPCRs, and provides new insights into their interactions with ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIUYDGGnHDArVg90H21EOLACvtfcHk0lj_P5mN5tknNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyksLjK&md5=c35d188eafbd5e26dddf7f4a12505de3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DM.%2BW.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DInsights%2520into%2520the%2520structure%2520of%2520class%2520B%2520GPCRs%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26issue%3D1%26spage%3D12%26epage%3D22%26doi%3D10.1016%2Fj.tips.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Structure of Class B GPCRs: new horizons for drug discovery</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3145</span><span class="refDoi"> DOI: 10.1111/bph.12689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1111%2Fbph.12689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=24628305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3132-3145&issue=13&author=A.+Bortolatoauthor=A.+S.+Doreauthor=K.+Hollensteinauthor=B.+G.+Tehanauthor=J.+S.+Masonauthor=F.+H.+Marshall&title=Structure+of+Class+B+GPCRs%3A+new+horizons+for+drug+discovery&doi=10.1111%2Fbph.12689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Class B GPCRs: new horizons for drug discovery</span></div><div class="casAuthors">Bortolato, Andrea; Dore, Andrew S.; Hollenstein, Kaspar; Tehan, Benjamin G.; Mason, Jonathan S.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3132-3145</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Class B GPCRs of the secretin family are important drug targets in many human diseases including diabetes, neurodegeneration, cardiovascular disease and psychiatric disorders.  X-ray crystal structures for the glucagon receptor and corticotropin-releasing factor receptor 1 have now been published.  In this review, we analyze the new structures and how they compare with each other and with Class A and F receptors.  We also consider the differences in druggability and possible similarity in the activation mechanisms.  Finally, we discuss the potential for the design of small-mol. modulators for these important targets in drug discovery.  This new structural insight allows, for the first time, structure-based drug design methods to be applied to Class B GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprqe_GGLyHcbVg90H21EOLACvtfcHk0lj_P5mN5tknNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKrtr0%253D&md5=3e08525e9309b28bc3a7a268fd83067e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fbph.12689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12689%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DTehan%26aufirst%3DB.%2BG.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DStructure%2520of%2520Class%2520B%2520GPCRs%253A%2520new%2520horizons%2520for%2520drug%2520discovery%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D13%26spage%3D3132%26epage%3D3145%26doi%3D10.1111%2Fbph.12689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">52</span><span class="NLM_x">) </span> <span class="NLM_fpage">49003</span><span class="NLM_x">–</span> <span class="NLM_lpage">49012</span><span class="refDoi"> DOI: 10.1074/jbc.M106827200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M106827200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=49003-49012&issue=52&author=N.+Shimizuauthor=J.+Guoauthor=T.+J.+Gardella&title=Parathyroid+hormone+%28PTH%29-%281-14%29+and+-%281-11%29+analogs+conformationally+constrained+by+alpha-aminoisobutyric+acid+mediate+full+agonist+responses+via+the+juxtamembrane+region+of+the+PTH-1+receptor&doi=10.1074%2Fjbc.M106827200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106827200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106827200%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DParathyroid%2520hormone%2520%2528PTH%2529-%25281-14%2529%2520and%2520-%25281-11%2529%2520analogs%2520conformationally%2520constrained%2520by%2520alpha-aminoisobutyric%2520acid%2520mediate%2520full%2520agonist%2520responses%2520via%2520the%2520juxtamembrane%2520region%2520of%2520the%2520PTH-1%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D52%26spage%3D49003%26epage%3D49012%26doi%3D10.1074%2Fjbc.M106827200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Caporale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schievano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittelsberger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, E.</span><span> </span><span class="NLM_article-title">Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">611</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.ejphar.2009.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19303868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Oluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=611&publication_year=2009&pages=1-7&issue=1%E2%80%933&author=A.+Caporaleauthor=B.+Biondiauthor=E.+Schievanoauthor=A.+Wittelsbergerauthor=S.+Mammiauthor=E.+Peggion&title=Structure-function+relationship+studies+of+PTH%281-11%29+analogues+containing+D-amino+acids&doi=10.1016%2Fj.ejphar.2009.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids</span></div><div class="casAuthors">Caporale, Andrea; Biondi, Barbara; Schievano, Elisabetta; Wittelsberger, Angela; Mammi, Stefano; Peggion, Evaristo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">611</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parathyroid hormone (PTH) is an 84-amino acid peptide hormone.  Produced in the parathyroid glands, it acts primarily on bone and kidney to maintain extracellular calcium levels within normal limits.  It has been shown that the 1-34 amino acid fragment of PTH is sufficient to bind and activate the PTH type-I receptor.  Recent investigations focusing on the interaction of N-terminal fragments of PTH with PTH type-I receptor showed that certain modifications can increase signaling potency in peptides as short as 11 amino acids.  To understand the role of the side chains of all the amino acid residues in PTH(1-11), we synthesized all- PTH, three retro-inverso analogs of the most active modified PTH(1-11), H-Aib-Val-Aib-Glu-Ile-Gln-Leu-Nle-His-Gln-Har-NH2, and we substituted every -AA of the latter with the corresponding -AA, obtaining a library of PTH(1-11) analogs that were tested as agonists.  The library was synthesized by SPPS, employing the Fmoc protocol.  The biol. tests showed that the activity of the -Har11 analog is of the same order of magnitude of that of the most active modified PTH(1-11).  This behavior is paralleled by an increase of the helical content on going from the -Val2 to the -Har11 analog.  This is in agreement with previous work where a correlation between activity and helical content has been demonstrated.  The importance of a pos. charged group in the C-terminal position is shown to be independent of the configuration of the Cα-carbon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqOjkNCNQVjbVg90H21EOLACvtfcHk0ljTKY1wj59OfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Oluro%253D&md5=378ff5e06f4cd39881452093311b9ead</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DCaporale%26aufirst%3DA.%26aulast%3DBiondi%26aufirst%3DB.%26aulast%3DSchievano%26aufirst%3DE.%26aulast%3DWittelsberger%26aufirst%3DA.%26aulast%3DMammi%26aufirst%3DS.%26aulast%3DPeggion%26aufirst%3DE.%26atitle%3DStructure-function%2520relationship%2520studies%2520of%2520PTH%25281-11%2529%2520analogues%2520containing%2520D-amino%2520acids%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D611%26issue%3D1%25E2%2580%25933%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.ejphar.2009.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Peterson-Kaufman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haase, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Residue-based preorganization of BH3-derived alpha/beta-peptides: modulating affinity, selectivity and proteolytic susceptibility in alpha-helix mimics</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1675</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00109</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00109" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1667-1675&issue=7&author=K.+J.+Peterson-Kaufmanauthor=H.+S.+Haaseauthor=M.+D.+Boersmaauthor=E.+F.+Leeauthor=W.+D.+Fairlieauthor=S.+H.+Gellman&title=Residue-based+preorganization+of+BH3-derived+alpha%2Fbeta-peptides%3A+modulating+affinity%2C+selectivity+and+proteolytic+susceptibility+in+alpha-helix+mimics&doi=10.1021%2Facschembio.5b00109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00109%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson-Kaufman%26aufirst%3DK.%2BJ.%26aulast%3DHaase%26aufirst%3DH.%2BS.%26aulast%3DBoersma%26aufirst%3DM.%2BD.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DResidue-based%2520preorganization%2520of%2520BH3-derived%2520alpha%252Fbeta-peptides%253A%2520modulating%2520affinity%252C%2520selectivity%2520and%2520proteolytic%2520susceptibility%2520in%2520alpha-helix%2520mimics%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D7%26spage%3D1667%26epage%3D1675%26doi%3D10.1021%2Facschembio.5b00109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Interplay among side chain sequence, backbone composition, and residue rigidification in polypeptide folding and assembly</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">27</span><span class="NLM_x">) </span> <span class="NLM_fpage">9151</span><span class="NLM_x">–</span> <span class="NLM_lpage">9156</span><span class="refDoi"> DOI: 10.1073/pnas.0801135105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0801135105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9151-9156&issue=27&author=W.+S.+Horneauthor=J.+L.+Priceauthor=S.+H.+Gellman&title=Interplay+among+side+chain+sequence%2C+backbone+composition%2C+and+residue+rigidification+in+polypeptide+folding+and+assembly&doi=10.1073%2Fpnas.0801135105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0801135105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0801135105%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DInterplay%2520among%2520side%2520chain%2520sequence%252C%2520backbone%2520composition%252C%2520and%2520residue%2520rigidification%2520in%2520polypeptide%2520folding%2520and%2520assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D27%26spage%3D9151%26epage%3D9156%26doi%3D10.1073%2Fpnas.0801135105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Johnson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortenson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">Enhancement of alpha-helix mimicry by an alpha/beta-peptide foldamer via incorporation of a dense ionic side-chain array</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">7317</span><span class="NLM_x">–</span> <span class="NLM_lpage">7320</span><span class="refDoi"> DOI: 10.1021/ja302428d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302428d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=7317-7320&issue=17&author=L.+M.+Johnsonauthor=D.+E.+Mortensonauthor=H.+G.+Yunauthor=W.+S.+Horneauthor=T.+J.+Ketasauthor=M.+Luauthor=J.+P.+Mooreauthor=S.+H.+Gellman&title=Enhancement+of+alpha-helix+mimicry+by+an+alpha%2Fbeta-peptide+foldamer+via+incorporation+of+a+dense+ionic+side-chain+array&doi=10.1021%2Fja302428d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja302428d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302428d%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BM.%26aulast%3DMortenson%26aufirst%3DD.%2BE.%26aulast%3DYun%26aufirst%3DH.%2BG.%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DEnhancement%2520of%2520alpha-helix%2520mimicry%2520by%2520an%2520alpha%252Fbeta-peptide%2520foldamer%2520via%2520incorporation%2520of%2520a%2520dense%2520ionic%2520side-chain%2520array%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D17%26spage%3D7317%26epage%3D7320%26doi%3D10.1021%2Fja302428d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Werner, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabalteja, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, W. S.</span><span> </span><span class="NLM_article-title">Peptide backbone composition and protease susceptibility: impact of modification type, position, and tandem substitution</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1002/cbic.201500312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fcbic.201500312" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=712-718&issue=8&author=H.+M.+Wernerauthor=C.+C.+Cabaltejaauthor=W.+S.+Horne&title=Peptide+backbone+composition+and+protease+susceptibility%3A+impact+of+modification+type%2C+position%2C+and+tandem+substitution&doi=10.1002%2Fcbic.201500312"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201500312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201500312%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DH.%2BM.%26aulast%3DCabalteja%26aufirst%3DC.%2BC.%26aulast%3DHorne%26aufirst%3DW.%2BS.%26atitle%3DPeptide%2520backbone%2520composition%2520and%2520protease%2520susceptibility%253A%2520impact%2520of%2520modification%2520type%252C%2520position%252C%2520and%2520tandem%2520substitution%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26issue%3D8%26spage%3D712%26epage%3D718%26doi%3D10.1002%2Fcbic.201500312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Karsdal, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riis, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, K.</span><span> </span><span class="NLM_article-title">Lessons learned from the clinical development of oral peptides</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span><span class="refDoi"> DOI: 10.1111/bcp.12557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1111%2Fbcp.12557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25408230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2015&pages=720-732&issue=5&author=M.+A.+Karsdalauthor=B.+J.+Riisauthor=N.+Mehtaauthor=W.+Sternauthor=E.+Arbitauthor=C.+Christiansenauthor=K.+Henriksen&title=Lessons+learned+from+the+clinical+development+of+oral+peptides&doi=10.1111%2Fbcp.12557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the clinical development of oral peptides</span></div><div class="casAuthors">Karsdal, Morten Asser; Riis, Bente Juul; Mehta, Nozer; Stern, William; Arbit, Ehud; Christiansen, Claus; Henriksen, Kim</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">720-732</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The oral delivery of peptides and proteins has been hampered by an array of obstacles.  However, several promising novel oral delivery systems have been developed.  This paper reviews the most advanced oral formulation technologies, and highlights key lessons and implications from studies undertaken to date with these oral formulations.  Special interest is given to oral salmon calcitonin (CT), glucagon-like peptide-1 (GLP-1), insulin, PYY-(3-36), recombinant human parathyroid hormone (rhPTH(1-31)-NH2) and PTH(1-34), by different technologies.  The issues addressed include (i) interaction with water, (ii) interaction with food, (iii) diurnal variation, (iv) inter- and intra-subject variability, (v) correlation between efficacy and exposure and (vi) key deliverables of different technologies.  These key lessons may aid research in the development of other oral formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBun32dB2rgrVg90H21EOLACvtfcHk0liI-TrI_qdkzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOnu7Y%253D&md5=0f636db3549478f73bbc4ecb958e385d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12557%26sid%3Dliteratum%253Aachs%26aulast%3DKarsdal%26aufirst%3DM.%2BA.%26aulast%3DRiis%26aufirst%3DB.%2BJ.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DStern%26aufirst%3DW.%26aulast%3DArbit%26aufirst%3DE.%26aulast%3DChristiansen%26aufirst%3DC.%26aulast%3DHenriksen%26aufirst%3DK.%26atitle%3DLessons%2520learned%2520from%2520the%2520clinical%2520development%2520of%2520oral%2520peptides%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D79%26issue%3D5%26spage%3D720%26epage%3D732%26doi%3D10.1111%2Fbcp.12557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Smart, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basit, A. W.</span><span> </span><span class="NLM_article-title">Oral peptide and protein delivery: intestinal obstacles and commercial prospects</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1323</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span><span class="refDoi"> DOI: 10.1517/17425247.2014.917077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1517%2F17425247.2014.917077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=1323-1335&issue=8&author=A.+L.+Smartauthor=S.+Gaisfordauthor=A.+W.+Basit&title=Oral+peptide+and+protein+delivery%3A+intestinal+obstacles+and+commercial+prospects&doi=10.1517%2F17425247.2014.917077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1517%2F17425247.2014.917077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2014.917077%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DA.%2BL.%26aulast%3DGaisford%26aufirst%3DS.%26aulast%3DBasit%26aufirst%3DA.%2BW.%26atitle%3DOral%2520peptide%2520and%2520protein%2520delivery%253A%2520intestinal%2520obstacles%2520and%2520commercial%2520prospects%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2014%26volume%3D11%26issue%3D8%26spage%3D1323%26epage%3D1335%26doi%3D10.1517%2F17425247.2014.917077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Henriksen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riis, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkol, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandersen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrjalsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedergaard, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglbjaerg, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsdal, M. A.</span><span> </span><span class="NLM_article-title">Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone rhPTH(1-31)NH2 in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1016/j.bone.2012.11.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.bone.2012.11.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=160-166&issue=1&author=K.+Henriksenauthor=J.+R.+Andersenauthor=B.+J.+Riisauthor=N.+Mehtaauthor=R.+Tavakkolauthor=P.+Alexandersenauthor=I.+Byrjalsenauthor=I.+Valterauthor=B.+S.+Nedergaardauthor=C.+S.+Teglbjaergauthor=W.+Sternauthor=A.+Sturmerauthor=S.+Mittaauthor=A.+J.+Ninoauthor=L.+A.+Fitzpatrickauthor=C.+Christiansenauthor=M.+A.+Karsdal&title=Evaluation+of+the+efficacy%2C+safety+and+pharmacokinetic+profile+of+oral+recombinant+human+parathyroid+hormone+rhPTH%281-31%29NH2+in+postmenopausal+women+with+osteoporosis&doi=10.1016%2Fj.bone.2012.11.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2012.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2012.11.045%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DK.%26aulast%3DAndersen%26aufirst%3DJ.%2BR.%26aulast%3DRiis%26aufirst%3DB.%2BJ.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DTavakkol%26aufirst%3DR.%26aulast%3DAlexandersen%26aufirst%3DP.%26aulast%3DByrjalsen%26aufirst%3DI.%26aulast%3DValter%26aufirst%3DI.%26aulast%3DNedergaard%26aufirst%3DB.%2BS.%26aulast%3DTeglbjaerg%26aufirst%3DC.%2BS.%26aulast%3DStern%26aufirst%3DW.%26aulast%3DSturmer%26aufirst%3DA.%26aulast%3DMitta%26aufirst%3DS.%26aulast%3DNino%26aufirst%3DA.%2BJ.%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26aulast%3DChristiansen%26aufirst%3DC.%26aulast%3DKarsdal%26aufirst%3DM.%2BA.%26atitle%3DEvaluation%2520of%2520the%2520efficacy%252C%2520safety%2520and%2520pharmacokinetic%2520profile%2520of%2520oral%2520recombinant%2520human%2520parathyroid%2520hormone%2520rhPTH%25281-31%2529NH2%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DBone%26date%3D2013%26volume%3D53%26issue%3D1%26spage%3D160%26epage%3D166%26doi%3D10.1016%2Fj.bone.2012.11.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">DiBonaventura, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodovicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentakota, S.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radican, L.</span><span> </span><span class="NLM_article-title">Multinational internet-based survey of patient preference for newer oral or injectable type 2 diabetes medication</span> <span class="citation_source-journal">Patient Prefer. Adherence</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.2147/PPA.S14477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.2147%2FPPA.S14477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=21206515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FovFyqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=397-406&author=M.+D.+DiBonaventuraauthor=J.+S.+Wagnerauthor=C.+J.+Girmanauthor=K.+Brodoviczauthor=Q.+Y.+Zhangauthor=Y.+Qiuauthor=S.-R.+Pentakotaauthor=L.+Radican&title=Multinational+internet-based+survey+of+patient+preference+for+newer+oral+or+injectable+type+2+diabetes+medication&doi=10.2147%2FPPA.S14477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication</span></div><div class="casAuthors">Dibonaventura Marco Dacosta; Wagner Jan-Samuel; Girman Cynthia J; Brodovicz Kimberly; Zhang Qiaoyi; Qiu Ying; Pentakota Sri-Ram; Radican Larry</div><div class="citationInfo"><span class="NLM_cas:title">Patient preference and adherence</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">397-406</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The prevalence of Type 2 diabetes mellitus continues to rise.  Although glucagon-like peptide-1 (GLP-1) analog and dipeptidyl peptidase-4 (DPP-4) inhibitor medications are effective, there are differences between these products, including method of administration (injectable versus oral).  The objective of this study was to examine patient preferences (and predictors of preferences) for two different medication profiles, one similar to a GLP-1 analog (liraglutide) and another similar to a DPP-4 inhibitor (sitagliptin).  METHODS:  Internet survey data were collected in two waves (wave 1, n = 2402; wave 2, n = 1340) using patients from the US and Europe.  Patients were presented with two hypothetical medication profiles ("drug A" and "drug B", resembling sitagliptin and liraglutide, respectively) and asked to report their preferences.  RESULTS:  Most patients in wave 1 and wave 2 reported that overall they would prefer a drug with the sitagliptin-like profile (81.9% and 84.4%, respectively) over a drug with the liraglutide-like profile (18.1% and 15.6%, respectively), and >80% of patients reported that they would be able to take a drug with the sitagliptin-like profile as directed by their physician for a longer period.  The likelihood of preferring the sitagliptin-like profile significantly increased as age (odds ratio [OR] = 1.02) and importance placed on method of administration (OR = 1.32) increased (P < 0.05).  Although the sitagliptin-like profile was preferred by the majority of patients in all subgroups, a lower proportion of patients with obesity, with weight gain, with A1C values above target, and who exercised preferred the sitagliptin-like profile compared with those without obesity (77.0% versus 87.9%), without weight gain (77.8% versus 86.7%), with A1C values at or below target (79.0% versus 86.5%), and who did not exercise (81.6% versus 86.4%), respectively (P < 0.05).  CONCLUSIONS:  This research suggests that patients (across geographies) prefer an oral medication with a profile resembling sitagliptin to an injectable medication with a profile resembling liraglutide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWeeUnfSbuqpPq5LRczm8ffW6udTcc2eaoc9wzMyGZubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FovFyqsw%253D%253D&md5=7a066686bbe18e69b3facadbb2d65759</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2147%2FPPA.S14477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FPPA.S14477%26sid%3Dliteratum%253Aachs%26aulast%3DDiBonaventura%26aufirst%3DM.%2BD.%26aulast%3DWagner%26aufirst%3DJ.%2BS.%26aulast%3DGirman%26aufirst%3DC.%2BJ.%26aulast%3DBrodovicz%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DPentakota%26aufirst%3DS.-R.%26aulast%3DRadican%26aufirst%3DL.%26atitle%3DMultinational%2520internet-based%2520survey%2520of%2520patient%2520preference%2520for%2520newer%2520oral%2520or%2520injectable%2520type%25202%2520diabetes%2520medication%26jtitle%3DPatient%2520Prefer.%2520Adherence%26date%3D2010%26volume%3D4%26spage%3D397%26epage%3D406%26doi%3D10.2147%2FPPA.S14477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fallowfield, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langridge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, M.</span><span> </span><span class="NLM_article-title">Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1093/annonc/mdj044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1093%2Fannonc%2Fmdj044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=16239231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FjvVGmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=205-210&issue=2&author=L.+Fallowfieldauthor=L.+Atkinsauthor=S.+Cattauthor=A.+Coxauthor=C.+Coxonauthor=C.+Langridgeauthor=R.+Morrisauthor=M.+Price&title=Patients%E2%80%99+preference+for+administration+of+endocrine+treatments+by+injection+or+tablets%3A+results+from+a+study+of+women+with+breast+cancer&doi=10.1093%2Fannonc%2Fmdj044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer</span></div><div class="casAuthors">Fallowfield L; Atkins L; Catt S; Cox A; Coxon C; Langridge C; Morris R; Price M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-10</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">BACKGROUND:  Endocrine therapies for advanced breast cancer include tablets and intramuscular injections.  When treatments have similar efficacy and tolerability profiles, addressing preferences about routes of administration is important.  PATIENTS AND METHODS:  Two hundred and eight women>2 years post-breast cancer diagnosis were interviewed about their preferences for daily tablets or monthly intramuscular injections.  Health-care professionals treating the women estimated patients' preferences.  RESULTS:  Sixty-three per cent of patients preferred tablets, 24.5% preferred the injection and 12.5% had no preference.  The most cited reasons for tablet preference were convenience and dislike of needles; for injection preference, adherence and convenience.  Variables associated with preferences were body mass index, educational level, attitudes towards injections and efficacy perceptions.  Estimates about patients' preferences by health-care professionals varied widely.  When asked to imagine scenarios where injections produced fewer hot flushes, or where two injections monthly improved efficacy, injection preference increased to 60.6% and 74.5%, respectively.  Disturbingly, approximately 50% of patients admitted they sometimes forgot or chose not to take their current oral medication.  CONCLUSIONS:  The majority of breast cancer patients preferred hormone therapy via daily tablets rather than monthly injections.  Information about side-effects or improved efficacy altered these preferences.  Adherence to treatment cannot be assumed; patients' preferences about drug administration may influence this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThMrYbu676lRwLZxei1HN8fW6udTcc2eb4uNszVZv5X7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FjvVGmtw%253D%253D&md5=f9364cd9c72101236a6c32f0612b2132</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdj044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdj044%26sid%3Dliteratum%253Aachs%26aulast%3DFallowfield%26aufirst%3DL.%26aulast%3DAtkins%26aufirst%3DL.%26aulast%3DCatt%26aufirst%3DS.%26aulast%3DCox%26aufirst%3DA.%26aulast%3DCoxon%26aufirst%3DC.%26aulast%3DLangridge%26aufirst%3DC.%26aulast%3DMorris%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DM.%26atitle%3DPatients%25E2%2580%2599%2520preference%2520for%2520administration%2520of%2520endocrine%2520treatments%2520by%2520injection%2520or%2520tablets%253A%2520results%2520from%2520a%2520study%2520of%2520women%2520with%2520breast%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2006%26volume%3D17%26issue%3D2%26spage%3D205%26epage%3D210%26doi%3D10.1093%2Fannonc%2Fmdj044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajiri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basit, A. W.</span><span> </span><span class="NLM_article-title">Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span><span class="refDoi"> DOI: 10.1021/mp500809f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500809f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=966-973&issue=3&author=J.+Wangauthor=V.+Yadavauthor=A.+L.+Smartauthor=S.+Tajiriauthor=A.+W.+Basit&title=Toward+oral+delivery+of+biopharmaceuticals%3A+an+assessment+of+the+gastrointestinal+stability+of+17+peptide+drugs&doi=10.1021%2Fmp500809f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Toward Oral Delivery of Biopharmaceuticals: An Assessment of the Gastrointestinal Stability of 17 Peptide Drugs</span></div><div class="casAuthors">Wang, Jie; Yadav, Vipul; Smart, Alice L.; Tajiri, Shinichiro; Basit, Abdul W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">966-973</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major barrier to successful oral delivery of peptide and protein mols. is their inherent instability in the lumen of the gastrointestinal tract.  The aim of this study was to det. the stability of 17 disparate peptide drugs (insulin, calcitonin, glucagon, secretin, somatostatin, desmopressin, oxytocin, [Arg8]-vasopressin, octreotide, ciclosporin, leuprolide, nafarelin, buserelin, histrelin, [D-Ser]4-gonadorelin, deslorelin, and goserelin) in gastric and small intestinal fluids from both humans and pigs, and in simulated gastric and intestinal fluids.  In human gastric fluid, the larger peptides including somatostatin, calcitonin, secretin, glucagon, and insulin were metabolized rapidly, while the smaller peptides showed good stability.  In human small intestinal fluid, however, both small and large peptides degraded rapidly with the exception of the cyclic peptide ciclosporin and the disulfide-bridge contg. peptides octreotide and desmopressin, which showed good stability.  The stability of peptides in both simulated gastric fluid and pig gastric fluid correlated well with stability in human gastric fluid.  However, it was not possible to establish such a correlation with the small intestinal fluids because of the rapid rate of peptide degrdn.  This work has identified the mol. features in the structure of a wide range of peptides that influence their stability in the environment of the gastrointestinal tract, which in turn will allow for better selection of peptide candidates for oral delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraciXJLe-z4rVg90H21EOLACvtfcHk0lhpoBu2hlhCJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyqsb8%253D&md5=a29abd913a44604892e879e735818ff9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fmp500809f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500809f%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYadav%26aufirst%3DV.%26aulast%3DSmart%26aufirst%3DA.%2BL.%26aulast%3DTajiri%26aufirst%3DS.%26aulast%3DBasit%26aufirst%3DA.%2BW.%26atitle%3DToward%2520oral%2520delivery%2520of%2520biopharmaceuticals%253A%2520an%2520assessment%2520of%2520the%2520gastrointestinal%2520stability%2520of%252017%2520peptide%2520drugs%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26issue%3D3%26spage%3D966%26epage%3D973%26doi%3D10.1021%2Fmp500809f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Pawar, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meher, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaurasia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chourasia, M. K.</span><span> </span><span class="NLM_article-title">Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: Strategies and industrial perspectives</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2014.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.jconrel.2014.09.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2014&pages=168-183&author=V.+K.+Pawarauthor=J.+G.+Meherauthor=Y.+Singhauthor=M.+Chaurasiaauthor=B.+S.+Reddyauthor=M.+K.+Chourasia&title=Targeting+of+gastrointestinal+tract+for+amended+delivery+of+protein%2Fpeptide+therapeutics%3A+Strategies+and+industrial+perspectives&doi=10.1016%2Fj.jconrel.2014.09.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DPawar%26aufirst%3DV.%2BK.%26aulast%3DMeher%26aufirst%3DJ.%2BG.%26aulast%3DSingh%26aufirst%3DY.%26aulast%3DChaurasia%26aufirst%3DM.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DChourasia%26aufirst%3DM.%2BK.%26atitle%3DTargeting%2520of%2520gastrointestinal%2520tract%2520for%2520amended%2520delivery%2520of%2520protein%252Fpeptide%2520therapeutics%253A%2520Strategies%2520and%2520industrial%2520perspectives%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2014%26volume%3D196%26spage%3D168%26epage%3D183%26doi%3D10.1016%2Fj.jconrel.2014.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Binkowski, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stecha, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggers, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidugiris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. V.</span><span> </span><span class="NLM_article-title">A luminescent biosensor with increased dynamic range for intracellular cAMP</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span><span class="refDoi"> DOI: 10.1021/cb200248h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200248h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1193-1197&issue=11&author=B.+F.+Binkowskiauthor=B.+L.+Butlerauthor=P.+F.+Stechaauthor=C.+T.+Eggersauthor=P.+Ottoauthor=K.+Zimmermanauthor=G.+Vidugirisauthor=M.+G.+Woodauthor=L.+P.+Encellauthor=F.+Fanauthor=K.+V.+Wood&title=A+luminescent+biosensor+with+increased+dynamic+range+for+intracellular+cAMP&doi=10.1021%2Fcb200248h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fcb200248h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200248h%26sid%3Dliteratum%253Aachs%26aulast%3DBinkowski%26aufirst%3DB.%2BF.%26aulast%3DButler%26aufirst%3DB.%2BL.%26aulast%3DStecha%26aufirst%3DP.%2BF.%26aulast%3DEggers%26aufirst%3DC.%2BT.%26aulast%3DOtto%26aufirst%3DP.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DVidugiris%26aufirst%3DG.%26aulast%3DWood%26aufirst%3DM.%2BG.%26aulast%3DEncell%26aufirst%3DL.%2BP.%26aulast%3DFan%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DA%2520luminescent%2520biosensor%2520with%2520increased%2520dynamic%2520range%2520for%2520intracellular%2520cAMP%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26issue%3D11%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fcb200248h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">LePlae, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">An efficient route to either enantiomer of trans-2-aminocyclopentanecarboxylic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5632</span><span class="refDoi"> DOI: 10.1021/jo010279h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010279h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=5629-5632&issue=16&author=P.+R.+LePlaeauthor=N.+Umezawaauthor=H.+S.+Leeauthor=S.+H.+Gellman&title=An+efficient+route+to+either+enantiomer+of+trans-2-aminocyclopentanecarboxylic+acid&doi=10.1021%2Fjo010279h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo010279h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010279h%26sid%3Dliteratum%253Aachs%26aulast%3DLePlae%26aufirst%3DP.%2BR.%26aulast%3DUmezawa%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAn%2520efficient%2520route%2520to%2520either%2520enantiomer%2520of%2520trans-2-aminocyclopentanecarboxylic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26issue%3D16%26spage%3D5629%26epage%3D5632%26doi%3D10.1021%2Fjo010279h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LePlae, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span> </span><span class="NLM_article-title">An efficient route to either enantiomer of orthogonally protected trans-3-aminopyrrolidine-4-carboxylic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3597</span><span class="NLM_x">–</span> <span class="NLM_lpage">3599</span><span class="refDoi"> DOI: 10.1021/jo001534l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo001534l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=3597-3599&issue=10&author=H.+S.+Leeauthor=P.+R.+LePlaeauthor=E.+A.+Porterauthor=S.+H.+Gellman&title=An+efficient+route+to+either+enantiomer+of+orthogonally+protected+trans-3-aminopyrrolidine-4-carboxylic+acid&doi=10.1021%2Fjo001534l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjo001534l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001534l%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DLePlae%26aufirst%3DP.%2BR.%26aulast%3DPorter%26aufirst%3DE.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAn%2520efficient%2520route%2520to%2520either%2520enantiomer%2520of%2520orthogonally%2520protected%2520trans-3-aminopyrrolidine-4-carboxylic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26issue%3D10%26spage%3D3597%26epage%3D3599%26doi%3D10.1021%2Fjo001534l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Lelais, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micuch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien-Lefebvre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seebach, D.</span><span> </span><span class="NLM_article-title">Preparation of protected beta(2)- and beta(3)-homocysteine, beta(2)- and beta(3)-homohistidine, and beta(2)-homoserine for solid-phase syntheses</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3131</span><span class="NLM_x">–</span> <span class="NLM_lpage">3159</span><span class="refDoi"> DOI: 10.1002/hlca.200490280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fhlca.200490280" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2004&pages=3131-3159&issue=12&author=G.+Lelaisauthor=P.+Micuchauthor=D.+Josien-Lefebvreauthor=F.+Rossiauthor=D.+Seebach&title=Preparation+of+protected+beta%282%29-+and+beta%283%29-homocysteine%2C+beta%282%29-+and+beta%283%29-homohistidine%2C+and+beta%282%29-homoserine+for+solid-phase+syntheses&doi=10.1002%2Fhlca.200490280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200490280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200490280%26sid%3Dliteratum%253Aachs%26aulast%3DLelais%26aufirst%3DG.%26aulast%3DMicuch%26aufirst%3DP.%26aulast%3DJosien-Lefebvre%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DSeebach%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520protected%2520beta%25282%2529-%2520and%2520beta%25283%2529-homocysteine%252C%2520beta%25282%2529-%2520and%2520beta%25283%2529-homohistidine%252C%2520and%2520beta%25282%2529-homoserine%2520for%2520solid-phase%2520syntheses%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2004%26volume%3D87%26issue%3D12%26spage%3D3131%26epage%3D3159%26doi%3D10.1002%2Fhlca.200490280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Carter, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhayana, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1210/me.2014-1129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fme.2014-1129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25584411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=307-321&issue=2&author=P.+H.+Carterauthor=T.+Deanauthor=B.+Bhayanaauthor=A.+Khatriauthor=R.+Rajurauthor=T.+J.+Gardella&title=Actions+of+the+small+molecule+ligands+SW106+and+AH-3960+on+the+type-1+parathyroid+hormone+receptor&doi=10.1210%2Fme.2014-1129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor</span></div><div class="casAuthors">Carter, Percy H.; Dean, Thomas; Bhayana, Brijesh; Khatri, Ashok; Rajur, Raj; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-321/1-307-321/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The parathyroid hormone receptor-1 (PTHR1) plays crit. roles in regulating blood calcium levels and bone metab. and is thus of interest for small-mol. ligand development.  Of the few small-mol. ligands reported for the PTHR1, most are of low affinity, and none has a well-defined mechanism of action.  Here, we show that SW106 and AH-3960, compds. previously identified to act as an antagonist and agonist, resp., on the PTHR1, each bind to PTHR1-delNT, a PTHR1 construct that lacks the large amino-terminal extracellular domain used for binding endogenous PTH peptide ligands, with the same micromolar affinity with which it binds to the intact PTHR1.  SW106 antagonized PTHR1-mediated cAMP signaling induced by the peptide analog, M-PTH(1-11), as well as by the native PTH(1-9) sequence, as tethered to the extracellular end of transmembrane domain (TMD) helix-1 of the receptor.  SW106, however, did not function as an inverse agonist on either PTHR1-H223R or PTHR1-T410P, which have activating mutations at the cytoplasmic ends of TMD helixes 2 and 6, resp.  The overall data indicate that SW106 and AH-3960 each bind to the PTHR1 TMD region and likely to within an extracellularly exposed area that is occupied by the N-terminal residues of PTH peptides.  Addnl., they suggest that the inhibitory effects of SW106 are limited to the extracellular portions of the TMD region that mediate interactions with agonist ligands but do not extend to receptor-activation determinants situated more deeply in the helical bundle.  The study helps to elucidate potential mechanisms of small-mol. binding at the PTHR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC428wNJkPF7Vg90H21EOLACvtfcHk0liYfXEdxYAmqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFGqt7Y%253D&md5=68b9c3fed11e185abeb3f2ce78d17464</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1210%2Fme.2014-1129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2014-1129%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DBhayana%26aufirst%3DB.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DRajur%26aufirst%3DR.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DActions%2520of%2520the%2520small%2520molecule%2520ligands%2520SW106%2520and%2520AH-3960%2520on%2520the%2520type-1%2520parathyroid%2520hormone%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2015%26volume%3D29%26issue%3D2%26spage%3D307%26epage%3D321%26doi%3D10.1210%2Fme.2014-1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hoare, S. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usdin, T. B.</span><span> </span><span class="NLM_article-title">Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor - Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">7741</span><span class="NLM_x">–</span> <span class="NLM_lpage">7753</span><span class="refDoi"> DOI: 10.1074/jbc.M009395200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M009395200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=7741-7753&issue=11&author=S.+R.+J.+Hoareauthor=T.+J.+Gardellaauthor=T.+B.+Usdin&title=Evaluating+the+signal+transduction+mechanism+of+the+parathyroid+hormone+1+receptor+-+Effect+of+receptor-G-protein+interaction+on+the+ligand+binding+mechanism+and+receptor+conformation&doi=10.1074%2Fjbc.M009395200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M009395200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M009395200%26sid%3Dliteratum%253Aachs%26aulast%3DHoare%26aufirst%3DS.%2BR.%2BJ.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DUsdin%26aufirst%3DT.%2BB.%26atitle%3DEvaluating%2520the%2520signal%2520transduction%2520mechanism%2520of%2520the%2520parathyroid%2520hormone%25201%2520receptor%2520-%2520Effect%2520of%2520receptor-G-protein%2520interaction%2520on%2520the%2520ligand%2520binding%2520mechanism%2520and%2520receptor%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D11%26spage%3D7741%26epage%3D7753%26doi%3D10.1074%2Fjbc.M009395200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Okazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouxsein, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">16525</span><span class="NLM_x">–</span> <span class="NLM_lpage">16530</span><span class="refDoi"> DOI: 10.1073/pnas.0808750105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0808750105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=16525-16530&issue=43&author=M.+Okazakiauthor=S.+Ferrandonauthor=J.+P.+Vilardagaauthor=M.+L.+Bouxseinauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Prolonged+signaling+at+the+parathyroid+hormone+receptor+by+peptide+ligands+targeted+to+a+specific+receptor+conformation&doi=10.1073%2Fpnas.0808750105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0808750105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0808750105%26sid%3Dliteratum%253Aachs%26aulast%3DOkazaki%26aufirst%3DM.%26aulast%3DFerrandon%26aufirst%3DS.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26aulast%3DBouxsein%26aufirst%3DM.%2BL.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DProlonged%2520signaling%2520at%2520the%2520parathyroid%2520hormone%2520receptor%2520by%2520peptide%2520ligands%2520targeted%2520to%2520a%2520specific%2520receptor%2520conformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D43%26spage%3D16525%26epage%3D16530%26doi%3D10.1073%2Fpnas.0808750105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Shimizu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Minimization of parathyroid hormone - Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">21836</span><span class="NLM_x">–</span> <span class="NLM_lpage">21843</span><span class="refDoi"> DOI: 10.1074/jbc.M909861199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M909861199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21836-21843&issue=29&author=M.+Shimizuauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Minimization+of+parathyroid+hormone+-+Novel+amino-terminal+parathyroid+hormone+fragments+with+enhanced+potency+in+activating+the+type-1+parathyroid+hormone+receptor&doi=10.1074%2Fjbc.M909861199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M909861199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M909861199%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DMinimization%2520of%2520parathyroid%2520hormone%2520-%2520Novel%2520amino-terminal%2520parathyroid%2520hormone%2520fragments%2520with%2520enhanced%2520potency%2520in%2520activating%2520the%2520type-1%2520parathyroid%2520hormone%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D29%26spage%3D21836%26epage%3D21843%26doi%3D10.1074%2Fjbc.M909861199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Tsomaia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierke, D. F.</span><span> </span><span class="NLM_article-title">Toward parathyroid hormone minimization: Conformational studies of cyclic PTH(1-14) analogues</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1021/bi035703i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi035703i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=690-699&issue=3&author=N.+Tsomaiaauthor=M.+Pellegriniauthor=K.+Hydeauthor=T.+J.+Gardellaauthor=D.+F.+Mierke&title=Toward+parathyroid+hormone+minimization%3A+Conformational+studies+of+cyclic+PTH%281-14%29+analogues&doi=10.1021%2Fbi035703i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fbi035703i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi035703i%26sid%3Dliteratum%253Aachs%26aulast%3DTsomaia%26aufirst%3DN.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DK.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DMierke%26aufirst%3DD.%2BF.%26atitle%3DToward%2520parathyroid%2520hormone%2520minimization%253A%2520Conformational%2520studies%2520of%2520cyclic%2520PTH%25281-14%2529%2520analogues%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26issue%3D3%26spage%3D690%26epage%3D699%26doi%3D10.1021%2Fbi035703i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Kent, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveridge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, J. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of synthetic human parathyroid-hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1042/cs0680171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1042%2Fcs0680171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=3967464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADyaL2MXhtVKrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1985&pages=171-177&issue=2&author=G.+N.+Kentauthor=N.+Loveridgeauthor=J.+Reeveauthor=J.+M.+Zanelli&title=Pharmacokinetics+of+synthetic+human+parathyroid-hormone+1-34+in+man+measured+by+cytochemical+bioassay+and+radioimmunoassay&doi=10.1042%2Fcs0680171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay</span></div><div class="casAuthors">Kent, G. N.; Loveridge, N.; Reeve, J.; Zanelli, Joan M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-7</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    </div><div class="casAbstract">Synthetic human parathyroid hormone (1-34) [(hPTH) 1-34]  [52232-67-4] was given by i.v. injection to healthy men.  The time course of its appearance in and disappearance from the plasma was monitored both by cytochem. bioassay and by a specific RIA system.  Immunoreactive N-region parathyroid hormone (iPTH) reached peak concns. in plasma at 2 min after injection, whereas peak concns. of biol. active parathyroid hormone (bioPTH) were delayed until 4-6 min.  Bioassayable PTH-like activity then disappeared from the plasma (mean transit times 5.8 and 8.6 min), approx. twice as fast as immunoreactivity.  After sep. s.c. administrations, a calcd. 22-37% of administered hPTH 1-34 was subsequently detected in the plasma, by both assay systems.  It was not possible to explain fully the nonparallel appearances of bio- and immuno-reactivities in the plasma after i.v. injection nor the non-parallel disappearances after both i.v. and s.c. injections on the basis of the present data.  In the process of biol. degrdn. the immunoreactive locus is apparently inactivated by a different reaction from that which destroys bioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonzJBnG_hx47Vg90H21EOLACvtfcHk0ljtZmLeFlnRzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtVKrtLY%253D&md5=a9941ea2009ad69c76ebd899a4ac2809</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1042%2Fcs0680171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fcs0680171%26sid%3Dliteratum%253Aachs%26aulast%3DKent%26aufirst%3DG.%2BN.%26aulast%3DLoveridge%26aufirst%3DN.%26aulast%3DReeve%26aufirst%3DJ.%26aulast%3DZanelli%26aufirst%3DJ.%2BM.%26atitle%3DPharmacokinetics%2520of%2520synthetic%2520human%2520parathyroid-hormone%25201-34%2520in%2520man%2520measured%2520by%2520cytochemical%2520bioassay%2520and%2520radioimmunoassay%26jtitle%3DClin.%2520Sci.%26date%3D1985%26volume%3D68%26issue%3D2%26spage%3D171%26epage%3D177%26doi%3D10.1042%2Fcs0680171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Serada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai-Tanikawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibusawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohira, T.</span><span> </span><span class="NLM_article-title">The role of the liver and kidneys in the pharmacokinetics of subcutaneously administered teriparatide acetate in rats</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.3109/00498254.2011.622811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.3109%2F00498254.2011.622811" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=398-407&issue=4&author=M.+Seradaauthor=A.+Sakurai-Tanikawaauthor=M.+Igarashiauthor=K.+Mitsugiauthor=T.+Takanoauthor=K.+Shibusawaauthor=T.+Kohira&title=The+role+of+the+liver+and+kidneys+in+the+pharmacokinetics+of+subcutaneously+administered+teriparatide+acetate+in+rats&doi=10.3109%2F00498254.2011.622811"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3109%2F00498254.2011.622811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2011.622811%26sid%3Dliteratum%253Aachs%26aulast%3DSerada%26aufirst%3DM.%26aulast%3DSakurai-Tanikawa%26aufirst%3DA.%26aulast%3DIgarashi%26aufirst%3DM.%26aulast%3DMitsugi%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DT.%26aulast%3DShibusawa%26aufirst%3DK.%26aulast%3DKohira%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520the%2520liver%2520and%2520kidneys%2520in%2520the%2520pharmacokinetics%2520of%2520subcutaneously%2520administered%2520teriparatide%2520acetate%2520in%2520rats%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26issue%3D4%26spage%3D398%26epage%3D407%26doi%3D10.3109%2F00498254.2011.622811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qie, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, J. X.</span><span> </span><span class="NLM_article-title">Metabolic stability of human parathyroid hormone peptide hPTH (1-34) in rat tissue homogenates: kinetics and products of proteolytic degradation</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1605</span><span class="refDoi"> DOI: 10.1007/s00726-009-0376-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1007%2Fs00726-009-0376-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1595-1605&issue=5&author=S.+Liaoauthor=J.+K.+Qieauthor=M.+Xueauthor=Z.+Q.+Zhangauthor=K.+L.+Liuauthor=J.+X.+Ruan&title=Metabolic+stability+of+human+parathyroid+hormone+peptide+hPTH+%281-34%29+in+rat+tissue+homogenates%3A+kinetics+and+products+of+proteolytic+degradation&doi=10.1007%2Fs00726-009-0376-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs00726-009-0376-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-009-0376-y%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DQie%26aufirst%3DJ.%2BK.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%2BQ.%26aulast%3DLiu%26aufirst%3DK.%2BL.%26aulast%3DRuan%26aufirst%3DJ.%2BX.%26atitle%3DMetabolic%2520stability%2520of%2520human%2520parathyroid%2520hormone%2520peptide%2520hPTH%2520%25281-34%2529%2520in%2520rat%2520tissue%2520homogenates%253A%2520kinetics%2520and%2520products%2520of%2520proteolytic%2520degradation%26jtitle%3DAmino%2520Acids%26date%3D2010%26volume%3D38%26issue%3D5%26spage%3D1595%26epage%3D1605%26doi%3D10.1007%2Fs00726-009-0376-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1210/me.2007-0274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fme.2007-0274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=17872377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1SitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=156-166&issue=1&author=T.+Deanauthor=J.+P.+Vilardagaauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Altered+selectivity+of+parathyroid+hormone+%28PTH%29+and+PTH-related+protein+%28PTHrP%29+for+distinct+conformations+of+the+PTH%2FPTHrP+receptor&doi=10.1210%2Fme.2007-0274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor</span></div><div class="casAuthors">Dean, Thomas; Vilardaga, Jean-Pierre; Potts, John T., Jr.; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">PTH and PTHrP use the same G protein-coupled receptor, the PTH/PTHrP receptor (PTHR), to mediate their distinct biol. actions.  The extent to which the mechanisms by which the two ligands bind to the PTHR differ is unclear.  The authors examd. this question using several pharmacol. and biophys. approaches.  Kinetic dissocn. and equil. binding assays revealed that the binding of [125I]PTHrP(1-36) to the PTHR was more sensitive to GTPγS (added to functionally uncouple PTHR-G protein complexes) than was the binding of [125I]PTH(1-34) (∼75% maximal inhibition vs. ∼20%).  Fluorescence resonance energy transfer-based kinetic analyses revealed that PTHrP(1-36) bound to the PTHR more slowly and dissocd. from it more rapidly than did PTH(1-34).  The cAMP signaling response capacity of PTHrP(1-36) in cells decayed more rapidly than did that of PTH(1-34) (t1/2 = ∼1 vs. ∼2 h).  Divergent residue 5 in the ligand, Ile in PTH and His in PTHrP, was identified as a key determinant of the altered receptor-interaction responses exhibited by the two peptides.  The authors conclude that, whereas PTH and PTHrP bind similarly to the G protein-coupled PTHR conformation (RG), PTH has a greater capacity to bind to the G protein-uncoupled conformation (Ro) and, hence, can produce cumulatively greater signaling responses (via Ro→RG isomerization) than can PTHrP.  Such conformational selectivity may relate to the distinct modes by which PTH and PTHrP act biol., endocrine vs. paracrine, and may help explain reported differences in the effects that the ligands have on calcium and bone metab. when administered to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgXJg6PTzY47Vg90H21EOLACvtfcHk0lgDbT4K3_sTug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1SitA%253D%253D&md5=da008d93f1a5261060589ad1a2246b56</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1210%2Fme.2007-0274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2007-0274%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DT.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DAltered%2520selectivity%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520and%2520PTH-related%2520protein%2520%2528PTHrP%2529%2520for%2520distinct%2520conformations%2520of%2520the%2520PTH%252FPTHrP%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2008%26volume%3D22%26issue%3D1%26spage%3D156%26epage%3D166%26doi%3D10.1210%2Fme.2007-0274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Ferrandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J.-P.</span><span> </span><span class="NLM_article-title">Sustained cyclic AMP production by parathyroid hormone receptor endocytosis</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span><span class="refDoi"> DOI: 10.1038/nchembio.206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=19701185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=734-742&issue=10&author=S.+Ferrandonauthor=T.+N.+Feinsteinauthor=M.+Castroauthor=B.+Wangauthor=R.+Bouleyauthor=J.+T.+Pottsauthor=T.+J.+Gardellaauthor=J.-P.+Vilardaga&title=Sustained+cyclic+AMP+production+by+parathyroid+hormone+receptor+endocytosis&doi=10.1038%2Fnchembio.206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained cyclic AMP production by parathyroid hormone receptor endocytosis</span></div><div class="casAuthors">Ferrandon, Sebastien; Feinstein, Timothy N.; Castro, Marian; Wang, Bin; Bouley, Richard; Potts, John T.; Gardella, Thomas J.; Vilardaga, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">734-742</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cell signaling mediated by the G protein-coupled parathyroid hormone receptor type 1 (PTHR) is fundamental to bone and kidney physiol.  It has been unclear how the two ligand systems-PTH, endocrine and homeostatic, and PTH-related peptide (PTHrP), paracrine-can effectively operate with only one receptor and trigger different durations of the cAMP responses.  Here we analyze the ligand response by measuring the kinetics of activation and deactivation for each individual reaction step along the PTHR signaling cascade.  We found that during the time frame of G protein coupling and cAMP prodn., PTHrP1-36 action was restricted to the cell surface, whereas PTH1-34 had moved to internalized compartments where it remained assocd. with the PTHR and Gαs, potentially as a persistent and active ternary complex.  Such marked differences suggest a mechanism by which PTH and PTHrP induce differential responses, and these results indicate that the central tenet that cAMP prodn. originates exclusively at the cell membrane must be revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLUPOKhhnJrVg90H21EOLACvtfcHk0lgDbT4K3_sTug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrO&md5=9df689536dcc90bc69ca6c558545d229</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.206%26sid%3Dliteratum%253Aachs%26aulast%3DFerrandon%26aufirst%3DS.%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DCastro%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBouley%26aufirst%3DR.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.-P.%26atitle%3DSustained%2520cyclic%2520AMP%2520production%2520by%2520parathyroid%2520hormone%2520receptor%2520endocytosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26issue%3D10%26spage%3D734%26epage%3D742%26doi%3D10.1038%2Fnchembio.206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Cupp, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayak, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adem, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W. J.</span><span> </span><span class="NLM_article-title">Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1124/jpet.112.199752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1124%2Fjpet.112.199752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23516330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=404-418&issue=3&author=M.+E.+Cuppauthor=S.+K.+Nayakauthor=A.+S.+Ademauthor=W.+J.+Thomsen&title=Parathyroid+hormone+%28PTH%29+and+PTH-related+peptide+domains+contributing+to+activation+of+different+PTH+receptor-mediated+signaling+pathways&doi=10.1124%2Fjpet.112.199752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways</span></div><div class="casAuthors">Cupp, Meghan E.; Nayak, Surendra K.; Adem, Amina S.; Thomsen, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">404-418</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP), acting through the osteoblast PTH1 receptor (PTH1R), play important roles in bone remodeling.  Intermittent administration of PTH(1-34) (teriparatide) leads to bone formation, whereas continuous administration paradoxically leads to bone resorption.  Activation of PTH1R promotes regulation of multiple signaling pathways, including Gs/cAMP/protein kinase A, Gq/calcium/protein kinase C, β-arrestin recruitment, and extracellular signal-related kinase (ERK)1/2 phosphorylation, as well as receptor internalization, but their role in promoting anabolic and catabolic actions of PTH(1-34) are unclear.  In the present investigation, a collection of PTH(1-34) and PTHrP(1-34) peptide analogs were evaluated in orthogonal human PTH1R (hPTH1R) functional assays capturing Gs- and Gq-signaling, β-arrestin recruitment, ERK1/2 phosphorylation, and receptor internalization to further define the patterns of PTH1R signaling that they stimulate and further establish peptide domains contributing to agonist activity.  Results indicate that both N- and C-terminal domains of PTH and PTHrP are crit. for activation of signaling pathways.  However, modifications of both regions lead to more substantial decreases in agonist potency and efficacy to stimulate Gq-signaling, β-arrestin recruitment, ERK1/2 phosphorylation, and receptor internalization than to stimulate Gs-signaling.  The substantial contribution of the peptide C-terminal domain in activation of hPTH1R signaling suggests a role in positioning of the peptide N-terminal region into the receptor J-domain.  Several PTH and PTHrP peptides evaluated in this study promote different patterns of biased agonist signaling and may serve as useful tools to further elucidate therapeutically relevant PTH1R signaling in osteoblasts.  With a better understanding of therapeutically relevant signaling, novel biased peptides with desired signaling could be designed for safer and more effective treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYnRF2BDhnkrVg90H21EOLACvtfcHk0lg6ITju7GjFwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgs7o%253D&md5=470334b657042c5ecbfb92a86aa28d7f</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.199752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.199752%26sid%3Dliteratum%253Aachs%26aulast%3DCupp%26aufirst%3DM.%2BE.%26aulast%3DNayak%26aufirst%3DS.%2BK.%26aulast%3DAdem%26aufirst%3DA.%2BS.%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26atitle%3DParathyroid%2520hormone%2520%2528PTH%2529%2520and%2520PTH-related%2520peptide%2520domains%2520contributing%2520to%2520activation%2520of%2520different%2520PTH%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D345%26issue%3D3%26spage%3D404%26epage%3D418%26doi%3D10.1124%2Fjpet.112.199752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Alphonse, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Endosomal generation of cAMP in GPCR signaling</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1038/nchembio.1611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.1611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25271346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOlur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=700-706&issue=9&author=J.+P.+Vilardagaauthor=F.+G.+Jean-Alphonseauthor=T.+J.+Gardella&title=Endosomal+generation+of+cAMP+in+GPCR+signaling&doi=10.1038%2Fnchembio.1611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal generation of cAMP in GPCR signaling</span></div><div class="casAuthors">Vilardaga, Jean-Pierre; Jean-Alphonse, Frederic G.; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">700-706</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has been widely assumed that the prodn. of the ubiquitous second messenger cAMP, which is mediated by cell surface G protein-coupled receptors (GPCRs), and its termination take place exclusively at the plasma membrane.  Recent studies reveal that diverse GPCRs do not always follow this conventional paradigm.  In the new model, GPCRs mediate G-protein signaling not only from the plasma membrane but also from endosomal membranes.  This model proposes that following ligand binding and activation, cell surface GPCRs internalize and redistribute into early endosomes, where trimeric G protein signaling can be maintained for an extended period of time.  This Perspective discusses the mol. and cellular mechanistic subtleties as well as the physiol. consequences of this unexpected process, which is considerably changing how we think about GPCR signaling and regulation and how we study drugs that target this receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoryRANziMK-LVg90H21EOLACvtfcHk0lg6ITju7GjFwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOlur%252FE&md5=437e81bee0c5fc175c4b57b75fe82a99</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1611%26sid%3Dliteratum%253Aachs%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26aulast%3DJean-Alphonse%26aufirst%3DF.%2BG.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DEndosomal%2520generation%2520of%2520cAMP%2520in%2520GPCR%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D9%26spage%3D700%26epage%3D706%26doi%3D10.1038%2Fnchembio.1611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linglart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastepe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juppner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for G alpha(S)-coupled receptor conformations</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span><span class="refDoi"> DOI: 10.1210/me.2005-0349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fme.2005-0349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=16339275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1yjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=931-943&issue=4&author=T.+Deanauthor=A.+Linglartauthor=M.+J.+Mahonauthor=M.+Bastepeauthor=H.+Juppnerauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Mechanisms+of+ligand+binding+to+the+parathyroid+hormone+%28PTH%29%2FPTH-related+protein+receptor%3A+selectivity+of+a+modified+PTH%281-15%29+radioligand+for+G+alpha%28S%29-coupled+receptor+conformations&doi=10.1210%2Fme.2005-0349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for Gαs-coupled receptor conformations</span></div><div class="casAuthors">Dean, Thomas; Linglart, Agnes; Mahon, Matthew J.; Bastepe, Murat; Juppner, Harald; Potts, John T., Jr.; Gardella, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">931-943</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Mechanisms of ligand binding to the PTH/PTHrP receptor (PTHR) were explored using PTH fragment analogs as radioligands in binding assays.  In particular, the modified amino-terminal fragment analog, 125I-[Aib1,3,Nle8,Gln10,homoarginine11,Ala12,Trp14,Tyr15]rPTH(1-15)NH2, 125I-[Aib1,3,M]PTH(1-15), was used as a radioligand that we hypothesized to bind solely to the juxtamembrane (J) portion of the PTHR contg. the extracellular loops and transmembrane helixes.  We also employed 125I-PTH(1-34) as a radioligand that binds to both the amino-terminal extracellular (N) and J domains of the PTHR.  Binding was examd. in membranes derived from cells expressing either wild-type or mutant PTHRs.  We found that the binding of 125I-[Aib1,3,M]PTH(1-15) to the wild-type PTHR was strongly (∼90%) inhibited by guanosine 5'-O-(3-thio)triphosphate (GTPγS), whereas the binding of 125I-PTH(1-34) was only mildly (∼25%) inhibited by GTPγS.  Of these two radioligands, only 125I-[Aib1,3,M]PTH(1-15) bound to PTHR-delNt, which lacks most of the receptor's N domain, and again this binding was strongly inhibited by GTPγS.  Binding of 125I-[Aib1,3,M]PTH(1-15) to the constitutively active receptor, PTHR-H223R, was only mildly (∼20%) inhibited by GTPγS, as was the binding of 125I-PTH(1-34).  In membranes prepd. from cells lacking Gαs via knockout mutation of Gnas, no binding of 125I-[Aib1,3,M]PTH(1-15) was obsd., but binding of 125I-[Aib1,3,M]PTH(1-15) was recovered by virally transducing the cells to heterologously express Gαs.  125I-PTH(1-34) bound to the membranes with or without Gαs.  The overall findings confirm the hypothesis that 125I-[Aib1,3,M]PTH(1-15) binds solely to the J domain of the PTHR.  They further show that this binding is strongly dependent on coupling of the receptor to Gαs-contg. heterotrimeric G proteins, whereas the binding of 125I-PTH(1-34) can occur in the absence of such coupling.  Thus, 125I-[Aib1,3,M]PTH(1-15) appears to function as a selective probe of Gαs-coupled, active-state PTHR conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrftLjkby1a_LVg90H21EOLACvtfcHk0ljdOMbdczm5yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1yjsrc%253D&md5=1a799a3c936112a4a773ea45d710789c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0349%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DT.%26aulast%3DLinglart%26aufirst%3DA.%26aulast%3DMahon%26aufirst%3DM.%2BJ.%26aulast%3DBastepe%26aufirst%3DM.%26aulast%3DJuppner%26aufirst%3DH.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DMechanisms%2520of%2520ligand%2520binding%2520to%2520the%2520parathyroid%2520hormone%2520%2528PTH%2529%252FPTH-related%2520protein%2520receptor%253A%2520selectivity%2520of%2520a%2520modified%2520PTH%25281-15%2529%2520radioligand%2520for%2520G%2520alpha%2528S%2529-coupled%2520receptor%2520conformations%26jtitle%3DMol.%2520Endocrinol.%26date%3D2006%26volume%3D20%26issue%3D4%26spage%3D931%26epage%3D943%26doi%3D10.1210%2Fme.2005-0349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Hattersley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.1210/en.2015-1726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fen.2015-1726" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=141-149&issue=1&author=G.+Hattersleyauthor=T.+Deanauthor=B.+A.+Corbinauthor=H.+Baharauthor=T.+J.+Gardella&title=Binding+selectivity+of+abaloparatide+for+PTH-type-1-receptor+conformations+and+effects+on+downstream+signaling&doi=10.1210%2Fen.2015-1726"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1210%2Fen.2015-1726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2015-1726%26sid%3Dliteratum%253Aachs%26aulast%3DHattersley%26aufirst%3DG.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DCorbin%26aufirst%3DB.%2BA.%26aulast%3DBahar%26aufirst%3DH.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DBinding%2520selectivity%2520of%2520abaloparatide%2520for%2520PTH-type-1-receptor%2520conformations%2520and%2520effects%2520on%2520downstream%2520signaling%26jtitle%3DEndocrinology%26date%3D2016%26volume%3D157%26issue%3D1%26spage%3D141%26epage%3D149%26doi%3D10.1210%2Fen.2015-1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Maeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Samra, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jueppner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloch, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span> </span><span class="NLM_article-title">Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5864</span><span class="NLM_x">–</span> <span class="NLM_lpage">5869</span><span class="refDoi"> DOI: 10.1073/pnas.1301674110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.1301674110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5864-5869&issue=15&author=A.+Maedaauthor=M.+Okazakiauthor=D.+M.+Baronauthor=T.+Deanauthor=A.+Khatriauthor=M.+Mahonauthor=H.+Segawaauthor=A.+B.+Abou-Samraauthor=H.+Jueppnerauthor=K.+D.+Blochauthor=J.+T.+Pottsauthor=T.+J.+Gardella&title=Critical+role+of+parathyroid+hormone+%28PTH%29+receptor-1+phosphorylation+in+regulating+acute+responses+to+PTH&doi=10.1073%2Fpnas.1301674110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301674110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301674110%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DA.%26aulast%3DOkazaki%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DD.%2BM.%26aulast%3DDean%26aufirst%3DT.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DMahon%26aufirst%3DM.%26aulast%3DSegawa%26aufirst%3DH.%26aulast%3DAbou-Samra%26aufirst%3DA.%2BB.%26aulast%3DJueppner%26aufirst%3DH.%26aulast%3DBloch%26aufirst%3DK.%2BD.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26atitle%3DCritical%2520role%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520receptor-1%2520phosphorylation%2520in%2520regulating%2520acute%2520responses%2520to%2520PTH%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D15%26spage%3D5864%26epage%3D5869%26doi%3D10.1073%2Fpnas.1301674110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Castro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaev, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">44</span><span class="NLM_x">) </span> <span class="NLM_fpage">16084</span><span class="NLM_x">–</span> <span class="NLM_lpage">16089</span><span class="refDoi"> DOI: 10.1073/pnas.0503942102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0503942102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16084-16089&issue=44&author=M.+Castroauthor=V.+O.+Nikolaevauthor=D.+Palmauthor=M.+J.+Lohseauthor=J.+P.+Vilardaga&title=Turn-on+switch+in+parathyroid+hormone+receptor+by+a+two-step+parathyroid+hormone+binding+mechanism&doi=10.1073%2Fpnas.0503942102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0503942102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0503942102%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DM.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DPalm%26aufirst%3DD.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DTurn-on%2520switch%2520in%2520parathyroid%2520hormone%2520receptor%2520by%2520a%2520two-step%2520parathyroid%2520hormone%2520binding%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D44%26spage%3D16084%26epage%3D16089%26doi%3D10.1073%2Fpnas.0503942102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehbi, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardura, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Retromer terminates the generation of cAMP by internalized PTH receptors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1038/nchembio.545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=21445058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=278-284&issue=5&author=T.+N.+Feinsteinauthor=V.+L.+Wehbiauthor=J.+A.+Arduraauthor=D.+S.+Wheelerauthor=S.+Ferrandonauthor=T.+J.+Gardellaauthor=J.+P.+Vilardaga&title=Retromer+terminates+the+generation+of+cAMP+by+internalized+PTH+receptors&doi=10.1038%2Fnchembio.545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Retromer terminates the generation of cAMP by internalized PTH receptors</span></div><div class="casAuthors">Feinstein, Timothy N.; Wehbi, Vanessa L.; Ardura, Juan A.; Wheeler, David S.; Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">278-284</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The generation of cAMP by G protein-coupled receptors (GPCRs) and its termination are currently thought to occur exclusively at the plasma membrane of cells.  Under existing models of receptor regulation, this signal is primarily restricted by desensitization of the receptors through their binding to β-arrestins.  However, this paradigm is not consistent with recent observations that the parathyroid hormone receptor type 1 (PTHR) continues to stimulate cAMP prodn. even after receptor internalization, as β-arrestins are known to rapidly bind and internalize activated PTHR.  Here we show that binding to β-arrestin1 prolongs rather than terminates the generation of cAMP by PTHR, and that cAMP generation correlates with the persistence of arrestin-receptor complexes on endosomes.  PTHR signaling is instead turned off by the retromer complex, which regulates the movement of internalized receptor from endosomes to the Golgi app.  Thus, binding by the retromer complex regulates the sustained generation of cAMP triggered by an internalized GPCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVgwwu0vNEhbVg90H21EOLACvtfcHk0lhIX2MkS47mIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOhsb8%253D&md5=3096a0b6cb76ce68b3dcf9ee1acdf0e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.545%26sid%3Dliteratum%253Aachs%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DWehbi%26aufirst%3DV.%2BL.%26aulast%3DArdura%26aufirst%3DJ.%2BA.%26aulast%3DWheeler%26aufirst%3DD.%2BS.%26aulast%3DFerrandon%26aufirst%3DS.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DRetromer%2520terminates%2520the%2520generation%2520of%2520cAMP%2520by%2520internalized%2520PTH%2520receptors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26issue%3D5%26spage%3D278%26epage%3D284%26doi%3D10.1038%2Fnchembio.545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehbi, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallows, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">39</span><span class="NLM_x">) </span> <span class="NLM_fpage">27849</span><span class="NLM_x">–</span> <span class="NLM_lpage">27860</span><span class="refDoi"> DOI: 10.1074/jbc.M112.445098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M112.445098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=27849-27860&issue=39&author=T.+N.+Feinsteinauthor=N.+Yuiauthor=M.+J.+Webberauthor=V.+L.+Wehbiauthor=H.+P.+Stevensonauthor=J.+D.+Kingauthor=K.+R.+Hallowsauthor=D.+Brownauthor=R.+Bouleyauthor=J.+P.+Vilardaga&title=Noncanonical+control+of+vasopressin+receptor+type+2+signaling+by+retromer+and+arrestin&doi=10.1074%2Fjbc.M112.445098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.445098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.445098%26sid%3Dliteratum%253Aachs%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DYui%26aufirst%3DN.%26aulast%3DWebber%26aufirst%3DM.%2BJ.%26aulast%3DWehbi%26aufirst%3DV.%2BL.%26aulast%3DStevenson%26aufirst%3DH.%2BP.%26aulast%3DKing%26aufirst%3DJ.%2BD.%26aulast%3DHallows%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBouley%26aufirst%3DR.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DNoncanonical%2520control%2520of%2520vasopressin%2520receptor%2520type%25202%2520signaling%2520by%2520retromer%2520and%2520arrestin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D39%26spage%3D27849%26epage%3D27860%26doi%3D10.1074%2Fjbc.M112.445098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Gidon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Bataineh, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Alphonse, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor-Soler, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1038/nchembio.1589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnchembio.1589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25064832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ait7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=707-709&issue=9&author=A.+Gidonauthor=M.+M.+Al-Batainehauthor=F.+G.+Jean-Alphonseauthor=H.+P.+Stevensonauthor=T.+Watanabeauthor=C.+Louetauthor=A.+Khatriauthor=G.+Caleroauthor=N.+M.+Pastor-Solerauthor=T.+J.+Gardellaauthor=J.+P.+Vilardaga&title=Endosomal+GPCR+signaling+turned+off+by+negative+feedback+actions+of+PKA+and+v-ATPase&doi=10.1038%2Fnchembio.1589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase</span></div><div class="casAuthors">Gidon, Alexandre; Al-Bataineh, Mohammad M.; Jean-Alphonse, Frederic G.; Stevenson, Hilary P.; Watanabe, Tomoyuki; Louet, Claire; Khatri, Ashok; Calero, Guillermo; Pastor-Soler, Nuria M.; Gardella, Thomas J.; Vilardaga, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">707-709</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The PTH receptor is to our knowledge one of the first G protein-coupled receptor (GPCR) found to sustain cAMP signaling after internalization of the ligand-receptor complex in endosomes.  This unexpected model is adding a new dimension on how we think about GPCR signaling, but its mechanism is incompletely understood.  We report here that endosomal acidification mediated by the PKA action on the v-ATPase provides a neg. feedback mechanism by which endosomal receptor signaling is turned off.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDTn8ZWbawmrVg90H21EOLACvtfcHk0lhIrGSLuynLjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ait7bP&md5=9fe3414e50fb69648783ed217ef5d14d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1589%26sid%3Dliteratum%253Aachs%26aulast%3DGidon%26aufirst%3DA.%26aulast%3DAl-Bataineh%26aufirst%3DM.%2BM.%26aulast%3DJean-Alphonse%26aufirst%3DF.%2BG.%26aulast%3DStevenson%26aufirst%3DH.%2BP.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DLouet%26aufirst%3DC.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DCalero%26aufirst%3DG.%26aulast%3DPastor-Soler%26aufirst%3DN.%2BM.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DEndosomal%2520GPCR%2520signaling%2520turned%2520off%2520by%2520negative%2520feedback%2520actions%2520of%2520PKA%2520and%2520v-ATPase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D9%26spage%3D707%26epage%3D709%26doi%3D10.1038%2Fnchembio.1589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Gidon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardaga, J. P.</span><span> </span><span class="NLM_article-title">Studying the regulation of endosomal cAMP production in GPCR signaling</span> <span class="citation_source-journal">Methods Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/bs.mcb.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fbs.mcb.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26928541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A280%3ADC%252BC28jlvValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2016&pages=109-126&author=A.+Gidonauthor=T.+N.+Feinsteinauthor=K.+H.+Xiaoauthor=J.+P.+Vilardaga&title=Studying+the+regulation+of+endosomal+cAMP+production+in+GPCR+signaling&doi=10.1016%2Fbs.mcb.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Studying the regulation of endosomal cAMP production in GPCR signaling</span></div><div class="casAuthors">Gidon Alexandre; Feinstein Timothy N; Xiao Kunhong; Vilardaga Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Methods in cell biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109-26</span>
        ISSN:<span class="NLM_cas:issn">0091-679X</span>.
    </div><div class="casAbstract">We describe methods based on live cell fluorescent microscopy and mass spectrometry to characterize the mechanism of endosomal cAMP production and its regulation using the parathyroid hormone (PTH) type 1 receptor as a prime example.  These methods permit to measure rapid changes of cAMP levels in response to PTH, kinetics of endosomal ligand-receptor interaction, pH changes associated with receptor trafficking, and to identify the endosomal receptor interactome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHWwt7jjsE3rHHuJhbyicZfW6udTcc2eYThgyrFERoGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jlvValsg%253D%253D&md5=8fb9b3d76c3d35cf506d6f9249b3db5d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fbs.mcb.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.mcb.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DGidon%26aufirst%3DA.%26aulast%3DFeinstein%26aufirst%3DT.%2BN.%26aulast%3DXiao%26aufirst%3DK.%2BH.%26aulast%3DVilardaga%26aufirst%3DJ.%2BP.%26atitle%3DStudying%2520the%2520regulation%2520of%2520endosomal%2520cAMP%2520production%2520in%2520GPCR%2520signaling%26jtitle%3DMethods%2520Cell%2520Biol.%26date%3D2016%26volume%3D132%26spage%3D109%26epage%3D126%26doi%3D10.1016%2Fbs.mcb.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Horwitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. F.</span><span> </span><span class="NLM_article-title">Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1210/jc.2002-021122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fjc.2002-021122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=12574182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtlChsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=569-575&issue=2&author=M.+J.+Horwitzauthor=M.+B.+Tedescoauthor=C.+Gundbergauthor=A.+Garcia-Ocanaauthor=A.+F.+Stewart&title=Short-term%2C+high-dose+parathyroid+hormone-related+protein+as+a+skeletal+anabolic+agent+for+the+treatment+of+postmenopausal+osteoporosis&doi=10.1210%2Fjc.2002-021122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis</span></div><div class="casAuthors">Horwitz, Mara J.; Tedesco, Mary Beth; Gundberg, Caren; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">569-575</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">PTH-related protein (PTHrP) is homologous with PTH.  PTH, an effective anabolic agent for treating osteoporosis, has been shown to stimulate both bone resorption by osteoclasts and bone formation by osteoblasts.  We examd. whether PTHrP might share anabolic properties in osteoporosis.  A 3-mo double-blind, prospective, placebo-controlled, randomized clin. trial was performed in 16 healthy postmenopausal women with osteoporosis.  All received calcium and vitamin D, and all continued their prior hormone replacement therapy.  One group also received daily s.c. PTHrP (6.56 μg/kg/d, or approx. 400 μg/d), and the other group received placebo injections.  The PTHrP group displayed a 4.7% increase in lumbar spine bone mineral d. (BMD) and also demonstrated an increase in osteoblastic bone formation, as assessed using serum osteocalcin measurements.  In contrast, there was no increase in bone-specific alk. phosphatase and collagen-1 propeptide or either of two markers of osteoclastic bone resorption, N-telopeptide, or deoxypyridinoline.  One subject in the placebo group withdrew from the study, but there were no significant adverse events in the PTHrP group.  PTHrP administered s.c. in high doses for only 3 mo appears to be a potent anabolic agent, producing a 4.7% increase in lumbar spine BMD.  This compares very favorably to available antiresorptive drugs for osteoporosis and is similar to the increases in BMD at this early time point reported for PTH.  Despite the high doses, PTHrP was well tolerated.  Larger clin. trials are required to confirm these results and fully assess the anabolic potential of PTHrP in osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_WiufiKZDibVg90H21EOLACvtfcHk0ljq1D6Wf_JWAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtlChsb8%253D&md5=dcdb06885b37163d11f57ddcc22a3f63</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fjc.2002-021122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2002-021122%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DM.%2BJ.%26aulast%3DTedesco%26aufirst%3DM.%2BB.%26aulast%3DGundberg%26aufirst%3DC.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DShort-term%252C%2520high-dose%2520parathyroid%2520hormone-related%2520protein%2520as%2520a%2520skeletal%2520anabolic%2520agent%2520for%2520the%2520treatment%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26issue%3D2%26spage%3D569%26epage%3D575%26doi%3D10.1210%2Fjc.2002-021122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Horwitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sereika, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prebehala, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundberg, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. F.</span><span> </span><span class="NLM_article-title">Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span><span class="refDoi"> DOI: 10.1210/jc.2009-0233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fjc.2009-0233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=20061412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Kqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1279-1287&issue=3&author=M.+J.+Horwitzauthor=M.+B.+Tedescoauthor=A.+Garcia-Ocanaauthor=S.+M.+Sereikaauthor=L.+Prebehalaauthor=A.+Biselloauthor=B.+W.+Hollisauthor=C.+M.+Gundbergauthor=A.+F.+Stewart&title=Parathyroid+hormone-related+protein+for+the+treatment+of+postmenopausal+osteoporosis%3A+defining+the+maximal+tolerable+dose&doi=10.1210%2Fjc.2009-0233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose</span></div><div class="casAuthors">Horwitz, Mara J.; Tedesco, Mary Beth; Garcia-Ocana, Adolfo; Sereika, Susan M.; Prebehala, Linda; Bisello, Alessandro; Hollis, Bruce W.; Gundberg, Caren M.; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1279-1287</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: PTH is the only approved skeletal anabolic agent for the treatment of human osteoporosis.  Unlike PTH, which is a mixed anabolic and catabolic agent, PTHrP displays features suggesting that it may be a pure anabolic agent when intermittently administered.  The full dose range of PTHrP is unknown.  Objectives: The primary objective of the study was to define the complete therapeutic window and dose-limiting toxicities of PTHrP.  The secondary objective was to det. whether PTHrP retains a pure anabolic profile at the highest usable doses.  Design: This was a single-blinded, two-part, dose-escalating clin. trial.  Setting: The study was conducted in a university academic setting.  Patients or Other Participants: Participants included 41 healthy postmenopausal women between the ages of 45 and 75 yr.  Intervention: Interventions included PTHrP(1-36) or placebo in a dose-escalating design for 3 wk.  Main Outcome Measures: Safety measures (hypercalcemia, nausea, vomiting, hemodynamics, flushing, misc.) and bone turnover markers were measured.  Results: Intermittent PTHrP was administered safely and without serious adverse events in subjects receiving 500 and 625 μg/d for 3 wk.  Subjects receiving 750 μg/d developed mild hypercalcemia.  Bone turnover markers suggested that even at the highest doses, daily s.c. PTHrP may not activate bone resorption, i.e. may be purely anabolic.  Interestingly, when hypercalcemia occurred, it may have resulted not from bone resorption but from activation of intestinal calcium absorption by 1,25 dihydroxyvitamin D.  Conclusions: In doses as high as 750 μg/d, in contrast to PTH, intermittently administered PTHrP appears to act as a pure skeletal anabolic agent.  Surprisingly, PTHrP in the High doses studied activates 1,25 dihydroxyvitamin D prodn.  Dosing information obtained herein can be used to design a longer term head-to-head comparative efficacy trial of PTHrP vs. PTH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOWyayTrRyk7Vg90H21EOLACvtfcHk0ljq1D6Wf_JWAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Kqt7Y%253D&md5=1da45c88d671a208e41530b2498fa96d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1210%2Fjc.2009-0233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2009-0233%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DM.%2BJ.%26aulast%3DTedesco%26aufirst%3DM.%2BB.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DSereika%26aufirst%3DS.%2BM.%26aulast%3DPrebehala%26aufirst%3DL.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DHollis%26aufirst%3DB.%2BW.%26aulast%3DGundberg%26aufirst%3DC.%2BM.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DParathyroid%2520hormone-related%2520protein%2520for%2520the%2520treatment%2520of%2520postmenopausal%2520osteoporosis%253A%2520defining%2520the%2520maximal%2520tolerable%2520dose%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26issue%3D3%26spage%3D1279%26epage%3D1287%26doi%3D10.1210%2Fjc.2009-0233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Horwitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laslavic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sereika, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundberg, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. F.</span><span> </span><span class="NLM_article-title">A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2266</span><span class="NLM_x">–</span> <span class="NLM_lpage">2276</span><span class="refDoi"> DOI: 10.1002/jbmr.1978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjbmr.1978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23661240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=2266-2276&issue=11&author=M.+J.+Horwitzauthor=M.+Augustineauthor=L.+Kahnauthor=E.+Martinauthor=C.+C.+Oakleyauthor=R.+M.+Carneiroauthor=M.+B.+Tedescoauthor=A.+Laslavicauthor=S.+M.+Sereikaauthor=A.+Biselloauthor=A.+Garcia-Ocanaauthor=C.+M.+Gundbergauthor=J.+A.+Cauleyauthor=A.+F.+Stewart&title=A+comparison+of+parathyroid+hormone-related+protein+%281-36%29+and+parathyroid+hormone+%281-34%29+on+markers+of+bone+turnover+and+bone+density+in+postmenopausal+women%3A+the+PrOP+study&doi=10.1002%2Fjbmr.1978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: The PrOP study</span></div><div class="casAuthors">Horwitz, Mara J.; Augustine, Marilyn; Kahn, Leila; Martin, Emily; Oakley, Christine C.; Carneiro, Raquel M.; Tedesco, Mary Beth; Laslavic, Angela; Sereika, Susan M.; Bisello, Alessandro; Garcia-Ocana, Adolfo; Gundberg, Caren M.; Cauley, Jane A.; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2266-2276</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Parathyroid hormone-related protein (PTHrP)(1-36) increases lumbar spine (LS) bone mineral d. (BMD), acting as an anabolic agent when injected intermittently, but it has not been directly compared with parathyroid hormone (PTH)(1-34).  We performed a 3-mo randomized, prospective study in 105 postmenopausal women with low bone d. or osteoporosis, comparing daily s.c. injections of PTHrP(1-36) to PTH(1-34).  Thirty-five women were randomized to each of three groups: PTHrP(1-36) 400 μg/day; PTHrP(1-36) 600 μg/day; and PTH(1-34) 20 μg/day.  The primary outcome measures were changes in amino-terminal telopeptides of procollagen 1 (PINP) and carboxy-terminal telopeptides of collagen 1 (CTX).  Secondary measures included safety parameters, 1,25(OH)2 vitamin D, and BMD.  The increase in bone resorption (CTX) by PTH(1-34) (92%) (p < 0.005) was greater than for PTHrP(1-36) (30%) (p < 0.05).  PTH(1-34) also increased bone formation (PINP) (171%) (p < 0.0005) more than either dose of PTHrP(1-36) (46% and 87%).  The increase in PINP was earlier (day 15) and greater than the increase in CTX for all three groups.  LS BMD increased equivalently in each group (p < 0.05 for all).  Total hip (TH) and femoral neck (FN) BMD increased equivalently in each group but were only significant for the two doses of PTHrP(1-36) (p < 0.05) at the TH and for PTHrP(1-36) 400 (p < 0.05) at the FN.  PTHrP(1-36) 400 induced mild, transient (day 15) hypercalcemia.  PTHrP(1-36) 600 required a dose redn. for hypercalcemia in three subjects.  PTH(1-34) was not assocd. with hypercalcemia.  Each peptide induced a marked biphasic increase in 1,25(OH)2D.  Adverse events (AE) were similar among the three groups.  This study demonstrates that PTHrP(1-36) and PTH(1-34) cause similar increases in LS BMD.  PTHrP(1-36) also increased hip BMD.  PTH(1-34) induced greater changes in bone turnover than PTHrP(1-36).  PTHrP(1-36) was assocd. with mild transient hypercalcemia.  Longer-term studies using lower doses of PTHrP(1-36) are needed to define both the optimal dose and full clin. benefits of PTHrP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq840iCWuvr1bVg90H21EOLACvtfcHk0lixx5Lk_GXd1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr3E&md5=e4f7b775087b7345cb48e09239bbe128</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.1978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.1978%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DM.%2BJ.%26aulast%3DAugustine%26aufirst%3DM.%26aulast%3DKahn%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DOakley%26aufirst%3DC.%2BC.%26aulast%3DCarneiro%26aufirst%3DR.%2BM.%26aulast%3DTedesco%26aufirst%3DM.%2BB.%26aulast%3DLaslavic%26aufirst%3DA.%26aulast%3DSereika%26aufirst%3DS.%2BM.%26aulast%3DBisello%26aufirst%3DA.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DGundberg%26aufirst%3DC.%2BM.%26aulast%3DCauley%26aufirst%3DJ.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520comparison%2520of%2520parathyroid%2520hormone-related%2520protein%2520%25281-36%2529%2520and%2520parathyroid%2520hormone%2520%25281-34%2529%2520on%2520markers%2520of%2520bone%2520turnover%2520and%2520bone%2520density%2520in%2520postmenopausal%2520women%253A%2520the%2520PrOP%2520study%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2013%26volume%3D28%26issue%3D11%26spage%3D2266%26epage%3D2276%26doi%3D10.1002%2Fjbmr.1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Pioszak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x"> (</span><span class="NLM_issue">41</span><span class="NLM_x">) </span> <span class="NLM_fpage">28382</span><span class="NLM_x">–</span> <span class="NLM_lpage">28391</span><span class="refDoi"> DOI: 10.1074/jbc.M109.022905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1074%2Fjbc.M109.022905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=28382-28391&issue=41&author=A.+A.+Pioszakauthor=N.+R.+Parkerauthor=T.+J.+Gardellaauthor=H.+E.+Xu&title=Structural+basis+for+parathyroid+hormone-related+protein+binding+to+the+parathyroid+hormone+receptor+and+design+of+conformation-selective+peptides&doi=10.1074%2Fjbc.M109.022905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.022905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.022905%26sid%3Dliteratum%253Aachs%26aulast%3DPioszak%26aufirst%3DA.%2BA.%26aulast%3DParker%26aufirst%3DN.%2BR.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520parathyroid%2520hormone-related%2520protein%2520binding%2520to%2520the%2520parathyroid%2520hormone%2520receptor%2520and%2520design%2520of%2520conformation-selective%2520peptides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D41%26spage%3D28382%26epage%3D28391%26doi%3D10.1074%2Fjbc.M109.022905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Shimizu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyashiki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayasu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, Y.</span><span> </span><span class="NLM_article-title">Pharmacodynamic actions of a long-acting PTH analog (LA-PTH) in thyroparathyroidectomized (TPTX) rats and normal monkeys</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.1002/jbmr.2811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjbmr.2811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=26865415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSisr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=1405-1412&issue=7&author=M.+Shimizuauthor=E.+Joyashikiauthor=H.+Nodaauthor=T.+Watanabeauthor=M.+Okazakiauthor=M.+Nagayasuauthor=K.+Adachiauthor=T.+Tamuraauthor=J.+T.+Pottsauthor=T.+J.+Gardellaauthor=Y.+Kawabe&title=Pharmacodynamic+actions+of+a+long-acting+PTH+analog+%28LA-PTH%29+in+thyroparathyroidectomized+%28TPTX%29+rats+and+normal+monkeys&doi=10.1002%2Fjbmr.2811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys</span></div><div class="casAuthors">Shimizu, Masaru; Joyashiki, Eri; Noda, Hiroshi; Watanabe, Tomoyuki; Okazaki, Makoto; Nagayasu, Miho; Adachi, Kenji; Tamura, Tatsuya; Potts, John T., Jr.; Gardella, Thomas J.; Kawabe, Yoshiki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1405-1412</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hypoparathyroidism is a disease of chronic hypocalcemia and hyperphosphatemia due to a deficiency of parathyroid hormone (PTH).  PTH and analogs of the hormone are of interest as potential therapies.  Accordingly, we examd. the pharmacol. properties of a long-acting PTH analog, [Ala1,3,12,18,22, Gln10,Arg11,Trp14,Lys26]-PTH(1-14)/PTHrP(15-36) (LA-PTH) in thyroparathyroidectomized (TPTX) rats, a model of HP, as well as in normal monkeys.  In TPTX rats, a single i.v. administration of LA-PTH at a dose of 0.9 nmol/kg increased serum calcium (sCa) and decreased serum phosphate (sPi) to near-normal levels for longer than 48 h, whereas PTH(1-34) and PTH(1-84), each injected at a dose 80-fold higher than that used for LA-PTH, increased sCa and decreased sPi only modestly and transiently (<6 h).  LA-PTH also exhibited enhanced and prolonged efficacy vs. PTH(1-34) and PTH(1-84) for elevating sCa when administered s.c. (s.c.) into monkeys.  Daily s.c. administration of LA-PTH (1.8 nmol/kg) into TPTX rats for 28 days elevated sCa to near normal levels without causing hypercalciuria or increasing bone resorption markers, a desirable goal in the treatment of hypoparathyroidism.  The results are supportive of further study of long-acting PTH analogs as potential therapies for patients with hypoparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRFGGixnuSILVg90H21EOLACvtfcHk0ljfAHrQ-phdYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSisr3N&md5=9e32912223b6ab446f7e15a7f0a1d65a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.2811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.2811%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DJoyashiki%26aufirst%3DE.%26aulast%3DNoda%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DM.%26aulast%3DNagayasu%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DPotts%26aufirst%3DJ.%2BT.%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DKawabe%26aufirst%3DY.%26atitle%3DPharmacodynamic%2520actions%2520of%2520a%2520long-acting%2520PTH%2520analog%2520%2528LA-PTH%2529%2520in%2520thyroparathyroidectomized%2520%2528TPTX%2529%2520rats%2520and%2520normal%2520monkeys%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2016%26volume%3D31%26issue%3D7%26spage%3D1405%26epage%3D1412%26doi%3D10.1002%2Fjbmr.2811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Varela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouinard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesage, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattersley, G.</span><span> </span><span class="NLM_article-title">One year of abaloparatide, a selective activator of the PTH1 receptor, increased bone formation and bone mass in osteopenic ovariectomized rats without increasing bone resorption</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1002/jbmr.3003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjbmr.3003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=27748532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Cjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=24-33&issue=1&author=A.+Varelaauthor=L.+Chouinardauthor=E.+Lesageauthor=S.+Y.+Smithauthor=G.+Hattersley&title=One+year+of+abaloparatide%2C+a+selective+activator+of+the+PTH1+receptor%2C+increased+bone+formation+and+bone+mass+in+osteopenic+ovariectomized+rats+without+increasing+bone+resorption&doi=10.1002%2Fjbmr.3003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption</span></div><div class="casAuthors">Varela, Aurore; Chouinard, Luc; Lesage, Elisabeth; Smith, Susan Y.; Hattersley, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-33</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Abaloparatide is a novel 34-amino acid peptide selected to be a potent and selective activator of the parathyroid hormone receptor (PTH1R) signaling pathway with 41% homol. to PTH(1-34) and 76% homol. to PTHrP(1-34).  A 12-mo treatment study was conducted in osteopenic ovariectomized (OVX) rats to characterize the mechanisms by which abaloparatide increases bone mass.  Sprague-Dawley (SD) rats were subjected to OVX or sham surgery at age 6 mo and left untreated for 3 mo to allow OVX-induced bone loss.  Ten OVX rats were euthanized after this bone depletion period, and the remaining OVX rats received daily s.c. injections of vehicle (n = 18) or abaloparatide at 1, 5, or 25 μg/kg/d (n = 18/dose level) for 12 mo.  Sham controls (n = 18) received vehicle daily.  Bone densitometry and biochem. markers of bone formation and resorption were assessed longitudinally, and L3 vertebra and tibia were collected at necropsy for histomorphometry.  Abaloparatide increased biochem. bone formation markers without increasing bone resorption markers or causing hypercalcemia.  Abaloparatide increased histomorphometric indexes of bone formation on trabecular, endocortical, and periosteal surfaces without increasing osteoclasts or eroded surfaces.  Abaloparatide induced substantial increases in trabecular bone vol. and d. and improvements in trabecular microarchitecture.  Abaloparatide stimulated periosteal expansion and endocortical bone apposition at the tibial diaphysis, leading to marked increases in cortical bone vol. and d.  Whole-body bone mineral d. (BMD) remained stable in OVX-Vehicle controls while increasing 25% after 12 mo of abaloparatide (25 μg/kg).  Histomorphometry and biomarker data suggest that gains in cortical and trabecular bone mass were attributable to selective anabolic effects of abaloparatide, without evidence for stimulated bone resorption. © 2016 American Society for Bone and Mineral Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZHU1bwilJ37Vg90H21EOLACvtfcHk0ljfAHrQ-phdYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Cjuw%253D%253D&md5=e3f5736a0ccdef9f1debaec8351532bb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.3003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.3003%26sid%3Dliteratum%253Aachs%26aulast%3DVarela%26aufirst%3DA.%26aulast%3DChouinard%26aufirst%3DL.%26aulast%3DLesage%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DS.%2BY.%26aulast%3DHattersley%26aufirst%3DG.%26atitle%3DOne%2520year%2520of%2520abaloparatide%252C%2520a%2520selective%2520activator%2520of%2520the%2520PTH1%2520receptor%252C%2520increased%2520bone%2520formation%2520and%2520bone%2520mass%2520in%2520osteopenic%2520ovariectomized%2520rats%2520without%2520increasing%2520bone%2520resorption%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D24%26epage%3D33%26doi%3D10.1002%2Fjbmr.3003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Leder, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dea, L. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchetta, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyttle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattersley, G.</span><span> </span><span class="NLM_article-title">Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1210/jc.2014-3718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1210%2Fjc.2014-3718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=25393645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=697-706&issue=2&author=B.+Z.+Lederauthor=L.+S.+L.+O%E2%80%99Deaauthor=J.+R.+Zanchettaauthor=P.+Kumarauthor=K.+Banksauthor=K.+McKayauthor=C.+R.+Lyttleauthor=G.+Hattersley&title=Effects+of+abaloparatide%2C+a+human+parathyroid+hormone-related+peptide+analog%2C+on+bone+mineral+density+in+postmenopausal+women+with+osteoporosis&doi=10.1210%2Fjc.2014-3718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis</span></div><div class="casAuthors">Leder, Benjamin Z.; O'Dea, Louis St. L.; Zanchetta, Jose R.; Kumar, Prasana; Banks, Kathleen; McKay, Kathleen; Lyttle, C. Richard; Hattersley, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">697-706</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Abaloparatide is a novel synthetic peptide analog of parathyroid hormone-related protein (PTHrP) that is currently being developed as a potential anabolic agent in the treatment of postmenopausal osteoporosis.  Objective: This study sought to assess the effects of abaloparatide on bone mineral d. (BMD) at the lumbar spine, total hip, and femoral neck in postmenopausal women with osteoporosis.  Design: Multi-center, multi-national, double-blind placebo controlled trial in which postmenopausal women were randomly assigned to receive 24 wk of treatment with daily s.c. injections of placebo, abaloparatide, 20, 40, or 80 μg, or teriparatide, 20 μg.  A 24-wk extension was also performed in a subset of subjects.  Participants: Postmenopausal women with osteoporosis (n = 222).  Main Outcome Measures: BMD by dual-x-ray absorptiometry and biochem. markers of bone turnover.  Results: At 24 wk, lumbar spine BMD increased by 2.9, 5.2, and 6.7% in the abaloparatide, 20-, 40-, and 80-μg groups, resp., and 5.5% in the teriparatide group.  The increases in the 40- and 80-μg abaloparatide groups and the teriparatide group were significantly greater than placebo (1.6%).  Femoral neck BMD increased by 2.7, 2.2, and 3.1% in abaloparatide, 20-, 40-, and 80-μg groups, resp., and 1.1% in the teriparatide group.  The increase in femoral neck BMD with abaloparatide, 80 μg was significantly greater than placebo (0.8%).  Total hip BMD increased by 1.4, 2.0, and 2.6% in the abaloparatide, 20-, 40-, and 80-μg groups, resp.  The total hip increases in the 40- and 80-μg abaloparatide groups were greater than both placebo (0.4%) and teriparatide (0.5%).  Conclusions: Compared with placebo, 24 wk of daily s.c. abaloparatide increases BMD of the lumbar spine, femoral neck, and total hip in a dose-dependent fashion.  Moreover, the abaloparatide-induced BMD increases at the total hip are greater than with the marketed dose of teriparatide.  These results support the further investigation of abaloparatide as an anabolic therapy in postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMfmPAtEaEK7Vg90H21EOLACvtfcHk0lizahGuulmJ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVWqtLw%253D&md5=a9f9c6fca641f9dc8fd589e69af02f91</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1210%2Fjc.2014-3718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2014-3718%26sid%3Dliteratum%253Aachs%26aulast%3DLeder%26aufirst%3DB.%2BZ.%26aulast%3DO%25E2%2580%2599Dea%26aufirst%3DL.%2BS.%2BL.%26aulast%3DZanchetta%26aufirst%3DJ.%2BR.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DBanks%26aufirst%3DK.%26aulast%3DMcKay%26aufirst%3DK.%26aulast%3DLyttle%26aufirst%3DC.%2BR.%26aulast%3DHattersley%26aufirst%3DG.%26atitle%3DEffects%2520of%2520abaloparatide%252C%2520a%2520human%2520parathyroid%2520hormone-related%2520peptide%2520analog%252C%2520on%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26issue%3D2%26spage%3D697%26epage%3D706%26doi%3D10.1210%2Fjc.2014-3718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Plum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, J. B.</span><span> </span><span class="NLM_article-title">In vitro protein binding of liraglutide in human plasma determined by reiterated stepwise equilibrium dialysis</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2882</span><span class="NLM_x">–</span> <span class="NLM_lpage">2888</span><span class="refDoi"> DOI: 10.1002/jps.23648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1002%2Fjps.23648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23853127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=2882-2888&issue=8&author=A.+Plumauthor=L.+B.+Jensenauthor=J.+B.+Kristensen&title=In+vitro+protein+binding+of+liraglutide+in+human+plasma+determined+by+reiterated+stepwise+equilibrium+dialysis&doi=10.1002%2Fjps.23648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro protein binding of liraglutide in human plasma determined by reiterated stepwise equilibrium dialysis</span></div><div class="casAuthors">Plum, Anne; Jensen, Lisbeth Bjerring; Kristensen, Jesper Boggild</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2882-2888</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Liraglutide is a human glucagon-like peptide-1 (GLP-1) analog approved for the treatment of type 2 diabetes.  It is based on human GLP-1 with the addn. of a 16-carbon fatty acid, which facilitates binding to plasma proteins, thus prolonging the elimination half-life and allowing once-daily administration.  It has not been possible to quantify liraglutide protein binding by ultrafiltration (the usual method of choice), as the lipophilic mol. becomes trapped in the filter membrane.  Therefore, the aim of this study was to develop a methodol. that could det. the extent of liraglutide binding to plasma proteins in vitro.  We report here the details of a novel reiterated stepwise equil. dialysis assay that has successfully been used to quantify liraglutide plasma protein binding.  The assay allowed quantification of liraglutide binding to proteins in purified plasma protein solns. and human plasma samples and was effective at plasma dilns. as low as 5%.  At a clin. relevant liraglutide concn. (104 pM), greater than 98.9% of liraglutide was bound to protein.  Specific binding to human serum albumin and α1-acid glycoprotein was 99.4% and 99.3%, resp.  The novel methodol. described herein could have an application in the quantification of plasma protein binding of other highly lipophilic drug mols. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYNomc4wEpbbVg90H21EOLACvtfcHk0lizahGuulmJ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsbrL&md5=6e2ea60f185c85351f3d46a5f17421ed</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fjps.23648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23648%26sid%3Dliteratum%253Aachs%26aulast%3DPlum%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DL.%2BB.%26aulast%3DKristensen%26aufirst%3DJ.%2BB.%26atitle%3DIn%2520vitro%2520protein%2520binding%2520of%2520liraglutide%2520in%2520human%2520plasma%2520determined%2520by%2520reiterated%2520stepwise%2520equilibrium%2520dialysis%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26issue%3D8%26spage%3D2882%26epage%3D2888%26doi%3D10.1002%2Fjps.23648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Sturmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagatay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkol, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, W.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of oral recombinant human parathyroid hormone rhPTH(1-31)NH2 in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1007/s40262-013-0083-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1007%2Fs40262-013-0083-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=23719683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=995-1004&issue=11&author=A.+Sturmerauthor=N.+Mehtaauthor=J.+Giacchiauthor=T.+Cagatayauthor=R.+Tavakkolauthor=S.+Mittaauthor=L.+Fitzpatrickauthor=J.+Waldauthor=J.+Trangauthor=W.+Stern&title=Pharmacokinetics+of+oral+recombinant+human+parathyroid+hormone+rhPTH%281-31%29NH2+in+postmenopausal+women+with+osteoporosis&doi=10.1007%2Fs40262-013-0083-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1-31)NH2] in Postmenopausal Women with Osteoporosis</span></div><div class="casAuthors">Sturmer, Amy; Mehta, Nozer; Giacchi, Jenna; Cagatay, Tulin; Tavakkol, Roxanne; Mitta, Sheela; Fitzpatrick, Lorraine; Wald, Jeff; Trang, John; Stern, William</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">995-1004</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives Teriparatide [rhPTH(1-34)OH] is a s.c. administered bone anabolic drug that increases bone mineral d. (BMD) and reduces the risk of osteoporotic fracture.  Because rhPTH(1-34)OH is administered by injection, oral delivery is a desirable alternative.  However, the peroral delivery of peptides is challenging due to their susceptibility to protease digestion and low permeability through the intestinal layers.  The objective of this study was to assess the pharmacokinetics of a PTH analog (rhPTH(1-31)NH2) in a novel oral tablet formulation and to compare them to s.c. administered teriparatide in postmenopausal osteoporotic women in a phase 2 proof-of-concept clin. study.  Methods This was a 24-wk repeat-dose, randomized, double blind, parallel group phase 2 study with three once-daily treatment arms: oral rhPTH(1-31)NH2 tablets (5 mg), matching placebo tablets, and open-label teriparatide (20 μg daily s.c. injection).  The primary endpoint of this study was to assess the change in lumbar spine BMD of orally administered rhPTH(1-31)NH2 tablets compared to baseline.  This study was conducted at three sites in Denmark and at one site in Estonia.  The patients included were women diagnosed with postmenopausal osteoporosis as detected by lumbar spine dual-energy X-ray absorptiometry, with exclusion of those with prior treatment with bone-active agents.  The study treatment consisted of orally formulated recombinant human PTH(1-31)NH2, placebo, or s.c. teriparatide as an active comparator.  Results The pharmacokinetic profile at first and last dose was evaluated and correlated with the primary endpoint, which was to characterize the percent change from baseline in BMD of the lumbar spine after 24 wk of once daily treatment with rhPTH(1-31)NH2.  The pharmacokinetic profile for the tablets showed a pulsatile peak with durations of at least 1 h but less than 5 h, which is consistent with the requirement for bone anabolic activity.  The mean max. (peak) plasma drug concn. (Cmax) values for patients receiving tablets at week 0 (n = 32) and week 24 (n = 28) were 295 and 207 pg/mL, resp.  The mean time to reach max. (peak) plasma concn. following drug administration (tmax) for both week 0 and week 24 was 3.25 h.  The mean area under the concn.-time curve (AUC) for week 0 and week 24 was 178 and 141 pg·h/mL, resp.  No significant differences were obsd. between weeks 0 and 24 in any pharmacokinetic parameters tested, demonstrating good reproducibility, no time-dependent changes, and little or no accumulation of the study drug.  The systemic exposure as measured by Cmax values was higher for the oral tablets formulation than for s.c. teriparatide.  Conclusions The obsd. data demonstrate that the enteric-coated tablet formulation technol. was able to generate consistently robust and pulsatile levels of exposure of rhPTH(1-31)NH2.  There was no apparent correlation between higher exposures and adverse events, even though the pharmacokinetic variability was somewhat higher with the tablets.  These pos. results recommend this orally delivered drug candidate for further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof4v0PbF9YmrVg90H21EOLACvtfcHk0lizahGuulmJ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtr3J&md5=ae35a7d88b5c1e74571218518a5cff30</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs40262-013-0083-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-013-0083-4%26sid%3Dliteratum%253Aachs%26aulast%3DSturmer%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DN.%26aulast%3DGiacchi%26aufirst%3DJ.%26aulast%3DCagatay%26aufirst%3DT.%26aulast%3DTavakkol%26aufirst%3DR.%26aulast%3DMitta%26aufirst%3DS.%26aulast%3DFitzpatrick%26aufirst%3DL.%26aulast%3DWald%26aufirst%3DJ.%26aulast%3DTrang%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DW.%26atitle%3DPharmacokinetics%2520of%2520oral%2520recombinant%2520human%2520parathyroid%2520hormone%2520rhPTH%25281-31%2529NH2%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26issue%3D11%26spage%3D995%26epage%3D1004%26doi%3D10.1007%2Fs40262-013-0083-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Guo, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M. X.</span><span> </span><span class="NLM_article-title">Preliminary evaluation of a novel oral delivery system for rhPTH1-34: In vitro and in vivo</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2011.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.ijpharm.2011.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=21888960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWmt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2011&pages=172-179&issue=1&author=L.+T.+Guoauthor=E.+L.+Maauthor=H.+W.+Zhaoauthor=Y.+F.+Longauthor=C.+X.+Zhengauthor=M.+X.+Duan&title=Preliminary+evaluation+of+a+novel+oral+delivery+system+for+rhPTH1-34%3A+In+vitro+and+in+vivo&doi=10.1016%2Fj.ijpharm.2011.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary evaluation of a novel oral delivery system for rhPTH1-34: In vitro and in vivo</span></div><div class="casAuthors">Guo, Liting; Ma, Erli; Zhao, Haiwei; Long, Yingfang; Zheng, Changxue; Duan, Mingxing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-179</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RhPTH1-34 is clin. used for osteoporosis treatment.  However, this peptide drug has no oral bioavailability because of proteolysis and low membrane permeability in gastrointestinal gut.  This study explored the possibility of absorption enhancement for rhPTH1-34 through the oral delivery of the microemulsion.  The microemulsion (85:15, oil/water) consisting of Labrasol, Crodamol GTCC, Solutol HS 15, D-α-tocopheryl acetate (6:2:1:1, wt./wt.) and saline water was developed and characterized, including particle size, morphol., drug loading efficiency and permeability, stability, and pharmacokinetics.  The microemulsion showed high drug loading efficiency (83%) and permeability, and significantly higher resistance to proteolysis in vitro study.  The relative oral bioavailability was 5.4% and 12.0% when delivered to gastric and ileum.  Besides, osteoporosis rats were induced and treated with oral rhPTH1-34 microemulsion (0.05 mg/kg), injection (0.01 mg/kg) and vehicle, resp., for 8 wk.  The proximal tibia bone mineral content and d. in oral rats (0.188 ± 0.008 g, 0.283 ± 0.014 g/cm2) was significantly increased compared to the control rats (0.169 ± 0.006 g, 0.266 ± 0.011 g/cm2), reaching to the sham rats.  And the proximal tibia microstructure of oral rats was improved greatly, approaching sham level too.  These findings revealed that oral microemulsion may represent an effective oral delivery system for rhPTH1-34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQly38MUAdrVg90H21EOLACvtfcHk0lg9MrWKaTkBdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWmt77L&md5=5a3453aa28d635d8fba9d67b8da5f52e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2011.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2011.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DL.%2BT.%26aulast%3DMa%26aufirst%3DE.%2BL.%26aulast%3DZhao%26aufirst%3DH.%2BW.%26aulast%3DLong%26aufirst%3DY.%2BF.%26aulast%3DZheng%26aufirst%3DC.%2BX.%26aulast%3DDuan%26aufirst%3DM.%2BX.%26atitle%3DPreliminary%2520evaluation%2520of%2520a%2520novel%2520oral%2520delivery%2520system%2520for%2520rhPTH1-34%253A%2520In%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D420%26issue%3D1%26spage%3D172%26epage%3D179%26doi%3D10.1016%2Fj.ijpharm.2011.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Leone-Bay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarubbi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughman, R. A.</span><span> </span><span class="NLM_article-title">Oral delivery of biologically active parathyroid hormone</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">964</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1023/A:1010936227570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1023%2FA%3A1010936227570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=964-970&issue=7&author=A.+Leone-Bayauthor=M.+Satoauthor=D.+Patonauthor=A.+H.+Huntauthor=D.+Sarubbiauthor=M.+Carozzaauthor=J.+Chouauthor=J.+McDonoughauthor=R.+A.+Baughman&title=Oral+delivery+of+biologically+active+parathyroid+hormone&doi=10.1023%2FA%3A1010936227570"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010936227570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010936227570%26sid%3Dliteratum%253Aachs%26aulast%3DLeone-Bay%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DPaton%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DA.%2BH.%26aulast%3DSarubbi%26aufirst%3DD.%26aulast%3DCarozza%26aufirst%3DM.%26aulast%3DChou%26aufirst%3DJ.%26aulast%3DMcDonough%26aufirst%3DJ.%26aulast%3DBaughman%26aufirst%3DR.%2BA.%26atitle%3DOral%2520delivery%2520of%2520biologically%2520active%2520parathyroid%2520hormone%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26issue%3D7%26spage%3D964%26epage%3D970%26doi%3D10.1023%2FA%3A1010936227570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Hammerle, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mindeholm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harfst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, M. R.</span><span> </span><span class="NLM_article-title">The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span><span class="refDoi"> DOI: 10.1016/j.bone.2012.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.bone.2012.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=965-973&issue=4&author=S.+P.+Hammerleauthor=L.+Mindeholmauthor=A.+Launonenauthor=B.+Kieseauthor=R.+Loefflerauthor=E.+Harfstauthor=M.+Azriaauthor=M.+Arnoldauthor=M.+R.+John&title=The+single+dose+pharmacokinetic+profile+of+a+novel+oral+human+parathyroid+hormone+formulation+in+healthy+postmenopausal+women&doi=10.1016%2Fj.bone.2012.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2012.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2012.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DHammerle%26aufirst%3DS.%2BP.%26aulast%3DMindeholm%26aufirst%3DL.%26aulast%3DLaunonen%26aufirst%3DA.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DLoeffler%26aufirst%3DR.%26aulast%3DHarfst%26aufirst%3DE.%26aulast%3DAzria%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DM.%26aulast%3DJohn%26aufirst%3DM.%2BR.%26atitle%3DThe%2520single%2520dose%2520pharmacokinetic%2520profile%2520of%2520a%2520novel%2520oral%2520human%2520parathyroid%2520hormone%2520formulation%2520in%2520healthy%2520postmenopausal%2520women%26jtitle%3DBone%26date%3D2012%26volume%3D50%26issue%3D4%26spage%3D965%26epage%3D973%26doi%3D10.1016%2Fj.bone.2012.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Leone-Bay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lercara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Toole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gschneidner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVincent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercogliano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipold, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughman, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span><span class="refDoi"> DOI: 10.1021/jm970811m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970811m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1163-1171&issue=7&author=A.+Leone-Bayauthor=D.+R.+Patonauthor=J.+Freemanauthor=C.+Lercaraauthor=D.+O%E2%80%99Tooleauthor=D.+Gschneidnerauthor=E.+Wangauthor=E.+Harrisauthor=C.+Rosadoauthor=T.+Riveraauthor=A.+DeVincentauthor=M.+Taiauthor=F.+Mercoglianoauthor=R.+Agarwalauthor=H.+Leipoldauthor=R.+A.+Baughman&title=Synthesis+and+evaluation+of+compounds+that+facilitate+the+gastrointestinal+absorption+of+heparin&doi=10.1021%2Fjm970811m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm970811m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970811m%26sid%3Dliteratum%253Aachs%26aulast%3DLeone-Bay%26aufirst%3DA.%26aulast%3DPaton%26aufirst%3DD.%2BR.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DLercara%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DD.%26aulast%3DGschneidner%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DE.%26aulast%3DRosado%26aufirst%3DC.%26aulast%3DRivera%26aufirst%3DT.%26aulast%3DDeVincent%26aufirst%3DA.%26aulast%3DTai%26aufirst%3DM.%26aulast%3DMercogliano%26aufirst%3DF.%26aulast%3DAgarwal%26aufirst%3DR.%26aulast%3DLeipold%26aufirst%3DH.%26aulast%3DBaughman%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520compounds%2520that%2520facilitate%2520the%2520gastrointestinal%2520absorption%2520of%2520heparin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D7%26spage%3D1163%26epage%3D1171%26doi%3D10.1021%2Fjm970811m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Bray, B. L.</span><span> </span><span class="NLM_article-title">Large-scale manufacture of peptide therapeutics by chemical synthesis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span><span class="refDoi"> DOI: 10.1038/nrd1133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1038%2Fnrd1133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=12815383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=587-593&issue=7&author=B.+L.+Bray&title=Large-scale+manufacture+of+peptide+therapeutics+by+chemical+synthesis&doi=10.1038%2Fnrd1133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Innovation: Large-scale manufacture of peptide therapeutics by chemical synthesis</span></div><div class="casAuthors">Bray, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">587-593</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The large-scale com. prodn. of a 36-amino-acid peptide by chem. synthesis has been demonstrated in the development of enfuvirtide (T-20 or Fuzeon), a first-in-class membrane fusion inhibitor for the treatment of HIV.  The rationale behind route selection and the scale-up of the process used to manuf. enfuvirtide are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq23FtVAsqBerVg90H21EOLACvtfcHk0lj9YX-I3JHMag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr4%253D&md5=cd8a087455cf8058855d84076bc75927</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnrd1133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1133%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DB.%2BL.%26atitle%3DLarge-scale%2520manufacture%2520of%2520peptide%2520therapeutics%2520by%2520chemical%2520synthesis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D7%26spage%3D587%26epage%3D593%26doi%3D10.1038%2Fnrd1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Hartman, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josephson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szostak, J. W.</span><span> </span><span class="NLM_article-title">Enzymatic aminoacylation of tRNA with unnatural amino acids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4361</span><span class="refDoi"> DOI: 10.1073/pnas.0509219103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1073%2Fpnas.0509219103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=16537388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjt1Kjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=4356-4361&issue=12&author=M.+C.+T.+Hartmanauthor=K.+Josephsonauthor=J.+W.+Szostak&title=Enzymatic+aminoacylation+of+tRNA+with+unnatural+amino+acids&doi=10.1073%2Fpnas.0509219103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic aminoacylation of tRNA with unnatural amino acids</span></div><div class="casAuthors">Hartman, Matthew C. T.; Josephson, Kristopher; Szostak, Jack W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4356-4361</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The biochem. flexibility of the cellular translation app. offers, in principle, a simple route to the synthesis of drug-like modified peptides and novel biopolymers.  However, only ≈ 75 unnatural building blocks are known to be fully compatible with enzymic tRNA acylation and subsequent ribosomal synthesis of modified peptides.  Although the translation system can reject substrate analogs at several steps along the pathway to peptide synthesis, much of the specificity resides at the level of the aminoacyl-tRNA synthetase (AARS) enzymes that are responsible for charging tRNAs with amino acids.  The authors have developed an AARS assay based on mass spectrometry that can be used to rapidly identify unnatural monomers that can be enzymically charged onto tRNA.  By using this assay, the authors have found 59 previously unknown AARS substrates.  These include numerous side-chain analogs with useful functional properties.  Remarkably, many β-amino acids, N-Me amino acids, and α,α-disubstituted amino acids are also AARS substrates.  These previously unidentified AARS substrates will be useful in studies of the specificity of subsequent steps in translation and may significantly expand the no. of analogs that can be used for the ribosomal synthesis of modified peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnEHUjtOS17Vg90H21EOLACvtfcHk0lj9YX-I3JHMag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjt1Kjsbg%253D&md5=52776e7a3eb8e6c37e1d49de7bdc404c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0509219103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0509219103%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DM.%2BC.%2BT.%26aulast%3DJosephson%26aufirst%3DK.%26aulast%3DSzostak%26aufirst%3DJ.%2BW.%26atitle%3DEnzymatic%2520aminoacylation%2520of%2520tRNA%2520with%2520unnatural%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D12%26spage%3D4356%26epage%3D4361%26doi%3D10.1073%2Fpnas.0509219103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Site-specific incorporation of novel backbone structures into proteins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x"> (</span><span class="NLM_issue">5041</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1126/science.1553546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1126%2Fscience.1553546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1553546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=1%3ACAS%3A528%3ADyaK38Xht1ensbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1992&pages=197-200&issue=5041&author=J.+A.+Ellmanauthor=D.+Mendelauthor=P.+G.+Schultz&title=Site-specific+incorporation+of+novel+backbone+structures+into+proteins&doi=10.1126%2Fscience.1553546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific incorporation of novel backbone structures into proteins</span></div><div class="casAuthors">Ellman, Jonathan A.; Mendel, David; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">5041</span>),
    <span class="NLM_cas:pages">197-200</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A no. of unnatural amino acids and amino acid analogs with modified backbone structures were substituted for alanine-82 in T4 lysozyme.  Replacements included α,α-disubstituted amino acids, N-alkyl amino acids, and lactic acid, an isoelectronic analog of alanine.  The effects of these electronic and structural perturbations on the stability of T4 lysozyme were detd.  The relatively broad substrate specificity of the Escherichia coli protein biosynthetic machinery suggests that a wide range of backbone and side-chain substitutions can be introduced, allowing a more precise definition of the factors affecting protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1fsNHwxpw0LVg90H21EOLACvtfcHk0liZECpjPLuVSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1ensbs%253D&md5=2892e6efc4a73b93eaf5569ef663dc38</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1126%2Fscience.1553546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1553546%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DMendel%26aufirst%3DD.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSite-specific%2520incorporation%2520of%2520novel%2520backbone%2520structures%2520into%2520proteins%26jtitle%3DScience%26date%3D1992%26volume%3D255%26issue%3D5041%26spage%3D197%26epage%3D200%26doi%3D10.1126%2Fscience.1553546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Tan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklow, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornish, V. W.</span><span> </span><span class="NLM_article-title">Amino acid backbone specificity of the Escherichia coli translation machinery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">40</span><span class="NLM_x">) </span> <span class="NLM_fpage">12752</span><span class="NLM_x">–</span> <span class="NLM_lpage">12753</span><span class="refDoi"> DOI: 10.1021/ja0472174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0472174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=12752-12753&issue=40&author=Z.+P.+Tanauthor=A.+C.+Forsterauthor=S.+C.+Blacklowauthor=V.+W.+Cornish&title=Amino+acid+backbone+specificity+of+the+Escherichia+coli+translation+machinery&doi=10.1021%2Fja0472174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fja0472174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0472174%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DZ.%2BP.%26aulast%3DForster%26aufirst%3DA.%2BC.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DCornish%26aufirst%3DV.%2BW.%26atitle%3DAmino%2520acid%2520backbone%2520specificity%2520of%2520the%2520Escherichia%2520coli%2520translation%2520machinery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D40%26spage%3D12752%26epage%3D12753%26doi%3D10.1021%2Fja0472174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Dedkova, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahmi, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span> </span><span class="NLM_article-title">beta-Puromycin selection of modified ribosomes for in vitro incorporation of beta-amino acids</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1021/bi2016124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2016124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=401-415&issue=1&author=L.+M.+Dedkovaauthor=N.+E.+Fahmiauthor=R.+Paulauthor=M.+del+Rosarioauthor=L.+Zhangauthor=S.+Chenauthor=G.+Federauthor=S.+M.+Hecht&title=beta-Puromycin+selection+of+modified+ribosomes+for+in+vitro+incorporation+of+beta-amino+acids&doi=10.1021%2Fbi2016124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fbi2016124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2016124%26sid%3Dliteratum%253Aachs%26aulast%3DDedkova%26aufirst%3DL.%2BM.%26aulast%3DFahmi%26aufirst%3DN.%2BE.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3Ddel%2BRosario%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeder%26aufirst%3DG.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3Dbeta-Puromycin%2520selection%2520of%2520modified%2520ribosomes%2520for%2520in%2520vitro%2520incorporation%2520of%2520beta-amino%2520acids%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26issue%3D1%26spage%3D401%26epage%3D415%26doi%3D10.1021%2Fbi2016124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Maini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedkova, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcala-Torano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span> </span><span class="NLM_article-title">Incorporation of beta-amino acids into dihydrofolate reductase by ribosomes having modifications in the peptidyltransferase center</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;key=10.1016%2Fj.bmc.2013.01.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1088-1096&issue=5&author=R.+Mainiauthor=D.+T.+Nguyenauthor=S.+X.+Chenauthor=L.+M.+Dedkovaauthor=S.+R.+Chowdhuryauthor=R.+Alcala-Toranoauthor=S.+M.+Hecht&title=Incorporation+of+beta-amino+acids+into+dihydrofolate+reductase+by+ribosomes+having+modifications+in+the+peptidyltransferase+center&doi=10.1016%2Fj.bmc.2013.01.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DD.%2BT.%26aulast%3DChen%26aufirst%3DS.%2BX.%26aulast%3DDedkova%26aufirst%3DL.%2BM.%26aulast%3DChowdhury%26aufirst%3DS.%2BR.%26aulast%3DAlcala-Torano%26aufirst%3DR.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DIncorporation%2520of%2520beta-amino%2520acids%2520into%2520dihydrofolate%2520reductase%2520by%2520ribosomes%2520having%2520modifications%2520in%2520the%2520peptidyltransferase%2520center%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D5%26spage%3D1088%26epage%3D1096%26doi%3D10.1016%2Fj.bmc.2013.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Fujino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span> </span><span class="NLM_article-title">Ribosomal synthesis of peptides with multiple beta-Amino Acids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1962</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span><span class="refDoi"> DOI: 10.1021/jacs.5b12482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b12482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=1962-1969&issue=6&author=T.+Fujinoauthor=Y.+Gotoauthor=H.+Sugaauthor=H.+Murakami&title=Ribosomal+synthesis+of+peptides+with+multiple+beta-Amino+Acids&doi=10.1021%2Fjacs.5b12482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b12482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b12482%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DSuga%26aufirst%3DH.%26aulast%3DMurakami%26aufirst%3DH.%26atitle%3DRibosomal%2520synthesis%2520of%2520peptides%2520with%2520multiple%2520beta-Amino%2520Acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D6%26spage%3D1962%26epage%3D1969%26doi%3D10.1021%2Fjacs.5b12482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Czekster, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepartz, A.</span><span> </span><span class="NLM_article-title">In vivo biosynthesis of a beta-amino acid-containing protein</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5194</span><span class="NLM_x">–</span> <span class="NLM_lpage">5197</span><span class="refDoi"> DOI: 10.1021/jacs.6b01023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b01023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=5194-5197&issue=16&author=C.+M.+Czeksterauthor=W.+E.+Robertsonauthor=A.+S.+Walkerauthor=D.+Sollauthor=A.+Schepartz&title=In+vivo+biosynthesis+of+a+beta-amino+acid-containing+protein&doi=10.1021%2Fjacs.6b01023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b01023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b01023%26sid%3Dliteratum%253Aachs%26aulast%3DCzekster%26aufirst%3DC.%2BM.%26aulast%3DRobertson%26aufirst%3DW.%2BE.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26aulast%3DSoll%26aufirst%3DD.%26aulast%3DSchepartz%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520biosynthesis%2520of%2520a%2520beta-amino%2520acid-containing%2520protein%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D16%26spage%3D5194%26epage%3D5197%26doi%3D10.1021%2Fjacs.6b01023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i25"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00876">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88610"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00876">10.1021/acs.jmedchem.7b00876</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_001.csv">CSV</a>)</p></li><li><p class="inline">Supplementary methods and supplementary Figures 1–17 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_001.csv">jm7b00876_si_001.csv (30.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00876/suppl_file/jm7b00876_si_002.pdf">jm7b00876_si_002.pdf (6.81 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00876&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-21%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00876" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00876" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a5c03fb23cac","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
